1	From	IN	O	from	_	0	SENT_1	[p1l93t785r157b807],
2	the	DT	O	the	det	12	SENT_1	[p1l173t783r214b807],
3	Wellcome	NNP	ORGANIZATION	Wellcome	nn	12	SENT_1	[p1l229t783r358b807],
4	Trust	NNP	ORGANIZATION	Trust	nn	12	SENT_1	[p1l373t785r440b807],
5	Sanger	NNP	ORGANIZATION	Sanger	nn	12	SENT_1	[p1l456t785r545b814],
6	Institute	NNP	ORGANIZATION	Institute	nn	12	SENT_1	[p1l562t785r626b807, p1l90t825r148b848],
7	,	,	O	,	_	0	SENT_1	[p1l562t785r626b807, p1l90t825r148b848],
8	Hinxton	NNP	PERSON	Hinxton	appos	12	SENT_1	[p1l159t823r269b848],
9	,	,	O	,	_	0	SENT_1	[p1l159t823r269b848],
10	Cambridge	NNP	LOCATION	Cambridge	appos	12	SENT_1	[p1l279t821r422b852],
11	(	CD	NUMBER	(	num	12	SENT_1	[p1l433t823r512b852],
12	U.M.	NNP	LOCATION	U.M.	pobj	1	SENT_1	[p1l433t823r512b852],
13	,	,	O	,	_	0	SENT_1	[p1l433t823r512b852],
14	M.R.S.	NNP	O	M.R.S.	appos	12	SENT_1	[p1l524t823r625b852],
15	)	CD	NUMBER	)	num	14	SENT_1	[p1l524t823r625b852],
16	;	:	O	;	_	0	SENT_1	[p1l524t823r625b852],
17	and	CC	O	and	_	0	SENT_1	[p1l91t858r137b882],
18	the	DT	O	the	det	19	SENT_1	[p1l157t858r198b882],
19	Institute	NNP	ORGANIZATION	Institute	conj_and	12	SENT_1	[p1l220t860r327b882],
20	of	IN	ORGANIZATION	of	_	0	SENT_1	[p1l347t858r375b882],
21	Cancer	NNP	ORGANIZATION	Cancer	nn	22	SENT_1	[p1l391t860r481b882],
22	Research	NNP	ORGANIZATION	Research	prep_of	19	SENT_1	[p1l502t858r625b886],
23	,	,	O	,	_	0	SENT_1	[p1l502t858r625b886],
24	Sutton	NNP	PERSON	Sutton	nn	28	SENT_1	[p1l91t898r185b923],
25	,	,	O	,	_	0	SENT_1	[p1l91t898r185b923],
26	Surrey	NNP	LOCATION	Surrey	appos	28	SENT_1	[p1l197t898r279b927],
27	(	CD	NUMBER	(	num	28	SENT_1	[p1l293t898r372b927],
28	U.M.	NNP	LOCATION	U.M.	conj_and	22	SENT_1	[p1l293t898r372b927],
29	,	,	O	,	_	0	SENT_1	[p1l293t898r372b927],
30	M.R.S.	NNP	O	M.R.S.	conj_and	22	SENT_1	[p1l386t898r479b927],
31	)	CD	NUMBER	)	number	32	SENT_1	[p1l386t898r479b927],
32	—	CD	NUMBER	—	num	33	SENT_1	[p1l492t910r523b912],
33	both	DT	O	both	dep	30	SENT_1	[p1l535t896r591b919],
34	in	IN	O	in	_	0	SENT_1	[p1l604t898r625b919],
35	the	DT	O	the	det	37	SENT_1	[p1l90t933r131b957],
36	United	NNP	LOCATION	United	nn	37	SENT_1	[p1l146t933r231b957],
37	Kingdom	NNP	LOCATION	Kingdom	prep_in	33	SENT_1	[p1l249t933r372b964],
38	;	:	O	;	_	0	SENT_1	[p1l249t933r372b964],
39	and	CC	O	and	_	0	SENT_1	[p1l387t933r433b957],
40	St.	NNP	ORGANIZATION	St.	nn	42	SENT_1	[p1l449t935r481b957],
41	Jude	NNP	ORGANIZATION	Jude	nn	42	SENT_1	[p1l492t933r553b963],
42	Children	NNP	ORGANIZATION	Children	poss	49	SENT_1	[p1l567t933r626b957, p1l91t971r169b994],
43	's	POS	ORGANIZATION	's	_	0	SENT_1	[p1l567t933r626b957, p1l91t971r169b994],
44	Research	NNP	ORGANIZATION	Research	nn	49	SENT_1	[p1l184t971r298b994],
45	Hospital	NNP	ORGANIZATION	Hospital	dep	49	SENT_1	[p1l314t971r430b1001],
46	,	,	O	,	_	0	SENT_1	[p1l314t971r430b1001],
47	Memphis	NNP	LOCATION	Memphis	dep	45	SENT_1	[p1l445t971r574b1001],
48	,	,	O	,	_	0	SENT_1	[p1l445t971r574b1001],
49	TN	NN	O	tn	conj_and	22	SENT_1	[p1l586t973r624b994],
50	(	CD	NUMBER	(	num	52	SENT_1	[p1l93t1010r195b1039],
51	j.R.D.	NN	O	j.r.d.	nn	52	SENT_1	[p1l93t1010r195b1039],
52	)	NN	O	)	dep	49	SENT_1	[p1l93t1010r195b1039],
53	.	.	O	.	_	0	SENT_1	[p1l93t1010r195b1039],

1	Address	NN	O	address	_	0	SENT_2	[p1l207t1008r313b1032],
2	reprint	VB	O	reprint	dep	1	SENT_2	[p1l328t1010r414b1039],
3	requests	NNS	O	request	dobj	2	SENT_2	[p1l428t1013r538b1039],
4	to	TO	O	to	_	0	SENT_2	[p1l550t1013r575b1032],
5	Dr.	NNP	O	Dr.	nn	6	SENT_2	[p1l590t1010r625b1032],
6	Stratton	NNP	PERSON	Stratton	prep_to	2	SENT_2	[p1l91t1048r195b1069],
7	at	IN	O	at	_	0	SENT_2	[p1l208t1050r231b1069],
8	Wellcome	NNP	ORGANIZATION	Wellcome	nn	11	SENT_2	[p1l241t1046r370b1069],
9	Trust	NNP	ORGANIZATION	Trust	nn	11	SENT_2	[p1l381t1048r448b1069],
10	Sanger	NNP	ORGANIZATION	Sanger	nn	11	SENT_2	[p1l460t1048r549b1072],
11	Institute	NNP	ORGANIZATION	Institute	prep_at	6	SENT_2	[p1l562t1048r626b1069, p1l90t1150r147b1173],
12	,	,	O	,	_	0	SENT_2	[p1l562t1048r626b1069, p1l90t1150r147b1173],

1	Hinxton	NNP	MISC	Hinxton	nn	3	SENT_3	[p1l158t1147r259b1169],
2	CB10	NNP	MISC	CB10	nn	3	SENT_3	[p1l268t1147r333b1169],
3	ISA	NNP	MISC	ISA	_	0	SENT_3	[p1l342t1147r398b1173],
4	,	,	O	,	_	0	SENT_3	[p1l342t1147r398b1173],
5	United	NNP	ORGANIZATION	United	nn	6	SENT_3	[p1l408t1145r492b1169],
6	kingdom	NN	O	kingdom	appos	3	SENT_3	[p1l503t1134r625b1177],
7	,	,	O	,	_	0	SENT_3	[p1l503t1134r625b1177],
8	or	CC	O	or	_	0	SENT_3	[p1l91t1191r117b1207],
9	at	IN	O	at	advmod	6	SENT_3	[p1l126t1187r149b1207],
10	mrs@sanger.ac.uk	NN	O	mrs@sanger.ac.uk	conj_or	6	SENT_3	[p1l159t1183r410b1214],
11	.	.	O	.	_	0	SENT_3	[p1l159t1183r410b1214],

1	N	NN	MISC	n	nn	3	SENT_4	[p1l93t1321r110b1343],
2	Englj	NNP	MISC	Englj	nn	3	SENT_4	[p1l124t1319r192b1350],
3	Med	NNP	O	Med	_	0	SENT_4	[p1l205t1319r260b1343],
4	2011	CD	DATE	2011	num	3	SENT_4	[p1l271t1321r491b1347],
5	;	:	O	;	_	0	SENT_4	[p1l271t1321r491b1347],
6	364:340	CD	NUMBER	364:340	number	7	SENT_4	[p1l271t1321r491b1347],
7	-50	CD	NUMBER	-50	dep	3	SENT_4	[p1l271t1321r491b1347],
8	.	.	O	.	_	0	SENT_4	[p1l271t1321r491b1347],

1	Copyright	NN	O	copyright	_	0	SENT_5	[p1l91t1361r185b1386],
2	©	CD	NUMBER	©	num	6	SENT_5	[p1l194t1363r215b1384],
3	2011	CD	DATE	2011	num	6	SENT_5	[p1l225t1362r272b1380],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_5	[p1l283t1361r423b1380],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_5	[p1l432t1361r509b1380],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_5	[p1l517t1362r589b1386],
7	.	.	O	.	_	0	SENT_5	[p1l517t1362r589b1386],

1	I	PRP	O	I	_	0	SENT_6	[p1l665t83r667b200],
2	REVIEW	NNP	O	REVIEW	nn	3	SENT_6	[p1l1180t131r1353b157],
3	ARTICLE	NN	O	article	dep	1	SENT_6	[p1l1365t131r1551b157],
4	I	PRP	O	I	dep	1	SENT_6	[p1l2063t83r2065b200],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_7	[p1l1180t275r1354b298],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_7	[p1l1371t275r1548b298],

1	W.	NNP	PERSON	W.	nn	2	SENT_8	[p1l886t318r921b341],
2	Gregory	NNP	PERSON	Gregory	_	0	SENT_8	[p1l932t318r1040b349],
3	Feero	NNP	PERSON	Feero	nn	7	SENT_8	[p1l1051t318r1132b346],
4	,	,	O	,	_	0	SENT_8	[p1l1051t318r1132b346],
5	M.D.	NNP	O	M.D.	appos	7	SENT_8	[p1l1145t318r1218b346],
6	,	,	O	,	_	0	SENT_8	[p1l1145t318r1218b346],
7	Ph.D.	NNP	O	Ph.D.	dep	2	SENT_8	[p1l1231t316r1311b346],
8	,	,	O	,	_	0	SENT_8	[p1l1231t316r1311b346],
9	and	CC	O	and	_	0	SENT_8	[p1l1322t316r1370b341],
10	Alan	NNP	PERSON	Alan	nn	11	SENT_8	[p1l1381t316r1440b341],
11	E.	NNP	PERSON	E.	dep	2	SENT_8	[p1l1453t318r1474b341],
12	Guttmacher	NNP	PERSON	Guttmacher	nn	16	SENT_8	[p1l1486t316r1656b346],
13	,	,	O	,	_	0	SENT_8	[p1l1486t316r1656b346],
14	M.D.	NNP	O	M.D.	appos	16	SENT_8	[p1l1669t318r1742b346],
15	,	,	O	,	_	0	SENT_8	[p1l1669t318r1742b346],
16	Editors	NNP	O	Editors	dep	2	SENT_8	[p1l1755t316r1842b341],

1	Genomics	NNS	O	genomic	_	0	SENT_9	[p1l894t409r1199b463],
2	and	CC	O	and	_	0	SENT_9	[p1l1229t408r1340b463],
3	the	DT	O	the	det	4	SENT_9	[p1l1369t408r1460b462],
4	Continuum	NN	O	continuum	conj_and	1	SENT_9	[p1l1490t409r1835b463],
5	of	IN	O	of	_	0	SENT_9	[p1l1135t490r1205b546],
6	Cancer	NNP	O	Cancer	nn	7	SENT_9	[p1l1222t495r1432b546],
7	Care	NNP	O	Care	prep_of	1	SENT_9	[p1l1459t495r1594b546],

1	Ultan	NNP	PERSON	Ultan	nn	12	SENT_10	[p1l834t614r922b645],
2	McDermott	NNP	PERSON	McDermott	nn	12	SENT_10	[p1l939t617r1144b651],
3	,	,	O	,	_	0	SENT_10	[p1l939t617r1144b651],
4	M.B.	NNP	LOCATION	M.B.	appos	12	SENT_10	[p1l1161t617r1246b651],
5	,	,	O	,	_	0	SENT_10	[p1l1161t617r1246b651],
6	B.S.	NNP	O	B.S.	appos	12	SENT_10	[p1l1263t617r1334b651],
7	,	,	O	,	_	0	SENT_10	[p1l1263t617r1334b651],
8	Ph.D.	NNP	O	Ph.D.	appos	12	SENT_10	[p1l1351t614r1566b654],
9	,	,	O	,	_	0	SENT_10	[p1l1351t614r1566b654],
10	James	NNP	PERSON	James	appos	12	SENT_10	[p1l1351t614r1566b654],
11	R.	NNP	PERSON	R.	nn	12	SENT_10	[p1l1583t617r1610b645],
12	Downing	NNP	PERSON	Downing	_	0	SENT_10	[p1l1627t617r1787b655],
13	,	,	O	,	_	0	SENT_10	[p1l1627t617r1787b655],
14	M.D.	NNP	O	M.D.	dep	12	SENT_10	[p1l1804t617r1894b651],
15	,	,	O	,	_	0	SENT_10	[p1l1804t617r1894b651],

1	and	CC	O	and	dep	4	SENT_11	[p1l1052t663r1111b695],
2	Michael	NNP	PERSON	Michael	nn	4	SENT_11	[p1l1128t663r1258b695],
3	R.	NNP	PERSON	R.	nn	4	SENT_11	[p1l1275t666r1303b694],
4	Stratton	NNP	PERSON	Stratton	_	0	SENT_11	[p1l1317t666r1462b700],
5	,	,	O	,	_	0	SENT_11	[p1l1317t666r1462b700],
6	M.D.	NNP	O	M.D.	nn	8	SENT_11	[p1l1480t666r1570b700],
7	,	,	O	,	_	0	SENT_11	[p1l1480t666r1570b700],
8	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_11	[p1l1587t663r1676b694],
9	.	.	O	.	_	0	SENT_11	[p1l1587t663r1676b694],

1	HE	PRP	O	he	_	0	SENT_12	[p1l782t783r831b805],
2	PROVISION	NNP	O	PROVISION	dep	1	SENT_12	[p1l843t783r1035b805],
3	OF	IN	O	of	_	0	SENT_12	[p1l1048t783r1092b805],
4	THE	DT	O	the	det	7	SENT_12	[p1l1101t783r1174b805],
5	HUMAN	NNP	O	HUMAN	nn	7	SENT_12	[p1l1186t783r1326b805],
6	GENOME	NNP	O	GENOME	nn	7	SENT_12	[p1l1339t783r1495b805],
7	SEQUENCE	NNP	O	SEQUENCE	prep_of	2	SENT_12	[p1l1506t783r1693b812],
8	IN	IN	O	in	_	0	SENT_12	[p1l1705t783r1746b805],
9	20001	CD	NUMBER	20001	prep_in	7	SENT_12	[p1l1759t781r1856b805],
10	SET	NNP	O	SET	dep	1	SENT_12	[p1l1867t783r1927b805],
11	IN	IN	O	in	_	0	SENT_12	[p1l1938t783r1979b805],
12	MOtion	NN	O	motion	prep_in	10	SENT_12	[p1l1992t783r2063b805, p1l781t825r847b855],
13	several	JJ	O	several	amod	14	SENT_12	[p1l865t825r979b855],
14	waves	NNS	O	wave	dep	1	SENT_12	[p1l995t835r1092b855],
15	of	IN	O	of	_	0	SENT_12	[p1l1111t824r1150b855],
16	cancer	NN	O	cancer	nn	17	SENT_12	[p1l1162t835r1271b855],
17	research	NN	O	research	prep_of	14	SENT_12	[p1l1287t825r1437b855],
18	.	.	O	.	_	0	SENT_12	[p1l1287t825r1437b855],

1	The	DT	O	the	det	2	SENT_13	[p1l1456t825r1518b855],
2	identiﬁcation	NN	O	identiﬁcation	nsubj	32	SENT_13	[p1l1536t824r1763b855],
3	of	IN	O	of	_	0	SENT_13	[p1l1781t824r1820b855],
4	an	DT	O	a	det	7	SENT_13	[p1l1830t834r1870b855],
5	essentially	RB	O	essentially	advmod	6	SENT_13	[p1l1889t825r2065b863],
6	complete	JJ	O	complete	amod	7	SENT_13	[p1l781t875r932b913],
7	set	NN	O	set	prep_of	2	SENT_13	[p1l950t881r996b905],
8	of	IN	O	of	_	0	SENT_13	[p1l1012t874r1050b905],
9	protein	NN	O	protein	nn	12	SENT_13	[p1l1060t875r1311b914],
10	—	CD	NUMBER	—	num	12	SENT_13	[p1l1060t875r1311b914],
11	coding	NN	O	coding	nn	12	SENT_13	[p1l1060t875r1311b914],
12	genes	NNS	O	gene	prep_of	7	SENT_13	[p1l1327t884r1430b914],
13	,	,	O	,	_	0	SENT_13	[p1l1327t884r1430b914],
14	coupled	VBN	O	couple	partmod	2	SENT_13	[p1l1449t875r1579b913],
15	with	IN	O	with	_	0	SENT_13	[p1l1594t875r1670b905],
16	the	DT	O	the	det	17	SENT_13	[p1l1687t875r1738b905],
17	discovery	NN	O	discovery	prep_with	14	SENT_13	[p1l1756t875r1912b913],
18	of	IN	O	of	_	0	SENT_13	[p1l1928t874r1967b905],
19	novel	JJ	O	novel	prep_of	17	SENT_13	[p1l1976t875r2064b905],
20	transcribed	VBN	O	transcribe	partmod	19	SENT_13	[p1l665t925r856b955],
21	elements	NNS	O	element	dobj	20	SENT_13	[p1l868t925r1016b955],
22	such	JJ	O	such	_	0	SENT_13	[p1l1030t925r1105b955],
23	as	IN	O	as	_	0	SENT_13	[p1l1117t935r1151b955],
24	microRNAs	NNPS	O	microRNAs	prep_such_as	21	SENT_13	[p1l1164t925r1358b957],
25	(	CD	NUMBER	(	nsubj	26	SENT_13	[p1l1374t927r1435b960],
26	see	VBP	O	see	rcmod	21	SENT_13	[p1l1374t927r1435b960],
27	the	DT	O	the	det	29	SENT_13	[p1l1447t925r1499b955],
28	Glossary	JJ	O	glossary	amod	29	SENT_13	[p1l1512t925r1677b963],
29	)	NN	O	)	dobj	26	SENT_13	[p1l1512t925r1677b963],
30	,	,	O	,	_	0	SENT_13	[p1l1512t925r1677b963],
31	has	VBZ	O	have	aux	32	SENT_13	[p1l1692t925r1748b955],
32	fostered	VBN	O	foster	_	0	SENT_13	[p1l1761t924r1896b955],
33	an	DT	O	a	det	34	SENT_13	[p1l1908t935r1948b955],
34	explosion	NN	O	explosion	dobj	32	SENT_13	[p1l1961t925r2063b963, p1l666t975r734b1005],
35	of	IN	O	of	_	0	SENT_13	[p1l746t974r785b1005],
36	investigation	NN	O	investigation	prep_of	34	SENT_13	[p1l790t975r1005b1014],
37	using	VBG	O	use	partmod	36	SENT_13	[p1l1017t975r1109b1014],
38	array	NN	O	array	nn	39	SENT_13	[p1l1120t975r1312b1013],
39	—	NN	O	—	dobj	37	SENT_13	[p1l1120t975r1312b1013],
40	based	VBN	O	base	partmod	39	SENT_13	[p1l1120t975r1312b1013],
41	approaches	NNS	O	approach	dobj	40	SENT_13	[p1l1324t975r1511b1013],
42	into	IN	O	into	_	0	SENT_13	[p1l1524t975r1590b1005],
43	patterns	NNS	O	pattern	prep_into	40	SENT_13	[p1l1602t981r1739b1013],
44	of	IN	O	of	_	0	SENT_13	[p1l1753t974r1791b1005],
45	gene	NN	O	gene	nn	46	SENT_13	[p1l1796t984r1874b1014],
46	expression	NN	O	expression	prep_of	43	SENT_13	[p1l1886t975r2063b1013],
47	in	IN	O	in	_	0	SENT_13	[p1l665t1025r697b1055],
48	most	JJS	O	most	amod	50	SENT_13	[p1l710t1031r794b1055],
49	cancer	NN	O	cancer	nn	50	SENT_13	[p1l806t1035r915b1055],
50	types	NNS	O	type	prep_in	46	SENT_13	[p1l927t1031r1024b1063],
51	.	.	O	.	_	0	SENT_13	[p1l927t1031r1024b1063],

1	Similarly	RB	O	similarly	dep	9	SENT_14	[p1l1040t1025r1195b1063],
2	,	,	O	,	_	0	SENT_14	[p1l1040t1025r1195b1063],
3	the	DT	O	the	det	4	SENT_14	[p1l1211t1025r1262b1055],
4	development	NN	O	development	nsubj	9	SENT_14	[p1l1276t1025r1489b1063],
5	of	IN	O	of	_	0	SENT_14	[p1l1500t1024r1539b1055],
6	systematic	JJ	O	systematic	amod	7	SENT_14	[p1l1546t1025r1720b1063],
7	approaches	NNS	O	approach	prep_of	4	SENT_14	[p1l1733t1025r1920b1063],
8	to	TO	O	to	aux	9	SENT_14	[p1l1935t1031r1966b1055],
9	identify	VB	O	identify	_	0	SENT_14	[p1l1980t1025r2063b1055, p1l665t1136r722b1176],

1	somatic	JJ	O	somatic	amod	2	SENT_15	[p1l735t1137r865b1167],
2	mutations	NNS	O	mutation	nsubj	4	SENT_15	[p1l878t1137r1047b1167],
3	has	VBZ	O	have	aux	4	SENT_15	[p1l1061t1137r1117b1167],
4	prompted	VBN	O	prompt	_	0	SENT_15	[p1l1131t1137r1294b1176],
5	exhaustive	JJ	O	exhaustive	amod	6	SENT_15	[p1l1308t1137r1482b1167],
6	analyses	NNS	O	analysis	dobj	4	SENT_15	[p1l1496t1137r1635b1176],
7	of	IN	O	of	_	0	SENT_15	[p1l1650t1136r1689b1167],
8	changes	NNS	O	change	prep_of	6	SENT_15	[p1l1696t1137r1830b1176],
9	in	IN	O	in	_	0	SENT_15	[p1l1845t1137r1877b1167],
10	cancer	NN	O	cancer	nn	11	SENT_15	[p1l1891t1147r2000b1167],
11	genomes	NNS	O	genome	prep_in	4	SENT_15	[p1l2012t1147r2063b1176, p1l665t1197r784b1224],
12	,	,	O	,	_	0	SENT_15	[p1l2012t1147r2063b1176, p1l665t1197r784b1224],
13	including	VBG	O	include	_	0	SENT_15	[p1l799t1187r958b1226],
14	copy-number	JJ	O	copy-number	amod	15	SENT_15	[p1l971t1187r1190b1226],
15	changes	NNS	O	change	prep_including	4	SENT_15	[p1l1203t1187r1338b1226],
16	(	VBP	O	(	rcmod	15	SENT_15	[p1l1354t1187r1514b1222],
17	deletions	NNS	O	deletion	dobj	16	SENT_15	[p1l1354t1187r1514b1222],
18	and	CC	O	and	_	0	SENT_15	[p1l1527t1187r1589b1218],
19	ampliﬁcations	NNS	O	ampliﬁcations	dobj	16	SENT_15	[p1l1602t1186r1845b1226],
20	of	IN	O	of	_	0	SENT_15	[p1l1859t1186r1898b1218],
21	DNA	NN	MISC	dna	nn	22	SENT_15	[p1l1904t1189r2003b1224],
22	)	NN	O	)	prep_of	17	SENT_15	[p1l1904t1189r2003b1224],
23	,	,	O	,	_	0	SENT_15	[p1l1904t1189r2003b1224],
24	rearrangements	NNS	O	rearrangement	appos	22	SENT_15	[p1l2019t1197r2062b1217, p1l665t1304r905b1337],
25	,	,	O	,	_	0	SENT_15	[p1l2019t1197r2062b1217, p1l665t1304r905b1337],

1	small	JJ	O	small	amod	2	SENT_16	[p1l931t1298r1022b1328],
2	insertions	NNS	O	insertion	_	0	SENT_16	[p1l1044t1298r1211b1329],
3	and	CC	O	and	_	0	SENT_16	[p1l1234t1298r1296b1329],
4	deletions	NNS	O	deletion	conj_and	2	SENT_16	[p1l1319t1298r1478b1335],
5	,	,	O	,	_	0	SENT_16	[p1l1319t1298r1478b1335],
6	and	CC	O	and	_	0	SENT_16	[p1l1503t1298r1564b1329],
7	point	NN	O	point	nn	8	SENT_16	[p1l1586t1298r1675b1337],
8	mutations	NNS	O	mutation	conj_and	2	SENT_16	[p1l1696t1298r1890b1329],
9	?	.	O	?	_	0	SENT_16	[p1l1696t1298r1890b1329],

1	Recently	RB	DATE	recently	advmod	6	SENT_17	[p1l1913t1298r2061b1337],
2	,	,	O	,	_	0	SENT_17	[p1l1913t1298r2061b1337],
3	these	DT	O	these	det	4	SENT_17	[p1l665t1348r752b1378],
4	efforts	NNS	O	effort	nsubj	6	SENT_17	[p1l769t1348r878b1379],
5	have	VBP	O	have	aux	6	SENT_17	[p1l896t1348r970b1379],
6	culminated	VBN	O	culminate	_	0	SENT_17	[p1l987t1348r1176b1379],
7	in	IN	O	in	_	0	SENT_17	[p1l1193t1348r1225b1378],
8	the	DT	O	the	det	9	SENT_17	[p1l1242t1348r1293b1378],
9	sequencing	NN	O	sequencing	prep_in	6	SENT_17	[p1l1311t1349r1499b1387],
10	of	IN	O	of	_	0	SENT_17	[p1l1515t1348r1553b1379],
11	complete	JJ	O	complete	amod	12	SENT_17	[p1l1563t1348r1714b1387],
12	genomes	NNS	O	genome	prep_of	9	SENT_17	[p1l1731t1358r1879b1387],
13	of	IN	O	of	_	0	SENT_17	[p1l1897t1348r1935b1379],
14	human	JJ	O	human	amod	15	SENT_17	[p1l1945t1348r2063b1379],
15	cancers	NNS	O	cancer	prep_of	12	SENT_17	[p1l665t1408r799b1435],
16	,	,	O	,	_	0	SENT_17	[p1l665t1408r799b1435],
17	providing	VBG	O	provide	xcomp	6	SENT_17	[p1l815t1398r977b1437],
18	comprehensive	JJ	O	comprehensive	amod	19	SENT_17	[p1l991t1398r1239b1437],
19	catalogues	NNS	O	catalogue	dobj	17	SENT_17	[p1l1254t1398r1431b1437],
20	of	IN	O	of	_	0	SENT_17	[p1l1446t1398r1485b1429],
21	somatic	JJ	O	somatic	amod	22	SENT_17	[p1l1493t1398r1623b1429],
22	mutations	NNS	O	mutation	prep_of	19	SENT_17	[p1l1637t1398r1854b1429],
23	.	.	O	.	_	0	SENT_17	[p1l1637t1398r1854b1429],

1	“	NN	O	“	nsubj	5	SENT_18	[p1l1637t1398r1854b1429],
2	These	DT	O	these	det	3	SENT_18	[p1l1867t1398r1965b1428],
3	studies	NNS	O	study	dep	1	SENT_18	[p1l1980t1398r2063b1429, p1l665t1447r708b1477],
4	have	VBP	O	have	aux	5	SENT_18	[p1l722t1447r796b1478],
5	yielded	VBN	O	yield	_	0	SENT_18	[p1l808t1447r926b1486],
6	insights	NNS	O	insight	dobj	5	SENT_18	[p1l939t1447r1071b1486],
7	into	IN	O	into	_	0	SENT_18	[p1l1085t1448r1150b1478],
8	the	DT	O	the	det	9	SENT_18	[p1l1164t1447r1216b1477],
9	genes	NNS	O	gene	prep_into	5	SENT_18	[p1l1229t1457r1323b1486],
10	that	WDT	O	that	nsubj	11	SENT_18	[p1l1337t1447r1404b1477],
11	contribute	VBP	O	contribute	rcmod	9	SENT_18	[p1l1416t1447r1587b1478],
12	to	TO	O	to	_	0	SENT_18	[p1l1601t1453r1633b1478],
13	cellular	JJ	O	cellular	amod	14	SENT_18	[p1l1647t1447r1771b1478],
14	transformation	NN	O	transformation	prep_to	11	SENT_18	[p1l1784t1447r2063b1478],
15	.	.	O	.	_	0	SENT_18	[p1l1784t1447r2063b1478],

1	’	NN	O	’	npadvmod	14	SENT_19	[p1l1784t1447r2063b1478],
2	In	IN	O	in	_	0	SENT_19	[p1l664t1499r699b1526],
3	parallel	NN	O	parallel	prep_in	14	SENT_19	[p1l715t1496r850b1535],
4	,	,	O	,	_	0	SENT_19	[p1l715t1496r850b1535],
5	the	DT	O	the	det	6	SENT_19	[p1l869t1496r920b1526],
6	characterization	NN	O	characterization	nsubj	14	SENT_19	[p1l938t1496r1209b1527],
7	of	IN	O	of	_	0	SENT_19	[p1l1226t1496r1265b1527],
8	inherited	VBN	O	inherit	amod	9	SENT_19	[p1l1274t1496r1426b1527],
9	variation	NN	O	variation	prep_of	6	SENT_19	[p1l1441t1496r1589b1527],
10	in	IN	O	in	_	0	SENT_19	[p1l1606t1497r1639b1526],
11	human	JJ	O	human	amod	12	SENT_19	[p1l1655t1496r1773b1527],
12	populations	NNS	O	population	prep_in	9	SENT_19	[p1l1789t1496r1988b1535],
13	has	VBZ	O	have	aux	14	SENT_19	[p1l2006t1496r2062b1526],
14	unleashed	VBN	O	unleash	_	0	SENT_19	[p1l665t1545r835b1576],
15	a	DT	O	a	det	16	SENT_19	[p1l854t1555r871b1575],
16	surge	NN	O	surge	dobj	14	SENT_19	[p1l891t1555r981b1584],
17	of	IN	O	of	_	0	SENT_19	[p1l1001t1545r1040b1576],
18	exploration	NN	O	exploration	prep_of	16	SENT_19	[p1l1053t1545r1242b1584],
19	into	IN	O	into	_	0	SENT_19	[p1l1261t1545r1327b1576],
20	cancer	NN	O	cancer	nn	21	SENT_19	[p1l1347t1555r1456b1575],
21	susceptibility	NN	O	susceptibility	prep_into	14	SENT_19	[p1l1475t1545r1703b1584],
22	,	,	O	,	_	0	SENT_19	[p1l1475t1545r1703b1584],
23	focusing	VBG	O	focus	partmod	14	SENT_19	[p1l1725t1545r1869b1584],
24	mainly	RB	O	mainly	advmod	23	SENT_19	[p1l1888t1545r2004b1584],
25	on	IN	O	on	_	0	SENT_19	[p1l2022t1555r2063b1576],
26	DNA	NN	O	dna	nn	27	SENT_19	[p1l664t1597r745b1625],
27	variants	NNS	O	variant	prep_on	23	SENT_19	[p1l760t1594r893b1625],
28	that	WDT	O	that	nsubj	30	SENT_19	[p1l912t1594r979b1624],
29	are	VBP	O	be	cop	30	SENT_19	[p1l994t1604r1044b1624],
30	common	JJ	O	common	ccomp	23	SENT_19	[p1l1062t1604r1210b1625],
31	in	IN	O	in	_	0	SENT_19	[p1l1228t1594r1260b1624],
32	the	DT	O	the	det	34	SENT_19	[p1l1278t1594r1330b1624],
33	general	JJ	O	general	amod	34	SENT_19	[p1l1347t1594r1470b1633],
34	population	NN	O	population	prep_in	30	SENT_19	[p1l1487t1594r1670b1633],
35	and	CC	O	and	_	0	SENT_19	[p1l1687t1594r1748b1625],
36	that	IN	O	that	complm	37	SENT_19	[p1l1766t1594r1833b1624],
37	confer	VBP	O	confer	conj_and	30	SENT_19	[p1l1849t1594r1955b1625],
38	small	JJ	O	small	amod	39	SENT_19	[p1l1972t1594r2063b1624],
39	increases	NNS	O	increase	dobj	37	SENT_19	[p1l665t1643r818b1673],
40	in	IN	O	in	_	0	SENT_19	[p1l831t1643r864b1673],
41	cancer	NN	O	cancer	nn	42	SENT_19	[p1l878t1653r986b1673],
42	risk	NN	O	risk	prep_in	39	SENT_19	[p1l999t1643r1069b1674],
43	.	.	O	.	_	0	SENT_19	[p1l999t1643r1069b1674],

1	Finally	RB	O	finally	advmod	9	SENT_20	[p1l1084t1643r1203b1682],
2	,	,	O	,	_	0	SENT_20	[p1l1084t1643r1203b1682],
3	sets	NNS	O	set	nsubjpass	9	SENT_20	[p1l1219t1649r1281b1673],
4	of	IN	O	of	_	0	SENT_20	[p1l1295t1643r1334b1674],
5	biologic	JJ	O	biologic	amod	6	SENT_20	[p1l1340t1643r1473b1682],
6	reagents	NNS	O	reagent	prep_of	3	SENT_20	[p1l1486t1649r1626b1682],
7	have	VBP	O	have	aux	9	SENT_20	[p1l1640t1643r1714b1674],
8	been	VBN	O	be	auxpass	9	SENT_20	[p1l1727t1643r1806b1674],
9	developed	VBN	O	develop	_	0	SENT_20	[p1l1819t1643r1985b1682],
10	that	IN	O	that	complm	11	SENT_20	[p1l1998t1643r2065b1673],
11	interfere	VBP	O	interfere	ccomp	9	SENT_20	[p1l665t1692r807b1722],
12	with	IN	O	with	_	0	SENT_20	[p1l820t1692r896b1723],
13	the	DT	O	the	det	14	SENT_20	[p1l911t1692r963b1722],
14	function	NN	O	function	prep_with	11	SENT_20	[p1l978t1692r1121b1723],
15	of	IN	O	of	_	0	SENT_20	[p1l1136t1692r1175b1723],
16	essentially	RB	O	essentially	advmod	17	SENT_20	[p1l1183t1692r1359b1731],
17	all	DT	O	all	amod	18	SENT_20	[p1l1372t1692r1413b1722],
18	genes	NNS	O	gene	prep_of	14	SENT_20	[p1l1428t1702r1522b1731],
19	in	IN	O	in	_	0	SENT_20	[p1l1537t1692r1570b1722],
20	living	NN	O	living	nn	21	SENT_20	[p1l1585t1692r1680b1731],
21	cells	NNS	O	cell	prep_in	11	SENT_20	[p1l1694t1692r1776b1729],
22	,	,	O	,	_	0	SENT_20	[p1l1694t1692r1776b1729],
23	the	DT	O	the	det	26	SENT_20	[p1l1794t1692r1845b1722],
24	most	RBS	O	most	advmod	26	SENT_20	[p1l1860t1698r1945b1723],
25	widely	RB	O	widely	advmod	26	SENT_20	[p1l1956t1692r2065b1731],
26	used	VBN	O	use	appos	21	SENT_20	[p1l665t1741r740b1772],
27	being	VBG	O	be	cop	28	SENT_20	[p1l754t1741r846b1780],
28	small	JJ	O	small	partmod	26	SENT_20	[p1l860t1741r949b1771],
29	interfering	VBG	O	interfere	dep	28	SENT_20	[p1l963t1741r1139b1780],
30	RNAs	NNS	O	rna	dobj	29	SENT_20	[p1l1151t1744r1256b1773],
31	.	.	O	.	_	0	SENT_20	[p1l1151t1744r1256b1773],

1	These	DT	O	these	nsubjpass	4	SENT_21	[p1l1271t1741r1367b1771],
2	are	VBP	O	be	aux	4	SENT_21	[p1l1381t1751r1430b1771],
3	being	VBG	O	be	auxpass	4	SENT_21	[p1l1445t1741r1537b1780],
4	used	VBN	O	use	_	0	SENT_21	[p1l1549t1741r1624b1772],
5	in	IN	O	in	_	0	SENT_21	[p1l1638t1741r1670b1771],
6	myriad	JJ	O	myriad	amod	7	SENT_21	[p1l1684t1741r1799b1780],
7	ways	NNS	O	way	prep_in	4	SENT_21	[p1l1811t1751r1890b1780],
8	—	VBP	O	—	rcmod	7	SENT_21	[p1l1903t1758r1945b1762],
9	for	IN	O	for	_	0	SENT_21	[p1l1957t1741r2005b1772],
10	example	NN	O	example	prep_for	8	SENT_21	[p1l2018t1751r2063b1771, p1l665t1790r772b1829],
11	,	,	O	,	_	0	SENT_21	[p1l2018t1751r2063b1771, p1l665t1790r772b1829],
12	to	TO	O	to	aux	14	SENT_21	[p1l788t1797r820b1821],
13	systematically	RB	O	systematically	advmod	14	SENT_21	[p1l834t1790r1064b1829],
14	determine	VB	O	determine	xcomp	8	SENT_21	[p1l1077t1790r1243b1821],
15	which	WDT	O	which	det	16	SENT_21	[p1l1255t1790r1355b1821],
16	genes	NNS	O	gene	nsubjpass	18	SENT_21	[p1l1369t1800r1461b1829],
17	are	VBP	O	be	auxpass	18	SENT_21	[p1l1475t1800r1525b1820],
18	required	VBN	O	require	dobj	14	SENT_21	[p1l1538t1790r1676b1829],
19	for	IN	O	for	_	0	SENT_21	[p1l1689t1790r1736b1821],
20	cancer	NN	O	cancer	nn	21	SENT_21	[p1l1749t1800r1856b1820],
21	cells	NNS	O	cell	prep_for	18	SENT_21	[p1l1869t1790r1940b1820],
22	to	TO	O	to	aux	23	SENT_21	[p1l1954t1796r1986b1821],
23	survive	VB	O	survive	xcomp	18	SENT_21	[p1l2000t1800r2063b1821, p1l663t1839r725b1870],
24	and	CC	O	and	_	0	SENT_21	[p1l737t1839r799b1870],
25	which	WDT	O	which	det	26	SENT_21	[p1l810t1839r912b1870],
26	genes	NNS	O	gene	nsubj	27	SENT_21	[p1l925t1849r1019b1878],
27	confer	VBP	O	confer	conj_and	18	SENT_21	[p1l1034t1839r1140b1870],
28	sensitivity	NN	O	sensitivity	dobj	27	SENT_21	[p1l1153t1839r1321b1878],
29	to	TO	O	to	_	0	SENT_21	[p1l1332t1845r1364b1870],
30	particular	JJ	O	particular	amod	31	SENT_21	[p1l1377t1839r1544b1878],
31	drugs	NNS	O	drug	prep_to	27	SENT_21	[p1l1557t1839r1661b1878],
32	.	.	O	.	_	0	SENT_21	[p1l1557t1839r1661b1878],

1	Some	DT	O	some	nsubjpass	22	SENT_22	[p1l716t1890r806b1919],
2	of	IN	O	of	_	0	SENT_22	[p1l822t1888r861b1919],
3	the	DT	O	the	det	5	SENT_22	[p1l870t1888r922b1918],
4	early	JJ	O	early	amod	5	SENT_22	[p1l938t1888r1018b1927],
5	fruits	NNS	O	fruit	prep_of	1	SENT_22	[p1l1032t1888r1122b1919],
6	of	IN	O	of	_	0	SENT_22	[p1l1139t1888r1178b1919],
7	this	DT	O	this	det	8	SENT_22	[p1l1187t1888r1249b1918],
8	research	NN	O	research	prep_of	5	SENT_22	[p1l1266t1888r1415b1925],
9	,	,	O	,	_	0	SENT_22	[p1l1266t1888r1415b1925],
10	along	IN	O	along	_	0	SENT_22	[p1l1433t1888r1527b1927],
11	with	IN	O	with	_	0	SENT_22	[p1l1540t1888r1616b1919],
12	the	DT	O	the	det	13	SENT_22	[p1l1632t1888r1684b1918],
13	techniques	NNS	O	technique	prep_along_with	14	SENT_22	[p1l1700t1888r1880b1927],
14	needed	VBN	O	need	partmod	1	SENT_22	[p1l1897t1888r2015b1919],
15	to	TO	O	to	aux	16	SENT_22	[p1l2031t1894r2062b1919],
16	implement	VB	O	implement	xcomp	14	SENT_22	[p1l665t1937r846b1976],
17	them	PRP	O	they	dobj	16	SENT_22	[p1l860t1937r955b1974],
18	,	,	O	,	_	0	SENT_22	[p1l860t1937r955b1974],
19	are	VBP	O	be	aux	22	SENT_22	[p1l973t1947r1023b1967],
20	already	RB	O	already	advmod	22	SENT_22	[p1l1040t1937r1161b1976],
21	being	VBG	O	be	auxpass	22	SENT_22	[p1l1175t1937r1269b1976],
22	incorporated	VBN	O	incorporate	_	0	SENT_22	[p1l1284t1937r1499b1976],
23	into	IN	O	into	_	0	SENT_22	[p1l1515t1937r1581b1968],
24	clinical	JJ	O	clinical	amod	25	SENT_22	[p1l1599t1937r1720b1967],
25	oncology	NN	O	oncology	prep_into	22	SENT_22	[p1l1737t1937r1895b1976],
26	.	.	O	.	_	0	SENT_22	[p1l1737t1937r1895b1976],

1	Here	RB	O	here	advmod	4	SENT_23	[p1l1913t1940r2000b1974],
2	,	,	O	,	_	0	SENT_23	[p1l1913t1940r2000b1974],
3	we	PRP	O	we	nsubj	4	SENT_23	[p1l2017t1947r2063b1968],
4	review	VBP	O	review	_	0	SENT_23	[p1l665t1986r774b2017],
5	the	DT	O	the	det	6	SENT_23	[p1l792t1986r843b2016],
6	effects	NNS	O	effect	dobj	4	SENT_23	[p1l863t1986r972b2016],
7	that	WDT	O	that	dobj	11	SENT_23	[p1l992t1986r1059b2016],
8	genomic	JJ	O	genomic	amod	9	SENT_23	[p1l1077t1986r1220b2025],
9	approaches	NNS	O	approach	nsubj	11	SENT_23	[p1l1239t1986r1426b2025],
10	are	VBP	O	be	aux	11	SENT_23	[p1l1446t1996r1496b2016],
11	having	VBG	O	have	rcmod	6	SENT_23	[p1l1516t1986r1629b2025],
12	on	IN	O	on	_	0	SENT_23	[p1l1647t1996r1688b2017],
13	tumor	NN	O	tumor	nn	14	SENT_23	[p1l1708t1992r1812b2017],
14	classification	NN	O	classification	prep_on	20	SENT_23	[p1l1830t1986r2061b2023],
15	,	,	O	,	_	0	SENT_23	[p1l1830t1986r2061b2023],
16	prognostic	JJ	O	prognostic	amod	17	SENT_23	[p1l664t2036r845b2074],
17	markers	NNS	O	marker	appos	14	SENT_23	[p1l864t2035r1010b2072],
18	,	,	O	,	_	0	SENT_23	[p1l864t2035r1010b2072],
19	predictive	JJ	O	predictive	amod	20	SENT_23	[p1l1031t2035r1194b2074],
20	indicators	NNS	O	indicator	dobj	11	SENT_23	[p1l1213t2035r1380b2066],
21	of	IN	O	of	_	0	SENT_23	[p1l1401t2035r1440b2066],
22	drug	NN	O	drug	nn	23	SENT_23	[p1l1453t2035r1532b2074],
23	response	NN	O	response	prep_of	20	SENT_23	[p1l1550t2045r1707b2074],
24	,	,	O	,	_	0	SENT_23	[p1l1550t2045r1707b2074],
25	the	DT	O	the	det	26	SENT_23	[p1l1729t2035r1780b2065],
26	development	NN	O	development	appos	23	SENT_23	[p1l1800t2035r2013b2074],
27	of	IN	O	of	_	0	SENT_23	[p1l2031t2035r2070b2066],
28	new	JJ	O	new	amod	30	SENT_23	[p1l665t2094r734b2115],
29	drug	NN	O	drug	nn	30	SENT_23	[p1l753t2084r832b2123],
30	therapies	NNS	O	therapy	prep_of	26	SENT_23	[p1l850t2084r1011b2123],
31	,	,	O	,	_	0	SENT_23	[p1l850t2084r1011b2123],
32	strategies	NNS	O	strategy	appos	30	SENT_23	[p1l1034t2085r1192b2123],
33	for	IN	O	for	_	0	SENT_23	[p1l1213t2084r1261b2115],
34	monitoring	VBG	O	monitor	amod	35	SENT_23	[p1l1279t2084r1471b2123],
35	disease	NN	O	disease	prep_for	32	SENT_23	[p1l1490t2084r1619b2121],
36	,	,	O	,	_	0	SENT_23	[p1l1490t2084r1619b2121],
37	and	CC	O	and	_	0	SENT_23	[p1l1641t2084r1702b2115],
38	the	DT	O	the	det	39	SENT_23	[p1l1722t2084r1774b2114],
39	management	NN	O	management	conj_and	20	SENT_23	[p1l1793t2091r2013b2123],
40	of	IN	O	of	_	0	SENT_23	[p1l2031t2084r2070b2115],
41	susceptibility	NN	O	susceptibility	prep_of	39	SENT_23	[p1l665t2133r888b2172],
42	to	TO	O	to	_	0	SENT_23	[p1l902t2139r934b2164],
43	cancer	NN	O	cancer	prep_to	11	SENT_23	[p1l950t2143r1065b2164],
44	.	.	O	.	_	0	SENT_23	[p1l950t2143r1065b2164],

1	BIOLOGIC	JJ	O	biologic	amod	2	SENT_24	[p1l1067t2249r1278b2272],
2	CLASSIFICATION	NN	O	classification	_	0	SENT_24	[p1l1299t2249r1660b2272],

1	For	IN	O	for	_	0	SENT_25	[p1l664t2336r720b2364],
2	most	JJS	O	most	amod	3	SENT_25	[p1l734t2340r818b2364],
3	cancers	NNS	O	cancer	prep_for	7	SENT_25	[p1l832t2343r966b2370],
4	,	,	O	,	_	0	SENT_25	[p1l832t2343r966b2370],
5	we	PRP	O	we	nsubj	7	SENT_25	[p1l982t2343r1028b2364],
6	still	RB	O	still	advmod	7	SENT_25	[p1l1044t2333r1107b2363],
7	rely	VBP	O	rely	_	0	SENT_25	[p1l1122t2333r1182b2372],
8	on	IN	O	on	_	0	SENT_25	[p1l1197t2343r1238b2364],
9	histologic	JJ	O	histologic	amod	10	SENT_25	[p1l1253t2333r1418b2372],
10	analysis	NN	O	analysis	prep_on	7	SENT_25	[p1l1434t2333r1565b2372],
11	of	IN	O	of	_	0	SENT_25	[p1l1582t2333r1621b2364],
12	stained	VBN	O	stain	prepc_of	10	SENT_25	[p1l1630t2333r1751b2364],
13	tissue	NN	O	tissue	nn	14	SENT_25	[p1l1767t2333r1862b2364],
14	sections	NNS	O	section	dobj	12	SENT_25	[p1l1878t2333r2013b2364],
15	or	CC	O	or	_	0	SENT_25	[p1l2030t2343r2064b2364],
16	cells	NNS	O	cell	conj_or	14	SENT_25	[p1l665t2382r738b2412],
17	for	IN	O	for	_	0	SENT_25	[p1l752t2382r800b2413],
18	diagnosis	NN	O	diagnosis	prep_for	12	SENT_25	[p1l812t2382r971b2421],
19	and	CC	O	and	_	0	SENT_25	[p1l985t2382r1047b2413],
20	subclassification	NN	O	subclassification	conj_and	18	SENT_25	[p1l1060t2382r1351b2413],
21	.	.	O	.	_	0	SENT_25	[p1l1060t2382r1351b2413],

1	In	IN	O	in	_	0	SENT_26	[p1l1365t2385r1400b2412],
2	some	DT	O	some	det	3	SENT_26	[p1l1414t2392r1501b2413],
3	tumor	NN	O	tumor	prep_in	5	SENT_26	[p1l1514t2388r1618b2413],
4	types	NNS	O	type	nsubj	5	SENT_26	[p1l1631t2388r1717b2421],
5	(	VBP	O	(	ccomp	19	SENT_26	[p1l1733t2385r1809b2421],
6	e.g.	FW	O	e.g.	dobj	5	SENT_26	[p1l1733t2385r1809b2421],
7	,	,	O	,	_	0	SENT_26	[p1l1733t2385r1809b2421],
8	breast	NN	O	breast	nn	9	SENT_26	[p1l1824t2382r1926b2413],
9	cancers	NNS	O	cancer	dobj	5	SENT_26	[p1l1938t2392r2062b2412],
10	and	CC	O	and	_	0	SENT_26	[p1l665t2431r726b2462],
11	the	DT	O	the	det	12	SENT_26	[p1l740t2431r791b2461],
12	leukemias	NNS	O	leukemia	dobj	5	SENT_26	[p1l804t2431r993b2468],
13	)	RB	O	)	advmod	5	SENT_26	[p1l804t2431r993b2468],
14	,	,	O	,	_	0	SENT_26	[p1l804t2431r993b2468],
15	molecular	JJ	O	molecular	amod	16	SENT_26	[p1l1009t2431r1177b2462],
16	markers	NNS	O	marker	nsubj	19	SENT_26	[p1l1189t2431r1325b2462],
17	have	VBP	O	have	aux	19	SENT_26	[p1l1340t2431r1413b2462],
18	been	VBN	O	be	cop	19	SENT_26	[p1l1427t2431r1506b2462],
19	adjuncts	NNS	O	adjunct	_	0	SENT_26	[p1l1519t2431r1657b2470],
20	to	TO	O	to	_	0	SENT_26	[p1l1672t2437r1704b2462],
21	histologic	JJ	O	histologic	amod	22	SENT_26	[p1l1718t2431r1883b2470],
22	classification	NN	O	classification	prep_to	19	SENT_26	[p1l1896t2431r2062b2461, p1l665t2480r731b2511],
23	for	IN	O	for	_	0	SENT_26	[p1l749t2480r797b2511],
24	decades	NNS	DURATION	decade	prep_for	19	SENT_26	[p1l815t2480r954b2511],
25	.	.	O	.	_	0	SENT_26	[p1l815t2480r954b2511],

1	The	DT	O	the	det	2	SENT_27	[p1l973t2480r1035b2510],
2	advent	NN	O	advent	nsubj	30	SENT_27	[p1l1054t2480r1162b2511],
3	of	IN	O	of	_	0	SENT_27	[p1l1179t2480r1218b2511],
4	microarray	NN	O	microarray	nn	5	SENT_27	[p1l1229t2480r1520b2519],
5	—	NN	O	—	prep_of	2	SENT_27	[p1l1229t2480r1520b2519],
6	based	VBN	O	base	partmod	5	SENT_27	[p1l1229t2480r1520b2519],
7	profiling	NN	O	profiling	dobj	6	SENT_27	[p1l1538t2480r1696b2519],
8	,	,	O	,	_	0	SENT_27	[p1l1538t2480r1696b2519],
9	which	WDT	O	which	nsubj	10	SENT_27	[p1l1715t2480r1817b2511],
10	measures	VBZ	O	measure	rcmod	2	SENT_27	[p1l1835t2490r1992b2511],
11	the	DT	O	the	det	13	SENT_27	[p1l2011t2480r2063b2510],
12	expression	NN	O	expression	nn	13	SENT_27	[p1l665t2530r842b2568],
13	level	NN	O	level	dobj	10	SENT_27	[p1l859t2529r932b2560],
14	of	IN	O	of	_	0	SENT_27	[p1l949t2529r988b2560],
15	thousands	NNS	O	thousand	prep_of	13	SENT_27	[p1l998t2529r1171b2560],
16	of	IN	O	of	_	0	SENT_27	[p1l1189t2529r1228b2560],
17	messenger	NN	O	messenger	nn	22	SENT_27	[p1l1238t2539r1416b2568],
18	RNA	NN	O	rna	nn	22	SENT_27	[p1l1432t2532r1513b2561],
19	(	NN	O	(	nn	22	SENT_27	[p1l1531t2532r1665b2564],
20	mRNA	NN	O	mrna	nn	22	SENT_27	[p1l1531t2532r1665b2564],
21	)	NN	O	)	nn	22	SENT_27	[p1l1531t2532r1665b2564],
22	transcripts	NNS	O	transcript	prep_of	15	SENT_27	[p1l1684t2529r1864b2568],
23	in	IN	O	in	_	0	SENT_27	[p1l1881t2529r1914b2559],
24	a	DT	O	a	det	26	SENT_27	[p1l1931t2539r1948b2559],
25	single	JJ	O	single	amod	26	SENT_27	[p1l1965t2529r2063b2568],
26	experiment	NN	O	experiment	prep_in	10	SENT_27	[p1l665t2578r863b2617],
27	,	,	O	,	_	0	SENT_27	[p1l665t2578r863b2617],
28	has	VBZ	O	have	aux	30	SENT_27	[p1l879t2578r935b2608],
29	substantially	RB	O	substantially	advmod	30	SENT_27	[p1l951t2578r1166b2617],
30	increased	VBN	O	increase	_	0	SENT_27	[p1l1179t2578r1337b2609],
31	the	DT	O	the	det	32	SENT_27	[p1l1352t2578r1403b2608],
32	power	NN	O	power	dobj	30	SENT_27	[p1l1417t2588r1521b2617],
33	to	TO	O	to	_	0	SENT_27	[p1l1535t2584r1566b2609],
34	subclassify	NN	O	subclassify	nn	35	SENT_27	[p1l1582t2578r1766b2617],
35	cancers	NNS	O	cancer	prep_to	30	SENT_27	[p1l1779t2588r1913b2609],
36	.	.	O	.	_	0	SENT_27	[p1l1779t2588r1913b2609],

1	Possibly	RB	O	possibly	dep	5	SENT_28	[p1l1929t2578r2065b2617],
2	the	DT	O	the	det	5	SENT_28	[p1l665t2627r717b2657],
3	most	RBS	O	most	advmod	5	SENT_28	[p1l732t2634r816b2658],
4	celebrated	JJ	O	celebrated	amod	5	SENT_28	[p1l830t2627r999b2658],
5	example	NN	O	example	_	0	SENT_28	[p1l1015t2627r1153b2666],
6	has	VBZ	O	have	aux	9	SENT_28	[p1l1168t2627r1224b2657],
7	been	VBN	O	be	cop	9	SENT_28	[p1l1241t2627r1319b2658],
8	the	DT	O	the	det	9	SENT_28	[p1l1335t2627r1386b2657],
9	contribution	NN	O	contribution	dep	5	SENT_28	[p1l1402t2627r1610b2658],
10	of	IN	O	of	_	0	SENT_28	[p1l1626t2627r1665b2658],
11	expression	NN	O	expression	nn	12	SENT_28	[p1l1674t2627r1851b2666],
12	profiling	NN	O	profiling	prep_of	9	SENT_28	[p1l1866t2627r2017b2666],
13	to	TO	O	to	_	0	SENT_28	[p1l2031t2633r2063b2658],
14	the	DT	O	the	det	15	SENT_28	[p1l665t2676r717b2706],
15	classification	NN	O	classification	prep_to	9	SENT_28	[p1l729t2676r951b2707],
16	of	IN	O	of	_	0	SENT_28	[p1l963t2676r1002b2707],
17	breast	NN	O	breast	nn	18	SENT_28	[p1l1007t2676r1109b2707],
18	tumors	NNS	O	tumor	prep_of	15	SENT_28	[p1l1119t2678r1262b2707],
19	.5	CD	NUMBER	.5	dep	25	SENT_28	[p1l1119t2678r1262b2707],
20	Although	IN	O	although	dep	25	SENT_28	[p1l1274t2676r1432b2715],
21	pathologists	NNS	O	pathologist	nsubj	25	SENT_28	[p1l1443t2676r1649b2715],
22	have	VBP	O	have	aux	25	SENT_28	[p1l1662t2676r1736b2707],
23	long	RB	O	long	advmod	25	SENT_28	[p1l1747t2676r1822b2715],
24	been	VBN	O	be	cop	25	SENT_28	[p1l1832t2676r1911b2707],
25	aware	JJ	O	aware	dep	9	SENT_28	[p1l1922t2686r2019b2707],
26	of	IN	O	of	prep	25	SENT_28	[p1l2032t2676r2070b2707],

1	N	NN	O	n	nn	3	SENT_29	[p1l1029t2803r1043b2819],
2	ENGLJ	NN	O	englj	nn	3	SENT_29	[p1l1057t2803r1135b2825],
3	MED	NN	O	med	_	0	SENT_29	[p1l1150t2803r1202b2818],
4	364	CD	NUMBER	364	dep	3	SENT_29	[p1l1212t2798r1281b2825],
5	;	:	O	;	_	0	SENT_29	[p1l1212t2798r1281b2825],
6	4	CD	NUMBER	4	num	8	SENT_29	[p1l1212t2798r1281b2825],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_29	[p1l1315t2803r1439b2825],
8	JANUARY	NN	DATE	january	dep	4	SENT_29	[p1l1470t2803r1583b2825],
9	27	CD	DATE	27	dep	8	SENT_29	[p1l1593t2803r1627b2824],
10	,	,	DATE	,	_	0	SENT_29	[p1l1593t2803r1627b2824],
11	2011	CD	DATE	2011	appos	9	SENT_29	[p1l1638t2803r1690b2819],

1	The	DT	O	the	det	4	SENT_30	[p1l878t2836r929b2860],
2	New	NNP	O	New	nn	4	SENT_30	[p1l938t2837r1000b2860],
3	England	NNP	O	England	nn	4	SENT_30	[p1l1010t2836r1120b2867],
4	Journal	NNP	O	Journal	_	0	SENT_30	[p1l1129t2836r1227b2860],
5	of	IN	O	of	_	0	SENT_30	[p1l1236t2836r1265b2860],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_30	[p1l1272t2836r1397b2860],

1	Downloaded	VBN	O	download	_	0	SENT_31	[p1l320t2877r490b2900],
2	from	IN	O	from	_	0	SENT_31	[p1l499t2877r564b2900],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_31	[p1l572t2877r691b2907],
4	at	IN	O	at	_	0	SENT_31	[p1l701t2881r724b2900],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_31	[p1l733t2877r915b2900],
6	on	IN	O	on	_	0	SENT_31	[p1l925t2884r957b2900],
7	J	NN	O	j	nn	8	SENT_31	[p1l966t2877r978b2900],
8	anuaty	NN	O	anuaty	prep_on	5	SENT_31	[p1l980t2884r1068b2907],
9	5	CD	NUMBER	5	num	8	SENT_31	[p1l1078t2877r1101b2904],
10	,	,	O	,	_	0	SENT_31	[p1l1078t2877r1101b2904],
11	2014	CD	DATE	2014	dobj	1	SENT_31	[p1l1112t2877r1184b2900],
12	.	.	O	.	_	0	SENT_31	[p1l1112t2877r1184b2900],

1	For	IN	O	for	_	0	SENT_32	[p1l1194t2877r1241b2900],
2	personal	JJ	O	personal	amod	3	SENT_32	[p1l1249t2877r1361b2907],
3	use	NN	O	use	pobj	1	SENT_32	[p1l1371t2884r1414b2900],
4	only	RB	O	only	advmod	3	SENT_32	[p1l1424t2877r1488b2907],
5	.	.	O	.	_	0	SENT_32	[p1l1424t2877r1488b2907],

1	No	DT	O	no	det	3	SENT_33	[p1l1499t2877r1539b2900],
2	other	JJ	O	other	amod	3	SENT_33	[p1l1549t2877r1617b2900],
3	uses	NNS	O	use	_	0	SENT_33	[p1l1625t2884r1681b2900],
4	without	IN	O	without	_	0	SENT_33	[p1l1691t2877r1793b2900],
5	permission	NN	O	permission	prep_without	3	SENT_33	[p1l1801t2877r1953b2907],
6	.	.	O	.	_	0	SENT_33	[p1l1801t2877r1953b2907],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_34	[p1l909t3024r1067b3043],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_34	[p1l1081t3024r1251b3043],

1	the	DT	O	the	dep	132	SENT_35	[p1l11t3239r144b3318],
2	heterogeneity	NN	O	heterogeneity	dep	132	SENT_35	[p1l176t3239r767b3341],
3	of	IN	O	of	dep	132	SENT_35	[p1l795t3238r896b3319],
4	this	DT	O	this	dep	132	SENT_35	[p1l909t3239r1070b3318],
5	disease	NN	O	disease	dep	132	SENT_35	[p1l1104t3239r1440b3336],
6	,	,	O	,	_	0	SENT_35	[p1l1104t3239r1440b3336],
7	expression	NN	O	expression	dep	132	SENT_35	[p1l1478t3240r1938b3340],
8	profiling	NN	O	profiling	dep	132	SENT_35	[p1l1968t3265r2148b3340, p1l10t3367r252b3470],
9	has	VBZ	O	have	dep	132	SENT_35	[p1l300t3368r446b3447],
10	contributed	VBN	O	contribute	dep	132	SENT_35	[p1l500t3368r1001b3448],
11	to	TO	O	to	dep	132	SENT_35	[p1l1053t3385r1135b3448],
12	the	DT	O	the	dep	132	SENT_35	[p1l1188t3368r1322b3447],
13	development	NN	O	development	dep	132	SENT_35	[p1l1374t3368r1928b3469],
14	of	IN	O	of	dep	132	SENT_35	[p1l1974t3367r2075b3448],
15	a	DT	O	a	dep	132	SENT_35	[p1l2107t3395r2152b3447],
16	classification	NN	O	classification	dep	132	SENT_35	[p1l11t3495r587b3575],
17	that	WDT	O	that	dep	132	SENT_35	[p1l617t3496r790b3574],
18	usually	RB	O	usually	dep	132	SENT_35	[p1l815t3496r1124b3596],
19	includes	VBZ	O	include	dep	132	SENT_35	[p1l1148t3496r1503b3575],
20	the	DT	O	the	dep	132	SENT_35	[p1l1535t3496r1669b3574],
21	major	JJ	O	major	dep	132	SENT_35	[p1l1698t3497r1950b3596],
22	molecular	JJ	O	molecular	dep	132	SENT_35	[p1l1976t3522r2148b3575, p1l9t3624r305b3703],
23	subtypes	NNS	O	subtype	dep	132	SENT_35	[p1l338t3624r716b3724],
24	of	IN	O	of	dep	132	SENT_35	[p1l754t3623r854b3703],
25	basallike	JJ	O	basallike	dep	132	SENT_35	[p1l872t3624r1280b3720],
26	,	,	O	,	_	0	SENT_35	[p1l872t3624r1280b3720],
27	positive	JJ	O	positive	dep	132	SENT_35	[p1l1319t3625r1652b3724],
28	for	IN	O	for	dep	132	SENT_35	[p1l1687t3623r1811b3703],
29	human	JJ	O	human	dep	132	SENT_35	[p1l1843t3624r2149b3704],
30	epidermal	JJ	O	epidermal	dep	132	SENT_35	[p2l11t22r446b123],
31	growth	NN	O	growth	dep	132	SENT_35	[p2l480t22r798b124],
32	factor	NN	O	factor	dep	132	SENT_35	[p2l833t21r1085b102],
33	receptor	NN	O	receptor	dep	132	SENT_35	[p2l1117t39r1476b123],
34	2	CD	NUMBER	2	dep	132	SENT_35	[p2l1508t28r1555b100],
35	(	CD	NUMBER	(	dep	132	SENT_35	[p2l1596t28r1931b119],
36	HER2	NN	O	her2	dep	132	SENT_35	[p2l1596t28r1931b119],
37	)	NN	O	)	dep	132	SENT_35	[p2l1596t28r1931b119],
38	,	,	O	,	_	0	SENT_35	[p2l1596t28r1931b119],
39	normal	JJ	O	normal	dep	132	SENT_35	[p2l1972t48r2148b102, p2l10t151r174b229],
40	breastlike	JJ	O	breastlike	dep	132	SENT_35	[p2l220t151r668b247],
41	,	,	O	,	_	0	SENT_35	[p2l220t151r668b247],
42	luminal	JJ	O	luminal	dep	132	SENT_35	[p2l719t151r1058b230],
43	A	NN	O	a	dep	132	SENT_35	[p2l1101t159r1189b247],
44	,	,	O	,	_	0	SENT_35	[p2l1101t159r1189b247],
45	and	CC	O	and	dep	132	SENT_35	[p2l1240t151r1399b230],
46	luminal	JJ	O	luminal	dep	132	SENT_35	[p2l1444t151r1784b230],
47	B.	NNP	O	B.	dep	132	SENT_35	[p2l1828t157r1909b230],
48	This	DT	O	this	dep	132	SENT_35	[p2l1957t151r2146b229],
49	classification	NN	O	classification	dep	132	SENT_35	[p2l11t279r587b360],
50	is	VBZ	O	be	dep	132	SENT_35	[p2l631t281r698b359],
51	still	RB	O	still	dep	132	SENT_35	[p2l747t280r910b359],
52	evolving	VBG	O	evolve	dep	132	SENT_35	[p2l955t280r1313b382],
53	but	CC	O	but	dep	132	SENT_35	[p2l1356t280r1496b360],
54	has	VBZ	O	have	dep	132	SENT_35	[p2l1536t280r1682b359],
55	become	VBN	O	become	dep	132	SENT_35	[p2l1730t280r2062b360],
56	a	DT	O	a	dep	132	SENT_35	[p2l2107t307r2152b359],
57	widely	RB	O	widely	dep	132	SENT_35	[p2l6t408r288b508],
58	used	VBN	O	use	dep	132	SENT_35	[p2l347t408r546b488],
59	conceptual	JJ	O	conceptual	dep	132	SENT_35	[p2l609t408r1083b508],
60	framework	NN	O	framework	dep	132	SENT_35	[p2l1146t407r1628b488],
61	in	IN	O	in	dep	132	SENT_35	[p2l1686t409r1770b486],
62	clinical	JJ	O	clinical	dep	132	SENT_35	[p2l1834t408r2150b486],
63	breast	NN	O	breast	dep	132	SENT_35	[p2l11t537r275b617],
64	oncology	NN	O	oncology	dep	132	SENT_35	[p2l305t537r714b639],
65	,	,	O	,	_	0	SENT_35	[p2l305t537r714b639],
66	with	IN	O	with	dep	132	SENT_35	[p2l749t537r945b617],
67	the	DT	O	the	dep	132	SENT_35	[p2l980t537r1113b616],
68	different	JJ	O	different	dep	132	SENT_35	[p2l1147t536r1526b617],
69	subtypes	NNS	O	subtype	dep	132	SENT_35	[p2l1556t537r1934b638],
70	having	VBG	O	have	dep	132	SENT_35	[p2l1970t537r2148b617, p2l10t667r150b768],
71	markedly	RB	O	markedly	dep	132	SENT_35	[p2l188t666r596b767],
72	different	JJ	O	different	dep	132	SENT_35	[p2l634t665r1013b746],
73	clinical	JJ	O	clinical	dep	132	SENT_35	[p2l1050t666r1365b745],
74	and	CC	O	and	dep	132	SENT_35	[p2l1406t666r1565b746],
75	biologic	JJ	O	biologic	dep	132	SENT_35	[p2l1606t666r1951b768],
76	features	NNS	O	feature	dep	132	SENT_35	[p2l1991t665r2148b745, p2l11t812r250b891],
77	,	,	O	,	_	0	SENT_35	[p2l1991t665r2148b745, p2l11t812r250b891],
78	including	VBG	O	include	dep	132	SENT_35	[p2l320t795r734b896],
79	patient	NN	O	patient	dep	132	SENT_35	[p2l795t796r1099b895],
80	survival	NN	O	survival	dep	132	SENT_35	[p2l1161t795r1618b874],
81	.6	CD	NUMBER	.6	dep	132	SENT_35	[p2l1161t795r1618b874],
82	>	JJR	O	>	dep	132	SENT_35	[p2l1161t795r1618b874],
83	7	CD	NUMBER	7	dep	132	SENT_35	[p2l1161t795r1618b874],
84	In	IN	O	in	dep	132	SENT_35	[p2l1683t803r1772b873],
85	routine	JJ	O	routine	dep	132	SENT_35	[p2l1838t796r2149b874],
86	clinical	JJ	O	clinical	dep	132	SENT_35	[p2l11t922r326b1000],
87	practice	NN	O	practice	dep	132	SENT_35	[p2l377t923r741b1022],
88	,	,	O	,	_	0	SENT_35	[p2l377t923r741b1022],
89	however	RB	O	however	dep	132	SENT_35	[p2l799t922r1177b1018],
90	,	,	O	,	_	0	SENT_35	[p2l799t922r1177b1018],
91	classification	NN	O	classification	dep	132	SENT_35	[p2l1236t921r1812b1001],
92	is	VBZ	O	be	dep	132	SENT_35	[p2l1864t923r1931b1000],
93	still	RB	O	still	dep	132	SENT_35	[p2l1987t922r2150b1000],
94	based	VBN	O	base	dep	132	SENT_35	[p2l11t1051r257b1130],
95	on	IN	O	on	dep	132	SENT_35	[p2l307t1077r413b1130],
96	conventional	JJ	O	conventional	dep	132	SENT_35	[p2l463t1051r1019b1130],
97	histologic	JJ	O	histologic	dep	132	SENT_35	[p2l1067t1051r1496b1152],
98	analysis	NN	O	analysis	dep	132	SENT_35	[p2l1544t1051r1911b1151],
99	,	,	O	,	_	0	SENT_35	[p2l1544t1051r1911b1151],
100	coupled	VBN	O	couple	dep	132	SENT_35	[p2l1966t1077r2148b1130, p2l9t1179r191b1280],
101	with	IN	O	with	dep	132	SENT_35	[p2l223t1179r420b1259],
102	immunohistochemical	JJ	O	immunohistochemical	dep	132	SENT_35	[p2l456t1179r1443b1259],
103	staining	NN	O	staining	dep	132	SENT_35	[p2l1480t1180r1839b1281],
104	for	IN	O	for	dep	132	SENT_35	[p2l1872t1178r1996b1259],
105	estrogen	NN	O	estrogen	dep	132	SENT_35	[p2l2030t1206r2148b1258, p2l11t1325r293b1410],
106	receptor	NN	O	receptor	dep	132	SENT_35	[p2l323t1325r681b1409],
107	(	CD	NUMBER	(	dep	132	SENT_35	[p2l713t1315r920b1405],
108	ER	NN	O	er	dep	132	SENT_35	[p2l713t1315r920b1405],
109	)	NN	O	)	dep	132	SENT_35	[p2l713t1315r920b1405],
110	,	,	O	,	_	0	SENT_35	[p2l713t1315r920b1405],
111	progesterone	NN	O	progesterone	dep	132	SENT_35	[p2l954t1325r1521b1410],
112	receptor	NN	O	receptor	dep	132	SENT_35	[p2l1552t1325r1910b1409],
113	(	CD	NUMBER	(	dep	132	SENT_35	[p2l1942t1315r2144b1405],
114	PR	NN	O	pr	dep	132	SENT_35	[p2l1942t1315r2144b1405],
115	)	NN	O	)	dep	132	SENT_35	[p2l1942t1315r2144b1405],
116	,	,	O	,	_	0	SENT_35	[p2l1942t1315r2144b1405],
117	and	CC	O	and	dep	132	SENT_35	[p2l10t1437r169b1516],
118	HER2	NN	O	her2	dep	132	SENT_35	[p2l227t1443r504b1533],
119	,	,	O	,	_	0	SENT_35	[p2l227t1443r504b1533],
120	which	WDT	O	which	dep	132	SENT_35	[p2l564t1437r829b1516],
121	when	WRB	O	when	dep	132	SENT_35	[p2l884t1437r1119b1516],
122	combined	VBN	O	combine	dep	132	SENT_35	[p2l1180t1437r1608b1516],
123	can	MD	O	can	dep	132	SENT_35	[p2l1668t1463r1818b1515],
124	reconstruct	VB	O	reconstruct	dep	132	SENT_35	[p2l1877t1463r2148b1516, p2l11t1582r263b1645],
125	most	JJS	O	most	dep	132	SENT_35	[p2l299t1582r517b1644],
126	of	IN	O	of	dep	132	SENT_35	[p2l553t1564r654b1644],
127	the	DT	O	the	dep	132	SENT_35	[p2l677t1565r811b1643],
128	subclasses	NNS	O	subclass	dep	132	SENT_35	[p2l854t1565r1304b1645],
129	defined	VBN	O	define	dep	132	SENT_35	[p2l1348t1564r1677b1644],
130	by	IN	O	by	dep	132	SENT_35	[p2l1718t1565r1816b1665],
131	mRNA	NN	O	mrna	dep	132	SENT_35	[p2l1853t1572r2153b1649],
132	expression	NN	O	expression	_	0	SENT_35	[p2l11t1696r494b1795],
133	.	.	O	.	_	0	SENT_35	[p2l11t1696r494b1795],

1	Beyond	IN	O	beyond	_	0	SENT_36	[p2l139t1823r456b1923],
2	refinement	NN	O	refinement	prep_beyond	12	SENT_36	[p2l521t1822r1004b1901],
3	of	IN	O	of	_	0	SENT_36	[p2l1064t1822r1165b1902],
4	tumor	NN	O	tumor	nn	5	SENT_36	[p2l1211t1840r1482b1903],
5	classiﬁcation	NN	O	classiﬁcation	prep_of	2	SENT_36	[p2l1544t1822r2144b1919],
6	,	,	O	,	_	0	SENT_36	[p2l1544t1822r2144b1919],
7	how	WRB	O	how	advmod	12	SENT_36	[p2l10t1953r196b2032],
8	might	MD	O	might	aux	12	SENT_36	[p2l231t1953r493b2054],
9	these	DT	O	these	det	10	SENT_36	[p2l527t1952r752b2031],
10	advances	NNS	O	advance	nsubjpass	12	SENT_36	[p2l791t1952r1176b2032],
11	be	VB	O	be	auxpass	12	SENT_36	[p2l1218t1952r1315b2032],
12	used	VBN	O	use	_	0	SENT_36	[p2l1354t1950r1590b2032],
13	?	.	O	?	_	0	SENT_36	[p2l1354t1950r1590b2032],

1	An	DT	O	a	det	2	SENT_37	[p2l1626t1960r1751b2030],
2	example	NN	O	example	nsubj	19	SENT_37	[p2l1791t1953r2149b2053],
3	of	IN	O	of	_	0	SENT_37	[p2l11t2079r111b2159],
4	a	DT	O	a	det	8	SENT_37	[p2l127t2106r171b2158],
5	standard	JJ	O	standard	amod	8	SENT_37	[p2l206t2080r588b2159],
6	clinical	JJ	O	clinical	amod	8	SENT_37	[p2l623t2080r939b2158],
7	classification	NN	O	classification	nn	8	SENT_37	[p2l974t2079r1551b2159],
8	problem	NN	O	problem	prep_of	2	SENT_37	[p2l1584t2080r1945b2180],
9	that	WDT	O	that	dobj	15	SENT_37	[p2l1981t2080r2154b2158],
10	conventional	JJ	O	conventional	amod	12	SENT_37	[p2l11t2209r567b2289],
11	histologic	JJ	O	histologic	amod	12	SENT_37	[p2l602t2209r1031b2311],
12	analysis	NN	O	analysis	nsubj	15	SENT_37	[p2l1066t2209r1408b2310],
13	has	VBZ	O	have	aux	15	SENT_37	[p2l1446t2209r1591b2288],
14	often	RB	O	often	advmod	15	SENT_37	[p2l1631t2208r1855b2289],
15	struggled	VBN	O	struggle	rcmod	8	SENT_37	[p2l1892t2226r2148b2311, p2l10t2338r192b2440],
16	to	TO	O	to	_	0	SENT_37	[p2l235t2355r317b2418],
17	address	NN	O	address	prep_to	15	SENT_37	[p2l359t2338r686b2418],
18	is	VBZ	O	be	cop	19	SENT_37	[p2l729t2339r796b2417],
19	ascertainment	NN	O	ascertainment	_	0	SENT_37	[p2l839t2339r1465b2417],
20	of	IN	O	of	_	0	SENT_37	[p2l1502t2337r1603b2418],
21	the	DT	O	the	det	23	SENT_37	[p2l1627t2338r1760b2417],
22	primary	JJ	O	primary	amod	23	SENT_37	[p2l1801t2339r2154b2439],
23	tissue	NN	O	tissue	prep_of	19	SENT_37	[p2l11t2468r258b2547],
24	of	IN	O	of	_	0	SENT_37	[p2l318t2466r418b2547],
25	origin	NN	O	origin	prep_of	23	SENT_37	[p2l458t2468r719b2569],
26	of	IN	O	of	_	0	SENT_37	[p2l778t2466r879b2547],
27	a	DT	O	a	det	29	SENT_37	[p2l917t2494r962b2546],
28	metastatic	JJ	O	metastatic	amod	29	SENT_37	[p2l1019t2468r1469b2546],
29	cancer	NN	O	cancer	prep_of	25	SENT_37	[p2l1527t2493r1828b2547],
30	.	.	O	.	_	0	SENT_37	[p2l1527t2493r1828b2547],

1	Geneexpression	NNP	MISC	Geneexpression	nn	2	SENT_38	[p2l1892t2473r2148b2547, p2l11t2597r471b2696],
2	signatures	NNS	O	signature	nsubj	7	SENT_38	[p2l506t2597r979b2697],
3	,	,	O	,	_	0	SENT_38	[p2l506t2597r979b2697],
4	however	RB	O	however	advmod	7	SENT_38	[p2l1018t2596r1396b2692],
5	,	,	O	,	_	0	SENT_38	[p2l1018t2596r1396b2692],
6	can	MD	O	can	aux	7	SENT_38	[p2l1436t2622r1586b2674],
7	provide	VB	O	provide	_	0	SENT_38	[p2l1618t2596r1938b2696],
8	acuity	NN	O	acuity	dobj	7	SENT_38	[p2l1972t2622r2148b2675, p2l10t2724r118b2823],
9	of	IN	O	of	_	0	SENT_38	[p2l154t2722r256b2802],
10	resolution	NN	O	resolution	prep_of	8	SENT_38	[p2l278t2723r714b2803],
11	beyond	IN	O	beyond	_	0	SENT_38	[p2l755t2723r1065b2823],
12	that	DT	O	that	prep_beyond	7	SENT_38	[p2l1106t2723r1279b2801],
13	of	IN	O	of	_	0	SENT_38	[p2l1316t2722r1417b2802],
14	the	DT	O	the	det	17	SENT_38	[p2l1439t2723r1573b2801],
15	microscopeaided	JJ	O	microscopeaided	amod	17	SENT_38	[p2l1614t2724r2148b2823, p2l10t2851r242b2930],
16	human	JJ	O	human	amod	17	SENT_38	[p2l307t2851r614b2931],
17	eye	NN	O	eye	prep_of	12	SENT_38	[p2l681t2877r836b2951],
18	,	,	O	,	_	0	SENT_38	[p2l681t2877r836b2951],
19	and	CC	O	and	_	0	SENT_38	[p2l907t2851r1066b2930],
20	since	IN	O	since	mark	33	SENT_38	[p2l1133t2852r1349b2929],
21	elements	NNS	O	element	nsubjpass	33	SENT_38	[p2l1416t2851r1798b2929],
22	of	IN	O	of	_	0	SENT_38	[p2l1868t2850r1968b2930],
23	the	DT	O	the	det	25	SENT_38	[p2l2016t2851r2149b2929],
24	expression	NN	O	expression	nn	25	SENT_38	[p2l11t2981r461b3081],
25	pattern	NN	O	pattern	prep_of	21	SENT_38	[p2l490t2997r797b3081],
26	of	IN	O	of	_	0	SENT_38	[p2l828t2979r928b3060],
27	the	DT	O	the	det	28	SENT_38	[p2l939t2980r1071b3059],
28	tissue	NN	O	tissue	prep_of	25	SENT_38	[p2l1101t2981r1344b3060],
29	of	IN	O	of	_	0	SENT_38	[p2l1375t2979r1474b3060],
30	origin	NN	O	origin	prep_of	28	SENT_38	[p2l1486t2981r1741b3082],
31	are	VBP	O	be	auxpass	33	SENT_38	[p2l1770t3006r1898b3059],
32	often	RB	O	often	advmod	33	SENT_38	[p2l1929t2979r2149b3060],
33	retained	VBN	O	retain	advcl	51	SENT_38	[p2l10t3108r368b3187],
34	in	IN	O	in	_	0	SENT_38	[p2l428t3109r512b3186],
35	the	DT	O	the	det	36	SENT_38	[p2l574t3108r708b3186],
36	cancer	NN	O	cancer	prep_in	33	SENT_38	[p2l770t3134r1071b3204],
37	,	,	O	,	_	0	SENT_38	[p2l770t3134r1071b3204],
38	analysis	NN	O	analysis	nsubj	51	SENT_38	[p2l1138t3108r1481b3208],
39	of	IN	O	of	_	0	SENT_38	[p2l1545t3107r1646b3187],
40	expression	NN	O	expression	nn	41	SENT_38	[p2l1690t3109r2149b3208],
41	profiles	NNS	O	profile	prep_of	38	SENT_38	[p2l8t3235r358b3336],
42	,	,	O	,	_	0	SENT_38	[p2l8t3235r358b3336],
43	particularly	RB	O	particularly	advmod	38	SENT_38	[p2l398t3236r893b3336],
44	those	DT	O	those	dep	38	SENT_38	[p2l925t3236r1154b3315],
45	that	WDT	O	that	nsubj	46	SENT_38	[p2l1190t3236r1361b3314],
46	include	VBP	O	include	rcmod	44	SENT_38	[p2l1391t3236r1697b3315],
47	expressed	VBN	O	express	dep	46	SENT_38	[p2l1734t3236r2149b3336],
48	microRNAs	NNPS	O	microRNAs	dobj	47	SENT_38	[p2l10t3366r530b3462],
49	,	,	O	,	_	0	SENT_38	[p2l10t3366r530b3462],
50	often	RB	O	often	advmod	51	SENT_38	[p2l582t3364r801b3445],
51	provide	VBP	O	provide	conj_and	7	SENT_38	[p2l844t3365r1158b3466],
52	additional	JJ	O	additional	amod	53	SENT_38	[p2l1203t3365r1634b3445],
53	insight	NN	O	insight	dobj	51	SENT_38	[p2l1677t3365r1994b3467],
54	,	,	O	,	_	0	SENT_38	[p2l1677t3365r1994b3467],
55	although	IN	O	although	mark	60	SENT_38	[p2l2045t3365r2148b3444, p2l11t3494r316b3595],
56	they	PRP	O	they	nsubjpass	60	SENT_38	[p2l373t3494r557b3594],
57	are	VBP	O	be	auxpass	60	SENT_38	[p2l609t3520r740b3572],
58	not	RB	O	not	neg	60	SENT_38	[p2l798t3511r941b3573],
59	currently	RB	DATE	currently	advmod	60	SENT_38	[p2l995t3494r1387b3594],
60	used	VBN	O	use	dep	53	SENT_38	[p2l1440t3494r1639b3573],
61	in	IN	O	in	_	0	SENT_38	[p2l1696t3495r1780b3572],
62	routine	JJ	O	routine	amod	64	SENT_38	[p2l1838t3495r2150b3573],
63	clinical	JJ	O	clinical	amod	64	SENT_38	[p2l11t3622r326b3700],
64	practice	NN	O	practice	prep_in	60	SENT_38	[p2l365t3623r771b3722],
65	.8	CD	NUMBER	.8	tmod	60	SENT_38	[p2l365t3623r771b3722],

1	PROGNOSTIC	NNP	O	PROGNOSTIC	nn	2	SENT_39	[p3l336t149r1063b209],
2	INDICATORS	NNS	O	indicator	_	0	SENT_39	[p3l1119t149r1825b209],

1	The	DT	O	the	det	2	SENT_40	[p3l7t368r169b447],
2	use	NN	O	use	nsubj	7	SENT_40	[p3l218t394r359b448],
3	of	IN	O	of	_	0	SENT_40	[p3l409t367r509b448],
4	gene-expression	NN	O	gene-expression	nn	5	SENT_40	[p3l539t369r1242b470],
5	signatures	NNS	O	signature	prep_of	2	SENT_40	[p3l1292t369r1740b470],
6	has	VBZ	O	have	aux	7	SENT_40	[p3l1791t368r1936b447],
7	empowered	VBN	O	empower	_	0	SENT_40	[p3l1987t394r2148b447, p3l9t497r379b598],
8	the	DT	O	the	det	9	SENT_40	[p3l442t497r576b576],
9	identification	NN	O	identification	dobj	7	SENT_40	[p3l638t496r1227b577],
10	of	IN	O	of	_	0	SENT_40	[p3l1291t496r1391b577],
11	prognostic	JJ	O	prognostic	amod	12	SENT_40	[p3l1434t498r1902b599],
12	subclasses	NNS	O	subclass	prep_of	9	SENT_40	[p3l1966t497r2148b577, p3l11t626r332b706],
13	.	.	O	.	_	0	SENT_40	[p3l1966t497r2148b577, p3l11t626r332b706],

1	For	IN	O	for	_	0	SENT_41	[p3l398t634r542b706],
2	example	NN	O	example	prep_for	10	SENT_41	[p3l601t626r983b727],
3	,	,	O	,	_	0	SENT_41	[p3l601t626r983b727],
4	gene	NN	O	gene	nn	7	SENT_41	[p3l1050t627r1754b728],
5	—	NN	O	—	nn	7	SENT_41	[p3l1050t627r1754b728],
6	eXpression	NN	O	expression	nn	7	SENT_41	[p3l1050t627r1754b728],
7	profiles	NNS	O	profile	nsubjpass	10	SENT_41	[p3l1814t625r2147b727],
8	have	VBP	O	have	aux	10	SENT_41	[p3l10t754r201b833],
9	been	VBN	O	be	auxpass	10	SENT_41	[p3l249t754r452b833],
10	used	VBN	O	use	_	0	SENT_41	[p3l499t754r698b833],
11	to	TO	O	to	aux	12	SENT_41	[p3l745t771r827b833],
12	define	VB	O	define	xcomp	10	SENT_41	[p3l876t753r1148b833],
13	the	DT	O	the	det	14	SENT_41	[p3l1196t754r1330b832],
14	risk	NN	O	risk	dobj	12	SENT_41	[p3l1377t754r1542b834],
15	of	IN	O	of	_	0	SENT_41	[p3l1586t753r1686b833],
16	relapse	NN	O	relapse	prep_of	14	SENT_41	[p3l1715t754r2019b854],
17	in	IN	O	in	_	0	SENT_41	[p3l2065t755r2149b832],
18	patients	NNS	O	patient	prep_in	12	SENT_41	[p3l9t884r352b983],
19	with	IN	O	with	_	0	SENT_41	[p3l415t883r612b962],
20	early	JJ	O	early	amod	24	SENT_41	[p3l677t883r1140b984],
21	—	JJ	O	—	amod	24	SENT_41	[p3l677t883r1140b984],
22	stage	NN	O	stage	nn	24	SENT_41	[p3l677t883r1140b984],
23	breast	NN	O	breast	nn	24	SENT_41	[p3l1206t883r1471b962],
24	cancer	NN	O	cancer	prep_with	18	SENT_41	[p3l1531t909r1833b962],
25	.	.	O	.	_	0	SENT_41	[p3l1531t909r1833b962],

1	Three	CD	NUMBER	three	num	2	SENT_42	[p3l1899t883r2149b962],
2	profiles	NNS	O	profile	nsubj	4	SENT_42	[p3l9t1010r342b1112],
3	have	VBP	O	have	aux	4	SENT_42	[p3l393t1011r585b1091],
4	shown	VBN	O	show	_	0	SENT_42	[p3l637t1011r920b1091],
5	prognostic	JJ	O	prognostic	amod	6	SENT_42	[p3l969t1012r1437b1113],
6	ability	NN	O	ability	dobj	4	SENT_42	[p3l1486t1011r1776b1112],
7	:	:	O	:	_	0	SENT_42	[p3l1486t1011r1776b1112],
8	the	DT	O	the	det	10	SENT_42	[p3l1830t1011r1964b1090],
9	70gene	JJ	O	70gene	amod	10	SENT_42	[p3l2015t1017r2148b1091, p3l10t1166r210b1242],
10	profile	NN	O	profile	dep	6	SENT_42	[p3l281t1139r572b1241],
11	(	CD	NUMBER	(	num	13	SENT_42	[p3l648t1141r1307b1237],
12	MammaPrint	NNP	O	MammaPrint	nn	13	SENT_42	[p3l648t1141r1307b1237],
13	)	NNP	O	)	dep	10	SENT_42	[p3l648t1141r1307b1237],
14	,	,	O	,	_	0	SENT_42	[p3l648t1141r1307b1237],
15	approved	VBN	O	approve	partmod	4	SENT_42	[p3l1384t1140r1777b1241],
16	by	IN	O	by	_	0	SENT_42	[p3l1850t1140r1948b1241],
17	the	DT	O	the	det	21	SENT_42	[p3l2016t1140r2149b1219],
18	Food	NNP	ORGANIZATION	Food	nn	21	SENT_42	[p3l8t1269r225b1348],
19	and	CC	ORGANIZATION	and	_	0	SENT_42	[p3l281t1269r440b1348],
20	Drug	NNP	ORGANIZATION	Drug	conj_and	18	SENT_42	[p3l496t1275r719b1370],
21	Administration	NNP	ORGANIZATION	Administration	agent	15	SENT_42	[p3l769t1269r1440b1348],
22	(	CD	NUMBER	(	num	23	SENT_42	[p3l1502t1275r1768b1365],
23	FDA	NNP	ORGANIZATION	FDA	dep	21	SENT_42	[p3l1502t1275r1768b1365],
24	)	CD	NUMBER	)	num	23	SENT_42	[p3l1502t1275r1768b1365],
25	;	:	O	;	_	0	SENT_42	[p3l1502t1275r1768b1365],
26	the	DT	O	the	det	30	SENT_42	[p3l1829t1269r1963b1347],
27	21gene	JJ	O	21gene	amod	30	SENT_42	[p3l2020t1275r2148b1347, p3l10t1423r210b1498],
28	recurrence	NN	O	recurrence	nn	30	SENT_42	[p3l266t1423r724b1476],
29	score	NN	NUMBER	score	nn	30	SENT_42	[p3l781t1423r1003b1476],
30	(	NN	O	(	agent	15	SENT_42	[p3l1063t1403r1505b1497],
31	Oncotype	NNP	O	Oncotype	nn	33	SENT_42	[p3l1063t1403r1505b1497],
32	DX	NNP	O	DX	nn	33	SENT_42	[p3l1559t1403r1743b1492],
33	)	NN	O	)	dep	30	SENT_42	[p3l1559t1403r1743b1492],
34	;	:	O	;	_	0	SENT_42	[p3l1559t1403r1743b1492],
35	and	CC	O	and	_	0	SENT_42	[p3l1801t1397r1961b1476],
36	the	DT	O	the	det	40	SENT_42	[p3l2016t1397r2149b1476],
37	76	CD	NUMBER	76	num	40	SENT_42	[p3l11t1531r348b1626],
38	—	NN	O	—	nn	40	SENT_42	[p3l11t1531r348b1626],
39	gene	NN	O	gene	nn	40	SENT_42	[p3l11t1531r348b1626],
40	outcome	NN	O	outcome	agent	15	SENT_42	[p3l384t1542r755b1604],
41	Rotterdam	NNP	LOCATION	Rotterdam	nn	42	SENT_42	[p3l790t1525r1256b1608],
42	signature	NN	O	signature	dep	40	SENT_42	[p3l1293t1526r1864b1626],
43	.9	CD	NUMBER	.9	number	44	SENT_42	[p3l1293t1526r1864b1626],
44	'11	CD	NUMBER	'11	num	46	SENT_42	[p3l1293t1526r1864b1626],
45	These	DT	O	these	det	46	SENT_42	[p3l1896t1525r2149b1604],
46	profiles	NNS	O	profile	dobj	15	SENT_42	[p3l8t1651r366b1752],
47	,	,	O	,	_	0	SENT_42	[p3l8t1651r366b1752],
48	which	WDT	O	which	nsubjpass	50	SENT_42	[p3l410t1652r674b1732],
49	are	VBP	O	be	auxpass	50	SENT_42	[p3l716t1678r846b1730],
50	obtained	VBN	O	obtain	rcmod	46	SENT_42	[p3l889t1652r1270b1731],
51	with	IN	O	with	_	0	SENT_42	[p3l1307t1652r1504b1732],
52	the	DT	O	the	det	53	SENT_42	[p3l1547t1652r1680b1730],
53	use	NN	O	use	prep_with	50	SENT_42	[p3l1722t1678r1864b1732],
54	of	IN	O	of	_	0	SENT_42	[p3l1907t1651r2007b1731],
55	tumor	NN	O	tumor	nn	56	SENT_42	[p3l2032t1669r2148b1731, p3l10t1781r535b1861],
56	—	NN	O	—	prep_of	53	SENT_42	[p3l2032t1669r2148b1731, p3l10t1781r535b1861],
57	derived	VBN	O	derive	partmod	56	SENT_42	[p3l2032t1669r2148b1731, p3l10t1781r535b1861],
58	mRNA	NN	O	mrna	dobj	57	SENT_42	[p3l582t1787r882b1865],
59	assayed	VBN	O	assay	conj_or	59	SENT_42	[p3l926t1781r1253b1881],
60	on	IN	O	on	_	0	SENT_42	[p3l1301t1807r1408b1860],
61	either	CC	O	either	prep_on	59	SENT_42	[p3l1457t1781r1706b1859],
62	DNA	NN	O	dna	nn	63	SENT_42	[p3l1749t1787r1959b1860],
63	microarrays	NNS	O	microarray	conj	59	SENT_42	[p3l2003t1782r2148b1859, p3l11t1937r408b2011],
64	or	CC	O	or	_	0	SENT_42	[p3l445t1937r534b1990],
65	by	IN	O	by	_	0	SENT_42	[p3l566t1911r664b2011],
66	quantitative	JJ	O	quantitative	amod	69	SENT_42	[p3l695t1912r1209b2011],
67	reverse	JJ	O	reverse	amod	69	SENT_42	[p3l1244t1912r2149b2011],
68	—	NN	O	—	nn	69	SENT_42	[p3l1244t1912r2149b2011],
69	transcriptase	NN	O	transcriptase	nn	72	SENT_42	[p3l1244t1912r2149b2011],
70	polymerase-chain	JJ	O	polymerase-chain	amod	72	SENT_42	[p3l8t2040r1171b2140],
71	—	NN	O	—	nn	72	SENT_42	[p3l8t2040r1171b2140],
72	reaction	NN	O	reaction	agent	59	SENT_42	[p3l8t2040r1171b2140],
73	(	CD	NUMBER	(	num	74	SENT_42	[p3l1242t2046r1634b2131],
74	RT	NN	O	rt	dep	59	SENT_42	[p3l1242t2046r1634b2131],
75	.	.	O	.	_	0	SENT_42	[p3l1242t2046r1634b2131],

1	—	NN	O	—	_	0	SENT_43	[p3l1242t2046r1634b2131],
2	.	.	O	.	_	0	SENT_43	[p3l1242t2046r1634b2131],

1	PCR	NN	O	pcr	nn	3	SENT_44	[p3l1242t2046r1634b2131],
2	)	NN	O	)	nn	3	SENT_44	[p3l1242t2046r1634b2131],
3	assay	NN	O	assay	_	0	SENT_44	[p3l1705t2066r1947b2140],
4	,	,	O	,	_	0	SENT_44	[p3l1705t2066r1947b2140],
5	are	VBP	O	be	aux	7	SENT_44	[p3l2019t2066r2149b2118],
6	being	VBG	O	be	auxpass	7	SENT_44	[p3l11t2169r253b2270],
7	used	VBN	O	use	rcmod	3	SENT_44	[p3l283t2169r481b2248],
8	in	IN	O	in	_	0	SENT_44	[p3l513t2170r597b2247],
9	clinical	JJ	O	clinical	amod	10	SENT_44	[p3l630t2169r946b2247],
10	practice	NN	O	practice	prep_in	7	SENT_44	[p3l977t2170r1318b2269],
11	to	TO	O	to	aux	12	SENT_44	[p3l1352t2186r1434b2248],
12	predict	VB	O	predict	ccomp	7	SENT_44	[p3l1466t2169r1772b2269],
13	prognosis	NN	O	prognosis	dobj	12	SENT_44	[p3l1799t2195r2148b2270, p3l11t2297r118b2374],
14	and	CC	O	and	_	0	SENT_44	[p3l163t2296r322b2375],
15	hence	RB	O	hence	advmod	12	SENT_44	[p3l365t2296r613b2374],
16	to	TO	O	to	aux	17	SENT_44	[p3l657t2313r739b2375],
17	influence	VB	O	influence	conj_and	12	SENT_44	[p3l782t2295r1189b2376],
18	therapeutic	JJ	O	therapeutic	amod	19	SENT_44	[p3l1233t2296r1722b2396],
19	intervenCancer	NN	O	intervencancer	dobj	17	SENT_44	[p3l1764t2297r2148b2376, p4l60t280r243b324],

1	genome	NN	O	genome	_	0	SENT_45	[p4l259t292r485b339],
2	:	:	O	:	_	0	SENT_45	[p4l259t292r485b339],
3	The	DT	O	the	det	5	SENT_45	[p4l503t276r598b324],
4	entire	JJ	O	entire	amod	5	SENT_45	[p4l617t281r762b324],
5	set	NN	O	set	dep	1	SENT_45	[p4l782t286r854b324],
6	of	IN	O	of	_	0	SENT_45	[p4l872t276r928b324],
7	unique	JJ	O	unique	amod	8	SENT_45	[p4l940t281r1114b339],
8	DNA	NN	O	dna	prep_of	5	SENT_45	[p4l1136t279r1261b324],
9	that	WDT	O	that	nsubj	10	SENT_45	[p4l1275t276r1377b324],
10	makes	VBZ	O	make	rcmod	5	SENT_45	[p4l1397t276r1559b324],
11	up	RP	O	up	prt	10	SENT_45	[p4l1581t293r1643b339],
12	a	DT	O	a	det	14	SENT_45	[p4l1662t293r1686b324],
13	speciﬁc	NN	O	speciﬁc	nn	14	SENT_45	[p4l1707t276r1899b339],
14	cancer	NN	O	cancer	dobj	10	SENT_45	[p4l1916t293r2096b324],
15	.	.	O	.	_	0	SENT_45	[p4l1916t293r2096b324],

1	Deep	JJ	O	deep	amod	2	SENT_46	[p4l64t353r197b411],
2	sequencing	NN	O	sequencing	_	0	SENT_46	[p4l215t349r530b411],
3	:	:	O	:	_	0	SENT_46	[p4l215t349r530b411],
4	Genetic	JJ	O	genetic	amod	5	SENT_46	[p4l551t352r751b396],
5	sequencing	NN	O	sequencing	dep	2	SENT_46	[p4l771t353r1070b412],
6	at	IN	O	at	_	0	SENT_46	[p4l1089t358r1135b396],
7	sufficiently	RB	O	sufficiently	advmod	8	SENT_46	[p4l1154t348r1436b411],
8	high	JJ	O	high	amod	9	SENT_46	[p4l1456t348r1563b412],
9	coverage	NN	O	coverage	prep_at	5	SENT_46	[p4l1586t365r1817b412],
10	to	TO	O	to	aux	11	SENT_46	[p4l1835t358r1886b396],
11	identify	VB	O	identify	infmod	5	SENT_46	[p4l1907t348r2097b412],
12	low-frequency	NN	O	low-frequency	nn	13	SENT_46	[p4l160t420r521b484],
13	mutations	NNS	O	mutation	dobj	11	SENT_46	[p4l542t425r821b469],
14	.	.	O	.	_	0	SENT_46	[p4l542t425r821b469],

1	Epigenomic	NNP	O	Epigenomic	_	0	SENT_47	[p4l64t494r385b555],
2	:	:	O	:	_	0	SENT_47	[p4l64t494r385b555],
3	Pertaining	VBG	O	pertain	dep	1	SENT_47	[p4l409t497r673b556],
4	to	TO	O	to	_	0	SENT_47	[p4l690t502r741b541],
5	changes	NNS	O	change	prep_to	3	SENT_47	[p4l760t492r974b556],
6	in	IN	O	in	_	0	SENT_47	[p4l997t497r1038b540],
7	the	DT	O	the	det	12	SENT_47	[p4l1059t492r1140b541],
8	regulation	NN	O	regulation	nn	12	SENT_47	[p4l1162t492r1422b556],
9	ofthe	NN	O	ofthe	nn	12	SENT_47	[p4l1444t492r1591b541],
10	expression	NN	O	expression	nn	12	SENT_47	[p4l1610t497r1887b555],
11	ofgene	NN	O	ofgene	nn	12	SENT_47	[p4l1909t492r2099b556],
12	activity	NN	O	activity	prep_in	5	SENT_47	[p4l158t569r339b628],
13	without	IN	O	without	_	0	SENT_47	[p4l355t565r555b613],
14	alteration	NN	O	alteration	prep_without	3	SENT_47	[p4l574t565r819b613],
15	of	IN	O	of	_	0	SENT_47	[p4l841t564r898b613],
16	genetic	JJ	O	genetic	amod	18	SENT_47	[p4l908t569r1096b628],
17	structu	NN	O	structu	nn	18	SENT_47	[p4l1115t574r1295b613],
18	re	NN	O	re	prep_of	14	SENT_47	[p4l1305t582r1363b613],
19	.	.	O	.	_	0	SENT_47	[p4l1305t582r1363b613],

1	Genomewide	JJ	MISC	genomewide	amod	3	SENT_48	[p4l60t637r409b685],
2	association	NN	O	association	nn	3	SENT_48	[p4l427t638r721b685],
3	study	NN	O	study	_	0	SENT_48	[p4l741t637r898b700],
4	:	:	O	:	_	0	SENT_48	[p4l741t637r898b700],
5	An	DT	O	a	det	6	SENT_48	[p4l916t640r983b684],
6	approach	NN	O	approach	dep	3	SENT_48	[p4l1007t637r1247b699],
7	used	VBN	O	use	partmod	6	SENT_48	[p4l1272t637r1391b685],
8	in	IN	O	in	_	0	SENT_48	[p4l1415t641r1456b684],
9	genetics	NNS	O	genetics	nn	10	SENT_48	[p4l1479t641r1693b700],
10	research	NN	O	research	prep_in	7	SENT_48	[p4l1716t637r1931b685],
11	to	TO	O	to	aux	12	SENT_48	[p4l1952t646r2002b685],
12	look	VB	O	look	xcomp	7	SENT_48	[p4l160t709r267b757],
13	for	IN	O	for	_	0	SENT_48	[p4l284t708r356b757],
14	associations	NNS	O	association	prep_for	12	SENT_48	[p4l374t713r698b757],
15	between	IN	O	between	_	0	SENT_48	[p4l721t709r933b757],
16	many	JJ	O	many	amod	19	SENT_48	[p4l958t726r1098b772],
17	(	JJ	O	(	amod	19	SENT_48	[p4l1121t709r1348b772],
18	typically	RB	O	typically	advmod	17	SENT_48	[p4l1121t709r1348b772],
19	hundreds	NNS	O	hundred	prep_between	14	SENT_48	[p4l1368t709r1613b757],
20	ofthousands	NNS	O	ofthousand	dobj	12	SENT_48	[p4l1634t708r1995b772],
21	)	CD	NUMBER	)	num	24	SENT_48	[p4l1634t708r1995b772],
22	specific	JJ	O	specific	amod	24	SENT_48	[p4l158t781r354b844],
23	genetic	JJ	O	genetic	amod	24	SENT_48	[p4l373t786r561b845],
24	variations	NNS	O	variation	nsubj	25	SENT_48	[p4l577t786r833b829],
25	(	VBP	O	(	rcmod	20	SENT_48	[p4l860t785r1011b844],
26	most	RBS	O	most	advmod	27	SENT_48	[p4l860t785r1011b844],
27	commonly	RB	O	commonly	advmod	30	SENT_48	[p4l1029t781r1308b844],
28	single-nucleotide	JJ	O	single-nucleotide	amod	30	SENT_48	[p4l1327t781r1774b845],
29	polymorphisms	NNS	O	polymorphism	nn	30	SENT_48	[p4l1796t781r2026b844, p4l160t853r367b916],
30	)	NN	O	)	dobj	25	SENT_48	[p4l1796t781r2026b844, p4l160t853r367b916],
31	and	CC	O	and	_	0	SENT_48	[p4l393t853r485b901],
32	particular	JJ	O	particular	amod	33	SENT_48	[p4l510t853r757b916],
33	diseases	NNS	O	disease	dobj	25	SENT_48	[p4l775t853r1011b901],
34	.	.	O	.	_	0	SENT_48	[p4l775t853r1011b901],

1	lnactivating	VBG	O	lnactivate	dep	5	SENT_49	[p4l64t926r371b988],
2	mutation	NN	O	mutation	dobj	1	SENT_49	[p4l390t926r641b973],
3	:	:	O	:	_	0	SENT_49	[p4l390t926r641b973],
4	A	DT	O	a	det	5	SENT_49	[p4l659t929r697b973],
5	change	NN	O	change	_	0	SENT_49	[p4l714t925r900b989],
6	in	IN	O	in	_	0	SENT_49	[p4l922t930r963b973],
7	the	DT	O	the	det	12	SENT_49	[p4l984t925r1065b973],
8	DNA	NN	O	dna	nn	12	SENT_49	[p4l1089t929r1214b973],
9	sequence	NN	O	sequence	nn	12	SENT_49	[p4l1233t942r1477b988],
10	ofa	NN	O	ofa	nn	12	SENT_49	[p4l1497t925r1589b973],
11	specific	JJ	O	specific	amod	12	SENT_49	[p4l1611t925r1806b988],
12	gene	NN	O	gene	prep_in	5	SENT_49	[p4l1825t942r1947b989],
13	that	WDT	O	that	nsubj	14	SENT_49	[p4l1965t925r2068b973],
14	results	VBZ	O	result	rcmod	12	SENT_49	[p4l160t997r330b1046],
15	in	IN	O	in	_	0	SENT_49	[p4l353t1002r394b1045],
16	loss	NN	O	loss	prep_in	14	SENT_49	[p4l419t997r517b1046],
17	of	IN	O	of	_	0	SENT_49	[p4l538t997r595b1046],
18	biologic	JJ	O	biologic	amod	19	SENT_49	[p4l608t997r812b1061],
19	function	NN	O	function	prep_of	16	SENT_49	[p4l829t997r1061b1046],
20	.	.	O	.	_	0	SENT_49	[p4l829t997r1061b1046],

1	Gene	NNP	O	Gene	nn	2	SENT_50	[p4l60t1073r198b1118],
2	knock-down	NN	O	knock-down	_	0	SENT_50	[p4l217t1069r548b1118],
3	:	:	O	:	_	0	SENT_50	[p4l217t1069r548b1118],
4	Techniques	NNS	O	technique	dep	2	SENT_50	[p4l566t1069r867b1132],
5	by	IN	O	by	_	0	SENT_50	[p4l890t1069r945b1133],
6	which	WDT	O	which	agent	17	SENT_50	[p4l961t1069r1111b1118],
7	the	DT	O	the	det	9	SENT_50	[p4l1132t1069r1213b1118],
8	expression	NN	O	expression	nn	9	SENT_50	[p4l1233t1074r1510b1132],
9	ofone	NN	O	ofone	poss	15	SENT_50	[p4l1532t1069r1694b1118],
10	or	CC	O	or	_	0	SENT_50	[p4l1713t1087r1766b1118],
11	more	JJR	O	more	amod	13	SENT_50	[p4l1786t1087r1919b1118],
12	ofan	JJ	O	ofan	amod	13	SENT_50	[p4l1938t1069r2064b1118],
13	organism	NN	O	organism	poss	15	SENT_50	[p4l157t1145r448b1205],
14	’s	POS	O	’s	_	0	SENT_50	[p4l157t1145r448b1205],
15	genes	NNS	O	gene	nsubjpass	17	SENT_50	[p4l470t1159r620b1205],
16	are	VBP	O	be	auxpass	17	SENT_50	[p4l641t1159r718b1190],
17	reduced	VBN	O	reduce	rcmod	4	SENT_50	[p4l740t1142r944b1190],
18	by	IN	O	by	_	0	SENT_50	[p4l969t1142r1023b1205],
19	treatment	NN	O	treatment	agent	17	SENT_50	[p4l1039t1151r1298b1190],
20	with	IN	O	with	_	0	SENT_50	[p4l1315t1142r1422b1190],
21	a	DT	O	a	det	23	SENT_50	[p4l1445t1159r1469b1190],
22	speciﬁc	NN	O	speciﬁc	nn	23	SENT_50	[p4l1491t1141r1687b1204],
23	sequence	NN	O	sequence	prep_with	17	SENT_50	[p4l1706t1159r1950b1204],
24	of	IN	O	of	_	0	SENT_50	[p4l1970t1141r2027b1190],
25	RNA	NN	O	rna	prep_of	23	SENT_50	[p4l161t1217r278b1262],
26	that	WDT	O	that	nsubj	27	SENT_50	[p4l294t1214r397b1262],
27	targets	VBZ	O	target	rcmod	23	SENT_50	[p4l414t1223r593b1277],
28	a	DT	O	a	det	30	SENT_50	[p4l614t1231r638b1262],
29	specific	JJ	O	specific	amod	30	SENT_50	[p4l660t1213r856b1276],
30	gene	NN	O	gene	dobj	27	SENT_50	[p4l874t1231r1011b1277],
31	.	.	O	.	_	0	SENT_50	[p4l874t1231r1011b1277],

1	Messenger	NN	O	messenger	nn	3	SENT_51	[p4l64t1290r347b1349],
2	RNA	NN	O	rna	nn	3	SENT_51	[p4l365t1290r483b1334],
3	(	NN	O	(	_	0	SENT_51	[p4l501t1290r723b1349],
4	mRNA	NN	O	mrna	dep	3	SENT_51	[p4l501t1290r723b1349],
5	)	CD	NUMBER	)	num	4	SENT_51	[p4l501t1290r723b1349],
6	:	:	O	:	_	0	SENT_51	[p4l501t1290r723b1349],
7	RNA	NN	O	rna	dep	3	SENT_51	[p4l746t1289r862b1334],
8	that	WDT	O	that	nsubj	9	SENT_51	[p4l876t1286r977b1334],
9	serves	VBZ	O	serve	rcmod	7	SENT_51	[p4l995t1303r1153b1334],
10	as	IN	O	as	_	0	SENT_51	[p4l1173t1303r1225b1334],
11	a	DT	O	a	det	12	SENT_51	[p4l1245t1303r1270b1334],
12	template	NN	O	template	prep_as	9	SENT_51	[p4l1287t1286r1514b1349],
13	for	IN	O	for	_	0	SENT_51	[p4l1531t1285r1603b1334],
14	protein	NN	O	protein	nn	15	SENT_51	[p4l1621t1290r1798b1349],
15	synthesis	NN	O	synthesis	prep_for	12	SENT_51	[p4l1821t1286r2070b1349],
16	.	.	O	.	_	0	SENT_51	[p4l1821t1286r2070b1349],

1	Microarray-based	JJ	O	microarray-based	amod	2	SENT_52	[p4l64t1358r516b1421],
2	proﬁling	NN	O	proﬁling	_	0	SENT_52	[p4l538t1357r770b1421],
3	:	:	O	:	_	0	SENT_52	[p4l538t1357r770b1421],
4	The	DT	O	the	det	7	SENT_52	[p4l788t1358r885b1406],
5	use	NN	O	use	nn	7	SENT_52	[p4l907t1375r993b1406],
6	ofgene-expression	NN	O	ofgene-expression	nn	7	SENT_52	[p4l1012t1358r1502b1422],
7	signatures	NNS	O	signature	dep	2	SENT_52	[p4l1525t1363r1795b1422],
8	from	IN	O	from	_	0	SENT_52	[p4l1815t1358r1937b1406],
9	cancer	NN	O	cancer	nn	10	SENT_52	[p4l1959t1375r2066b1406, p4l157t1447r235b1478],
10	samples	NNS	O	sample	prep_from	7	SENT_52	[p4l253t1430r468b1493],
11	to	TO	O	to	aux	12	SENT_52	[p4l488t1439r538b1478],
12	define	VB	O	define	infmod	7	SENT_52	[p4l558t1430r717b1478],
13	some	DT	O	some	det	15	SENT_52	[p4l738t1447r879b1478],
14	aspect	NN	O	aspect	nn	15	SENT_52	[p4l899t1439r1067b1493],
15	ofoutcome	NN	O	ofoutcome	dobj	12	SENT_52	[p4l1086t1430r1384b1478],
16	(	CD	NUMBER	(	tmod	12	SENT_52	[p4l1409t1434r1530b1494],
17	e.g.	FW	O	e.g.	dep	12	SENT_52	[p4l1409t1434r1530b1494],
18	,	,	O	,	_	0	SENT_52	[p4l1409t1434r1530b1494],
19	recurrence	NN	O	recurrence	nn	20	SENT_52	[p4l1555t1447r1829b1478],
20	rates	NNS	O	rate	dep	17	SENT_52	[p4l1851t1439r1973b1478],
21	and	CC	O	and	_	0	SENT_52	[p4l1995t1430r2087b1478],
22	drug	NN	O	drug	nn	24	SENT_52	[p4l157t1502r277b1566],
23	response	NN	O	response	nn	24	SENT_52	[p4l298t1506r571b1565],
24	)	NN	O	)	dep	17	SENT_52	[p4l298t1506r571b1565],
25	.	.	O	.	_	0	SENT_52	[p4l298t1506r571b1565],

1	MicroRNA	NN	O	microrna	_	0	SENT_53	[p4l64t1575r351b1623],
2	:	:	O	:	_	0	SENT_53	[p4l64t1575r351b1623],
3	A	DT	O	a	det	6	SENT_53	[p4l369t1578r407b1622],
4	short	JJ	O	short	amod	6	SENT_53	[p4l426t1574r559b1623],
5	regulatory	JJ	O	regulatory	amod	6	SENT_53	[p4l581t1574r841b1638],
6	form	NN	O	form	dep	1	SENT_53	[p4l858t1574r980b1623],
7	of	IN	O	of	_	0	SENT_53	[p4l1002t1574r1059b1623],
8	RNA	NN	O	rna	prep_of	6	SENT_53	[p4l1073t1578r1190b1622],
9	that	WDT	O	that	nsubj	17	SENT_53	[p4l1206t1574r1309b1623],
10	binds	VBZ	O	bind	rcmod	6	SENT_53	[p4l1330t1574r1469b1623],
11	to	TO	O	to	_	0	SENT_53	[p4l1488t1584r1539b1623],
12	a	DT	O	a	det	14	SENT_53	[p4l1560t1591r1584b1622],
13	target	NN	O	target	nn	14	SENT_53	[p4l1603t1584r1755b1638],
14	RNA	NN	O	rna	prep_to	10	SENT_53	[p4l1778t1578r1895b1622],
15	and	CC	O	and	_	0	SENT_53	[p4l1913t1574r2005b1622],
16	generally	RB	O	generally	advmod	17	SENT_53	[p4l158t1646r390b1710],
17	suppresses	VBZ	O	suppress	rcmod	6	SENT_53	[p4l410t1663r703b1709],
18	its	PRP$	O	its	poss	19	SENT_53	[p4l726t1651r782b1695],
19	translation	NN	O	translation	dobj	17	SENT_53	[p4l801t1646r1082b1695],
20	by	IN	O	by	_	0	SENT_53	[p4l1107t1646r1161b1710],
21	ribosomes	NNS	O	ribosome	prep_by	17	SENT_53	[p4l1181t1646r1469b1695],
22	.	.	O	.	_	0	SENT_53	[p4l1181t1646r1469b1695],

1	Next-generation	JJ	O	next-generation	amod	2	SENT_54	[p4l64t1720r483b1781],
2	sequencing	NN	O	sequencing	_	0	SENT_54	[p4l504t1720r819b1781],
3	:	:	O	:	_	0	SENT_54	[p4l504t1720r819b1781],
4	DNA	NN	O	dna	nn	5	SENT_54	[p4l843t1722r968b1766],
5	sequencing	NN	O	sequencing	dep	2	SENT_54	[p4l987t1723r1286b1782],
6	that	WDT	O	that	nsubj	7	SENT_54	[p4l1302t1718r1405b1767],
7	harnesses	VBZ	O	harness	rcmod	5	SENT_54	[p4l1426t1718r1685b1767],
8	advances	NNS	O	advance	dobj	7	SENT_54	[p4l1707t1718r1946b1767],
9	in	IN	O	in	_	0	SENT_54	[p4l1969t1723r2011b1766],
10	miniaturization	NN	O	miniaturization	nn	11	SENT_54	[p4l160t1795r558b1839],
11	technology	NN	O	technology	prep_in	8	SENT_54	[p4l578t1791r867b1854],
12	to	TO	O	to	_	0	SENT_54	[p4l883t1800r934b1839],
13	simultaneously	RB	O	simultaneously	advmod	14	SENT_54	[p4l955t1791r1353b1854],
14	sequence	NN	O	sequence	prep_to	7	SENT_54	[p4l1372t1808r1617b1853],
15	multiple	JJ	O	multiple	amod	16	SENT_54	[p4l1639t1791r1852b1853],
16	areas	NNS	O	area	dep	14	SENT_54	[p4l1872t1808r2007b1839],
17	of	IN	O	of	_	0	SENT_54	[p4l2028t1790r2085b1839],
18	the	DT	O	the	det	19	SENT_54	[p4l155t1863r237b1911],
19	genome	NN	O	genome	prep_of	14	SENT_54	[p4l257t1880r468b1926],
20	rapidly	RB	O	rapidly	dep	14	SENT_54	[p4l490t1863r663b1926],
21	and	CC	O	and	_	0	SENT_54	[p4l681t1863r773b1911],
22	at	IN	O	at	dep	14	SENT_54	[p4l796t1872r842b1911],
23	low	JJ	O	low	amod	24	SENT_54	[p4l863t1863r950b1911],
24	cost	NN	O	cost	pobj	22	SENT_54	[p4l968t1872r1088b1911],
25	.	.	O	.	_	0	SENT_54	[p4l968t1872r1088b1911],

1	Quantitative	JJ	O	quantitative	amod	3	SENT_55	[p4l60t1936r389b1997],
2	reverse-transcriptase	JJ	O	reverse-transcriptase	amod	3	SENT_55	[p4l408t1936r957b1997],
3	polymerase	NN	O	polymerase	dep	7	SENT_55	[p4l977t1935r1277b1998],
4	chain	NN	O	chain	dep	3	SENT_55	[p4l1294t1935r1433b1983],
5	reaction	NN	O	reaction	dep	7	SENT_55	[p4l1456t1936r1663b1983],
6	(	CD	NUMBER	(	num	5	SENT_55	[p4l1686t1939r1936b1999],
7	RT-PCR	NN	O	rt-pcr	dep	10	SENT_55	[p4l1686t1939r1936b1999],
8	)	CD	NUMBER	)	dep	7	SENT_55	[p4l1686t1939r1936b1999],
9	:	:	O	:	_	0	SENT_55	[p4l1686t1939r1936b1999],
10	A	DT	O	a	_	0	SENT_55	[p4l1954t1938r1991b1982],

1	laboratory	NN	O	laboratory	nn	2	SENT_56	[p4l160t2007r422b2071],
2	technique	NN	O	technique	nsubj	3	SENT_56	[p4l438t2007r697b2070],
3	based	VBN	O	base	_	0	SENT_56	[p4l718t2007r866b2055],
4	on	IN	O	on	_	0	SENT_56	[p4l888t2024r950b2055],
5	the	DT	O	the	det	8	SENT_56	[p4l970t2007r1052b2055],
6	polymerase	NN	O	polymerase	nn	8	SENT_56	[p4l1074t2007r1372b2070],
7	chain	NN	O	chain	nn	8	SENT_56	[p4l1392t2007r1528b2055],
8	reaction	NN	O	reaction	prep_on	3	SENT_56	[p4l1553t2012r1775b2064],
9	,	,	O	,	_	0	SENT_56	[p4l1553t2012r1775b2064],
10	which	WDT	O	which	nsubj	11	SENT_56	[p4l1795t2007r1946b2055],
11	enables	VBZ	O	enable	rcmod	8	SENT_56	[p4l1968t2024r2046b2055, p4l158t2079r290b2127],
12	both	DT	O	both	preconj	13	SENT_56	[p4l313t2079r425b2127],
13	detection	NN	O	detection	dobj	11	SENT_56	[p4l447t2079r688b2127],
14	and	CC	O	and	_	0	SENT_56	[p4l711t2079r802b2127],
15	quantification	NN	O	quantification	nn	17	SENT_56	[p4l825t2079r1184b2142],
16	ofgene	NN	O	ofgene	nn	17	SENT_56	[p4l1206t2079r1396b2143],
17	expression	NN	O	expression	conj_and	13	SENT_56	[p4l1416t2084r1710b2142],
18	.	.	O	.	_	0	SENT_56	[p4l1416t2084r1710b2142],

1	Small	JJ	O	small	dep	2	SENT_57	[p4l60t2151r204b2199],
2	interfering	VBG	O	interfere	dep	11	SENT_57	[p4l225t2150r498b2214],
3	RNA	NN	O	rna	dobj	2	SENT_57	[p4l518t2156r650b2199],
4	:	:	O	:	_	0	SENT_57	[p4l518t2156r650b2199],
5	A	DT	O	a	det	11	SENT_57	[p4l668t2155r705b2199],
6	short	JJ	O	short	amod	11	SENT_57	[p4l724t2151r871b2208],
7	,	,	O	,	_	0	SENT_57	[p4l724t2151r871b2208],
8	double-stranded	JJ	O	double-stranded	amod	11	SENT_57	[p4l893t2151r1321b2199],
9	regulatory	JJ	O	regulatory	amod	11	SENT_57	[p4l1345t2151r1606b2215],
10	RNA	NN	O	rna	nn	11	SENT_57	[p4l1628t2155r1745b2199],
11	molecule	NN	O	molecule	_	0	SENT_57	[p4l1765t2151r2001b2199],
12	that	WDT	O	that	nsubj	13	SENT_57	[p4l155t2223r258b2272],
13	binds	VBZ	O	bind	rcmod	11	SENT_57	[p4l279t2223r418b2272],
14	to	TO	O	to	prep	13	SENT_57	[p4l438t2233r488b2272],
15	and	CC	O	and	_	0	SENT_57	[p4l509t2223r601b2272],
16	induces	VBZ	O	induce	conj_and	13	SENT_57	[p4l625t2223r824b2272],
17	the	DT	O	the	det	21	SENT_57	[p4l843t2223r924b2272],
18	degradation	NN	O	degradation	nn	21	SENT_57	[p4l944t2223r1255b2287],
19	oftarget	NN	O	oftarget	nn	21	SENT_57	[p4l1278t2223r1496b2287],
20	RNA	NN	O	rna	nn	21	SENT_57	[p4l1518t2227r1636b2271],
21	molecules	NNS	O	molecule	dobj	16	SENT_57	[p4l1656t2223r1934b2272],
22	.	.	O	.	_	0	SENT_57	[p4l1656t2223r1934b2272],

1	Transcriptomic	NNP	MISC	Transcriptomic	_	0	SENT_58	[p4l59t2297r473b2358],
2	:	:	O	:	_	0	SENT_58	[p4l59t2297r473b2358],
3	Pertaining	VBG	O	pertain	dep	1	SENT_58	[p4l497t2300r761b2359],
4	to	TO	O	to	_	0	SENT_58	[p4l778t2305r828b2344],
5	the	DT	O	the	det	8	SENT_58	[p4l846t2295r928b2344],
6	study	NN	O	study	nn	8	SENT_58	[p4l949t2295r1088b2359],
7	ofthe	NN	O	ofthe	nn	8	SENT_58	[p4l1106t2295r1253b2344],
8	transcriptome	NN	O	transcriptome	prep_to	3	SENT_58	[p4l1270t2300r1656b2358],
9	,	,	O	,	_	0	SENT_58	[p4l1270t2300r1656b2358],
10	the	DT	O	the	det	11	SENT_58	[p4l1676t2295r1758b2344],
11	set	NN	O	set	appos	8	SENT_58	[p4l1778t2305r1852b2344],
12	of	IN	O	of	_	0	SENT_58	[p4l1870t2295r1927b2344],
13	all	DT	O	all	prep_of	11	SENT_58	[p4l1938t2295r1991b2344],

1	RNA	NN	O	rna	nn	2	SENT_59	[p4l161t2371r278b2415],
2	molecules	NNS	O	molecule	nsubjpass	18	SENT_59	[p4l299t2368r561b2416],
3	in	IN	O	in	_	0	SENT_59	[p4l584t2372r625b2415],
4	any	DT	O	any	det	6	SENT_59	[p4l649t2385r736b2431],
5	population	NN	O	population	nn	6	SENT_59	[p4l757t2368r1036b2430],
6	ofcells	NNS	O	ofcell	prep_in	2	SENT_59	[p4l1058t2367r1252b2424],
7	;	:	O	;	_	0	SENT_59	[p4l1058t2367r1252b2424],
8	the	DT	O	the	det	12	SENT_59	[p4l1272t2368r1353b2416],
9	examination	NN	O	examination	nn	12	SENT_59	[p4l1373t2372r1692b2416],
10	ofthe	NN	O	ofthe	nn	12	SENT_59	[p4l1714t2367r1861b2416],
11	expression	NN	O	expression	nn	12	SENT_59	[p4l1881t2385r2065b2430, p4l158t2444r263b2488],
12	level	NN	O	level	dep	6	SENT_59	[p4l288t2440r398b2488],
13	of	IN	O	of	_	0	SENT_59	[p4l420t2439r477b2488],
14	messenger	NN	O	messenger	nn	15	SENT_59	[p4l490t2457r775b2503],
15	RNA	NN	O	rna	prep_of	12	SENT_59	[p4l797t2443r914b2488],
16	is	VBZ	O	be	auxpass	18	SENT_59	[p4l934t2444r970b2488],
17	typically	RB	O	typically	advmod	18	SENT_59	[p4l989t2440r1200b2503],
18	carried	VBN	O	carry	_	0	SENT_59	[p4l1218t2440r1393b2488],
19	out	RP	O	out	prt	18	SENT_59	[p4l1415t2449r1501b2488],
20	with	IN	O	with	_	0	SENT_59	[p4l1517t2440r1624b2488],
21	the	DT	O	the	det	22	SENT_59	[p4l1645t2440r1726b2488],
22	use	NN	O	use	prep_with	18	SENT_59	[p4l1748t2457r1835b2488],
23	of	IN	O	of	_	0	SENT_59	[p4l1854t2439r1911b2488],
24	DNA	NN	O	dna	nn	26	SENT_59	[p4l1925t2443r2051b2488],
25	microarray	NN	O	microarray	nn	26	SENT_59	[p4l160t2516r439b2575],
26	platforms	NNS	O	platform	prep_of	22	SENT_59	[p4l459t2511r723b2575],
27	.	.	O	.	_	0	SENT_59	[p4l459t2511r723b2575],

1	tion	NN	O	tion	_	0	SENT_60	[p4l10t2772r153b2830],
2	.	.	O	.	_	0	SENT_60	[p4l10t2772r153b2830],

1	The	DT	O	the	det	2	SENT_61	[p4l194t2771r314b2829],
2	use	NN	O	use	nsubjpass	9	SENT_61	[p4l353t2790r457b2830],
3	of	IN	O	of	_	0	SENT_61	[p4l497t2770r572b2830],
4	the	DT	O	the	det	7	SENT_61	[p4l597t2771r696b2829],
5	Oncotype	NNP	O	Oncotype	nn	7	SENT_61	[p4l735t2775r1042b2845],
6	DX	NNP	O	DX	nn	7	SENT_61	[p4l1080t2776r1176b2829],
7	assay	NN	O	assay	prep_of	2	SENT_61	[p4l1212t2790r1381b2845],
8	is	VBZ	O	be	auxpass	9	SENT_61	[p4l1416t2772r1465b2829],
9	included	VBN	O	include	_	0	SENT_61	[p4l1505t2772r1591b2828, p4l11t2866r218b2925],
10	in	IN	O	in	_	0	SENT_61	[p4l254t2867r316b2923],
11	the	DT	O	the	det	13	SENT_61	[p4l353t2866r452b2924],
12	2007	CD	DATE	2007	num	13	SENT_61	[p4l489t2870r641b2925],
13	guidelines	NNS	O	guideline	prep_in	9	SENT_61	[p4l678t2866r1010b2941],
14	of	IN	O	of	_	0	SENT_61	[p4l1048t2865r1123b2925],
15	the	DT	O	the	det	17	SENT_61	[p4l1146t2866r1245b2924],
16	American	NNP	ORGANIZATION	American	nn	17	SENT_61	[p4l1279t2867r1592b2924],
17	Society	NNP	ORGANIZATION	Society	prep_of	13	SENT_61	[p4l12t2962r239b3035],
18	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l259t2960r333b3020],
19	Clinical	JJ	ORGANIZATION	clinical	amod	20	SENT_61	[p4l343t2961r591b3020],
20	Oncology	NN	ORGANIZATION	oncology	prep_of	17	SENT_61	[p4l614t2961r923b3036],
21	for	IN	O	for	_	0	SENT_61	[p4l943t2960r1034b3020],
22	the	DT	O	the	det	23	SENT_61	[p4l1056t2961r1155b3019],
23	evaluation	NN	O	evaluation	prep_for	20	SENT_61	[p4l1179t2961r1508b3020],
24	of	IN	O	of	_	0	SENT_61	[p4l1532t2960r1606b3020],
25	patients	NNS	O	patient	prep_of	23	SENT_61	[p4l9t3057r263b3130],
26	with	IN	O	with	_	0	SENT_61	[p4l294t3056r440b3115],
27	node-negative	JJ	O	node-negative	amod	30	SENT_61	[p4l472t3056r936b3131],
28	,	,	O	,	_	0	SENT_61	[p4l472t3056r936b3131],
29	ER-positive	JJ	O	er-positive	amod	30	SENT_61	[p4l971t3057r1328b3130],
30	disease	NN	O	disease	prep_with	25	SENT_61	[p4l1361t3056r1592b3115],
31	to	TO	O	to	aux	32	SENT_61	[p4l10t3163r71b3210],
32	identify	VB	O	identify	xcomp	9	SENT_61	[p4l101t3150r349b3225],
33	those	DT	O	those	dobj	32	SENT_61	[p4l375t3151r548b3210],
34	who	WP	O	who	nsubj	36	SENT_61	[p4l574t3151r711b3210],
35	may	MD	O	may	aux	36	SENT_61	[p4l741t3170r874b3225],
36	obtain	VB	O	obtain	dep	32	SENT_61	[p4l901t3151r1107b3210],
37	the	DT	O	the	dobj	36	SENT_61	[p4l1137t3151r1236b3209],
38	most	RBS	O	most	advmod	37	SENT_61	[p4l1265t3163r1426b3210],
39	benefit	VB	O	benefit	dep	36	SENT_61	[p4l1453t3151r1591b3210, p4l11t3245r119b3304],
40	from	IN	O	from	_	0	SENT_61	[p4l150t3245r306b3305],
41	adjuvant	JJ	O	adjuvant	amod	42	SENT_61	[p4l341t3246r611b3320],
42	tamoxifen	NN	O	tamoxifen	prep_from	39	SENT_61	[p4l642t3245r970b3305],
43	and	CC	O	and	_	0	SENT_61	[p4l1004t3246r1121b3305],
44	who	WP	O	who	nsubj	47	SENT_61	[p4l1153t3246r1289b3305],
45	may	MD	O	may	aux	47	SENT_61	[p4l1325t3265r1458b3320],
46	not	RB	O	not	neg	47	SENT_61	[p4l1489t3258r1596b3305],
47	require	VB	O	require	conj_and	36	SENT_61	[p4l10t3342r238b3415],
48	chemotherapy	NN	O	chemotherapy	dobj	47	SENT_61	[p4l261t3341r725b3415],
49	.	.	O	.	_	0	SENT_61	[p4l261t3341r725b3415],

1	Remarkably	RB	O	remarkably	advmod	10	SENT_62	[p4l751t3341r1146b3415],
2	,	,	O	,	_	0	SENT_62	[p4l751t3341r1146b3415],
3	a	DT	O	a	det	6	SENT_62	[p4l1173t3360r1206b3399],
4	recent	JJ	O	recent	amod	6	SENT_62	[p4l1227t3353r1425b3399],
5	multicenter	NN	O	multicenter	nn	6	SENT_62	[p4l1443t3341r1591b3400, p4l10t3437r253b3494],
6	study	NN	O	study	nsubj	10	SENT_62	[p4l284t3436r455b3510],
7	of	IN	O	of	_	0	SENT_62	[p4l485t3435r559b3495],
8	physician	NN	O	physician	nn	9	SENT_62	[p4l576t3436r878b3510],
9	practice	NN	O	practice	prep_of	6	SENT_62	[p4l909t3437r1161b3510],
10	showed	VBD	O	show	_	0	SENT_62	[p4l1194t3436r1435b3495],
11	that	IN	O	that	complm	19	SENT_62	[p4l1467t3436r1596b3494],
12	the	DT	O	the	det	17	SENT_62	[p5l10t17r109b75],
13	medical	JJ	O	medical	amod	17	SENT_62	[p5l146t17r765b92],
14	—	NN	O	—	nn	17	SENT_62	[p5l146t17r765b92],
15	oncologist	NN	O	oncologist	nn	17	SENT_62	[p5l146t17r765b92],
16	treatment	NN	O	treatment	nn	17	SENT_62	[p5l799t29r1115b75],
17	recommendation	NN	O	recommendation	nsubj	19	SENT_62	[p5l1148t17r1591b76, p5l10t113r136b171],
18	has	VBZ	O	have	aux	19	SENT_62	[p5l159t112r266b170],
19	changed	VBN	O	change	ccomp	10	SENT_62	[p5l291t112r560b187],
20	for	IN	O	for	_	0	SENT_62	[p5l583t111r674b171],
21	almost	RB	O	almost	quantmod	23	SENT_62	[p5l694t112r916b171],
22	a	DT	O	a	quantmod	23	SENT_62	[p5l934t131r967b170],
23	third	JJ	ORDINAL	third	prep_for	19	SENT_62	[p5l988t112r1147b171],
24	of	IN	O	of	_	0	SENT_62	[p5l1170t111r1244b171],
25	patients	NNS	O	patient	prep_of	23	SENT_62	[p5l1252t113r1506b186],
26	in	IN	O	in	_	0	SENT_62	[p5l1530t113r1592b170],
27	this	DT	O	this	det	28	SENT_62	[p5l10t207r129b265],
28	subgroup	NN	O	subgroup	prep_in	25	SENT_62	[p5l158t207r458b282],
29	on	IN	O	on	_	0	SENT_62	[p5l486t226r565b266],
30	the	DT	O	the	det	31	SENT_62	[p5l591t207r690b265],
31	basis	NN	O	basis	prep_on	28	SENT_62	[p5l716t207r874b266],
32	of	IN	O	of	_	0	SENT_62	[p5l902t206r976b266],
33	this	DT	O	this	det	34	SENT_62	[p5l989t207r1107b265],
34	assay	NN	O	assay	prep_of	31	SENT_62	[p5l1134t211r1372b281],
35	.	.	O	.	_	0	SENT_62	[p5l1134t211r1372b281],

1	”	NN	O	”	_	0	SENT_63	[p5l1134t211r1372b281],

1	In	IN	O	in	_	0	SENT_64	[p5l105t308r171b360],
2	a	DT	O	a	det	4	SENT_64	[p5l199t321r232b360],
3	similar	JJ	O	similar	amod	4	SENT_64	[p5l260t302r488b360],
4	vein	NN	O	vein	prep_in	12	SENT_64	[p5l511t303r659b373],
5	,	,	O	,	_	0	SENT_64	[p5l511t303r659b373],
6	a	DT	O	a	det	9	SENT_64	[p5l691t321r724b360],
7	12-gene	JJ	O	12-gene	amod	9	SENT_64	[p5l753t306r1000b377],
8	expression	NN	O	expression	nn	9	SENT_64	[p5l1029t303r1370b376],
9	signature	NN	O	signature	nsubjpass	12	SENT_64	[p5l1399t303r1591b377, p5l10t409r137b456],
10	has	VBZ	O	have	aux	12	SENT_64	[p5l161t397r269b455],
11	been	VBN	O	be	auxpass	12	SENT_64	[p5l295t397r445b456],
12	developed	VBN	O	develop	_	0	SENT_64	[p5l469t397r788b471],
13	for	IN	O	for	_	0	SENT_64	[p5l811t396r903b456],
14	colon	NN	O	colon	nn	15	SENT_64	[p5l926t397r1099b456],
15	cancer	NN	O	cancer	prep_for	12	SENT_64	[p5l1124t416r1346b456],
16	.	.	O	.	_	0	SENT_64	[p5l1124t416r1346b456],

1	It	PRP	O	it	nsubj	5	SENT_65	[p5l1373t402r1422b455],
2	is	VBZ	O	be	cop	5	SENT_65	[p5l1441t398r1490b455],
3	an	DT	O	a	det	5	SENT_65	[p5l1515t416r1592b455],
4	independent	JJ	O	independent	amod	5	SENT_65	[p5l10t492r411b566],
5	predictor	NN	O	predictor	_	0	SENT_65	[p5l441t492r736b566],
6	of	IN	O	of	_	0	SENT_65	[p5l769t491r844b551],
7	recurrence	NN	O	recurrence	prep_of	5	SENT_65	[p5l865t511r1205b551],
8	in	IN	O	in	_	0	SENT_65	[p5l1240t493r1302b549],
9	patients	NNS	O	patient	prep_in	7	SENT_65	[p5l1336t493r1590b566],
10	with	IN	O	with	_	0	SENT_65	[p5l7t587r150b646],
11	stage	NN	O	stage	nn	13	SENT_65	[p5l174t599r335b662],
12	II	CD	NUMBER	ii	num	13	SENT_65	[p5l358t592r405b645],
13	disease	NN	O	disease	prep_with	9	SENT_65	[p5l429t587r655b646],
14	and	CC	O	and	_	0	SENT_65	[p5l678t587r794b646],
15	may	MD	O	may	aux	16	SENT_65	[p5l817t606r949b661],
16	help	VB	O	help	conj_and	5	SENT_65	[p5l969t587r1101b661],
17	to	TO	O	to	aux	18	SENT_65	[p5l1126t599r1186b646],
18	define	VB	O	define	xcomp	16	SENT_65	[p5l1211t586r1408b646],
19	more	RBR	O	more	advmod	20	SENT_65	[p5l1431t606r1592b646],
20	accurately	RB	O	accurately	advmod	18	SENT_65	[p5l10t682r332b756],
21	patients	NNS	O	patient	dobj	18	SENT_65	[p5l373t683r627b756],
22	who	WP	O	who	nsubj	25	SENT_65	[p5l671t682r807b741],
23	will	MD	O	will	aux	25	SENT_65	[p5l850t682r973b741],
24	not	RB	O	not	neg	25	SENT_65	[p5l1018t694r1124b741],
25	benefit	VB	O	benefit	rcmod	21	SENT_65	[p5l1166t681r1394b741],
26	from	IN	O	from	_	0	SENT_65	[p5l1435t681r1592b741],
27	chemotherapy	NN	O	chemotherapy	prep_from	25	SENT_65	[p5l11t777r533b851],
28	.13	CD	NUMBER	.13	nsubj	37	SENT_65	[p5l11t777r533b851],
29	Among	IN	O	among	_	0	SENT_65	[p5l587t783r825b852],
30	hematologic	JJ	O	hematologic	amod	31	SENT_65	[p5l878t777r1275b852],
31	cancers	NNS	O	cancer	prep_among	28	SENT_65	[p5l1331t796r1588b848],
32	,	,	O	,	_	0	SENT_65	[p5l1331t796r1588b848],
33	gene	NN	O	gene	nn	36	SENT_65	[p5l10t873r530b947],
34	—	CD	NUMBER	—	num	36	SENT_65	[p5l10t873r530b947],
35	eXpression	NN	O	expression	nn	36	SENT_65	[p5l10t873r530b947],
36	profiling	NN	O	profiling	appos	31	SENT_65	[p5l565t871r855b947],
37	identified	VBD	O	identify	rcmod	27	SENT_65	[p5l888t871r1198b931],
38	a	DT	O	a	det	40	SENT_65	[p5l1234t891r1267b930],
39	133-gene	JJ	O	133-gene	amod	40	SENT_65	[p5l1305t876r1592b947],
40	signature	NN	O	signature	dobj	37	SENT_65	[p5l11t968r311b1042],
41	in	IN	O	in	_	0	SENT_65	[p5l352t968r414b1024],
42	adult	JJ	O	adult	amod	43	SENT_65	[p5l455t967r617b1026],
43	patients	NNS	O	patient	prep_in	37	SENT_65	[p5l654t968r908b1041],
44	with	IN	O	with	_	0	SENT_65	[p5l948t967r1094b1026],
45	acute	JJ	O	acute	amod	47	SENT_65	[p5l1135t979r1300b1026],
46	myeloid	JJ	O	myeloid	amod	47	SENT_65	[p5l1342t967r1592b1041],
47	leukemia	NN	O	leukemia	prep_with	37	SENT_65	[p5l9t1062r298b1121],
48	of	IN	O	of	_	0	SENT_65	[p5l320t1061r394b1121],
49	normal	JJ	O	normal	amod	50	SENT_65	[p5l404t1062r633b1121],
50	karyotype	NN	O	karyotype	prep_of	47	SENT_65	[p5l656t1062r967b1136],
51	that	WDT	O	that	nsubj	52	SENT_65	[p5l991t1062r1117b1120],
52	provides	VBZ	O	provide	rcmod	47	SENT_65	[p5l1135t1062r1398b1136],
53	prognostic	JJ	O	prognostic	amod	54	SENT_65	[p5l1422t1081r1591b1137, p5l10t1158r199b1216],
54	information	NN	O	information	dobj	52	SENT_65	[p5l229t1156r619b1216],
55	independent	JJ	O	independent	amod	54	SENT_65	[p5l649t1157r1051b1231],
56	of	IN	O	of	_	0	SENT_65	[p5l1079t1156r1153b1216],
57	other	JJ	O	other	amod	60	SENT_65	[p5l1172t1157r1341b1216],
58	known	JJ	O	known	amod	60	SENT_65	[p5l1370t1157r1592b1216],
59	adverse	JJ	O	adverse	amod	60	SENT_65	[p5l10t1252r244b1311],
60	features	NNS	O	feature	prep_of	54	SENT_65	[p5l309t1251r640b1311],
61	.	.	O	.	_	0	SENT_65	[p5l309t1251r640b1311],

1	“	NN	O	“	_	0	SENT_66	[p5l309t1251r640b1311],
2	Similarly	RB	O	similarly	advmod	9	SENT_66	[p5l706t1252r1003b1326],
3	,	,	O	,	_	0	SENT_66	[p5l706t1252r1003b1326],
4	gene	NN	O	gene	nn	7	SENT_66	[p5l1072t1253r1592b1327],
5	—	NN	O	—	nn	7	SENT_66	[p5l1072t1253r1592b1327],
6	eXpression	NN	O	expression	nn	7	SENT_66	[p5l1072t1253r1592b1327],
7	analyses	NNS	O	analysis	nsubj	9	SENT_66	[p5l10t1347r277b1421],
8	have	VBP	O	have	aux	9	SENT_66	[p5l329t1347r471b1406],
9	identified	VBN	O	identify	rcmod	1	SENT_66	[p5l520t1346r831b1406],
10	new	JJ	O	new	amod	12	SENT_66	[p5l881t1366r1013b1406],
11	prognostic	JJ	O	prognostic	amod	12	SENT_66	[p5l1059t1348r1406b1422],
12	subtypes	NNS	O	subtype	xcomp	9	SENT_66	[p5l1456t1347r1591b1406, p5l10t1454r177b1516],
13	in	IN	O	in	_	0	SENT_66	[p5l205t1443r267b1500],
14	diffuse	JJ	O	diffuse	amod	16	SENT_66	[p5l294t1441r519b1501],
15	large-B-cell	JJ	O	large-b-cell	amod	16	SENT_66	[p5l544t1442r913b1517],
16	lymphoma	NN	O	lymphoma	prep_in	12	SENT_66	[p5l938t1442r1281b1516],
17	(	CD	NUMBER	(	num	19	SENT_66	[p5l1311t1446r1588b1513],
18	DLBCL	NN	O	dlbcl	nn	19	SENT_66	[p5l1311t1446r1588b1513],
19	)	NN	O	)	dep	12	SENT_66	[p5l1311t1446r1588b1513],
20	,	,	O	,	_	0	SENT_66	[p5l1311t1446r1588b1513],

1	N	NN	O	n	nn	3	SENT_67	[p5l555t1602r569b1617],
2	ENGLJ	NN	O	englj	nn	3	SENT_67	[p5l584t1602r662b1624],
3	MED	NN	O	med	_	0	SENT_67	[p5l676t1602r728b1617],
4	364	CD	NUMBER	364	dep	3	SENT_67	[p5l738t1596r807b1624],
5	;	:	O	;	_	0	SENT_67	[p5l738t1596r807b1624],
6	4	CD	NUMBER	4	num	8	SENT_67	[p5l738t1596r807b1624],
7	NEjM.ORG	NN	O	nejm.org	nn	8	SENT_67	[p5l842t1602r966b1624],
8	JANUARY	NN	DATE	january	dep	3	SENT_67	[p5l997t1602r1109b1624],
9	27	CD	DATE	27	dep	8	SENT_67	[p5l1119t1602r1153b1623],
10	,	,	DATE	,	_	0	SENT_67	[p5l1119t1602r1153b1623],
11	2011	CD	DATE	2011	appos	9	SENT_67	[p5l1164t1602r1216b1618],
12	The	DT	O	the	det	16	SENT_67	[p5l702t1635r753b1659],
13	New	NNP	LOCATION	New	nn	16	SENT_67	[p5l762t1636r824b1659],
14	England	NNP	LOCATION	England	nn	16	SENT_67	[p5l833t1635r944b1666],
15	J	NNP	O	J	nn	16	SENT_67	[p5l952t1636r965b1659],
16	oumal	NN	O	oumal	dep	3	SENT_67	[p5l966t1635r1050b1659],
17	of	IN	O	of	_	0	SENT_67	[p5l1059t1635r1088b1659],
18	Medicine	NN	O	medicine	prep_of	16	SENT_67	[p5l1095t1635r1220b1659],

1	Downloaded	VBN	O	download	_	0	SENT_68	[p5l144t1676r314b1699],
2	from	IN	O	from	_	0	SENT_68	[p5l323t1676r387b1699],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_68	[p5l396t1676r514b1706],
4	at	IN	O	at	_	0	SENT_68	[p5l524t1680r547b1699],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_68	[p5l556t1676r738b1699],
6	on	IN	O	on	_	0	SENT_68	[p5l748t1683r780b1699],
7	January	NNP	DATE	January	prep_on	1	SENT_68	[p5l789t1676r892b1706],
8	5	CD	DATE	5	num	7	SENT_68	[p5l902t1676r924b1704],
9	,	,	DATE	,	_	0	SENT_68	[p5l902t1676r924b1704],
10	2014	CD	DATE	2014	num	7	SENT_68	[p5l935t1676r1007b1699],
11	.	.	O	.	_	0	SENT_68	[p5l935t1676r1007b1699],

1	For	IN	O	for	_	0	SENT_69	[p5l1018t1676r1064b1699],
2	personal	JJ	O	personal	amod	3	SENT_69	[p5l1072t1676r1185b1706],
3	use	NN	O	use	pobj	1	SENT_69	[p5l1194t1683r1237b1699],
4	only	RB	O	only	advmod	3	SENT_69	[p5l1247t1676r1312b1706],
5	.	.	O	.	_	0	SENT_69	[p5l1247t1676r1312b1706],

1	No	DT	O	no	det	3	SENT_70	[p5l1322t1676r1362b1699],
2	other	JJ	O	other	amod	3	SENT_70	[p5l1372t1676r1440b1699],
3	uses	NNS	O	use	_	0	SENT_70	[p5l1448t1683r1504b1699],
4	without	IN	O	without	_	0	SENT_70	[p5l1515t1676r1616b1699],
5	permission	NN	O	permission	prep_without	3	SENT_70	[p5l1624t1676r1776b1706],
6	.	.	O	.	_	0	SENT_70	[p5l1624t1676r1776b1706],

1	The	DT	O	the	det	4	SENT_71	[p5l817t1759r862b1780],
2	NEW	NNP	O	NEW	nn	4	SENT_71	[p5l880t1761r966b1780],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_71	[p5l985t1761r1173b1780],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_71	[p5l1192t1761r1372b1787],
5	of	IN	O	of	_	0	SENT_71	[p5l1391t1759r1419b1786],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_71	[p5l1432t1761r1630b1780],

1	High	JJ	O	high	amod	3	SENT_72	[p5l1296t1967r1360b1999],
2	molecular	JJ	O	molecular	amod	3	SENT_72	[p5l1373t1967r1507b1992],
3	risk	NN	O	risk	_	0	SENT_72	[p5l1517t1967r1572b1997],
4	,	,	O	,	_	0	SENT_72	[p5l1517t1967r1572b1997],
5	high	JJ	O	high	advmod	3	SENT_72	[p5l1296t2022r1353b2055],
6	clinical	JJ	O	clinical	dep	3	SENT_72	[p5l1364t2022r1457b2047],
7	risk	NN	O	risk	dep	6	SENT_72	[p5l1469t2022r1517b2047],
8	T	NN	O	t	dobj	7	SENT_72	[p5l1296t2069r1606b2108],
9	»	CD	NUMBER	»	num	8	SENT_72	[p5l1296t2069r1606b2108],
10	"	''	O	"	punct	8	SENT_72	[p5l514t2172r530b2196],

1	i.	IN	O	i.	_	0	SENT_73	[p5l514t2172r530b2196],

1	Brehst	NNP	O	Brehst	nn	2	SENT_74	[p5l291t2260r375b2304],
2	adegpjca	NN	O	adegpjca	_	0	SENT_74	[p5l384t2269r498b2309],
3	I	PRP	O	I	nsubj	4	SENT_74	[p5l522t2306r524b2309],
4	bniﬁ	VBP	O	bniﬁ	rcmod	2	SENT_74	[p5l552t2266r619b2301],
5	,	,	O	,	_	0	SENT_74	[p5l552t2266r619b2301],

1	node	NN	O	node	_	0	SENT_75	[p5l228t2308r479b2348],
2	;	:	O	;	_	0	SENT_75	[p5l228t2308r479b2348],
3	negative.	NNP	O	negative.	dep	1	SENT_75	[p5l228t2308r479b2348],
4	:	:	O	:	_	0	SENT_75	[p5l228t2308r479b2348],
5	-	:	O	-	_	0	SENT_75	[p5l228t2308r479b2348],
6	ind	NN	O	ind	dep	1	SENT_75	[p5l228t2308r479b2348],
7	1	CD	NUMBER	1	number	8	SENT_75	[p5l490t2312r502b2336],
8	3	CD	NUMBER	3	dep	6	SENT_75	[p5l552t2310r565b2336],
9	poqggjqive	NN	O	poqggjqive	dep	1	SENT_75	[p5l577t2311r681b2353],

1	Low	JJ	O	low	amod	3	SENT_76	[p5l1296t2203r1350b2226],
2	molecular	JJ	O	molecular	amod	3	SENT_76	[p5l1361t2201r1495b2226],
3	risk	NN	O	risk	_	0	SENT_76	[p5l1505t2201r1560b2231],
4	,	,	O	,	_	0	SENT_76	[p5l1505t2201r1560b2231],
5	high	JJ	O	high	amod	7	SENT_76	[p5l1296t2256r1353b2289],
6	clinical	JJ	O	clinical	amod	7	SENT_76	[p5l1364t2256r1457b2281],
7	risk	NN	O	risk	appos	3	SENT_76	[p5l1469t2256r1517b2281],
8	expression	NN	O	expression	nn	9	SENT_76	[p5l759t2204r903b2235],
9	proﬁle	NN	O	proﬁle	dep	3	SENT_76	[p5l790t2242r874b2275],

1	High	JJ	O	high	amod	3	SENT_77	[p5l1296t2435r1360b2467],
2	molecular	JJ	O	molecular	amod	3	SENT_77	[p5l1373t2435r1507b2460],
3	risk	NN	O	risk	_	0	SENT_77	[p5l1517t2435r1572b2465],
4	,	,	O	,	_	0	SENT_77	[p5l1517t2435r1572b2465],
5	low	JJ	O	low	amod	8	SENT_77	[p5l1295t2490r1341b2515],
6	clinical	JJ	O	clinical	amod	8	SENT_77	[p5l1351t2490r1444b2515],
7	risk	NN	O	risk	nn	8	SENT_77	[p5l1456t2490r1504b2515],
8	T	NN	O	t	appos	3	SENT_77	[p5l1296t2538r1606b2577],
9	»	CD	NUMBER	»	dep	3	SENT_77	[p5l1296t2538r1606b2577],

1	c	NN	O	c	_	0	SENT_78	[p5l313t2351r316b2353],
2	I	CD	NUMBER	i	dep	1	SENT_78	[p5l363t2349r371b2377],
3	h	NN	O	h	dep	2	SENT_78	[p5l434t2349r449b2375],
4	"	''	O	"	punct	3	SENT_78	[p5l514t2348r522b2353],
5	-	:	O	-	_	0	SENT_78	[p5l570t2373r572b2375],
6	R	NN	O	r	nn	8	SENT_78	[p5l639t2359r641b2361],
7	M	NN	O	m	nn	8	SENT_78	[p5l485t2422r517b2451],
8	Г	NN	O	г	dep	3	SENT_78	[p5l653t2415r660b2458],
9	+	CC	O	+	rcmod	8	SENT_78	[p5l653t2415r660b2458],
10	,	,	O	,	_	0	SENT_78	[p5l643t2454r658b2470],
11	.	.	O	.	_	0	SENT_78	[p5l643t2454r658b2470],

1	Low	JJ	O	low	amod	3	SENT_79	[p5l1296t2671r1350b2694],
2	molecular	JJ	O	molecular	amod	3	SENT_79	[p5l1361t2669r1495b2694],
3	risk	NN	O	risk	_	0	SENT_79	[p5l1505t2669r1560b2699],
4	,	,	O	,	_	0	SENT_79	[p5l1505t2669r1560b2699],
5	low	JJ	O	low	amod	7	SENT_79	[p5l1295t2724r1341b2749],
6	clinical	JJ	O	clinical	amod	7	SENT_79	[p5l1351t2724r1444b2749],
7	risk	NN	O	risk	appos	3	SENT_79	[p5l1456t2724r1504b2749],
8	-	:	O	-	_	0	SENT_79	[p5l1296t2774r1606b2812],
9	T	NN	O	t	dep	3	SENT_79	[p5l1296t2774r1606b2812],
10	»	CD	NUMBER	»	dep	9	SENT_79	[p5l1296t2774r1606b2812],

1	Adjuvant	JJ	O	adjuvant	amod	2	SENT_80	[p5l1667t1954r1790b1987],
2	chemotherapy	NN	O	chemotherapy	_	0	SENT_80	[p5l1800t1953r1995b1986],
3	Hormonal	JJ	MISC	hormonal	amod	4	SENT_80	[p5l1691t2020r1828b2045],
4	therapy	NN	O	therapy	dep	2	SENT_80	[p5l1839t2020r1941b2053],
5	if	IN	O	if	_	0	SENT_80	[p5l1952t2020r1971b2045],
6	ER	NN	O	er	prep_if	4	SENT_80	[p5l1711t2062r1753b2085],
7	-	:	O	-	_	0	SENT_80	[p5l1711t2062r1753b2085],
8	or	CC	O	or	_	0	SENT_80	[p5l1764t2069r1792b2085],
9	PR-positive	JJ	O	pr-positive	prep_if	4	SENT_80	[p5l1803t2062r1954b2093],

1	Randomized	VBN	O	randomize	_	0	SENT_81	[p5l1745t2348r1914b2374],

1	No	DT	O	no	det	2	SENT_82	[p5l1711t2639r1749b2662],
2	chemotherapy	NN	O	chemotherapy	_	0	SENT_82	[p5l1760t2637r1955b2670],
3	Hormonal	JJ	MISC	hormonal	amod	4	SENT_82	[p5l1691t2704r1827b2729],
4	therapy	NN	O	therapy	dep	2	SENT_82	[p5l1839t2704r1941b2737],
5	if	IN	O	if	_	0	SENT_82	[p5l1952t2704r1971b2729],
6	ER	NN	O	er	prep_if	4	SENT_82	[p5l1711t2746r1753b2769],
7	-	:	O	-	_	0	SENT_82	[p5l1711t2746r1753b2769],
8	or	CC	O	or	_	0	SENT_82	[p5l1764t2753r1791b2769],
9	PR-positive	JJ	O	pr-positive	prep_if	4	SENT_82	[p5l1803t2746r1954b2776],

1	Figure	NNP	O	Figure	_	0	SENT_83	[p5l122t2877r206b2909],
2	1	CD	NUMBER	1	dep	1	SENT_83	[p5l218t2878r240b2901],
3	.	.	O	.	_	0	SENT_83	[p5l218t2878r240b2901],

1	Use	NN	O	use	_	0	SENT_84	[p5l252t2878r304b2901],
2	of	IN	O	of	_	0	SENT_84	[p5l314t2876r346b2901],
3	a	DT	O	a	det	5	SENT_84	[p5l351t2884r365b2901],
4	Gene-Expression	NNP	O	Gene-Expression	nn	5	SENT_84	[p5l376t2877r611b2909],
5	Proﬁle	NNP	O	Proﬁle	prep_of	1	SENT_84	[p5l625t2876r714b2901],
6	to	TO	O	to	aux	7	SENT_84	[p5l724t2880r751b2901],
7	Define	VB	O	define	infmod	1	SENT_84	[p5l763t2876r855b2901],
8	the	DT	O	the	det	9	SENT_84	[p5l864t2876r909b2901],
9	Risk	NN	O	risk	dobj	7	SENT_84	[p5l921t2876r977b2901],
10	of	IN	O	of	_	0	SENT_84	[p5l987t2876r1018b2901],
11	Relapse	NN	O	relapse	prep_of	9	SENT_84	[p5l1025t2876r1131b2909],
12	in	IN	O	in	_	0	SENT_84	[p5l1142t2877r1165b2901],
13	Patients	NNS	O	patient	prep_in	7	SENT_84	[p5l1179t2877r1289b2901],
14	with	IN	O	with	_	0	SENT_84	[p5l1299t2876r1358b2901],
15	Early-Stage	JJ	O	early-stage	amod	17	SENT_84	[p5l1372t2876r1524b2909],
16	Breast	NN	O	breast	nn	17	SENT_84	[p5l1537t2878r1624b2901],
17	Cancer	NN	O	cancer	prep_with	13	SENT_84	[p5l1633t2878r1735b2901],
18	.	.	O	.	_	0	SENT_84	[p5l1633t2878r1735b2901],

1	In	IN	O	in	_	0	SENT_85	[p5l122t2928r144b2951],
2	the	DT	O	the	det	6	SENT_85	[p5l156t2926r200b2951],
3	ongoing	JJ	O	ongoing	amod	6	SENT_85	[p5l211t2928r324b2959],
4	MINDACT	NNP	O	MINDACT	nn	6	SENT_85	[p5l337t2928r481b2951],
5	(	CD	NUMBER	(	num	6	SENT_85	[p5l494t2928r653b2959],
6	Microarray	NNP	O	Microarray	prep_in	26	SENT_85	[p5l494t2928r653b2959],
7	in	IN	O	in	_	0	SENT_85	[p5l665t2928r687b2951],
8	Node	NNP	O	Node	prep_in	6	SENT_85	[p5l702t2926r775b2951],
9	Negative	JJ	O	negative	amod	8	SENT_85	[p5l789t2928r909b2959],
10	and	CC	O	and	_	0	SENT_85	[p5l921t2926r969b2951],
11	1	CD	NUMBER	1	number	13	SENT_85	[p5l984t2928r995b2951],
12	to	TO	O	to	dep	13	SENT_85	[p5l1007t2931r1034b2951],
13	3	CD	NUMBER	3	prep_in	26	SENT_85	[p5l1046t2928r1058b2951],
14	Positive	JJ	O	positive	amod	22	SENT_85	[p5l1073t2928r1179b2951],
15	Lymph	NNP	O	Lymph	nn	22	SENT_85	[p5l1192t2926r1281b2959],
16	Node	NNP	O	Node	nn	22	SENT_85	[p5l1296t2926r1370b2951],
17	Disease	NNP	O	Disease	nn	22	SENT_85	[p5l1383t2928r1489b2951],
18	May	NNP	DATE	May	nn	22	SENT_85	[p5l1502t2928r1557b2959],
19	Avoid	NNP	O	Avoid	nn	22	SENT_85	[p5l1567t2926r1644b2951],
20	Chemotherapy	NNP	O	Chemotherapy	nn	22	SENT_85	[p5l1657t2926r1861b2959],
21	Trial	NNP	O	Trial	nn	22	SENT_85	[p5l1871t2926r1949b2959],
22	)	NNP	O	)	dep	13	SENT_85	[p5l1871t2926r1949b2959],
23	,	,	O	,	_	0	SENT_85	[p5l1871t2926r1949b2959],
24	investigators	NNS	O	investigator	nsubj	26	SENT_85	[p5l1963t2928r2041b2951, p5l119t2970r224b3001],
25	are	VBP	O	be	aux	26	SENT_85	[p5l237t2977r277b2993],
26	comparing	VBG	O	compare	_	0	SENT_85	[p5l289t2970r438b3001],
27	a	DT	O	a	det	34	SENT_85	[p5l449t2977r462b2993],
28	70-gene	JJ	O	70-gene	amod	34	SENT_85	[p5l475t2969r753b3001],
29	—	NN	O	—	nn	34	SENT_85	[p5l475t2969r753b3001],
30	eXpression	NN	O	expression	nn	34	SENT_85	[p5l475t2969r753b3001],
31	signature	NN	O	signature	nn	34	SENT_85	[p5l767t2970r895b3001],
32	(	CD	NUMBER	(	num	34	SENT_85	[p5l909t2970r1111b3001],
33	MammaPrint	NNP	O	MammaPrint	nn	34	SENT_85	[p5l909t2970r1111b3001],
34	)	NN	O	)	dobj	26	SENT_85	[p5l909t2970r1111b3001],
35	and	CC	O	and	_	0	SENT_85	[p5l1125t2968r1174b2993],
36	common	JJ	O	common	amod	38	SENT_85	[p5l1187t2977r1309b2993],
37	clinicopathological	JJ	O	clinicopathological	amod	38	SENT_85	[p5l1322t2968r1583b3001],
38	criteria	NNS	O	criterion	conj_and	34	SENT_85	[p5l1595t2970r1690b2993],
39	in	IN	O	in	_	0	SENT_85	[p5l1704t2970r1725b2993],
40	selecting	NN	O	selecting	nn	41	SENT_85	[p5l1739t2968r1863b3001],
41	patients	NNS	O	patient	prep_in	38	SENT_85	[p5l1875t2970r1985b3001],
42	with	IN	O	with	_	0	SENT_85	[p5l119t3009r176b3035],
43	node-negative	JJ	O	node-negative	amod	45	SENT_85	[p5l190t3009r387b3043],
44	breast	NN	O	breast	nn	45	SENT_85	[p5l399t3009r483b3035],
45	cancer	NN	O	cancer	prep_with	41	SENT_85	[p5l494t3018r586b3035],
46	or	CC	O	or	_	0	SENT_85	[p5l596t3018r624b3035],
47	1	CD	NUMBER	1	number	49	SENT_85	[p5l636t3012r647b3034],
48	to	TO	O	to	dep	49	SENT_85	[p5l659t3014r686b3035],
49	3	CD	NUMBER	3	num	51	SENT_85	[p5l698t3011r710b3034],
50	positive	JJ	O	positive	amod	51	SENT_85	[p5l725t3012r831b3042],
51	nodes	NNS	O	node	conj_or	41	SENT_85	[p5l843t3009r925b3035],
52	for	IN	O	for	_	0	SENT_85	[p5l937t3009r976b3035],
53	adjuvant	JJ	O	adjuvant	amod	54	SENT_85	[p5l986t3009r1105b3042],
54	chemotherapy	NN	O	chemotherapy	prep_for	51	SENT_85	[p5l1116t3009r1321b3042],
55	.	.	O	.	_	0	SENT_85	[p5l1116t3009r1321b3042],

1	In	IN	O	in	_	0	SENT_86	[p5l1335t3012r1358b3034],
2	cases	NNS	O	case	prep_in	18	SENT_86	[p5l1370t3018r1445b3035],
3	in	IN	O	in	_	0	SENT_86	[p5l1458t3012r1480b3034],
4	which	WDT	O	which	rel	13	SENT_86	[p5l1492t3009r1571b3035],
5	the	DT	O	the	det	7	SENT_86	[p5l1583t3009r1627b3035],
6	clinicopathological	JJ	O	clinicopathological	amod	7	SENT_86	[p5l1638t3009r1899b3043],
7	risk	NN	O	risk	nsubj	13	SENT_86	[p5l1913t3009r1960b3035],
8	and	CC	O	and	_	0	SENT_86	[p5l1971t3009r2019b3035],
9	the	DT	O	the	det	11	SENT_86	[p5l119t3051r162b3076],
10	70-signature	JJ	O	70-signature	amod	11	SENT_86	[p5l175t3053r347b3084],
11	risk	NN	O	risk	nsubj	13	SENT_86	[p5l360t3051r407b3076],
12	are	VBP	O	be	cop	13	SENT_86	[p5l418t3060r458b3076],
13	discordant	JJ	O	discordant	rcmod	2	SENT_86	[p5l470t3051r624b3081],
14	,	,	O	,	_	0	SENT_86	[p5l470t3051r624b3081],
15	patients	NNS	O	patient	nsubjpass	18	SENT_86	[p5l638t3053r748b3084],
16	are	VBP	O	be	auxpass	18	SENT_86	[p5l760t3060r801b3076],
17	randomly	RB	O	randomly	advmod	18	SENT_86	[p5l813t3051r943b3084],
18	assigned	VBN	O	assign	_	0	SENT_86	[p5l955t3051r1074b3084],
19	to	TO	O	to	_	0	SENT_86	[p5l1086t3056r1113b3076],
20	a	DT	O	a	det	22	SENT_86	[p5l1125t3060r1138b3076],
21	treatment	NN	O	treatment	nn	22	SENT_86	[p5l1149t3056r1286b3076],
22	strategy	NN	O	strategy	prep_to	18	SENT_86	[p5l1298t3056r1408b3084],
23	on	IN	O	on	_	0	SENT_86	[p5l1419t3060r1451b3076],
24	the	DT	O	the	det	27	SENT_86	[p5l1463t3051r1507b3076],
25	basis	NN	O	basis	nn	27	SENT_86	[p5l1519t3051r1587b3076],
26	ofeither	NN	O	ofeither	nn	27	SENT_86	[p5l1599t3051r1715b3076],
27	set	NN	O	set	prep_on	18	SENT_86	[p5l1726t3056r1765b3076],
28	of	IN	O	of	_	0	SENT_86	[p5l1776t3051r1806b3076],
29	criteria	NNS	O	criterion	prep_of	27	SENT_86	[p5l1813t3053r1916b3076],
30	.	.	O	.	_	0	SENT_86	[p5l1813t3053r1916b3076],

1	The	DT	O	the	det	2	SENT_87	[p5l1928t3051r1979b3076],
2	study	NN	O	study	nsubj	3	SENT_87	[p5l121t3093r195b3126],
3	shows	VBZ	O	show	_	0	SENT_87	[p5l206t3093r292b3118],
4	how	WRB	O	how	advmod	9	SENT_87	[p5l305t3093r361b3118],
5	gene-expression	JJ	O	gene-expression	amod	6	SENT_87	[p5l372t3095r597b3126],
6	signatures	NNS	O	signature	nsubjpass	9	SENT_87	[p5l611t3095r753b3126],
7	can	MD	O	can	aux	9	SENT_87	[p5l765t3102r811b3118],
8	be	VB	O	be	auxpass	9	SENT_87	[p5l825t3093r856b3118],
9	incorporated	VBN	O	incorporate	ccomp	3	SENT_87	[p5l868t3093r1044b3126],
10	with	IN	O	with	_	0	SENT_87	[p5l1056t3093r1113b3118],
11	clinical	JJ	O	clinical	amod	12	SENT_87	[p5l1126t3093r1220b3118],
12	decision	NN	O	decision	prep_with	9	SENT_87	[p5l1233t3093r1347b3118],
13	making	VBG	O	make	xcomp	9	SENT_87	[p5l1361t3093r1462b3126],
14	in	IN	O	in	_	0	SENT_87	[p5l1473t3095r1495b3118],
15	the	DT	O	the	det	16	SENT_87	[p5l1507t3093r1550b3118],
16	design	NN	O	design	prep_in	13	SENT_87	[p5l1562t3093r1651b3126],
17	ofclinical	JJ	O	ofclinical	amod	18	SENT_87	[p5l1664t3093r1794b3118],
18	trials	NNS	O	trial	dobj	13	SENT_87	[p5l1806t3093r1874b3118],
19	that	WDT	O	that	nsubj	20	SENT_87	[p5l1885t3093r1939b3118],
20	address	VBP	O	address	rcmod	18	SENT_87	[p5l1951t3093r1992b3118, p5l120t3134r192b3160],
21	questions	NNS	O	question	dobj	20	SENT_87	[p5l204t3137r339b3167],
22	such	JJ	O	such	_	0	SENT_87	[p5l352t3134r414b3160],
23	as	IN	O	as	_	0	SENT_87	[p5l427t3143r455b3160],
24	the	DT	O	the	det	25	SENT_87	[p5l466t3134r509b3160],
25	utility	NN	O	utility	prep_such_as	21	SENT_87	[p5l522t3134r598b3167],
26	of	IN	O	of	_	0	SENT_87	[p5l609t3134r639b3160],
27	adjuvant	JJ	O	adjuvant	amod	28	SENT_87	[p5l646t3134r764b3167],
28	treatment	NN	O	treatment	prep_of	25	SENT_87	[p5l774t3139r912b3160],
29	in	IN	O	in	_	0	SENT_87	[p5l924t3137r945b3159],
30	patients	NNS	O	patient	prep_in	28	SENT_87	[p5l960t3137r1070b3167],
31	with	IN	O	with	_	0	SENT_87	[p5l1081t3134r1138b3160],
32	cancer	NN	O	cancer	prep_with	30	SENT_87	[p5l1151t3143r1242b3160],
33	after	IN	O	after	_	0	SENT_87	[p5l1253t3134r1316b3160],
34	resection	NN	O	resection	nn	37	SENT_87	[p5l1328t3137r1453b3160],
35	ofthe	NN	O	ofthe	nn	37	SENT_87	[p5l1466t3134r1545b3160],
36	primary	JJ	O	primary	amod	37	SENT_87	[p5l1557t3137r1664b3167],
37	tumor	NN	O	tumor	prep_after	20	SENT_87	[p5l1674t3139r1765b3160],
38	.	.	O	.	_	0	SENT_87	[p5l1674t3139r1765b3160],

1	ER	NN	O	er	nsubj	2	SENT_88	[p5l1780t3137r1812b3159],
2	denotes	VBZ	O	denote	_	0	SENT_88	[p5l1824t3134r1933b3160],
3	estrogen	NN	O	estrogen	nn	4	SENT_88	[p5l1945t3139r2025b3160, p5l120t3185r168b3209],
4	receptor	NN	O	receptor	dobj	2	SENT_88	[p5l182t3181r301b3209],
5	,	,	O	,	_	0	SENT_88	[p5l182t3181r301b3209],
6	and	CC	O	and	_	0	SENT_88	[p5l314t3176r363b3201],
7	PR	NN	O	pr	nn	9	SENT_88	[p5l378t3178r412b3201],
8	progesterone	NN	O	progesterone	nn	9	SENT_88	[p5l424t3181r608b3209],
9	receptor	NN	O	receptor	dobj	2	SENT_88	[p5l620t3181r740b3209],
10	.	.	O	.	_	0	SENT_88	[p5l620t3181r740b3209],

1	which	WDT	O	which	dep	2	SENT_89	[p5l7t3436r265b3515],
2	improves	VBZ	O	improve	_	0	SENT_89	[p5l315t3437r698b3537],
3	the	DT	O	the	det	5	SENT_89	[p5l751t3436r882b3515],
4	difficult	JJ	O	difficult	amod	5	SENT_89	[p5l933t3436r1279b3515],
5	discrimination	NN	O	discrimination	nsubj	13	SENT_89	[p5l1325t3436r1950b3515],
6	between	IN	O	between	_	0	SENT_89	[p5l2002t3436r2133b3515, p5l12t3581r268b3643],
7	Burkitt	NN	PERSON	burkitt	poss	9	SENT_89	[p5l306t3564r671b3644],
8	’s	POS	O	’s	_	0	SENT_89	[p5l306t3564r671b3644],
9	lymphoma	NN	O	lymphoma	prep_between	5	SENT_89	[p5l712t3564r1173b3665],
10	and	CC	O	and	_	0	SENT_89	[p5l1210t3564r1368b3643],
11	DLBCL	NN	O	dlbcl	prep_between	5	SENT_89	[p5l1405t3569r1901b3643],
12	.14	CD	NUMBER	.14	npadvmod	13	SENT_89	[p5l1405t3569r1901b3643],
13	>	JJR	O	>	xcomp	2	SENT_89	[p5l1405t3569r1901b3643],
14	15	CD	NUMBER	15	nsubj	2	SENT_89	[p5l1405t3569r1901b3643],

1	There	EX	O	there	expl	2	SENT_90	[p5l137t3692r381b3771],
2	is	VBZ	O	be	_	0	SENT_90	[p5l414t3693r479b3771],
3	concern	NN	O	concern	nsubj	2	SENT_90	[p5l515t3718r879b3788],
4	,	,	O	,	_	0	SENT_90	[p5l515t3718r879b3788],
5	however	RB	O	however	advmod	3	SENT_90	[p5l916t3692r1291b3788],
6	,	,	O	,	_	0	SENT_90	[p5l916t3692r1291b3788],
7	about	IN	O	about	_	0	SENT_90	[p5l1329t3692r1573b3771],
8	the	DT	O	the	det	9	SENT_90	[p5l1600t3692r1733b3771],
9	incorporation	NN	O	incorporation	prep_about	3	SENT_90	[p5l1765t3693r2133b3793, p6l12t21r267b99],

1	of	IN	O	of	_	0	SENT_91	[p6l300t20r400b99],
2	gene	NN	O	gene	nn	3	SENT_91	[p6l413t21r1110b121],
3	—	NN	O	—	prep_of	5	SENT_91	[p6l413t21r1110b121],
4	expression	NN	O	expression	nn	5	SENT_91	[p6l413t21r1110b121],
5	signatures	NNS	O	signature	_	0	SENT_91	[p6l1144t21r1588b121],
6	into	IN	O	into	_	0	SENT_91	[p6l1622t21r1791b99],
7	routine	JJ	O	routine	amod	9	SENT_91	[p6l1824t21r2134b99],
8	clinical	JJ	O	clinical	amod	9	SENT_91	[p6l13t148r326b227],
9	practice	NN	O	practice	prep_into	5	SENT_91	[p6l364t149r701b249],
10	before	IN	O	before	_	0	SENT_91	[p6l742t148r1011b227],
11	confirmation	NN	O	confirmation	prep_before	9	SENT_91	[p6l1052t148r1626b227],
12	of	IN	O	of	_	0	SENT_91	[p6l1667t148r1767b227],
13	their	PRP$	O	they	poss	14	SENT_91	[p6l1788t148r1992b227],
14	efficacy	NN	O	efficacy	prep_of	11	SENT_91	[p6l2029t148r2133b227, p6l12t276r264b377],
15	from	IN	O	from	prep	14	SENT_91	[p6l301t276r511b355],
16	suitably	RB	O	suitably	pcomp	15	SENT_91	[p6l554t276r888b377],
17	powered	VBN	O	power	partmod	9	SENT_91	[p6l923t276r1312b377],
18	,	,	O	,	_	0	SENT_91	[p6l923t276r1312b377],
19	randomized	VBN	O	randomize	dep	17	SENT_91	[p6l1359t276r1903b372],
20	,	,	O	,	_	0	SENT_91	[p6l1359t276r1903b372],
21	controlled	VBN	O	control	partmod	5	SENT_91	[p6l1949t302r2133b355, p6l12t404r294b483],
22	trials	NNS	O	trial	dobj	21	SENT_91	[p6l340t404r583b483],
23	.	.	O	.	_	0	SENT_91	[p6l340t404r583b483],

1	This	DT	O	this	nsubj	3	SENT_92	[p6l631t404r819b483],
2	has	VBZ	O	have	aux	3	SENT_92	[p6l867t404r1011b483],
3	prompted	VBN	O	prompt	dep	51	SENT_92	[p6l1057t404r1478b505],
4	large	JJ	O	large	amod	5	SENT_92	[p6l1522t404r1737b505],
5	trials	NNS	O	trial	dobj	3	SENT_92	[p6l1783t404r2002b483],
6	to	TO	O	to	aux	7	SENT_92	[p6l2051t421r2132b483],
7	test	VB	O	test	xcomp	3	SENT_92	[p6l12t549r167b611],
8	the	DT	O	the	det	9	SENT_92	[p6l209t532r341b611],
9	efficacy	NN	O	efficacy	dobj	7	SENT_92	[p6l390t532r726b633],
10	of	IN	O	of	_	0	SENT_92	[p6l769t532r869b611],
11	MammaPrint	NNP	ORGANIZATION	MammaPrint	nn	14	SENT_92	[p6l894t533r1476b611],
12	and	CC	O	and	_	0	SENT_92	[p6l1517t532r1675b611],
13	Oncotype	NNP	O	Oncotype	conj_and	11	SENT_92	[p6l1722t538r2134b633],
14	DX	NNP	O	DX	prep_of	9	SENT_92	[p6l11t667r139b738],
15	in	IN	O	in	_	0	SENT_92	[p6l175t661r258b738],
16	predicting	VBG	O	predict	prepc_in	7	SENT_92	[p6l297t660r744b761],
17	the	DT	O	the	det	18	SENT_92	[p6l781t660r914b739],
18	benefit	NN	O	benefit	dobj	16	SENT_92	[p6l955t660r1260b739],
19	of	IN	O	of	_	0	SENT_92	[p6l1295t660r1395b739],
20	adjuvant	JJ	O	adjuvant	amod	21	SENT_92	[p6l1417t660r1779b761],
21	chemotherapy	NN	O	chemotherapy	prep_of	18	SENT_92	[p6l1815t660r2133b739, p6l12t788r323b889],
22	in	IN	O	in	_	0	SENT_92	[p6l354t789r435b866],
23	patients	NNS	O	patient	prep_in	16	SENT_92	[p6l470t789r799b889],
24	with	IN	O	with	_	0	SENT_92	[p6l832t788r1022b867],
25	node	NN	O	node	nn	29	SENT_92	[p6l1057t788r1636b889],
26	—	CD	NUMBER	—	num	29	SENT_92	[p6l1057t788r1636b889],
27	negative	JJ	O	negative	amod	29	SENT_92	[p6l1057t788r1636b889],
28	breast	NN	O	breast	nn	29	SENT_92	[p6l1672t788r1926b867],
29	cancer	NN	O	cancer	prep_with	23	SENT_92	[p6l1957t814r2133b867, p6l13t943r155b995],
30	:	:	O	:	_	0	SENT_92	[p6l1957t814r2133b867, p6l13t943r155b995],
31	the	DT	O	the	det	32	SENT_92	[p6l199t916r332b995],
32	Microarray	NNP	O	Microarray	dep	23	SENT_92	[p6l369t917r844b1017],
33	in	IN	O	in	_	0	SENT_92	[p6l880t917r963b994],
34	Node	NNP	O	Node	prep_in	32	SENT_92	[p6l1000t916r1228b995],
35	Negative	JJ	O	negative	amod	34	SENT_92	[p6l1266t917r1638b1017],
36	and	CC	O	and	_	0	SENT_92	[p6l1677t916r1835b995],
37	1	CD	NUMBER	1	number	39	SENT_92	[p6l1878t922r1923b994],
38	to	TO	O	to	dep	39	SENT_92	[p6l1964t933r2045b995],
39	3	CD	NUMBER	3	conj_and	23	SENT_92	[p6l2087t922r2131b995],
40	Positive	JJ	O	positive	amod	47	SENT_92	[p6l11t1045r337b1123],
41	Lymph	NNP	O	Lymph	nn	47	SENT_92	[p6l371t1044r664b1145],
42	Node	NNP	O	Node	nn	47	SENT_92	[p6l696t1044r923b1123],
43	Disease	NNP	O	Disease	nn	47	SENT_92	[p6l956t1045r1283b1123],
44	May	NNP	DATE	May	nn	47	SENT_92	[p6l1315t1052r1496b1145],
45	Avoid	NNP	O	Avoid	nn	47	SENT_92	[p6l1522t1044r1761b1123],
46	Chemotherapy	NNP	O	Chemotherapy	nn	47	SENT_92	[p6l1796t1044r2133b1123, p6l12t1172r326b1273],
47	Trial	NNP	O	Trial	dep	39	SENT_92	[p6l348t1172r546b1251],
48	(	CD	NUMBER	(	num	47	SENT_92	[p6l580t1179r801b1264],
49	MIN	NNP	DURATION	MIN	nn	50	SENT_92	[p6l580t1179r801b1264],
50	DACT	NNP	O	DACT	nsubj	51	SENT_92	[p6l803t1178r1079b1263],
51	)	VBD	O	)	_	0	SENT_92	[p6l803t1178r1079b1263],
52	(	CD	NUMBER	(	num	53	SENT_92	[p6l1119t1172r1728b1264],
53	ClinicalTrials	NNS	O	clinicaltrial	dobj	51	SENT_92	[p6l1119t1172r1728b1264],
54	.	.	O	.	_	0	SENT_92	[p6l1119t1172r1728b1264],

1	gov	NN	O	gov	_	0	SENT_93	[p6l1734t1198r1883b1273],
2	number	NN	O	number	dep	1	SENT_93	[p6l1909t1198r2132b1251, p6l12t1300r163b1396],
3	,	,	O	,	_	0	SENT_93	[p6l1909t1198r2132b1251, p6l12t1300r163b1396],
4	NCTOO433589	NN	O	nctoo433589	appos	2	SENT_93	[p6l200t1306r837b1391],
5	)	CD	NUMBER	)	num	7	SENT_93	[p6l200t1306r837b1391],
6	testing	NN	O	testing	nn	7	SENT_93	[p6l876t1301r1173b1401],
7	MammaPrint	NNP	ORGANIZATION	MammaPrint	dep	1	SENT_93	[p6l1201t1301r1782b1379],
8	and	CC	O	and	_	0	SENT_93	[p6l1810t1300r1967b1379],
9	the	DT	O	the	det	11	SENT_93	[p6l2001t1300r2133b1379],
10	Trial	NNP	O	Trial	nn	11	SENT_93	[p6l8t1428r211b1507],
11	Assigning	NNP	O	Assigning	dep	1	SENT_93	[p6l240t1429r678b1529],
12	Individualized	NNP	O	Individualized	nn	13	SENT_93	[p6l706t1428r1327b1507],
13	Options	NNPS	O	Options	dep	1	SENT_93	[p6l1359t1429r1701b1529],
14	for	IN	O	for	_	0	SENT_93	[p6l1735t1428r1858b1507],
15	Treatment	NN	O	treatment	prep_for	13	SENT_93	[p6l1885t1434r2133b1507, p6l12t1572r233b1634],
16	(	CD	NUMBER	(	num	15	SENT_93	[p6l285t1562r741b1646],
17	TAILORX	NNP	O	TAILORX	dep	1	SENT_93	[p6l285t1562r741b1646],
18	)	CD	NUMBER	)	number	19	SENT_93	[p6l285t1562r741b1646],
19	(	CD	NUMBER	(	num	20	SENT_93	[p6l804t1562r1467b1647],
20	NCTOO310180	NN	O	nctoo310180	dep	17	SENT_93	[p6l804t1562r1467b1647],
21	)	CD	NUMBER	)	num	22	SENT_93	[p6l804t1562r1467b1647],
22	testing	NN	O	testing	dep	1	SENT_93	[p6l1526t1557r1823b1656],
23	Oncotype	NNP	O	Oncotype	nn	26	SENT_93	[p6l1872t1562r2133b1634, p6l12t1701r193b1785],
24	DX	NNP	O	DX	nn	26	SENT_93	[p6l257t1691r385b1762],
25	(	NNP	O	(	nn	26	SENT_93	[p6l452t1685r634b1785],
26	Fig	NNP	O	Fig	dep	22	SENT_93	[p6l452t1685r634b1785],
27	.	.	O	.	_	0	SENT_93	[p6l452t1685r634b1785],

1	1	CD	NUMBER	1	_	0	SENT_94	[p6l710t1690r805b1775],
2	)	NN	O	)	dep	1	SENT_94	[p6l710t1690r805b1775],
3	.	.	O	.	_	0	SENT_94	[p6l710t1690r805b1775],

1	Although	IN	O	although	mark	5	SENT_95	[p6l872t1684r1279b1785],
2	both	DT	O	both	det	3	SENT_95	[p6l1344t1684r1542b1763],
3	studies	NNS	O	study	nsubj	5	SENT_95	[p6l1609t1684r1908b1763],
4	will	MD	O	will	aux	5	SENT_95	[p6l1970t1684r2134b1763],
5	contribute	VB	O	contribute	advcl	22	SENT_95	[p6l13t1812r454b1891],
6	substantially	RB	O	substantially	advmod	5	SENT_95	[p6l505t1812r1057b1913],
7	to	TO	O	to	_	0	SENT_95	[p6l1102t1829r1183b1891],
8	evidence	NN	O	evidence	nn	9	SENT_95	[p6l1233t1812r1883b1891],
9	—	NN	O	—	prep_to	5	SENT_95	[p6l1233t1812r1883b1891],
10	based	VBN	O	base	partmod	9	SENT_95	[p6l1233t1812r1883b1891],
11	decisions	NNS	O	decision	dobj	10	SENT_95	[p6l1931t1812r2133b1891, p6l13t1941r230b2019],
12	in	IN	O	in	_	0	SENT_95	[p6l278t1941r361b2018],
13	the	DT	O	the	det	14	SENT_95	[p6l407t1940r540b2019],
14	treatment	NN	O	treatment	prep_in	10	SENT_95	[p6l586t1957r1009b2019],
15	of	IN	O	of	_	0	SENT_95	[p6l1052t1940r1151b2019],
16	early	JJ	O	early	amod	18	SENT_95	[p6l1179t1940r1385b2041],
17	breast	NN	O	breast	nn	18	SENT_95	[p6l1427t1940r1689b2019],
18	cancer	NN	O	cancer	prep_of	14	SENT_95	[p6l1730t1966r2029b2036],
19	,	,	O	,	_	0	SENT_95	[p6l1730t1966r2029b2036],
20	it	PRP	O	it	nsubj	22	SENT_95	[p6l2080t1941r2139b2019],
21	is	VBZ	O	be	cop	22	SENT_95	[p6l11t2069r77b2147],
22	notable	JJ	O	notable	_	0	SENT_95	[p6l124t2068r441b2147],
23	that	IN	O	that	complm	26	SENT_95	[p6l487t2068r659b2147],
24	each	DT	O	each	nsubj	26	SENT_95	[p6l700t2068r892b2147],
25	has	VBZ	O	have	aux	26	SENT_95	[p6l937t2068r1080b2147],
26	required	VBN	O	require	ccomp	22	SENT_95	[p6l1128t2068r1489b2169],
27	enrollment	NN	O	enrollment	dobj	26	SENT_95	[p6l1535t2068r2012b2147],
28	of	IN	O	of	_	0	SENT_95	[p6l2053t2068r2152b2147],
29	many	JJ	O	many	amod	30	SENT_95	[p6l12t2222r251b2297],
30	thousands	NNS	O	thousand	prep_of	27	SENT_95	[p6l289t2196r734b2275],
31	of	IN	O	of	_	0	SENT_95	[p6l780t2196r879b2275],
32	patients	NNS	O	patient	prep_of	30	SENT_95	[p6l903t2197r1244b2297],
33	in	IN	O	in	mark	36	SENT_95	[p6l1289t2197r1372b2274],
34	order	NN	O	order	dep	36	SENT_95	[p6l1415t2196r1643b2275],
35	to	TO	O	to	aux	36	SENT_95	[p6l1683t2213r1764b2275],
36	address	VB	O	address	purpcl	26	SENT_95	[p6l1808t2196r2133b2275],
37	the	DT	O	the	det	40	SENT_95	[p6l12t2324r145b2403],
38	complex	NN	O	complex	nn	40	SENT_95	[p6l190t2324r550b2425],
39	trial	NN	O	trial	nn	40	SENT_95	[p6l591t2324r768b2403],
40	designs	NNS	O	design	dobj	36	SENT_95	[p6l813t2324r1135b2425],
41	needed	VBN	O	need	partmod	40	SENT_95	[p6l1181t2324r1484b2403],
42	to	TO	O	to	aux	44	SENT_95	[p6l1529t2341r1610b2403],
43	definitively	RB	O	definitively	advmod	44	SENT_95	[p6l1656t2324r2139b2425],
44	answer	VB	O	answer	xcomp	41	SENT_95	[p6l11t2478r318b2531],
45	this	DT	O	this	det	47	SENT_95	[p6l364t2452r524b2531],
46	specific	JJ	O	specific	amod	47	SENT_95	[p6l577t2452r906b2553],
47	question	NN	O	question	dobj	44	SENT_95	[p6l954t2453r1346b2553],
48	.	.	O	.	_	0	SENT_95	[p6l954t2453r1346b2553],

1	It	PRP	O	it	nsubj	3	SENT_96	[p6l1398t2460r1463b2531],
2	is	VBZ	O	be	cop	3	SENT_96	[p6l1506t2453r1572b2531],
3	critical	JJ	O	critical	_	0	SENT_96	[p6l1623t2452r1918b2531],
4	that	IN	O	that	complm	9	SENT_96	[p6l1966t2452r2139b2531],
5	any	DT	O	any	det	7	SENT_96	[p6l11t2606r162b2681],
6	new	JJ	O	new	amod	7	SENT_96	[p6l202t2606r379b2659],
7	test	NN	O	test	nsubjpass	9	SENT_96	[p6l421t2597r575b2659],
8	be	VB	O	be	auxpass	9	SENT_96	[p6l615t2580r711b2659],
9	subjected	VBN	O	subject	ccomp	3	SENT_96	[p6l758t2580r1157b2681],
10	to	TO	O	to	_	0	SENT_96	[p6l1202t2597r1283b2659],
11	the	DT	O	the	det	14	SENT_96	[p6l1330t2580r1462b2659],
12	same	JJ	O	same	amod	14	SENT_96	[p6l1509t2606r1729b2659],
13	rigorous	JJ	O	rigorous	amod	14	SENT_96	[p6l1774t2581r2132b2681],
14	appraisal	NN	O	appraisal	prep_to	9	SENT_96	[p6l11t2708r404b2809],
15	required	VBN	O	require	partmod	14	SENT_96	[p6l457t2708r819b2809],
16	for	IN	O	for	_	0	SENT_96	[p6l871t2708r995b2787],
17	any	DT	O	any	det	19	SENT_96	[p6l1044t2734r1194b2809],
18	new	JJ	O	new	amod	19	SENT_96	[p6l1243t2734r1421b2787],
19	drug	NN	O	drug	prep_for	15	SENT_96	[p6l1471t2708r1674b2809],
20	or	CC	O	or	_	0	SENT_96	[p6l1725t2734r1813b2787],
21	procedure	NN	O	procedure	conj_or	19	SENT_96	[p6l1862t2734r2133b2809, p6l13t2836r202b2915],
22	in	IN	O	in	_	0	SENT_96	[p6l253t2837r336b2914],
23	patients	NNS	O	patient	prep_in	19	SENT_96	[p6l386t2837r727b2937],
24	and	CC	O	and	_	0	SENT_96	[p6l780t2836r937b2915],
25	therefore	RB	O	therefore	advmod	44	SENT_96	[p6l990t2836r1378b2915],
26	that	IN	O	that	dep	44	SENT_96	[p6l1430t2836r1603b2915],
27	new	JJ	O	new	amod	28	SENT_96	[p6l1649t2862r1826b2915],
28	signatures	NNS	O	signature	nsubjpass	44	SENT_96	[p6l1876t2837r2133b2937, p6l12t2981r225b3043],
29	of	IN	O	of	_	0	SENT_96	[p6l272t2964r372b3043],
30	relapse	NN	O	relapse	nn	31	SENT_96	[p6l398t2964r700b3065],
31	risk	NN	O	risk	prep_of	28	SENT_96	[p6l744t2964r926b3060],
32	,	,	O	,	_	0	SENT_96	[p6l744t2964r926b3060],
33	such	JJ	O	such	_	0	SENT_96	[p6l978t2964r1171b3043],
34	as	IN	O	as	_	0	SENT_96	[p6l1214t2991r1300b3043],
35	that	DT	O	that	prep_such_as	28	SENT_96	[p6l1347t2964r1519b3043],
36	described	VBN	O	describe	partmod	35	SENT_96	[p6l1559t2964r1970b3043],
37	for	IN	O	for	_	0	SENT_96	[p6l2014t2964r2137b3043],
38	colon	NN	O	colon	nn	39	SENT_96	[p6l13t3092r246b3171],
39	cancer	NN	O	cancer	prep_for	36	SENT_96	[p6l292t3118r590b3188],
40	,	,	O	,	_	0	SENT_96	[p6l292t3118r590b3188],
41	should	MD	O	should	aux	44	SENT_96	[p6l644t3092r931b3171],
42	also	RB	O	also	advmod	44	SENT_96	[p6l975t3092r1147b3171],
43	be	VB	O	be	auxpass	44	SENT_96	[p6l1195t3092r1291b3171],
44	tested	VBN	O	test	conj_and	9	SENT_96	[p6l1338t3092r1591b3171],
45	in	IN	O	in	_	0	SENT_96	[p6l1636t3093r1720b3170],
46	prospective	JJ	O	prospective	amod	50	SENT_96	[p6l1764t3118r2132b3193, p6l12t3221r182b3316],
47	,	,	O	,	_	0	SENT_96	[p6l1764t3118r2132b3193, p6l12t3221r182b3316],
48	randomized	JJ	O	randomized	amod	50	SENT_96	[p6l239t3220r759b3299],
49	clinical	JJ	O	clinical	amod	50	SENT_96	[p6l810t3220r1124b3299],
50	trials	NNS	O	trial	prep_in	44	SENT_96	[p6l1174t3220r1495b3299],
51	.16	CD	NUMBER	.16	tmod	44	SENT_96	[p6l1174t3220r1495b3299],
52	Although	IN	O	although	mark	68	SENT_96	[p6l1543t3220r1950b3321],
53	the	DT	O	the	det	54	SENT_96	[p6l2001t3220r2134b3299],
54	number	NN	O	number	nsubj	68	SENT_96	[p6l12t3348r349b3427],
55	of	IN	O	of	_	0	SENT_96	[p6l396t3348r496b3427],
56	samples	NNS	O	sample	prep_of	54	SENT_96	[p6l528t3348r873b3449],
57	required	VBN	O	require	partmod	56	SENT_96	[p6l924t3348r1285b3449],
58	for	IN	O	for	_	0	SENT_96	[p6l1334t3348r1457b3427],
59	these	DT	O	these	det	60	SENT_96	[p6l1504t3348r1728b3427],
60	types	NNS	O	type	prep_for	57	SENT_96	[p6l1777t3365r2001b3449],
61	of	IN	O	of	_	0	SENT_96	[p6l2053t3348r2152b3427],
62	clinical	JJ	O	clinical	amod	63	SENT_96	[p6l13t3476r326b3555],
63	trials	NNS	O	trial	prep_of	60	SENT_96	[p6l389t3476r607b3555],
64	is	VBZ	O	be	cop	68	SENT_96	[p6l671t3477r737b3555],
65	large	JJ	O	large	amod	68	SENT_96	[p6l800t3476r1038b3577],
66	,	,	O	,	_	0	SENT_96	[p6l800t3476r1038b3577],
67	technological	JJ	O	technological	amod	68	SENT_96	[p6l1106t3476r1688b3577],
68	advances	NNS	O	advance	advcl	86	SENT_96	[p6l1749t3476r2132b3555],
69	such	JJ	O	such	_	0	SENT_96	[p6l13t3604r207b3683],
70	as	IN	O	as	_	0	SENT_96	[p6l262t3631r347b3683],
71	those	DT	O	those	prep_such_as	68	SENT_96	[p6l405t3604r637b3683],
72	enabling	VBG	O	enable	partmod	71	SENT_96	[p6l693t3604r1069b3705],
73	gene	NN	O	gene	nn	76	SENT_96	[p6l1121t3605r1818b3705],
74	—	NN	O	—	nn	76	SENT_96	[p6l1121t3605r1818b3705],
75	expression	NN	O	expression	nn	76	SENT_96	[p6l1121t3605r1818b3705],
76	signatures	NNS	O	signature	dobj	72	SENT_96	[p6l1876t3605r2133b3705, p6l12t3750r225b3812],
77	to	TO	O	to	aux	79	SENT_96	[p6l283t3750r364b3812],
78	be	VB	O	be	auxpass	79	SENT_96	[p6l421t3733r518b3812],
79	derived	VBN	O	derive	xcomp	72	SENT_96	[p6l573t3733r882b3812],
80	from	IN	O	from	_	0	SENT_96	[p6l937t3733r1146b3812],
81	formalin	NN	LOCATION	formalin	prep_from	79	SENT_96	[p6l1202t3733r1832b3812],
82	—	CD	NUMBER	—	num	84	SENT_96	[p6l1202t3733r1832b3812],
83	f1Xed	JJ	O	f1xed	amod	84	SENT_96	[p6l1202t3733r1832b3812],
84	tissue	NN	O	tissue	nsubj	86	SENT_96	[p6l1887t3734r2134b3812],
85	will	MD	O	will	aux	86	SENT_96	[p7l7t46r172b125],
86	facilitate	VB	O	facilitate	rcmod	51	SENT_96	[p7l211t46r582b125],
87	these	DT	O	these	det	88	SENT_96	[p7l622t46r846b125],
88	trials	NNS	O	trial	dobj	86	SENT_96	[p7l886t46r1129b125],
89	.	.	O	.	_	0	SENT_96	[p7l886t46r1129b125],

1	OPTIMIZING	VBG	O	optimize	_	0	SENT_97	[p7l460t380r1171b439],
2	THE	DT	O	the	det	3	SENT_97	[p7l1218t380r1437b438],
3	USE	NN	O	use	dobj	1	SENT_97	[p7l1491t380r1686b439],

1	OF	IN	O	of	_	0	SENT_98	[p7l554t485r685b544],
2	THERAPEUTICS	NNS	O	therapeutics	pobj	1	SENT_98	[p7l733t485r1591b544],

1	The	DT	O	the	det	3	SENT_99	[p7l8t718r169b797],
2	common	JJ	O	common	amod	3	SENT_99	[p7l228t744r610b797],
3	experience	NN	O	experience	nsubj	7	SENT_99	[p7l668t719r1124b819],
4	of	IN	O	of	_	0	SENT_99	[p7l1183t718r1283b797],
5	practicing	VBG	O	practice	prepc_of	3	SENT_99	[p7l1321t719r1756b819],
6	oncologists	NNS	O	oncologist	dobj	5	SENT_99	[p7l1812t718r2133b797, p7l12t847r211b947],
7	is	VBZ	O	be	_	0	SENT_99	[p7l257t847r322b925],
8	that	IN	O	that	complm	21	SENT_99	[p7l370t846r542b925],
9	only	RB	O	only	advmod	11	SENT_99	[p7l582t846r766b947],
10	a	DT	O	a	det	11	SENT_99	[p7l805t873r850b925],
11	subgroup	NN	O	subgroup	nsubj	21	SENT_99	[p7l894t846r1297b947],
12	of	IN	O	of	_	0	SENT_99	[p7l1344t846r1444b925],
13	patients	NNS	O	patient	prep_of	11	SENT_99	[p7l1469t847r1810b947],
14	with	IN	O	with	_	0	SENT_99	[p7l1853t846r2048b926],
15	a	DT	O	a	det	17	SENT_99	[p7l2091t873r2136b925],
16	specific	JJ	O	specific	amod	17	SENT_99	[p7l13t974r343b1075],
17	type	NN	O	type	prep_with	13	SENT_99	[p7l403t991r584b1075],
18	of	IN	O	of	_	0	SENT_99	[p7l645t974r745b1053],
19	cancer	NN	O	cancer	prep_of	17	SENT_99	[p7l787t1000r1067b1053],
20	will	MD	O	will	aux	21	SENT_99	[p7l1120t974r1285b1053],
21	derive	VB	O	derive	ccomp	7	SENT_99	[p7l1346t974r1597b1053],
22	substantial	JJ	O	substantial	amod	23	SENT_99	[p7l1659t974r2135b1053],
23	benefit	NN	O	benefit	dobj	21	SENT_99	[p7l12t1102r318b1181],
24	from	IN	O	from	_	0	SENT_99	[p7l350t1102r561b1181],
25	a	DT	O	a	det	27	SENT_99	[p7l599t1129r643b1181],
26	particular	JJ	O	particular	amod	27	SENT_99	[p7l678t1102r1107b1203],
27	therapy	NN	O	therapy	prep_from	21	SENT_99	[p7l1143t1102r1478b1203],
28	.	.	O	.	_	0	SENT_99	[p7l1143t1102r1478b1203],

1	Differences	NNS	O	difference	nsubj	11	SENT_100	[p7l1520t1102r2012b1181],
2	in	IN	O	in	_	0	SENT_100	[p7l2051t1103r2134b1180],
3	responses	NNS	O	response	prep_in	1	SENT_100	[p7l12t1256r435b1331],
4	to	TO	O	to	_	0	SENT_100	[p7l471t1247r553b1309],
5	the	DT	O	the	det	7	SENT_100	[p7l588t1230r721b1309],
6	same	JJ	O	same	amod	7	SENT_100	[p7l756t1256r976b1309],
7	treatment	NN	O	treatment	prep_to	3	SENT_100	[p7l1010t1247r1435b1309],
8	among	IN	O	among	_	0	SENT_100	[p7l1462t1256r1762b1331],
9	patients	NNS	O	patient	prep_among	7	SENT_100	[p7l1791t1231r2132b1331],
10	are	VBP	O	be	cop	11	SENT_100	[p7l11t1384r140b1437],
11	unsurprising	JJ	O	unsurprising	_	0	SENT_100	[p7l189t1359r749b1459],
12	in	IN	O	in	_	0	SENT_100	[p7l792t1359r875b1436],
13	light	NN	O	light	prep_in	11	SENT_100	[p7l923t1358r1124b1459],
14	of	IN	O	of	_	0	SENT_100	[p7l1168t1358r1267b1437],
15	the	DT	O	the	det	17	SENT_100	[p7l1298t1358r1430b1437],
16	substantial	JJ	O	substantial	amod	17	SENT_100	[p7l1480t1358r1956b1437],
17	ge342	NN	O	ge342	prep_of	13	SENT_100	[p7l2003t1385r2133b1459, p7l149t1534r206b1557],

1	N	NN	O	n	nn	3	SENT_101	[p7l948t1544r962b1559],
2	ENGLJ	NN	O	englj	nn	3	SENT_101	[p7l977t1544r1054b1566],
3	MED	NN	O	med	_	0	SENT_101	[p7l1069t1544r1121b1559],
4	364	CD	NUMBER	364	num	6	SENT_101	[p7l1131t1538r1200b1566],
5	;	:	O	;	_	0	SENT_101	[p7l1131t1538r1200b1566],
6	4	CD	NUMBER	4	dep	3	SENT_101	[p7l1131t1538r1200b1566],
7	NEJM	NNP	ORGANIZATION	NEJM	nn	10	SENT_101	[p7l1235t1544r1359b1566],
8	,	,	O	,	_	0	SENT_101	[p7l1235t1544r1359b1566],
9	ORG	NNP	O	ORG	appos	10	SENT_101	[p7l1235t1544r1359b1566],
10	JANUARY	NNP	DATE	JANUARY	dep	3	SENT_101	[p7l1390t1544r1502b1566],
11	27,2011	CD	NUMBER	27,2011	num	10	SENT_101	[p7l1512t1544r1609b1565],

1	The	DT	O	the	det	4	SENT_102	[p7l936t1577r987b1601],
2	New	NNP	O	New	nn	4	SENT_102	[p7l996t1578r1058b1601],
3	England	NNP	O	England	nn	4	SENT_102	[p7l1067t1577r1178b1608],
4	Journal	NNP	O	Journal	_	0	SENT_102	[p7l1187t1577r1284b1601],
5	of	IN	O	of	_	0	SENT_102	[p7l1294t1577r1323b1601],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_102	[p7l1330t1577r1455b1601],

1	Downloaded	VBN	O	download	_	0	SENT_103	[p7l378t1618r548b1641],
2	from	IN	O	from	_	0	SENT_103	[p7l557t1618r622b1641],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_103	[p7l630t1618r749b1648],
4	at	IN	O	at	_	0	SENT_103	[p7l759t1622r782b1641],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_103	[p7l790t1618r973b1641],
6	on	IN	O	on	_	0	SENT_103	[p7l982t1625r1015b1641],
7	January	NNP	DATE	January	prep_on	1	SENT_103	[p7l1023t1618r1126b1648],
8	5	CD	DATE	5	num	7	SENT_103	[p7l1136t1618r1159b1645],
9	,	,	DATE	,	_	0	SENT_103	[p7l1136t1618r1159b1645],
10	2014	CD	DATE	2014	num	7	SENT_103	[p7l1169t1618r1242b1641],
11	.	.	O	.	_	0	SENT_103	[p7l1169t1618r1242b1641],

1	For	IN	O	for	_	0	SENT_104	[p7l1252t1618r1299b1641],
2	personal	JJ	O	personal	amod	3	SENT_104	[p7l1307t1618r1419b1648],
3	use	NN	O	use	pobj	1	SENT_104	[p7l1428t1625r1472b1641],
4	only	RB	O	only	advmod	3	SENT_104	[p7l1481t1618r1546b1648],
5	.	.	O	.	_	0	SENT_104	[p7l1481t1618r1546b1648],

1	No	DT	O	no	det	3	SENT_105	[p7l1557t1618r1596b1641],
2	other	JJ	O	other	amod	3	SENT_105	[p7l1606t1618r1674b1641],
3	uses	NNS	O	use	_	0	SENT_105	[p7l1683t1625r1739b1641],
4	without	IN	O	without	_	0	SENT_105	[p7l1749t1618r1850b1641],
5	permission	NN	O	permission	prep_without	3	SENT_105	[p7l1858t1618r2011b1648],
6	.	.	O	.	_	0	SENT_105	[p7l1858t1618r2011b1648],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_106	[p7l909t1765r1067b1784],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_106	[p7l1081t1765r1251b1784],

1	nomic	JJ	O	nomic	amod	2	SENT_107	[p7l11t1979r279b2057],
2	heterogeneity	NN	O	heterogeneity	_	0	SENT_107	[p7l324t1978r911b2079],
3	that	WDT	O	that	nsubj	4	SENT_107	[p7l952t1978r1125b2056],
4	exists	VBZ	O	exist	rcmod	2	SENT_107	[p7l1166t1979r1405b2057],
5	among	IN	O	among	_	0	SENT_107	[p7l1453t2004r1753b2079],
6	tumors	NNS	O	tumor	prep_among	4	SENT_107	[p7l1796t1995r2128b2057],
7	.	.	O	.	_	0	SENT_107	[p7l1796t1995r2128b2057],

1	Some	DT	O	some	nsubj	6	SENT_108	[p7l13t2112r244b2185],
2	of	IN	O	of	_	0	SENT_108	[p7l288t2105r388b2185],
3	these	DT	O	these	det	5	SENT_108	[p7l413t2106r636b2185],
4	genomic	JJ	O	genomic	amod	5	SENT_108	[p7l679t2107r1048b2207],
5	differences	NNS	O	difference	prep_of	1	SENT_108	[p7l1091t2105r1565b2185],
6	have	VBP	O	have	_	0	SENT_108	[p7l1610t2106r1800b2185],
7	an	DT	O	a	det	9	SENT_108	[p7l1842t2132r1945b2184],
8	important	JJ	O	important	amod	9	SENT_108	[p7l1987t2107r2132b2184, p7l9t2251r336b2334],
9	role	NN	O	role	dobj	6	SENT_108	[p7l377t2234r537b2313],
10	in	IN	O	in	_	0	SENT_108	[p7l583t2235r667b2312],
11	determining	VBG	O	determine	prepc_in	9	SENT_108	[p7l715t2234r1253b2335],
12	the	DT	O	the	det	13	SENT_108	[p7l1297t2234r1430b2312],
13	likelihood	NN	O	likelihood	dobj	11	SENT_108	[p7l1476t2234r1915b2313],
14	of	IN	O	of	_	0	SENT_108	[p7l1963t2233r2063b2313],
15	a	DT	O	a	det	17	SENT_108	[p7l2091t2260r2135b2312],
16	clinical	JJ	O	clinical	amod	17	SENT_108	[p7l12t2362r325b2440],
17	response	NN	O	response	prep_of	13	SENT_108	[p7l381t2388r762b2461],
18	to	TO	O	to	_	0	SENT_108	[p7l819t2379r901b2440],
19	treatment	NN	O	treatment	prep_to	11	SENT_108	[p7l960t2379r1404b2440],
20	.	.	O	.	_	0	SENT_108	[p7l960t2379r1404b2440],

1	Notably	RB	O	notably	advmod	29	SENT_109	[p7l1464t2362r1816b2461],
2	,	,	O	,	_	0	SENT_109	[p7l1464t2362r1816b2461],
3	in	IN	O	in	_	0	SENT_109	[p7l1877t2363r1961b2439],
4	instances	NNS	O	instance	prep_in	29	SENT_109	[p7l2017t2363r2132b2439, p7l12t2507r326b2568],
5	in	IN	O	in	_	0	SENT_109	[p7l365t2491r448b2568],
6	which	WDT	O	which	rel	11	SENT_109	[p7l483t2490r745b2569],
7	the	DT	O	the	det	9	SENT_109	[p7l783t2490r916b2568],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_109	[p7l955t2490r1440b2590],
9	agent	NN	O	agent	nsubjpass	11	SENT_109	[p7l1477t2507r1714b2591],
10	is	VBZ	O	be	auxpass	11	SENT_109	[p7l1746t2491r1812b2568],
11	targeted	VBN	O	target	rcmod	4	SENT_109	[p7l1853t2507r2132b2591, p7l12t2618r108b2697],
12	at	IN	O	at	_	0	SENT_109	[p7l158t2635r237b2696],
13	a	DT	O	a	det	16	SENT_109	[p7l282t2644r326b2696],
14	particular	JJ	O	particular	amod	16	SENT_109	[p7l373t2618r803b2718],
15	cellular	JJ	O	cellular	amod	16	SENT_109	[p7l852t2618r1172b2697],
16	protein	NN	O	protein	prep_at	11	SENT_109	[p7l1218t2619r1552b2718],
17	,	,	O	,	_	0	SENT_109	[p7l1218t2619r1552b2718],
18	genomic	JJ	O	genomic	amod	19	SENT_109	[p7l1608t2619r1978b2719],
19	alterations	NNS	O	alteration	nsubj	29	SENT_109	[p7l2027t2618r2132b2696, p7l12t2747r388b2825],
20	in	IN	O	in	_	0	SENT_109	[p7l433t2747r516b2824],
21	the	DT	O	the	det	22	SENT_109	[p7l560t2746r692b2825],
22	gene	NN	O	gene	prep_in	19	SENT_109	[p7l736t2772r935b2847],
23	encoding	VBG	O	encode	partmod	22	SENT_109	[p7l979t2746r1379b2847],
24	that	IN	O	that	complm	25	SENT_109	[p7l1420t2746r1592b2824],
25	protein	NN	O	protein	dep	23	SENT_109	[p7l1629t2747r1941b2846],
26	can	MD	O	can	aux	29	SENT_109	[p7l1985t2772r2134b2824],
27	be	VB	O	be	cop	29	SENT_109	[p7l12t2873r108b2952],
28	major	JJ	O	major	amod	29	SENT_109	[p7l139t2874r389b2973],
29	determinants	NNS	O	determinant	_	0	SENT_109	[p7l417t2873r994b2952],
30	of	IN	O	of	_	0	SENT_109	[p7l1027t2872r1127b2952],
31	response	NN	O	response	prep_of	29	SENT_109	[p7l1139t2899r1543b2973],
32	.	.	O	.	_	0	SENT_109	[p7l1139t2899r1543b2973],

1	For	IN	O	for	_	0	SENT_110	[p7l1578t2881r1721b2952],
2	example	NN	O	example	prep_for	15	SENT_110	[p7l1749t2873r2128b2973],
3	,	,	O	,	_	0	SENT_110	[p7l1749t2873r2128b2973],
4	overexpression	NN	O	overexpression	nsubj	15	SENT_110	[p7l12t3002r649b3101],
5	and	CC	O	and	_	0	SENT_110	[p7l719t3001r877b3080],
6	amplification	NN	O	amplification	nsubj	15	SENT_110	[p7l946t3000r1529b3101],
7	of	IN	O	of	_	0	SENT_110	[p7l1601t3000r1701b3080],
8	HER2	NN	O	her2	prep_of	4	SENT_110	[p7l1751t3008r1979b3081],
9	in	IN	O	in	_	0	SENT_110	[p7l2050t3002r2133b3079],
10	breast	NN	O	breast	nn	11	SENT_110	[p7l12t3130r274b3209],
11	cancer	NN	O	cancer	prep_in	8	SENT_110	[p7l331t3156r612b3208],
12	is	VBZ	O	be	cop	15	SENT_110	[p7l669t3131r735b3208],
13	a	DT	O	a	det	15	SENT_110	[p7l797t3156r842b3208],
14	strong	JJ	O	strong	amod	15	SENT_110	[p7l902t3147r1180b3231],
15	predictor	NN	O	predictor	_	0	SENT_110	[p7l1236t3130r1631b3230],
16	of	IN	O	of	_	0	SENT_110	[p7l1690t3129r1790b3209],
17	benefit	NN	O	benefit	prep_of	15	SENT_110	[p7l1833t3129r2138b3209],
18	from	IN	O	from	_	0	SENT_110	[p7l11t3256r221b3336],
19	treatment	NN	O	treatment	prep_from	17	SENT_110	[p7l271t3274r695b3335],
20	with	IN	O	with	_	0	SENT_110	[p7l735t3257r930b3337],
21	trastuzumab	NN	O	trastuzumab	prep_with	19	SENT_110	[p7l980t3257r1551b3353],
22	,	,	O	,	_	0	SENT_110	[p7l980t3257r1551b3353],
23	an	DT	O	a	det	24	SENT_110	[p7l1606t3283r1709b3335],
24	antibody	NN	O	antibody	appos	21	SENT_110	[p7l1758t3257r2138b3357],
25	directed	VBN	O	direct	partmod	24	SENT_110	[p7l12t3386r360b3465],
26	against	IN	O	against	_	0	SENT_110	[p7l411t3387r726b3487],
27	HER2	NN	O	her2	prep_against	25	SENT_110	[p7l772t3391r1124b3469],
28	.	.	O	.	_	0	SENT_110	[p7l772t3391r1124b3469],

1	“	NN	O	“	npadvmod	11	SENT_111	[p7l772t3391r1124b3469],
2	On	IN	O	on	_	0	SENT_111	[p7l1176t3392r1302b3465],
3	the	DT	O	the	det	4	SENT_111	[p7l1355t3386r1487b3464],
4	basis	NN	O	basis	prep_on	11	SENT_111	[p7l1539t3386r1751b3465],
5	of	IN	O	of	_	0	SENT_111	[p7l1805t3385r1905b3465],
6	such	JJ	O	such	amod	7	SENT_111	[p7l1939t3386r2133b3465],
7	findings	NNS	O	finding	prep_of	4	SENT_111	[p7l11t3513r399b3615],
8	,	,	O	,	_	0	SENT_111	[p7l11t3513r399b3615],
9	the	DT	O	the	det	10	SENT_111	[p7l436t3514r569b3592],
10	FDA	NNP	ORGANIZATION	FDA	nsubj	11	SENT_111	[p7l599t3521r784b3592],
11	approved	VBD	O	approve	_	0	SENT_111	[p7l811t3514r1200b3614],
12	trastuzumab	NN	O	trastuzumab	dobj	11	SENT_111	[p7l1232t3514r1781b3593],
13	in	IN	O	in	_	0	SENT_111	[p7l1813t3515r1896b3592],
14	1998	CD	DATE	1998	prep_in	11	SENT_111	[p7l1930t3520r2131b3593],

1	for	IN	O	for	_	0	SENT_112	[p8l11t19r134b99],
2	use	NN	O	use	pobj	1	SENT_112	[p8l167t46r308b100],
3	in	IN	O	in	_	0	SENT_112	[p8l343t21r426b98],
4	the	DT	O	the	det	5	SENT_112	[p8l463t20r595b98],
5	treatment	NN	O	treatment	prep_in	2	SENT_112	[p8l632t37r1056b98],
6	of	IN	O	of	_	0	SENT_112	[p8l1088t19r1187b99],
7	HER2	NN	O	her2	prep_of	5	SENT_112	[p8l1205t19r1907b120],
8	—	CD	NUMBER	—	num	7	SENT_112	[p8l1205t19r1907b120],
9	amplif1ed	VBN	O	amplif1e	partmod	7	SENT_112	[p8l1205t19r1907b120],
10	metastatic	JJ	O	metastatic	amod	12	SENT_112	[p8l1943t37r2132b98, p8l11t127r289b204],
11	breast	NN	O	breast	nn	12	SENT_112	[p8l324t126r586b205],
12	cancer	NN	O	cancer	dobj	9	SENT_112	[p8l617t152r915b205],
13	.	.	O	.	_	0	SENT_112	[p8l617t152r915b205],

1	Following	VBG	O	follow	_	0	SENT_113	[p8l138t254r573b355],
2	this	DT	O	this	prep_following	19	SENT_113	[p8l604t254r764b332],
3	and	CC	O	and	_	0	SENT_113	[p8l800t254r958b333],
4	other	JJ	O	other	amod	5	SENT_113	[p8l992t254r1220b333],
5	examples	NNS	O	example	conj_and	2	SENT_113	[p8l1252t254r1674b354],
6	,	,	O	,	_	0	SENT_113	[p8l1252t254r1674b354],
7	most	JJS	O	most	amod	9	SENT_113	[p8l1714t271r1930b333],
8	new	JJ	O	new	amod	9	SENT_113	[p8l1959t280r2137b333],
9	agents	NNS	O	agent	nsubjpass	19	SENT_113	[p8l11t399r286b483],
10	entering	VBG	O	enter	partmod	9	SENT_113	[p8l337t383r697b483],
11	clinical	JJ	O	clinical	amod	12	SENT_113	[p8l742t382r1056b460],
12	trials	NNS	O	trial	dobj	10	SENT_113	[p8l1104t382r1323b460],
13	over	IN	O	over	_	0	SENT_113	[p8l1374t408r1552b461],
14	the	DT	DATE	the	det	16	SENT_113	[p8l1597t382r1730b460],
15	past	JJ	DATE	past	amod	16	SENT_113	[p8l1778t399r1958b482],
16	decade	NN	DATE	decade	prep_over	10	SENT_113	[p8l2002t382r2132b461, p8l12t509r201b588],
17	have	VBP	O	have	aux	19	SENT_113	[p8l234t509r424b589],
18	been	VBN	O	be	auxpass	19	SENT_113	[p8l458t509r660b588],
19	postulated	VBN	O	postulate	_	0	SENT_113	[p8l691t509r1147b609],
20	to	TO	O	to	_	0	SENT_113	[p8l1181t526r1262b588],
21	inﬂuence	NN	O	inﬂuence	nn	22	SENT_113	[p8l1296t508r1700b589],
22	pathways	NNS	O	pathway	prep_to	19	SENT_113	[p8l1732t509r2130b609],
23	important	JJ	O	important	amod	22	SENT_113	[p8l11t638r452b737],
24	for	IN	O	for	_	0	SENT_113	[p8l511t636r635b716],
25	the	DT	O	the	det	26	SENT_113	[p8l697t637r830b715],
26	proliferation	NN	O	proliferation	prep_for	23	SENT_113	[p8l893t636r1438b737],
27	or	CC	O	or	_	0	SENT_113	[p8l1503t663r1592b716],
28	survival	NN	O	survival	conj_or	26	SENT_113	[p8l1655t637r1987b717],
29	of	IN	O	of	_	0	SENT_113	[p8l2053t636r2152b716],
30	cancer	NN	O	cancer	nn	31	SENT_113	[p8l12t792r292b844],
31	cells	NNS	O	cell	prep_of	26	SENT_113	[p8l326t766r537b845],
32	.	.	O	.	_	0	SENT_113	[p8l326t766r537b845],

1	The	DT	O	the	det	2	SENT_114	[p8l575t766r736b844],
2	genes	NNS	O	gene	nsubjpass	10	SENT_114	[p8l771t792r1013b867],
3	involved	VBN	O	involve	partmod	2	SENT_114	[p8l1050t766r1402b845],
4	in	IN	O	in	_	0	SENT_114	[p8l1436t767r1519b844],
5	these	DT	O	these	det	7	SENT_114	[p8l1555t766r1778b845],
6	cellular	JJ	O	cellular	amod	7	SENT_114	[p8l1815t766r2136b845],
7	pathways	NNS	O	pathway	prep_in	3	SENT_114	[p8l9t893r408b993],
8	are	VBP	O	be	auxpass	10	SENT_114	[p8l476t919r606b971],
9	frequently	RB	O	frequently	advmod	10	SENT_114	[p8l672t892r1111b993],
10	mutated	VBN	O	mutate	_	0	SENT_114	[p8l1173t893r1527b973],
11	as	IN	O	as	_	0	SENT_114	[p8l1593t919r1678b971],
12	a	DT	O	a	det	13	SENT_114	[p8l1746t919r1790b971],
13	consequence	NN	O	consequence	prep_as	10	SENT_114	[p8l1856t919r2132b972, p8l12t1047r310b1121],
14	of	IN	O	of	_	0	SENT_114	[p8l357t1020r456b1100],
15	somatic	JJ	O	somatic	amod	16	SENT_114	[p8l485t1022r821b1100],
16	alterations	NNS	O	alteration	prep_of	13	SENT_114	[p8l865t1021r1319b1100],
17	(	CD	NUMBER	(	num	19	SENT_114	[p8l1372t1022r1629b1121],
18	point	NN	O	point	nn	19	SENT_114	[p8l1372t1022r1629b1121],
19	mutations	NNS	O	mutation	dobj	10	SENT_114	[p8l1669t1022r2128b1117],
20	,	,	O	,	_	0	SENT_114	[p8l1669t1022r2128b1117],
21	deletions	NNS	O	deletion	conj_and	19	SENT_114	[p8l12t1149r423b1245],
22	,	,	O	,	_	0	SENT_114	[p8l12t1149r423b1245],
23	amplifications	NNS	O	amplification	conj_and	19	SENT_114	[p8l510t1148r1161b1249],
24	,	,	O	,	_	0	SENT_114	[p8l510t1148r1161b1249],
25	and	CC	O	and	_	0	SENT_114	[p8l1249t1149r1406b1228],
26	translocations	NNS	O	translocation	dobj	10	SENT_114	[p8l1489t1149r2128b1240],
27	)	RB	O	)	advmod	28	SENT_114	[p8l1489t1149r2128b1240],
28	known	VBN	O	know	amod	26	SENT_114	[p8l11t1278r309b1357],
29	as	IN	O	as	_	0	SENT_114	[p8l352t1304r437b1356],
30	driver	NN	O	driver	nn	31	SENT_114	[p8l484t1278r732b1357],
31	mutations	NNS	O	mutation	prep_as	10	SENT_114	[p8l773t1279r1232b1373],
32	,	,	O	,	_	0	SENT_114	[p8l773t1279r1232b1373],
33	which	WDT	O	which	nsubj	35	SENT_114	[p8l1277t1278r1540b1357],
34	directly	RB	O	directly	advmod	35	SENT_114	[p8l1584t1278r1908b1377],
35	contribute	VBP	O	contribute	rcmod	31	SENT_114	[p8l1948t1304r2132b1356, p8l12t1406r297b1485],
36	to	TO	O	to	_	0	SENT_114	[p8l354t1423r435b1485],
37	the	DT	O	the	det	39	SENT_114	[p8l494t1406r627b1484],
38	abnormal	JJ	O	abnormal	amod	39	SENT_114	[p8l683t1406r1100b1485],
39	growth	NN	O	growth	prep_to	35	SENT_114	[p8l1155t1406r1470b1507],
40	of	IN	O	of	_	0	SENT_114	[p8l1528t1405r1627b1485],
41	the	DT	O	the	det	43	SENT_114	[p8l1666t1406r1799b1484],
42	cancer	NN	O	cancer	nn	43	SENT_114	[p8l1856t1432r2137b1485],
43	cell	NN	O	cell	prep_of	39	SENT_114	[p8l12t1533r180b1612],
44	.	.	O	.	_	0	SENT_114	[p8l12t1533r180b1612],

1	As	IN	O	as	_	0	SENT_115	[p8l221t1541r327b1611],
2	a	DT	O	a	det	3	SENT_115	[p8l367t1559r412b1611],
3	result	NN	O	result	prep_as	15	SENT_115	[p8l449t1533r713b1629],
4	,	,	O	,	_	0	SENT_115	[p8l449t1533r713b1629],
5	the	DT	O	the	det	6	SENT_115	[p8l758t1533r891b1611],
6	presence	NN	O	presence	nsubj	15	SENT_115	[p8l928t1559r1304b1633],
7	or	CC	O	or	_	0	SENT_115	[p8l1343t1559r1432b1612],
8	absence	NN	O	absence	nsubj	15	SENT_115	[p8l1467t1533r1805b1612],
9	of	IN	O	of	_	0	SENT_115	[p8l1845t1532r1944b1612],
10	mutations	NNS	O	mutation	prep_of	6	SENT_115	[p8l1965t1559r2132b1613, p8l12t1663r305b1741],
11	within	IN	O	within	_	0	SENT_115	[p8l345t1662r630b1741],
12	these	DT	O	these	det	13	SENT_115	[p8l673t1662r896b1741],
13	genes	NNS	O	gene	prep_within	10	SENT_115	[p8l939t1688r1181b1763],
14	can	MD	O	can	aux	15	SENT_115	[p8l1226t1688r1375b1740],
15	have	VB	O	have	_	0	SENT_115	[p8l1418t1662r1607b1741],
16	a	DT	O	a	det	18	SENT_115	[p8l1649t1688r1694b1740],
17	profound	JJ	O	profound	amod	18	SENT_115	[p8l1733t1661r2134b1762],
18	effect	NN	O	effect	dobj	15	SENT_115	[p8l12t1788r253b1867],
19	on	IN	O	on	_	0	SENT_115	[p8l297t1815r403b1868],
20	a	DT	O	a	det	21	SENT_115	[p8l451t1815r495b1867],
21	patient	NN	O	patient	poss	23	SENT_115	[p8l540t1790r903b1889],
22	’s	POS	O	’s	_	0	SENT_115	[p8l540t1790r903b1889],
23	response	NN	O	response	prep_on	18	SENT_115	[p8l953t1815r1334b1889],
24	to	TO	O	to	_	0	SENT_115	[p8l1383t1806r1464b1868],
25	a	DT	O	a	det	28	SENT_115	[p8l1513t1815r1557b1867],
26	specific	JJ	O	specific	dep	27	SENT_115	[p8l1605t1788r1934b1889],
27	targeted	VBN	O	target	amod	28	SENT_115	[p8l1983t1806r2132b1867, p8l11t1918r243b2019],
28	therapy	NN	O	therapy	prep_to	23	SENT_115	[p8l283t1918r617b2018],
29	.	.	O	.	_	0	SENT_115	[p8l283t1918r617b2018],

1	For	IN	O	for	_	0	SENT_116	[p8l139t2053r281b2124],
2	example	NN	O	example	prep_for	20	SENT_116	[p8l356t2045r735b2145],
3	,	,	O	,	_	0	SENT_116	[p8l356t2045r735b2145],
4	small	JJ	O	small	amod	7	SENT_116	[p8l818t2045r1474b2125],
5	—	NN	O	—	nn	7	SENT_116	[p8l818t2045r1474b2125],
6	molecule	NN	O	molecule	nn	7	SENT_116	[p8l818t2045r1474b2125],
7	inhibitors	NNS	O	inhibitor	nsubjpass	20	SENT_116	[p8l1551t2045r1972b2124],
8	of	IN	O	of	_	0	SENT_116	[p8l2052t2044r2152b2124],
9	epidermal	JJ	O	epidermal	amod	15	SENT_116	[p8l12t2174r443b2274],
10	growth	NN	O	growth	nn	15	SENT_116	[p8l479t2174r794b2275],
11	factor	NN	O	factor	nn	15	SENT_116	[p8l830t2173r1080b2253],
12	receptor	NN	O	receptor	nn	15	SENT_116	[p8l1113t2191r1469b2274],
13	(	CD	NUMBER	(	num	15	SENT_116	[p8l1507t2180r1813b2265],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_116	[p8l1507t2180r1813b2265],
15	)	NN	O	)	prep_of	7	SENT_116	[p8l1507t2180r1813b2265],
16	kinase	NN	O	kinase	nn	17	SENT_116	[p8l1854t2174r2133b2253],
17	activity	NN	O	activity	dep	15	SENT_116	[p8l11t2303r320b2402],
18	were	VBD	O	be	auxpass	20	SENT_116	[p8l387t2328r589b2381],
19	originally	RB	O	originally	advmod	20	SENT_116	[p8l666t2302r1083b2403],
20	developed	VBN	O	develop	_	0	SENT_116	[p8l1155t2302r1582b2402],
21	for	IN	O	for	_	0	SENT_116	[p8l1658t2301r1781b2381],
22	cancer	NN	O	cancer	nn	23	SENT_116	[p8l1855t2328r2136b2380],
23	treatment	NN	O	treatment	prep_for	20	SENT_116	[p8l12t2447r435b2508],
24	because	IN	O	because	_	0	SENT_116	[p8l466t2430r803b2509],
25	of	IN	O	of	_	0	SENT_116	[p8l839t2429r939b2509],
26	the	DT	O	the	det	28	SENT_116	[p8l957t2430r1089b2508],
27	known	JJ	O	known	amod	28	SENT_116	[p8l1125t2430r1422b2509],
28	role	NN	O	role	prep_because_of	20	SENT_116	[p8l1458t2430r1618b2509],
29	of	IN	O	of	_	0	SENT_116	[p8l1654t2429r1755b2509],
30	EGFR	NN	ORGANIZATION	egfr	prep_of	28	SENT_116	[p8l1770t2436r2026b2514],
31	in	IN	O	in	_	0	SENT_116	[p8l2050t2431r2134b2507],
32	regulating	VBG	O	regulate	prepc_in	30	SENT_116	[p8l11t2558r461b2659],
33	cellular	JJ	O	cellular	amod	34	SENT_116	[p8l496t2558r817b2637],
34	proliferation	NN	O	proliferation	dobj	32	SENT_116	[p8l850t2557r1394b2658],
35	and	CC	O	and	_	0	SENT_116	[p8l1431t2558r1588b2637],
36	because	IN	O	because	mark	40	SENT_116	[p8l1626t2558r1962b2637],
37	the	DT	O	the	det	38	SENT_116	[p8l2001t2558r2133b2636],
38	gene	NN	O	gene	nsubjpass	40	SENT_116	[p8l11t2713r210b2788],
39	is	VBZ	O	be	auxpass	40	SENT_116	[p8l260t2688r326b2765],
40	overexpressed	VBN	O	overexpress	conj_and	20	SENT_116	[p8l380t2687r981b2787],
41	in	IN	O	in	_	0	SENT_116	[p8l1031t2688r1114b2765],
42	many	JJ	O	many	amod	43	SENT_116	[p8l1165t2713r1403b2787],
43	cancers	NNS	O	cancer	prep_in	40	SENT_116	[p8l1450t2713r1795b2766],
44	.	.	O	.	_	0	SENT_116	[p8l1450t2713r1795b2766],

1	Subsequently	RB	O	subsequently	advmod	19	SENT_117	[p8l1854t2687r2132b2766, p8l12t2815r343b2915],
2	,	,	O	,	_	0	SENT_117	[p8l1854t2687r2132b2766, p8l12t2815r343b2915],
3	the	DT	O	the	det	4	SENT_117	[p8l390t2815r522b2894],
4	discovery	NN	O	discovery	nsubj	19	SENT_117	[p8l564t2815r968b2915],
5	of	IN	O	of	_	0	SENT_117	[p8l1005t2814r1105b2894],
6	activating	VBG	O	activate	prepc_of	4	SENT_117	[p8l1128t2816r1550b2916],
7	somatic	JJ	O	somatic	amod	8	SENT_117	[p8l1588t2816r1924b2894],
8	mutations	NNS	O	mutation	dobj	6	SENT_117	[p8l1965t2841r2132b2894, p8l12t2944r305b3022],
9	of	IN	O	of	_	0	SENT_117	[p8l359t2942r460b3022],
10	EGFR	NN	ORGANIZATION	egfr	prep_of	8	SENT_117	[p8l491t2949r746b3026],
11	in	IN	O	in	_	0	SENT_117	[p8l787t2944r870b3021],
12	non	JJ	O	non	amod	18	SENT_117	[p8l921t2943r1564b3022],
13	—	JJ	O	—	amod	18	SENT_117	[p8l921t2943r1564b3022],
14	small	JJ	O	small	amod	18	SENT_117	[p8l921t2943r1564b3022],
15	—	NN	O	—	nn	18	SENT_117	[p8l921t2943r1564b3022],
16	cell	NN	O	cell	nn	18	SENT_117	[p8l921t2943r1564b3022],
17	lung	NN	O	lung	nn	18	SENT_117	[p8l1614t2943r1807b3044],
18	cancer	NN	O	cancer	prep_in	6	SENT_117	[p8l1855t2969r2137b3021],
19	defined	VBD	O	define	_	0	SENT_117	[p8l12t3070r338b3150],
20	a	DT	O	a	det	21	SENT_117	[p8l384t3097r428b3149],
21	subgroup	NN	O	subgroup	nsubj	34	SENT_117	[p8l475t3071r878b3172],
22	of	IN	O	of	_	0	SENT_117	[p8l927t3070r1027b3150],
23	patients	NNS	O	patient	prep_of	21	SENT_117	[p8l1054t3072r1395b3171],
24	who	WP	O	who	nsubj	25	SENT_117	[p8l1440t3071r1622b3150],
25	had	VBD	O	have	rcmod	23	SENT_117	[p8l1671t3071r1827b3150],
26	a	DT	O	a	det	29	SENT_117	[p8l1873t3097r1917b3149],
27	particularly	RB	O	particularly	advmod	28	SENT_117	[p8l1961t3097r2132b3171, p8l12t3199r366b3299],
28	good	JJ	O	good	amod	29	SENT_117	[p8l407t3199r623b3300],
29	response	NN	O	response	dobj	25	SENT_117	[p8l669t3225r1049b3299],
30	to	TO	O	to	_	0	SENT_117	[p8l1097t3216r1178b3278],
31	EGFR	NN	ORGANIZATION	egfr	nn	32	SENT_117	[p8l1225t3205r1480b3282],
32	inhibitors	NNS	O	inhibitor	prep_to	25	SENT_117	[p8l1516t3199r2133b3278],
33	.18	CD	NUMBER	.18	npadvmod	34	SENT_117	[p8l1516t3199r2133b3278],
34	>	JJR	O	>	xcomp	19	SENT_117	[p8l1516t3199r2133b3278],
35	19	CD	NUMBER	19	nsubj	42	SENT_117	[p8l1516t3199r2133b3278],
36	A	DT	O	a	det	39	SENT_117	[p8l7t3335r73b3405],
37	large	JJ	O	large	amod	39	SENT_117	[p8l120t3327r335b3428],
38	prospective	JJ	O	prospective	amod	39	SENT_117	[p8l385t3328r874b3427],
39	study	NN	O	study	dep	35	SENT_117	[p8l926t3327r1156b3427],
40	has	VBZ	O	have	aux	42	SENT_117	[p8l1203t3327r1346b3405],
41	now	RB	DATE	now	advmod	42	SENT_117	[p8l1400t3353r1584b3406],
42	shown	VBN	O	show	ccomp	19	SENT_117	[p8l1633t3327r1915b3406],
43	that	IN	O	that	complm	48	SENT_117	[p8l1966t3327r2138b3405],
44	the	DT	O	the	det	46	SENT_117	[p8l12t3455r144b3533],
45	response	NN	O	response	nn	46	SENT_117	[p8l181t3481r562b3555],
46	rate	NN	O	rate	nsubj	48	SENT_117	[p8l599t3472r759b3533],
47	to	TO	O	to	aux	48	SENT_117	[p8l797t3472r879b3534],
48	targeted	VBN	O	target	ccomp	42	SENT_117	[p8l917t3455r1273b3556],
49	EGFR	NN	ORGANIZATION	egfr	nn	50	SENT_117	[p8l1308t3461r1564b3538],
50	inhibitors	NNS	O	inhibitor	dobj	48	SENT_117	[p8l1590t3455r2012b3534],
51	in	IN	O	in	_	0	SENT_117	[p8l2050t3456r2134b3533],
52	patients	NNS	O	patient	prep_in	48	SENT_117	[p8l10t3584r351b3683],
53	with	IN	O	with	_	0	SENT_117	[p8l391t3583r586b3662],
54	non	JJ	O	non	amod	60	SENT_117	[p8l628t3583r1270b3662],
55	—	JJ	O	—	amod	60	SENT_117	[p8l628t3583r1270b3662],
56	small	JJ	O	small	amod	60	SENT_117	[p8l628t3583r1270b3662],
57	—	NN	O	—	nn	60	SENT_117	[p8l628t3583r1270b3662],
58	cell	NN	O	cell	nn	60	SENT_117	[p8l628t3583r1270b3662],
59	lung	NN	O	lung	nn	60	SENT_117	[p8l1311t3583r1504b3684],
60	cancer	NN	O	cancer	prep_with	52	SENT_117	[p8l1543t3609r1824b3661],
61	whose	WP$	O	whose	poss	62	SENT_117	[p8l1859t3583r2133b3662],
62	tumors	NNS	O	tumor	nsubj	63	SENT_117	[p8l12t3728r319b3790],
63	harbor	VBP	O	harbor	rcmod	52	SENT_117	[p8l371t3711r663b3790],
64	an	DT	O	a	det	67	SENT_117	[p8l710t3737r812b3789],
65	activating	VBG	O	activate	amod	67	SENT_117	[p8l862t3712r1283b3812],
66	EGFR	NN	ORGANIZATION	egfr	nn	67	SENT_117	[p8l1329t3717r1585b3795],
67	mutation	NN	O	mutation	nsubj	68	SENT_117	[p8l1624t3712r2017b3790],
68	is	VBZ	O	be	ccomp	63	SENT_117	[p8l2065t3712r2131b3789],

1	71	CD	PERCENT	71	num	2	SENT_118	[p9l12t28r213b118],
2	%	NN	PERCENT	%	_	0	SENT_118	[p9l12t28r213b118],
3	,	,	O	,	_	0	SENT_118	[p9l12t28r213b118],
4	as	IN	O	as	mark	2	SENT_118	[p9l263t48r349b100],
5	compared	VBN	O	compare	_	0	SENT_118	[p9l396t22r822b122],
6	with	IN	O	with	prepc_compared_with	2	SENT_118	[p9l863t22r1058b102],
7	1	CD	PERCENT	1	num	8	SENT_118	[p9l1106t28r1231b101],
8	%	NN	PERCENT	%	pobj	2	SENT_118	[p9l1106t28r1231b101],
9	for	IN	O	for	_	0	SENT_118	[p9l1275t21r1398b101],
10	those	DT	O	those	prep_for	8	SENT_118	[p9l1440t22r1671b101],
11	without	IN	O	without	_	0	SENT_118	[p9l1712t22r2052b102],
12	a	DT	O	a	det	13	SENT_118	[p9l2091t48r2135b100],
13	mutation	NN	O	mutation	prep_without	10	SENT_118	[p9l11t151r506b229],
14	?	.	O	?	_	0	SENT_118	[p9l11t151r506b229],

1	“	RB	O	“	advmod	36	SENT_119	[p9l11t151r506b229],
2	As	IN	O	as	_	0	SENT_119	[p9l546t158r652b228],
3	a	DT	O	a	det	4	SENT_119	[p9l698t176r742b228],
4	consequence	NN	O	consequence	prep_as	36	SENT_119	[p9l785t176r1332b250],
5	of	IN	O	of	_	0	SENT_119	[p9l1377t149r1476b229],
6	this	DT	O	this	prep_of	4	SENT_119	[p9l1502t150r1662b228],
7	and	CC	O	and	_	0	SENT_119	[p9l1707t150r1865b229],
8	other	JJ	O	other	amod	10	SENT_119	[p9l1908t150r2136b229],
9	similar	JJ	O	similar	amod	10	SENT_119	[p9l12t278r318b356],
10	trials	NNS	O	trial	prep_of	4	SENT_119	[p9l354t278r597b374],
11	,	,	O	,	_	0	SENT_119	[p9l354t278r597b374],
12	the	DT	O	the	det	13	SENT_119	[p9l641t278r773b356],
13	analysis	NN	O	analysis	nsubjpass	36	SENT_119	[p9l811t278r1150b378],
14	of	IN	O	of	_	0	SENT_119	[p9l1191t277r1291b357],
15	tumor	NN	O	tumor	nn	18	SENT_119	[p9l1311t278r1890b378],
16	—	CD	NUMBER	—	num	18	SENT_119	[p9l1311t278r1890b378],
17	biopsy	NN	O	biopsy	nn	18	SENT_119	[p9l1311t278r1890b378],
18	samples	NNS	O	sample	prep_of	13	SENT_119	[p9l1925t304r2132b356, p9l10t407r177b507],
19	for	IN	O	for	_	0	SENT_119	[p9l225t406r348b486],
20	a	DT	O	a	det	21	SENT_119	[p9l390t433r434b485],
21	subgroup	NN	O	subgroup	prep_for	13	SENT_119	[p9l480t407r883b508],
22	of	IN	O	of	_	0	SENT_119	[p9l932t406r1031b486],
23	key	JJ	O	key	amod	24	SENT_119	[p9l1058t407r1203b507],
24	mutations	NNS	O	mutation	prep_of	21	SENT_119	[p9l1244t408r1679b486],
25	in	IN	O	in	_	0	SENT_119	[p9l1726t408r1809b485],
26	cancer	NN	O	cancer	nn	27	SENT_119	[p9l1855t433r2137b485],
27	genes	NNS	O	gene	prep_in	24	SENT_119	[p9l11t561r252b636],
28	that	WDT	O	that	nsubj	29	SENT_119	[p9l304t535r476b613],
29	confer	VBP	O	confer	rcmod	21	SENT_119	[p9l521t534r795b614],
30	sensitivity	NN	O	sensitivity	dobj	29	SENT_119	[p9l842t536r1275b635],
31	to	TO	O	to	_	0	SENT_119	[p9l1320t552r1401b614],
32	targeted	VBN	O	target	amod	33	SENT_119	[p9l1452t535r1807b636],
33	agents	NNS	O	agent	prep_to	29	SENT_119	[p9l1855t552r2131b636],
34	has	VBZ	O	have	aux	36	SENT_119	[p9l11t663r155b741],
35	been	VBN	O	be	auxpass	36	SENT_119	[p9l196t663r398b742],
36	introduced	VBN	O	introduce	_	0	SENT_119	[p9l435t663r903b742],
37	as	IN	O	as	_	0	SENT_119	[p9l941t689r1026b741],
38	a	DT	O	a	det	41	SENT_119	[p9l1066t689r1110b741],
39	routine	JJ	O	routine	amod	41	SENT_119	[p9l1147t664r1457b742],
40	diagnostic	JJ	O	diagnostic	amod	41	SENT_119	[p9l1496t663r1946b764],
41	test	NN	O	test	prep_as	36	SENT_119	[p9l1984t680r2138b741],
42	in	IN	O	in	_	0	SENT_119	[p9l11t789r94b841],
43	some	DT	O	some	det	44	SENT_119	[p9l135t789r358b842],
44	centers	NNS	O	center	prep_in	41	SENT_119	[p9l399t780r726b842],
45	.	.	O	.	_	0	SENT_119	[p9l399t780r726b842],

1	In	IN	O	in	_	0	SENT_120	[p9l138t899r228b969],
2	some	DT	O	some	det	3	SENT_120	[p9l282t917r505b970],
3	instances	NNS	O	instance	prep_in	9	SENT_120	[p9l557t892r985b987],
4	,	,	O	,	_	0	SENT_120	[p9l557t892r985b987],
5	a	DT	O	a	det	7	SENT_120	[p9l1043t917r1087b969],
6	therapeutic	JJ	O	therapeutic	amod	7	SENT_120	[p9l1138t891r1623b991],
7	agent	NN	O	agent	nsubj	9	SENT_120	[p9l1675t908r1911b992],
8	may	MD	O	may	aux	9	SENT_120	[p9l1958t917r2138b991],
9	have	VB	O	have	_	0	SENT_120	[p9l11t1019r201b1098],
10	synergistic	JJ	O	synergistic	amod	11	SENT_120	[p9l269t1020r732b1120],
11	effects	NNS	O	effect	xcomp	9	SENT_120	[p9l799t1018r1079b1098],
12	with	IN	O	with	_	0	SENT_120	[p9l1143t1019r1339b1098],
13	a	DT	O	a	det	15	SENT_120	[p9l1405t1045r1449b1097],
14	mutated	VBN	O	mutate	amod	15	SENT_120	[p9l1514t1019r1867b1098],
15	gene	NN	O	gene	prep_with	11	SENT_120	[p9l1934t1045r2133b1120],
16	even	RB	O	even	advmod	23	SENT_120	[p9l21t1173r210b1226],
17	though	IN	O	though	dep	23	SENT_120	[p9l249t1147r558b1248],
18	the	DT	O	the	det	19	SENT_120	[p9l597t1147r730b1225],
19	agent	NN	O	agent	nsubjpass	23	SENT_120	[p9l769t1164r1005b1248],
20	is	VBZ	O	be	auxpass	23	SENT_120	[p9l1038t1148r1104b1225],
21	not	RB	O	not	neg	23	SENT_120	[p9l1144t1164r1288b1226],
22	directly	RB	O	directly	advmod	23	SENT_120	[p9l1321t1147r1646b1247],
23	targeted	VBN	O	target	ccomp	9	SENT_120	[p9l1681t1147r2037b1248],
24	at	IN	O	at	_	0	SENT_120	[p9l2074t1164r2153b1225],
25	the	DT	O	the	det	26	SENT_120	[p9l21t1275r153b1353],
26	protein	NN	O	protein	prep_at	23	SENT_120	[p9l206t1276r518b1375],
27	encoded	VBN	O	encode	partmod	26	SENT_120	[p9l573t1275r931b1354],
28	by	IN	O	by	_	0	SENT_120	[p9l985t1275r1082b1375],
29	the	DT	O	the	det	31	SENT_120	[p9l1132t1275r1266b1353],
30	mutated	VBN	O	mutate	amod	31	SENT_120	[p9l1320t1275r1674b1354],
31	gene	NN	O	gene	agent	27	SENT_120	[p9l1728t1301r1951b1376],
32	.	.	O	.	_	0	SENT_120	[p9l1728t1301r1951b1376],

1	For	IN	O	for	dep	4	SENT_121	[p9l2009t1283r2152b1354],
2	example	NN	O	example	pobj	1	SENT_121	[p9l21t1402r400b1502],
3	,	,	O	,	_	0	SENT_121	[p9l21t1402r400b1502],
4	inhibitors	NNS	O	inhibitor	_	0	SENT_121	[p9l475t1402r898b1481],
5	of	IN	O	of	_	0	SENT_121	[p9l971t1401r1071b1481],
6	protein	NN	O	protein	nn	7	SENT_121	[p9l1121t1403r1434b1502],
7	poly	NN	O	poly	prep_of	4	SENT_121	[p9l1502t1402r2148b1502],
8	(	CD	NUMBER	(	num	9	SENT_121	[p9l1502t1402r2148b1502],
9	adenosine	NN	O	adenosine	dep	7	SENT_121	[p9l1502t1402r2148b1502],
10	diphosphate	NN	O	diphosphate	nn	13	SENT_121	[p9l21t1531r551b1631],
11	[	CD	NUMBER	[	num	13	SENT_121	[p9l617t1531r1211b1622],
12	ADP	NN	O	adp	nn	13	SENT_121	[p9l617t1531r1211b1622],
13	]	NN	O	]	dep	9	SENT_121	[p9l617t1531r1211b1622],
14	.	.	O	.	_	0	SENT_121	[p9l617t1531r1211b1622],

1	—	NN	O	—	_	0	SENT_122	[p9l617t1531r1211b1622],
2	.	.	O	.	_	0	SENT_122	[p9l617t1531r1211b1622],

1	ribose	NN	O	ribose	nsubj	16	SENT_123	[p9l617t1531r1211b1622],
2	)	CD	NUMBER	)	num	1	SENT_123	[p9l617t1531r1211b1622],
3	polymerase	NN	O	polymerase	nn	6	SENT_123	[p9l1272t1531r1765b1631],
4	(	CD	NUMBER	(	num	6	SENT_123	[p9l1827t1537r2143b1627],
5	PARP	NN	O	parp	nn	6	SENT_123	[p9l1827t1537r2143b1627],
6	)	NN	O	)	dep	1	SENT_123	[p9l1827t1537r2143b1627],
7	,	,	O	,	_	0	SENT_123	[p9l1827t1537r2143b1627],
8	Which	WDT	O	which	nsubj	9	SENT_123	[p9l16t1659r279b1739],
9	suppress	VBP	O	suppress	rcmod	1	SENT_123	[p9l321t1685r693b1759],
10	a	DT	O	a	det	11	SENT_123	[p9l736t1685r781b1737],
11	type	NN	O	type	dobj	9	SENT_123	[p9l820t1676r1002b1759],
12	of	IN	O	of	_	0	SENT_123	[p9l1044t1658r1144b1738],
13	DNA	NN	MISC	dna	nn	14	SENT_123	[p9l1166t1666r1374b1738],
14	repair	NN	O	repair	prep_of	11	SENT_123	[p9l1413t1660r1687b1759],
15	,	,	O	,	_	0	SENT_123	[p9l1413t1660r1687b1759],
16	appear	VBP	O	appear	_	0	SENT_123	[p9l1734t1685r2026b1759],
17	to	TO	O	to	aux	20	SENT_123	[p9l2065t1676r2147b1738],
18	be	VB	O	be	cop	20	SENT_123	[p9l21t1787r117b1866],
19	particularly	RB	O	particularly	advmod	20	SENT_123	[p9l167t1787r671b1887],
20	effective	JJ	O	effective	xcomp	16	SENT_123	[p9l718t1786r1077b1866],
21	in	IN	O	in	_	0	SENT_123	[p9l1128t1788r1211b1865],
22	cancers	NNS	O	cancer	nn	29	SENT_123	[p9l1263t1813r1584b1865],
23	defective	JJ	O	defective	amod	29	SENT_123	[p9l1638t1786r2015b1867],
24	in	IN	O	in	_	0	SENT_123	[p9l2065t1788r2148b1865],
25	double	JJ	O	double	amod	27	SENT_123	[p9l21t1915r622b1994],
26	—	JJ	O	—	amod	27	SENT_123	[p9l21t1915r622b1994],
27	strand	NN	O	strand	prep_in	23	SENT_123	[p9l21t1915r622b1994],
28	break	NN	O	break	nn	29	SENT_123	[p9l666t1915r910b1995],
29	repair	NN	O	repair	prep_in	20	SENT_123	[p9l949t1916r1206b2015],
30	because	IN	O	because	mark	62	SENT_123	[p9l1247t1915r1585b1995],
31	of	IN	O	of	_	0	SENT_123	[p9l1629t1914r1730b1994],
32	inactivating	VBG	O	inactivate	prepc_of	62	SENT_123	[p9l1754t1916r2147b1995, p9l20t2045r160b2145],
33	mutations	NNS	O	mutation	dobj	32	SENT_123	[p9l199t2045r635b2123],
34	in	IN	O	in	_	0	SENT_123	[p9l679t2045r763b2122],
35	BRCA1	NN	O	brca1	prep_in	32	SENT_123	[p9l805t2050r1070b2124],
36	or	CC	O	or	_	0	SENT_123	[p9l1117t2070r1206b2123],
37	BRCAZF1	NN	O	brcazf1	prep_in	32	SENT_123	[p9l1245t2049r1615b2124],
38	This	DT	O	this	det	39	SENT_123	[p9l1655t2044r1843b2122],
39	synergy	NN	O	synergy	nsubj	62	SENT_123	[p9l1890t2070r2147b2144, p9l20t2198r135b2273],
40	,	,	O	,	_	0	SENT_123	[p9l1890t2070r2147b2144, p9l20t2198r135b2273],
41	often	RB	O	often	advmod	42	SENT_123	[p9l180t2171r403b2251],
42	termed	VBN	O	term	partmod	39	SENT_123	[p9l443t2172r746b2251],
43	synthetic	JJ	O	synthetic	amod	44	SENT_123	[p9l786t2172r1175b2272],
44	lethality	NN	O	lethality	dobj	42	SENT_123	[p9l1212t2172r1663b2272],
45	,22	CD	NUMBER	,22	nsubjpass	47	SENT_123	[p9l1212t2172r1663b2272],
46	is	VBZ	O	be	auxpass	47	SENT_123	[p9l1702t2173r1768b2250],
47	thought	VBN	O	think	rcmod	44	SENT_123	[p9l1809t2172r2153b2273],
48	to	TO	O	to	aux	49	SENT_123	[p9l21t2317r102b2379],
49	occur	VB	O	occur	xcomp	47	SENT_123	[p9l139t2326r379b2379],
50	consequent	JJ	O	consequent	dobj	49	SENT_123	[p9l412t2317r904b2400],
51	to	TO	O	to	_	0	SENT_123	[p9l934t2317r1016b2379],
52	an	DT	O	a	det	54	SENT_123	[p9l1052t2326r1155b2378],
53	overwhelming	JJ	O	overwhelming	amod	54	SENT_123	[p9l1190t2300r1813b2401],
54	burden	NN	O	burden	prep_to	49	SENT_123	[p9l1845t2300r2148b2379],
55	of	IN	O	of	_	0	SENT_123	[p9l21t2427r121b2507],
56	unrepaired	JJ	O	unrepaired	amod	58	SENT_123	[p9l148t2428r622b2528],
57	DNA	NN	O	dna	nn	58	SENT_123	[p9l666t2435r875b2507],
58	damage	NN	O	damage	prep_of	54	SENT_123	[p9l918t2428r1257b2529],
59	in	IN	O	in	_	0	SENT_123	[p9l1302t2429r1385b2506],
60	tumor	NN	O	tumor	nn	61	SENT_123	[p9l1431t2445r1699b2507],
61	cells	NNS	O	cell	prep_in	58	SENT_123	[p9l1743t2428r1931b2506],
62	rendered	VBD	O	render	advcl	20	SENT_123	[p9l1978t2454r2147b2506, p9l21t2555r257b2634],
63	defective	JJ	O	defective	acomp	62	SENT_123	[p9l297t2554r673b2635],
64	for	IN	O	for	prep	63	SENT_123	[p9l713t2554r837b2634],
65	both	CC	O	both	prep	62	SENT_123	[p9l874t2555r1072b2634],
66	DNA	NN	O	dna	nn	69	SENT_123	[p9l1110t2556r1608b2655],
67	—	NN	O	—	nn	69	SENT_123	[p9l1110t2556r1608b2655],
68	repair	NN	O	repair	nn	69	SENT_123	[p9l1110t2556r1608b2655],
69	processes	NNS	O	process	dep	65	SENT_123	[p9l1643t2581r2083b2655],
70	.	.	O	.	_	0	SENT_123	[p9l1643t2581r2083b2655],

1	It	PRP	O	it	nsubjpass	3	SENT_124	[p9l148t2691r213b2761],
2	is	VBZ	O	be	auxpass	3	SENT_124	[p9l251t2684r317b2761],
3	anticipated	VBN	O	anticipate	_	0	SENT_124	[p9l362t2683r840b2783],
4	that	IN	O	that	complm	16	SENT_124	[p9l884t2683r1056b2761],
5	many	JJ	O	many	nsubj	16	SENT_124	[p9l1095t2709r1334b2783],
6	of	IN	O	of	_	0	SENT_124	[p9l1375t2682r1475b2762],
7	the	DT	O	the	det	10	SENT_124	[p9l1501t2683r1633b2761],
8	new	JJ	O	new	amod	10	SENT_124	[p9l1678t2709r1856b2763],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_124	[p9l1897t2683r2147b2761, p9l19t2813r283b2912],
10	agents	NNS	O	agent	prep_of	5	SENT_124	[p9l318t2829r595b2913],
11	currently	RB	DATE	currently	advmod	10	SENT_124	[p9l634t2812r1025b2912],
12	in	IN	O	in	_	0	SENT_124	[p9l1056t2813r1140b2890],
13	development	NN	O	development	nn	14	SENT_124	[p9l1177t2812r1728b2912],
14	pipelines	NNS	O	pipeline	prep_in	10	SENT_124	[p9l1758t2812r2147b2912],
15	will	MD	O	will	aux	16	SENT_124	[p9l16t2940r180b3019],
16	enter	VB	O	enter	ccomp	3	SENT_124	[p9l240t2957r457b3018],
17	the	DT	O	the	det	18	SENT_124	[p9l514t2940r647b3018],
18	clinic	NN	O	clinic	dobj	16	SENT_124	[p9l707t2940r941b3018],
19	accompanied	VBN	O	accompany	partmod	18	SENT_124	[p9l999t2940r1570b3040],
20	by	IN	O	by	_	0	SENT_124	[p9l1629t2940r1727b3040],
21	evidence	NN	O	evidence	agent	19	SENT_124	[p9l1782t2940r2148b3019],
22	implicating	VBG	O	implicate	xcomp	19	SENT_124	[p9l20t3069r519b3170],
23	specific	JJ	O	specific	amod	25	SENT_124	[p9l573t3068r904b3169],
24	genetic	JJ	O	genetic	amod	25	SENT_124	[p9l958t3070r1267b3170],
25	alterations	NNS	O	alteration	dobj	22	SENT_124	[p9l1322t3069r1778b3148],
26	as	IN	O	as	_	0	SENT_124	[p9l1835t3095r1920b3147],
27	predictive	JJ	O	predictive	prep_as	22	SENT_124	[p9l1977t3095r2147b3169, p9l21t3196r299b3276],
28	of	IN	O	of	_	0	SENT_124	[p9l336t3195r436b3275],
29	response	NN	O	response	nn	31	SENT_124	[p9l453t3222r835b3296],
30	(	CD	NUMBER	(	num	31	SENT_124	[p9l876t3196r1139b3287],
31	Table	NNP	O	Table	prep_of	27	SENT_124	[p9l876t3196r1139b3287],
32	1	CD	NUMBER	1	number	33	SENT_124	[p9l1181t3202r1277b3287],
33	)	CD	NUMBER	)	num	31	SENT_124	[p9l1181t3202r1277b3287],
34	.	.	O	.	_	0	SENT_124	[p9l1181t3202r1277b3287],

1	If	IN	O	if	mark	4	SENT_125	[p9l1317t3195r1400b3274],
2	this	DT	O	this	nsubj	4	SENT_125	[p9l1418t3196r1578b3274],
3	indeed	RB	O	indeed	advmod	4	SENT_125	[p9l1615t3196r1903b3275],
4	transpires	VBZ	O	transpire	advcl	23	SENT_125	[p9l1939t3213r2147b3274, p9l21t3326r294b3425],
5	,	,	O	,	_	0	SENT_125	[p9l1939t3213r2147b3274, p9l21t3326r294b3425],
6	an	DT	O	a	det	8	SENT_125	[p9l352t3351r455b3403],
7	ever	RB	O	ever	advmod	8	SENT_125	[p9l509t3326r1162b3426],
8	—	JJ	O	—	nsubjpass	23	SENT_125	[p9l509t3326r1162b3426],
9	increasing	VBG	O	increase	partmod	8	SENT_125	[p9l509t3326r1162b3426],
10	battery	NN	O	battery	dobj	9	SENT_125	[p9l1212t3325r1514b3425],
11	of	IN	O	of	_	0	SENT_125	[p9l1563t3324r1663b3404],
12	diagnostic	JJ	O	diagnostic	amod	14	SENT_125	[p9l1699t3325r2149b3426],
13	genetic	JJ	O	genetic	amod	14	SENT_125	[p9l20t3454r329b3554],
14	tests	NNS	O	test	prep_of	10	SENT_125	[p9l387t3470r581b3531],
15	to	TO	O	to	aux	17	SENT_125	[p9l642t3470r724b3532],
16	be	VB	O	be	auxpass	17	SENT_125	[p9l784t3453r880b3532],
17	performed	VBN	O	perform	xcomp	9	SENT_125	[p9l938t3452r1395b3553],
18	on	IN	O	on	_	0	SENT_125	[p9l1454t3479r1560b3532],
19	each	DT	O	each	det	20	SENT_125	[p9l1619t3453r1812b3531],
20	cancer	NN	O	cancer	prep_on	17	SENT_125	[p9l1871t3479r2152b3532],
21	will	MD	O	will	aux	23	SENT_125	[p9l16t3581r181b3660],
22	be	VB	O	be	auxpass	23	SENT_125	[p9l234t3581r331b3660],
23	required	VBN	O	require	_	0	SENT_125	[p9l385t3581r747b3681],
24	to	TO	O	to	aux	25	SENT_125	[p9l801t3598r883b3660],
25	deploy	VB	O	deploy	xcomp	23	SENT_125	[p9l938t3581r1219b3681],
26	these	DT	O	these	det	27	SENT_125	[p9l1269t3581r1493b3660],
27	agents	NNS	O	agent	dobj	25	SENT_125	[p9l1546t3598r1822b3682],
28	in	IN	O	in	_	0	SENT_125	[p9l1877t3582r1961b3659],
29	the	DT	O	the	det	34	SENT_125	[p9l2015t3581r2148b3659],
30	most	RBS	O	most	advmod	31	SENT_125	[p9l20t3725r234b3787],
31	effective	JJ	O	effective	amod	34	SENT_125	[p9l268t3707r618b3787],
32	and	CC	O	and	_	0	SENT_125	[p9l656t3708r812b3787],
33	parsimonious	JJ	O	parsimonious	amod	34	SENT_125	[p9l849t3709r1431b3808],
34	manner	NN	O	manner	prep_in	25	SENT_125	[p9l1472t3734r1822b3787],
35	.	.	O	.	_	0	SENT_125	[p9l1472t3734r1822b3787],

1	Recent	JJ	O	recent	amod	3	SENT_126	[p9l1864t3715r2153b3792],
2	sequencing	NN	O	sequencing	nn	3	SENT_126	[p10l21t24r509b124],
3	studies	NNS	O	study	nsubj	8	SENT_126	[p10l551t23r852b102],
4	of	IN	O	of	_	0	SENT_126	[p10l899t22r999b102],
5	solid	JJ	O	solid	amod	6	SENT_126	[p10l1026t23r1231b102],
6	tumors	NNS	O	tumor	prep_of	3	SENT_126	[p10l1275t40r1583b102],
7	have	VBP	O	have	aux	8	SENT_126	[p10l1629t23r1820b102],
8	shown	VBN	O	show	_	0	SENT_126	[p10l1866t23r2148b102],
9	that	IN	O	that	complm	14	SENT_126	[p10l21t151r193b229],
10	many	JJ	O	many	amod	12	SENT_126	[p10l223t177r463b251],
11	cancer	NN	O	cancer	nn	12	SENT_126	[p10l494t177r776b229],
12	genes	NNS	O	gene	nsubjpass	14	SENT_126	[p10l807t177r1050b252],
13	are	VBP	O	be	auxpass	14	SENT_126	[p10l1087t177r1215b229],
14	mutated	VBN	O	mutate	ccomp	8	SENT_126	[p10l1251t151r1606b230],
15	in	IN	O	in	_	0	SENT_126	[p10l1640t152r1724b229],
16	less	JJR	O	less	mwe	17	SENT_126	[p10l1757t151r1914b229],
17	than	IN	O	than	quantmod	18	SENT_126	[p10l1951t151r2148b229],
18	10	CD	PERCENT	10	num	19	SENT_126	[p10l24t284r205b358],
19	%	NN	PERCENT	%	prep_in	14	SENT_126	[p10l24t284r205b358],
20	of	IN	O	of	_	0	SENT_126	[p10l242t278r342b358],
21	tumors	NNS	O	tumor	prep_of	19	SENT_126	[p10l361t296r669b358],
22	of	IN	O	of	_	0	SENT_126	[p10l709t278r809b358],
23	any	DT	O	any	det	25	SENT_126	[p10l827t305r977b379],
24	single	JJ	O	single	amod	25	SENT_126	[p10l1011t279r1263b380],
25	type	NN	O	type	prep_of	21	SENT_126	[p10l1301t296r1505b379],
26	.	.	O	.	_	0	SENT_126	[p10l1301t296r1505b379],

1	Therefore	RB	O	therefore	advmod	26	SENT_127	[p10l1545t278r1986b375],
2	,	,	O	,	_	0	SENT_127	[p10l1545t278r1986b375],
3	for	IN	O	for	mark	7	SENT_127	[p10l2028t278r2152b358],
4	this	DT	O	this	det	6	SENT_127	[p10l21t407r180b485],
5	targeting	VBG	O	target	amod	6	SENT_127	[p10l225t408r625b508],
6	approach	NN	O	approach	nsubj	7	SENT_127	[p10l664t407r1059b507],
7	is	VBZ	O	be	advcl	26	SENT_127	[p10l1101t408r1166b485],
8	to	TO	O	to	aux	11	SENT_127	[p10l1211t424r1293b486],
9	be	VB	O	be	cop	11	SENT_127	[p10l1337t407r1434b486],
10	generally	RB	O	generally	advmod	11	SENT_127	[p10l1475t407r1871b508],
11	effective	JJ	O	effective	xcomp	7	SENT_127	[p10l1910t406r2147b486, p10l21t536r187b631],
12	,	,	O	,	_	0	SENT_127	[p10l1910t406r2147b486, p10l21t536r187b631],
13	a	DT	O	a	det	16	SENT_127	[p10l228t561r273b613],
14	much	JJ	O	much	amod	16	SENT_127	[p10l308t535r544b614],
15	larger	JJR	O	larger	amod	16	SENT_127	[p10l580t535r830b636],
16	repertoire	NN	O	repertoire	nsubjpass	26	SENT_127	[p10l863t536r1279b635],
17	of	IN	O	of	_	0	SENT_127	[p10l1317t534r1416b614],
18	drugs	NNS	O	drug	prep_of	16	SENT_127	[p10l1435t535r1675b636],
19	(	CD	NUMBER	(	num	18	SENT_127	[p10l1718t535r1898b626],
20	and	CC	O	and	_	0	SENT_127	[p10l1718t535r1898b626],
21	diagnostic	JJ	O	diagnostic	amod	22	SENT_127	[p10l1936t535r2147b636, p10l20t664r275b742],
22	tests	NNS	O	test	conj_and	18	SENT_127	[p10l321t670r542b754],
23	)	CD	NUMBER	)	dep	22	SENT_127	[p10l321t670r542b754],
24	will	MD	O	will	aux	26	SENT_127	[p10l591t663r756b743],
25	be	VB	O	be	auxpass	26	SENT_127	[p10l805t663r901b742],
26	required	VBN	O	require	_	0	SENT_127	[p10l950t663r1313b763],
27	to	TO	O	to	aux	29	SENT_127	[p10l1361t680r1443b742],
28	optimally	RB	O	optimally	advmod	29	SENT_127	[p10l1494t663r1910b763],
29	treat	VB	O	treat	xcomp	26	SENT_127	[p10l1954t680r2153b741],
30	most	RBS	O	most	advmod	29	SENT_127	[p10l20t808r237b870],
31	patients	NNS	O	patient	dobj	29	SENT_127	[p10l269t792r611b891],
32	with	IN	O	with	_	0	SENT_127	[p10l647t791r843b871],
33	a	DT	O	a	det	35	SENT_127	[p10l880t817r925b869],
34	particular	JJ	O	particular	amod	35	SENT_127	[p10l960t791r1391b891],
35	type	NN	O	type	prep_with	31	SENT_127	[p10l1427t808r1609b891],
36	of	IN	O	of	_	0	SENT_127	[p10l1647t790r1748b870],
37	cancer	NN	O	cancer	prep_of	35	SENT_127	[p10l1769t797r2147b870],
38	.23	CD	NUMBER	.23	num	37	SENT_127	[p10l1769t797r2147b870],

1	DEVELOPMENT	NNP	O	DEVELOPMENT	_	0	SENT_128	[p10l427t1117r1264b1178],
2	OF	IN	O	of	_	0	SENT_128	[p10l1312t1117r1444b1177],
3	NEW	NNP	O	NEW	prep_of	1	SENT_128	[p10l1498t1118r1750b1177],

1	THERAPEUTICS	NNS	O	therapeutics	_	0	SENT_129	[p10l651t1226r1512b1286],

1	The	DT	O	the	det	2	SENT_130	[p10l16t1454r178b1532],
2	development	NN	O	development	nsubjpass	16	SENT_130	[p10l228t1454r779b1554],
3	of	IN	O	of	_	0	SENT_130	[p10l824t1453r925b1533],
4	inhibitors	NNS	O	inhibitor	prep_of	2	SENT_130	[p10l955t1454r1378b1533],
5	targeted	VBN	O	target	partmod	4	SENT_130	[p10l1431t1454r1787b1555],
6	to	TO	O	to	_	0	SENT_130	[p10l1837t1471r1919b1533],
7	proteins	NNS	O	protein	prep_to	5	SENT_130	[p10l1968t1480r2147b1554, p10l21t1583r225b1661],
8	encoded	VBN	O	encode	partmod	7	SENT_130	[p10l266t1582r623b1661],
9	by	IN	O	by	_	0	SENT_130	[p10l661t1582r759b1682],
10	mutated	VBN	O	mutate	amod	12	SENT_130	[p10l792t1582r1147b1661],
11	cancer	NN	O	cancer	nn	12	SENT_130	[p10l1185t1608r1466b1660],
12	genes	NNS	O	gene	agent	8	SENT_130	[p10l1501t1608r1743b1683],
13	has	VBZ	O	have	aux	16	SENT_130	[p10l1783t1582r1928b1660],
14	now	RB	DATE	now	advmod	16	SENT_130	[p10l1968t1608r2152b1661],
15	been	VBN	O	be	auxpass	16	SENT_130	[p10l21t1710r223b1789],
16	achieved	VBN	O	achieve	_	0	SENT_130	[p10l268t1710r636b1789],
17	with	IN	O	with	_	0	SENT_130	[p10l677t1710r873b1790],
18	repeated	VBN	O	repeat	amod	19	SENT_130	[p10l919t1710r1286b1810],
19	success	NN	O	success	prep_with	16	SENT_130	[p10l1333t1736r1673b1789],
20	.	.	O	.	_	0	SENT_130	[p10l1333t1736r1673b1789],

1	The	DT	O	the	det	2	SENT_131	[p10l1721t1710r1882b1788],
2	paradigm	NN	O	paradigm	nsubj	4	SENT_131	[p10l1926t1736r2147b1810, p10l21t1839r244b1940],
3	is	VBZ	O	be	cop	4	SENT_131	[p10l277t1840r343b1917],
4	best	JJS	O	best	_	0	SENT_131	[p10l380t1839r558b1918],
5	exemplified	VBN	O	exemplify	partmod	4	SENT_131	[p10l587t1838r1095b1939],
6	by	IN	O	by	_	0	SENT_131	[p10l1130t1839r1227b1939],
7	imatinib	NN	O	imatinib	nn	10	SENT_131	[p10l1255t1839r1625b1918],
8	(	CD	NUMBER	(	num	10	SENT_131	[p10l1665t1839r2067b1935],
9	Gleevec	NNP	O	Gleevec	nn	10	SENT_131	[p10l1665t1839r2067b1935],
10	)	NN	O	)	agent	5	SENT_131	[p10l1665t1839r2067b1935],
11	,	,	O	,	_	0	SENT_131	[p10l1665t1839r2067b1935],
12	a	DT	O	a	det	14	SENT_131	[p10l2106t1865r2150b1917],
13	potent	JJ	O	potent	amod	14	SENT_131	[p10l18t1983r299b2066],
14	inhibitor	NN	O	inhibitor	appos	4	SENT_131	[p10l334t1966r717b2045],
15	of	IN	O	of	_	0	SENT_131	[p10l756t1965r856b2045],
16	the	DT	O	the	det	21	SENT_131	[p10l877t1966r1011b2044],
17	Abelson	NN	PERSON	abelson	nn	21	SENT_131	[p10l1048t1966r1399b2045],
18	(	NN	O	(	nn	21	SENT_131	[p10l1444t1973r1672b2057],
19	ABL	NN	ORGANIZATION	abl	nn	21	SENT_131	[p10l1444t1973r1672b2057],
20	)	NN	O	)	nn	21	SENT_131	[p10l1444t1973r1672b2057],
21	kinase	NN	O	kinase	prep_of	14	SENT_131	[p10l1717t1966r2020b2062],
22	,	,	O	,	_	0	SENT_131	[p10l1717t1966r2020b2062],
23	in	IN	O	in	_	0	SENT_131	[p10l2065t1967r2148b2044],
24	chronic	JJ	O	chronic	amod	26	SENT_131	[p10l21t2095r345b2174],
25	myeloid	JJ	O	myeloid	amod	26	SENT_131	[p10l390t2095r726b2195],
26	leukemia	NN	O	leukemia	prep_in	4	SENT_131	[p10l771t2095r1166b2175],
27	(	CD	NUMBER	(	num	29	SENT_131	[p10l1215t2101r1492b2186],
28	CML	NN	O	cml	nn	29	SENT_131	[p10l1215t2101r1492b2186],
29	)	NN	O	)	dep	26	SENT_131	[p10l1215t2101r1492b2186],
30	.	.	O	.	_	0	SENT_131	[p10l1215t2101r1492b2186],

1	The	DT	O	the	det	2	SENT_132	[p10l1541t2095r1702b2173],
2	discovery	NN	O	discovery	nsubj	16	SENT_132	[p10l1748t2095r2153b2195],
3	of	IN	O	of	_	0	SENT_132	[p10l21t2222r121b2302],
4	the	DT	O	the	det	6	SENT_132	[p10l132t2223r265b2301],
5	Philadelphia	NNP	LOCATION	Philadelphia	nn	6	SENT_132	[p10l293t2223r831b2323],
6	chromosome	NN	O	chromosome	prep_of	2	SENT_132	[p10l859t2223r1424b2302],
7	in	IN	O	in	_	0	SENT_132	[p10l1453t2224r1536b2301],
8	1960	CD	DATE	1960	prep_in	6	SENT_132	[p10l1568t2229r1771b2302],
9	in	IN	O	in	_	0	SENT_132	[p10l1801t2224r1884b2301],
10	a	DT	O	a	det	11	SENT_132	[p10l1912t2249r1957b2301],
11	majority	NN	O	majority	prep_in	8	SENT_132	[p10l1985t2249r2147b2301, p10l7t2353r245b2452],
12	of	IN	O	of	_	0	SENT_132	[p10l291t2351r392b2431],
13	patients	NNS	O	patient	prep_of	11	SENT_132	[p10l422t2353r764b2452],
14	with	IN	O	with	_	0	SENT_132	[p10l813t2352r1008b2431],
15	CML	NN	ORGANIZATION	cml	prep_with	13	SENT_132	[p10l1059t2358r1263b2431],
16	set	VBD	O	set	_	0	SENT_132	[p10l1312t2369r1433b2430],
17	the	DT	O	the	det	18	SENT_132	[p10l1479t2352r1611b2430],
18	stage	NN	O	stage	dobj	16	SENT_132	[p10l1664t2369r1884b2453],
19	for	IN	O	for	_	0	SENT_132	[p10l1935t2351r2059b2431],
20	a	DT	O	a	det	21	SENT_132	[p10l2106t2378r2150b2430],
21	series	NN	O	series	prep_for	18	SENT_132	[p10l21t2480r261b2557],
22	of	IN	O	of	_	0	SENT_132	[p10l316t2478r416b2558],
23	discoveries	NNS	O	discovery	prep_of	21	SENT_132	[p10l451t2479r921b2559],
24	that	WDT	O	that	nsubj	26	SENT_132	[p10l976t2479r1149b2557],
25	ultimately	RB	O	ultimately	advmod	26	SENT_132	[p10l1196t2479r1634b2579],
26	revolutionized	VBD	O	revolutionize	rcmod	23	SENT_132	[p10l1682t2479r2147b2559, p10l20t2608r197b2687],
27	the	DT	O	the	det	28	SENT_132	[p10l229t2608r363b2687],
28	treatment	NN	O	treatment	dobj	26	SENT_132	[p10l395t2625r820b2687],
29	of	IN	O	of	_	0	SENT_132	[p10l847t2607r948b2687],
30	this	DT	O	this	det	31	SENT_132	[p10l961t2608r1121b2686],
31	disease	NN	O	disease	prep_of	28	SENT_132	[p10l1156t2608r1571b2687],
32	.	.	O	.	_	0	SENT_132	[p10l1156t2608r1571b2687],

1	“	NN	O	“	nsubj	5	SENT_133	[p10l1156t2608r1571b2687],
2	This	DT	O	this	det	4	SENT_133	[p10l1598t2608r1787b2686],
3	genomic	JJ	O	genomic	amod	4	SENT_133	[p10l1820t2634r2147b2709, p10l20t2737r89b2814],
4	alteration	NN	O	alteration	dep	1	SENT_133	[p10l127t2736r540b2815],
5	results	VBZ	O	result	_	0	SENT_133	[p10l580t2736r864b2815],
6	in	IN	O	in	_	0	SENT_133	[p10l904t2737r988b2814],
7	a	DT	O	a	det	9	SENT_133	[p10l1026t2762r1071b2814],
8	reciprocal	JJ	O	reciprocal	amod	9	SENT_133	[p10l1109t2736r1536b2836],
9	translocation	NN	O	translocation	prep_in	5	SENT_133	[p10l1576t2736r2148b2815],
10	between	IN	O	between	_	0	SENT_133	[p10l21t2865r380b2944],
11	two	CD	NUMBER	two	num	12	SENT_133	[p10l413t2882r571b2944],
12	genes	NNS	O	gene	prep_between	9	SENT_133	[p10l606t2891r848b2966],
13	on	IN	O	on	_	0	SENT_133	[p10l885t2891r992b2944],
14	the	DT	O	the	det	16	SENT_133	[p10l1025t2865r1158b2943],
15	long	JJ	O	long	amod	16	SENT_133	[p10l1192t2865r1383b2966],
16	arms	NNS	O	arm	prep_on	12	SENT_133	[p10l1413t2891r1628b2943],
17	of	IN	O	of	_	0	SENT_133	[p10l1664t2864r1765b2944],
18	chromosome	NN	O	chromosome	nn	20	SENT_133	[p10l1780t2865r2147b2944, p10l21t3019r246b3072],
19	22	CD	NUMBER	22	num	20	SENT_133	[p10l278t2999r378b3071],
20	(	NN	O	(	prep_of	16	SENT_133	[p10l416t2993r699b3084],
21	where	WRB	O	where	advmod	25	SENT_133	[p10l416t2993r699b3084],
22	BCR	NN	O	bcr	nsubj	25	SENT_133	[p10l729t2999r897b3073],
23	is	VBZ	O	be	cop	25	SENT_133	[p10l921t2994r987b3071],
24	located	JJ	O	located	amod	25	SENT_133	[p10l1020t2993r1358b3084],
25	)	NN	O	)	advcl	5	SENT_133	[p10l1020t2993r1358b3084],
26	and	CC	O	and	_	0	SENT_133	[p10l1394t2993r1552b3072],
27	chromosome	NN	O	chromosome	nn	29	SENT_133	[p10l1584t2993r2148b3072],
28	9	CD	NUMBER	9	num	29	SENT_133	[p10l20t3128r67b3201],
29	(	NN	O	(	conj_and	25	SENT_133	[p10l109t3122r392b3213],
30	where	WRB	O	where	advmod	32	SENT_133	[p10l109t3122r392b3213],
31	ABL	NNP	ORGANIZATION	ABL	nsubj	32	SENT_133	[p10l422t3128r584b3200],
32	resides	VBZ	O	reside	rcmod	29	SENT_133	[p10l617t3122r962b3218],
33	)	RB	O	)	advmod	32	SENT_133	[p10l617t3122r962b3218],
34	,	,	O	,	_	0	SENT_133	[p10l617t3122r962b3218],
35	resulting	VBG	O	result	xcomp	32	SENT_133	[p10l1004t3122r1391b3223],
36	in	IN	O	in	_	0	SENT_133	[p10l1423t3123r1507b3200],
37	the	DT	O	the	det	38	SENT_133	[p10l1544t3122r1677b3200],
38	formation	NN	O	formation	prep_in	35	SENT_133	[p10l1714t3121r2148b3201],
39	of	IN	O	of	_	0	SENT_133	[p10l21t3249r121b3329],
40	a	DT	O	a	det	48	SENT_133	[p10l157t3276r201b3328],
41	chimeric	JJ	O	chimeric	amod	48	SENT_133	[p10l255t3250r654b3346],
42	,	,	O	,	_	0	SENT_133	[p10l255t3250r654b3346],
43	oncogenic	JJ	O	oncogenic	amod	48	SENT_133	[p10l715t3251r1155b3351],
44	fusion	NN	O	fusion	nn	48	SENT_133	[p10l1210t3249r1479b3329],
45	protein	NN	O	protein	nn	48	SENT_133	[p10l1533t3251r1845b3350],
46	(	CD	NUMBER	(	num	48	SENT_133	[p10l1906t3256r2147b3341, p10l16t3384r220b3469],
47	BCRABL	NN	O	bcrabl	nn	48	SENT_133	[p10l1906t3256r2147b3341, p10l16t3384r220b3469],
48	)	NN	O	)	prep_of	38	SENT_133	[p10l1906t3256r2147b3341, p10l16t3384r220b3469],
49	in	IN	O	in	_	0	SENT_133	[p10l259t3379r342b3456],
50	which	WDT	O	which	rel	55	SENT_133	[p10l373t3378r636b3458],
51	the	DT	O	the	det	53	SENT_133	[p10l672t3378r804b3456],
52	ABL	NN	ORGANIZATION	abl	nn	53	SENT_133	[p10l836t3384r1016b3456],
53	kinase	NN	O	kinase	nsubjpass	55	SENT_133	[p10l1048t3378r1329b3458],
54	is	VBZ	O	be	auxpass	55	SENT_133	[p10l1363t3379r1429b3456],
55	activated	VBN	O	activate	rcmod	48	SENT_133	[p10l1465t3378r1867b3458],
56	.	.	O	.	_	0	SENT_133	[p10l1465t3378r1867b3458],

1	Clinical	JJ	O	clinical	amod	2	SENT_134	[p10l1907t3378r2147b3457, p10l21t3507r141b3585],
2	trials	NNS	O	trial	nsubj	10	SENT_134	[p10l188t3507r408b3585],
3	of	IN	O	of	_	0	SENT_134	[p10l457t3506r558b3586],
4	imatinib	NN	O	imatinib	prep_of	2	SENT_134	[p10l585t3507r955b3586],
5	for	IN	O	for	_	0	SENT_134	[p10l1003t3506r1127b3586],
6	the	DT	O	the	det	7	SENT_134	[p10l1171t3507r1304b3585],
7	treatment	NN	O	treatment	prep_for	4	SENT_134	[p10l1351t3524r1776b3585],
8	of	IN	O	of	_	0	SENT_134	[p10l1819t3506r1919b3586],
9	CML	NN	ORGANIZATION	cml	prep_of	7	SENT_134	[p10l1947t3513r2151b3586],
10	showed	VBD	O	show	_	0	SENT_134	[p10l21t3635r345b3714],
11	its	PRP$	O	its	poss	13	SENT_134	[p10l395t3636r494b3713],
12	substantial	JJ	O	substantial	amod	13	SENT_134	[p10l548t3635r1025b3714],
13	superiority	NN	O	superiority	dobj	10	SENT_134	[p10l1077t3636r1543b3735],
14	over	IN	O	over	_	0	SENT_134	[p10l1590t3661r1769b3714],
15	conventional	JJ	O	conventional	prep_over	10	SENT_134	[p10l1817t3661r2147b3715, p11l20t21r271b100],

1	chemotherapy	NN	O	chemotherapy	_	0	SENT_135	[p11l321t21r947b121],
2	,	,	O	,	_	0	SENT_135	[p11l321t21r947b121],
3	and	CC	O	and	_	0	SENT_135	[p11l1003t21r1161b100],
4	in	IN	O	in	mark	11	SENT_135	[p11l1211t22r1294b99],
5	the	DT	O	the	det	7	SENT_135	[p11l1345t21r1478b99],
6	United	NNP	LOCATION	United	nn	7	SENT_135	[p11l1528t21r1817b100],
7	States	NNPS	LOCATION	States	nsubj	11	SENT_135	[p11l1869t27r2143b117],
8	,	,	O	,	_	0	SENT_135	[p11l1869t27r2143b117],
9	the	DT	O	the	det	10	SENT_135	[p11l20t149r153b227],
10	FDA	NNP	ORGANIZATION	FDA	appos	7	SENT_135	[p11l182t156r367b227],
11	approved	VBD	O	approve	conj_and	1	SENT_135	[p11l392t149r783b249],
12	imatinib	NN	O	imatinib	dobj	11	SENT_135	[p11l811t149r1180b228],
13	as	IN	O	as	_	0	SENT_135	[p11l1211t175r1296b227],
14	first	JJ	ORDINAL	first	amod	17	SENT_135	[p11l1328t148r1699b227],
15	—	NN	O	—	nn	17	SENT_135	[p11l1328t148r1699b227],
16	line	NN	O	line	nn	17	SENT_135	[p11l1328t148r1699b227],
17	treatment	NN	O	treatment	prep_as	11	SENT_135	[p11l1728t166r2153b227],

1	N	NN	O	n	nn	3	SENT_136	[p11l555t334r569b349],
2	ENGLJ	NN	O	englj	nn	3	SENT_136	[p11l584t334r662b356],
3	MED	NN	O	med	_	0	SENT_136	[p11l676t334r728b349],
4	364	CD	NUMBER	364	num	6	SENT_136	[p11l738t328r807b356],
5	;	:	O	;	_	0	SENT_136	[p11l738t328r807b356],
6	4	CD	NUMBER	4	dep	3	SENT_136	[p11l738t328r807b356],

1	NEjM.ORG	NN	O	nejm.org	nn	2	SENT_137	[p11l842t334r966b356],
2	JANUARY	NN	DATE	january	_	0	SENT_137	[p11l997t334r1109b356],
3	27	CD	DATE	27	dep	2	SENT_137	[p11l1119t334r1153b355],
4	,	,	DATE	,	_	0	SENT_137	[p11l1119t334r1153b355],
5	2011	CD	DATE	2011	appos	3	SENT_137	[p11l1164t334r1216b350],
6	The	DT	O	the	det	9	SENT_137	[p11l702t367r753b391],
7	New	NNP	O	New	nn	9	SENT_137	[p11l762t368r824b391],
8	England	NNP	O	England	nn	9	SENT_137	[p11l833t367r944b398],
9	Journal	NNP	O	Journal	dep	5	SENT_137	[p11l952t367r1050b391],
10	of	IN	O	of	_	0	SENT_137	[p11l1059t367r1088b391],
11	Medicine	NNP	O	Medicine	prep_of	9	SENT_137	[p11l1095t367r1220b391],

1	Downloaded	VBN	O	download	_	0	SENT_138	[p11l144t408r314b431],
2	from	IN	O	from	_	0	SENT_138	[p11l323t408r387b431],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_138	[p11l396t408r514b438],
4	at	IN	O	at	_	0	SENT_138	[p11l524t412r547b431],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_138	[p11l556t408r738b431],
6	on	IN	O	on	_	0	SENT_138	[p11l748t415r780b431],
7	January	NNP	DATE	January	prep_on	1	SENT_138	[p11l789t408r892b438],
8	5	CD	DATE	5	num	7	SENT_138	[p11l902t408r924b436],
9	,	,	DATE	,	_	0	SENT_138	[p11l902t408r924b436],
10	2014	CD	DATE	2014	num	7	SENT_138	[p11l935t408r1007b431],
11	.	.	O	.	_	0	SENT_138	[p11l935t408r1007b431],

1	For	IN	O	for	_	0	SENT_139	[p11l1018t408r1064b431],
2	personal	JJ	O	personal	amod	3	SENT_139	[p11l1072t408r1185b438],
3	use	NN	O	use	pobj	1	SENT_139	[p11l1194t415r1237b431],
4	only	RB	O	only	advmod	3	SENT_139	[p11l1247t408r1312b438],
5	.	.	O	.	_	0	SENT_139	[p11l1247t408r1312b438],

1	No	DT	O	no	det	3	SENT_140	[p11l1322t408r1362b431],
2	other	JJ	O	other	amod	3	SENT_140	[p11l1372t408r1440b431],
3	uses	NNS	O	use	_	0	SENT_140	[p11l1448t415r1504b431],
4	without	IN	O	without	_	0	SENT_140	[p11l1515t408r1616b431],
5	permission	NN	O	permission	prep_without	3	SENT_140	[p11l1624t408r1776b438],
6	.	.	O	.	_	0	SENT_140	[p11l1624t408r1776b438],

1	The	DT	O	the	det	4	SENT_141	[p11l813t491r859b512],
2	NEW	NNP	O	NEW	nn	4	SENT_141	[p11l877t493r962b512],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_141	[p11l981t493r1170b512],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_141	[p11l1189t493r1368b519],
5	of	IN	O	of	_	0	SENT_141	[p11l1388t491r1416b518],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_141	[p11l1428t493r1627b512],

1	Table	NNP	O	Table	_	0	SENT_142	[p11l116t621r190b646],
2	1	CD	NUMBER	1	dep	1	SENT_142	[p11l200t624r221b646],
3	.	.	O	.	_	0	SENT_142	[p11l200t624r221b646],

1	Targeted	VBN	O	target	_	0	SENT_143	[p11l231t621r350b654],
2	Therapeutics	NNPS	O	Therapeutics	dobj	1	SENT_143	[p11l359t621r537b654],
3	in	IN	O	in	_	0	SENT_143	[p11l548t622r570b646],
4	Cancer	NNP	O	Cancer	prep_in	2	SENT_143	[p11l581t623r700b646],
5	.	.	O	.	_	0	SENT_143	[p11l581t623r700b646],

1	*	NN	O	*	_	0	SENT_144	[p11l581t623r700b646],

1	Gene	NN	PERSON	gene	_	0	SENT_145	[p11l117t698r188b722],

1	Genetic	JJ	O	genetic	amod	2	SENT_146	[p11l579t697r684b722],
2	Alteration	NN	O	alteration	_	0	SENT_146	[p11l694t696r826b722],

1	Receptor	NN	O	receptor	nn	3	SENT_147	[p11l118t756r238b787],
2	tyrosine	NN	O	tyrosine	nn	3	SENT_147	[p11l245t755r355b787],
3	kinase	NN	O	kinase	_	0	SENT_147	[p11l365t754r451b779],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_147	[p11l118t814r194b837],
5	ERBB2	NN	O	erbb2	nn	6	SENT_147	[p11l118t872r209b895],
6	FGFR1	NN	O	fgfr1	dep	3	SENT_147	[p11l118t930r207b953],
7	FGFR2	NN	O	fgfr2	nn	9	SENT_147	[p11l118t988r210b1011],
8	FGFR3	NN	O	fgfr3	nn	9	SENT_147	[p11l118t1046r209b1069],
9	PDGFRA	NN	O	pdgfra	dep	3	SENT_147	[p11l118t1103r237b1127],

1	PDGFRB	NN	O	pdgfrb	nn	2	SENT_148	[p11l118t1199r237b1222],
2	ALK	NN	O	alk	_	0	SENT_148	[p11l115t1256r173b1279],

1	C-MET	NN	O	c-met	_	0	SENT_149	[p11l116t1352r205b1375],

1	IGFIR	NN	O	igfir	_	0	SENT_150	[p11l118t1447r202b1470],

1	c-KIT	NN	O	c-kit	_	0	SENT_151	[p11l116t1542r187b1565],

1	FLT3	NN	O	flt3	nn	2	SENT_152	[p11l118t1637r183b1660],
2	RET	NN	O	ret	_	0	SENT_152	[p11l118t1695r173b1718],

1	Mutation	NN	O	mutation	nn	5	SENT_153	[p11l469t814r600b841],
2	,	,	O	,	_	0	SENT_153	[p11l469t814r600b841],
3	ampliﬁcation	NN	O	ampliﬁcation	dep	5	SENT_153	[p11l611t812r788b845],
4	Ampliﬁcation	NNP	O	Ampliﬁcation	nn	5	SENT_153	[p11l466t869r648b902],
5	Translocation	NN	O	translocation	_	0	SENT_153	[p11l466t927r652b953],
6	Ampliﬁcation	NN	O	ampliﬁcation	dep	5	SENT_153	[p11l466t985r657b1018],
7	,	,	O	,	_	0	SENT_153	[p11l466t985r657b1018],
8	mutation	NN	O	mutation	nn	9	SENT_153	[p11l669t988r791b1011],
9	Translocation	NN	O	translocation	appos	6	SENT_153	[p11l466t1043r661b1073],
10	,	,	O	,	_	0	SENT_153	[p11l466t1043r661b1073],
11	mutation	NN	O	mutation	nn	12	SENT_153	[p11l673t1046r795b1068],
12	Mutation	NN	O	mutation	appos	6	SENT_153	[p11l469t1103r591b1126],

1	Translocation	NN	O	translocation	nn	2	SENT_154	[p11l466t1196r652b1221],
2	Mutation	NN	O	mutation	_	0	SENT_154	[p11l469t1256r591b1279],
3	or	CC	O	or	_	0	SENT_154	[p11l602t1263r630b1279],
4	ampliﬁcation	NN	O	ampliﬁcation	conj_or	2	SENT_154	[p11l639t1254r816b1287],

1	Ampliﬁcation	NN	O	ampliﬁcation	_	0	SENT_155	[p11l466t1349r648b1382],

1	Activation	NN	O	activation	_	0	SENT_156	[p11l466t1446r601b1470],
2	by	IN	O	by	_	0	SENT_156	[p11l614t1445r642b1477],
3	insulin-like	JJ	O	insulin-like	amod	5	SENT_156	[p11l653t1445r799b1470],
4	growth	NN	O	growth	nn	5	SENT_156	[p11l809t1444r902b1478],
5	factor	NN	O	factor	prep_by	1	SENT_156	[p11l516t1482r595b1507],
6	II	CD	NUMBER	ii	num	8	SENT_156	[p11l606t1484r619b1507],
7	ligand	NN	O	ligand	nn	8	SENT_156	[p11l633t1482r713b1515],
8	Mutation	NN	O	mutation	dep	1	SENT_156	[p11l469t1542r591b1565],

1	Internal	JJ	O	internal	amod	4	SENT_157	[p11l469t1635r570b1660],
2	tandem	JJ	O	tandem	amod	4	SENT_157	[p11l581t1635r684b1660],
3	duplication	NN	O	duplication	nn	4	SENT_157	[p11l696t1635r847b1668],
4	Mutation	NN	O	mutation	_	0	SENT_157	[p11l469t1695r599b1722],
5	,	,	O	,	_	0	SENT_157	[p11l469t1695r599b1722],
6	translocation	NN	O	translocation	appos	4	SENT_157	[p11l610t1693r788b1718],

1	Non	JJ	O	non	amod	3	SENT_158	[p11l118t1753r307b1783],
2	—	NN	O	—	nn	3	SENT_158	[p11l118t1753r307b1783],
3	receptor	NN	O	receptor	_	0	SENT_158	[p11l118t1753r307b1783],
4	tyrosine	NN	O	tyrosine	nn	5	SENT_158	[p11l314t1751r424b1784],
5	kinase	NN	O	kinase	dep	3	SENT_158	[p11l167t1788r253b1813],

1	ABL	NNP	ORGANIZATION	ABL	nsubj	2	SENT_159	[p11l115t1848r171b1871],
2	_	VBD	O	_	_	0	SENT_159	[p11l109t1906r181b1937],
3	]	CD	NUMBER	]	num	4	SENT_159	[p11l109t1906r181b1937],
4	AK2	NN	O	ak2	dobj	2	SENT_159	[p11l109t1906r181b1937],

1	SRC	NN	O	src	_	0	SENT_160	[p11l117t2001r174b2024],

1	Translocation	NN	O	translocation	nn	4	SENT_161	[p11l465t1846r652b1871],
2	(	CD	NUMBER	(	num	4	SENT_161	[p11l666t1847r807b1879],
3	BCR-ABL	NN	O	bcr-abl	nn	4	SENT_161	[p11l666t1847r807b1879],
4	)	NN	O	)	_	0	SENT_161	[p11l666t1847r807b1879],
5	Mutation	NN	O	mutation	nn	8	SENT_161	[p11l469t1906r591b1929],
6	(	CD	NUMBER	(	num	8	SENT_161	[p11l605t1906r718b1937],
7	V6l7F	NN	O	v6l7f	nn	8	SENT_161	[p11l605t1906r718b1937],
8	)	NN	O	)	dep	4	SENT_161	[p11l605t1906r718b1937],
9	,	,	O	,	_	0	SENT_161	[p11l605t1906r718b1937],
10	translocation	NN	O	translocation	appos	8	SENT_161	[p11l728t1904r907b1929],

1	Overexpression	NN	O	overexpression	_	0	SENT_162	[p11l467t2001r678b2032],

1	Serine	NN	O	serine	nn	6	SENT_163	[p11l116t2094r426b2127],
2	—	NN	O	—	nn	6	SENT_163	[p11l116t2094r426b2127],
3	threonine	NN	O	threonine	nn	6	SENT_163	[p11l116t2094r426b2127],
4	—	CD	NUMBER	—	num	6	SENT_163	[p11l116t2094r426b2127],
5	|	NN	O	|	nn	6	SENT_163	[p11l116t2094r426b2127],
6	ipid	NN	O	ipid	_	0	SENT_163	[p11l116t2094r426b2127],
7	kinase	NN	O	kinase	nn	10	SENT_163	[p11l167t2131r253b2157],
8	BRAF	NN	O	braf	nn	10	SENT_163	[p11l118t2191r193b2214],
9	Aurora	NNP	LOCATION	Aurora	nn	10	SENT_163	[p11l115t2249r207b2272],
10	A	NNP	O	A	dep	6	SENT_163	[p11l217t2249r236b2272],
11	and	CC	O	and	_	0	SENT_163	[p11l246t2247r294b2272],
12	B	NN	O	b	nn	13	SENT_163	[p11l307t2249r322b2272],
13	kinases	NNS	O	kinase	conj_and	10	SENT_163	[p11l334t2247r433b2272],
14	Polo-like	JJ	MISC	polo-like	amod	17	SENT_163	[p11l118t2305r232b2330],
15	kinases	NNS	O	kinase	nn	17	SENT_163	[p11l243t2305r342b2330],
16	MTOR	NN	O	mtor	nn	17	SENT_163	[p11l118t2364r207b2388],
17	PI3K	NN	O	pi3k	dep	6	SENT_163	[p11l118t2422r181b2445],

1	Mutation	NN	O	mutation	_	0	SENT_164	[p11l468t2191r591b2214],
2	(	CD	NUMBER	(	num	1	SENT_164	[p11l605t2191r709b2222],
3	V60OE	NN	O	v60oe	nn	6	SENT_164	[p11l605t2191r709b2222],
4	)	CD	NUMBER	)	num	6	SENT_164	[p11l605t2191r709b2222],
5	Overexpression	NN	MISC	overexpression	nn	6	SENT_164	[p11l467t2249r678b2280],
6	Overexpression	NN	MISC	overexpression	dep	1	SENT_164	[p11l467t2307r678b2337],
7	Increased	VBN	MISC	increase	partmod	1	SENT_164	[p11l468t2362r597b2387],
8	activation	NN	O	activation	nn	9	SENT_164	[p11l609t2365r739b2388],
9	P	NN	O	p	iobj	7	SENT_164	[p11l468t2422r569b2445],
10	|	CD	NUMBER	|	num	12	SENT_164	[p11l468t2422r569b2445],
11	K3CA	NN	O	k3ca	nn	12	SENT_164	[p11l468t2422r569b2445],
12	mutations	NNS	O	mutation	dobj	7	SENT_164	[p11l580t2423r717b2445],

1	DNA	NN	O	dna	nn	2	SENT_165	[p11l118t2518r184b2540],
2	damage	NN	O	damage	_	0	SENT_165	[p11l192t2515r301b2548],
3	or	CC	O	or	_	0	SENT_165	[p11l310t2524r338b2541],
4	repair	NN	O	repair	nn	5	SENT_165	[p11l347t2516r426b2548],
5	BRCA1	NN	O	brca1	conj_or	2	SENT_165	[p11l118t2575r208b2598],
6	and	CC	O	and	_	0	SENT_165	[p11l220t2573r268b2598],
7	BRCA2	NN	O	brca2	conj_and	2	SENT_165	[p11l281t2575r374b2598],

1	Mutation	NN	O	mutation	_	0	SENT_166	[p11l468t2575r590b2598],
2	(	CD	NUMBER	(	num	5	SENT_166	[p11l605t2573r736b2606],
3	synthetic	JJ	O	synthetic	amod	5	SENT_166	[p11l605t2573r736b2606],
4	lethal	JJ	O	lethal	amod	5	SENT_166	[p11l747t2573r817b2598],
5	effect	NN	O	effect	dep	1	SENT_166	[p11l829t2573r911b2606],
6	)	IN	O	)	amod	5	SENT_166	[p11l829t2573r911b2606],

1	Tumor	NN	O	tumor	nn	2	SENT_167	[p11l1145t699r1237b722],
2	Type	NN	O	type	_	0	SENT_167	[p11l1246t699r1312b729],

1	Lung	NN	O	lung	nn	2	SENT_168	[p11l977t814r1043b845],
2	cancer	NN	O	cancer	_	0	SENT_168	[p11l1053t821r1148b841],
3	,	,	O	,	_	0	SENT_168	[p11l1053t821r1148b841],
4	glioblastoma	NN	O	glioblastoma	nn	6	SENT_168	[p11l1159t812r1336b845],
5	Breast	NN	O	breast	nn	6	SENT_168	[p11l977t872r1061b895],
6	cancer	NN	O	cancer	appos	2	SENT_168	[p11l1071t878r1160b895],
7	Chronic	JJ	O	chronic	amod	9	SENT_168	[p11l975t927r1082b953],
8	myeloid	JJ	O	myeloid	amod	9	SENT_168	[p11l1093t927r1197b960],
9	leukemia	NN	O	leukemia	dep	6	SENT_168	[p11l1209t927r1330b953],
10	Gastric	JJ	O	gastric	amod	15	SENT_168	[p11l975t987r1079b1015],
11	,	,	O	,	_	0	SENT_168	[p11l975t987r1079b1015],
12	breast	NN	O	breast	dep	15	SENT_168	[p11l1091t985r1181b1015],
13	,	,	O	,	_	0	SENT_168	[p11l1091t985r1181b1015],
14	endometrial	JJ	O	endometrial	amod	15	SENT_168	[p11l1192t985r1355b1011],
15	cancer	NN	O	cancer	dep	6	SENT_168	[p11l1367t994r1456b1011],
16	Multiple	JJ	O	multiple	amod	18	SENT_168	[p11l977t1043r1088b1076],
17	myeloma	NN	O	myeloma	nn	18	SENT_168	[p11l1100t1043r1223b1076],
18	Glioblastoma	NNP	ORGANIZATION	Glioblastoma	dep	2	SENT_168	[p11l975t1101r1166b1131],
19	,	,	O	,	_	0	SENT_168	[p11l975t1101r1166b1131],
20	gastrointestinal	JJ	O	gastrointestinal	amod	22	SENT_168	[p11l1177t1101r1388b1134],
21	stromal	JJ	O	stromal	amod	22	SENT_168	[p11l1026t1139r1128b1164],
22	tumor	NN	O	tumor	appos	18	SENT_168	[p11l1138t1143r1223b1164],

1	Chronic	JJ	O	chronic	amod	3	SENT_169	[p11l975t1196r1082b1221],
2	myelomonocytic	JJ	O	myelomonocytic	amod	3	SENT_169	[p11l1092t1196r1316b1229],
3	leukemia	NN	O	leukemia	_	0	SENT_169	[p11l1327t1196r1447b1222],
4	Lung	NN	O	lung	nn	5	SENT_169	[p11l977t1256r1043b1287],
5	cancer	NN	O	cancer	dep	3	SENT_169	[p11l1052t1263r1148b1284],
6	,	,	O	,	_	0	SENT_169	[p11l1052t1263r1148b1284],
7	neuroblastoma	NN	O	neuroblastoma	appos	5	SENT_169	[p11l1160t1254r1373b1284],
8	,	,	O	,	_	0	SENT_169	[p11l1160t1254r1373b1284],
9	anaplastic	JJ	O	anaplastic	amod	11	SENT_169	[p11l1385t1263r1441b1279, p11l1026t1292r1113b1324],
10	large-cell	JJ	O	large-cell	amod	11	SENT_169	[p11l1124t1292r1242b1325],
11	lymphoma	NN	O	lymphoma	appos	5	SENT_169	[p11l1255t1292r1398b1325],
12	Gefitinib-resistant	JJ	O	gefitinib-resistant	amod	17	SENT_169	[p11l975t1349r1221b1375],
13	non	JJ	O	non	amod	17	SENT_169	[p11l1232t1349r1428b1375],
14	—	NN	O	—	nn	17	SENT_169	[p11l1232t1349r1428b1375],
15	small-cell	NN	O	small-cell	nn	17	SENT_169	[p11l1232t1349r1428b1375],
16	lung	NN	O	lung	nn	17	SENT_169	[p11l1026t1387r1084b1420],
17	cancer	NN	O	cancer	dep	11	SENT_169	[p11l1094t1396r1189b1416],
18	,	,	O	,	_	0	SENT_169	[p11l1094t1396r1189b1416],
19	gastric	JJ	O	gastric	amod	20	SENT_169	[p11l1201t1389r1291b1420],
20	cancer	NN	O	cancer	appos	5	SENT_169	[p11l1300t1396r1390b1412],
21	Colorectal	JJ	O	colorectal	amod	24	SENT_169	[p11l975t1445r1119b1474],
22	,	,	O	,	_	0	SENT_169	[p11l975t1445r1119b1474],
23	pancreatic	JJ	O	pancreatic	amod	24	SENT_169	[p11l1132t1447r1272b1477],
24	cancer	NN	O	cancer	dep	3	SENT_169	[p11l1281t1453r1371b1470],

1	Gastrointestinal	JJ	O	gastrointestinal	amod	3	SENT_170	[p11l975t1540r1193b1565],
2	stromal	JJ	O	stromal	amod	3	SENT_170	[p11l1205t1540r1307b1565],
3	tumor	NN	O	tumor	_	0	SENT_170	[p11l1024t1582r1109b1602],

1	Acute	JJ	O	acute	amod	4	SENT_171	[p11l974t1636r1051b1660],
2	myeloid	JJ	O	myeloid	amod	4	SENT_171	[p11l1063t1635r1167b1668],
3	leukemia	NN	O	leukemia	nn	4	SENT_171	[p11l1179t1635r1300b1660],
4	Thyroid	NN	MISC	thyroid	_	0	SENT_171	[p11l974t1693r1076b1726],
5	medullary	JJ	O	medullary	amod	6	SENT_171	[p11l1089t1693r1222b1726],
6	carcinoma	NN	O	carcinoma	dep	4	SENT_171	[p11l1231t1695r1373b1718],

1	Chronic	JJ	O	chronic	amod	3	SENT_172	[p11l975t1846r1081b1871],
2	myeloid	JJ	O	myeloid	amod	3	SENT_172	[p11l1092t1846r1196b1879],
3	leukemia	NN	O	leukemia	_	0	SENT_172	[p11l1209t1846r1330b1871],
4	Chronic	JJ	O	chronic	amod	6	SENT_172	[p11l975t1904r1081b1929],
5	myeloid	JJ	O	myeloid	amod	6	SENT_172	[p11l1092t1904r1196b1937],
6	leukemia	NN	O	leukemia	dep	3	SENT_172	[p11l1209t1904r1337b1933],
7	,	,	O	,	_	0	SENT_172	[p11l1209t1904r1337b1933],
8	myeloproliferative	JJ	O	myeloproliferative	amod	6	SENT_172	[p11l1350t1904r1439b1937, p11l1026t1941r1187b1974],

1	disorders	NNS	O	disorder	_	0	SENT_173	[p11l1197t1941r1324b1966],
2	Non	VBP	O	non	dep	1	SENT_173	[p11l977t1999r1179b2024],
3	—	CD	NUMBER	—	num	6	SENT_173	[p11l977t1999r1179b2024],
4	small-cell	JJ	O	small-cell	amod	6	SENT_173	[p11l977t1999r1179b2024],
5	lung	NN	O	lung	nn	6	SENT_173	[p11l1192t1999r1250b2032],
6	cancer	NN	O	cancer	dobj	2	SENT_173	[p11l1260t2008r1355b2029],
7	;	:	O	;	_	0	SENT_173	[p11l1260t2008r1355b2029],
8	ovarian	JJ	O	ovarian	dep	1	SENT_173	[p11l1366t2001r1473b2028],
9	,	,	O	,	_	0	SENT_173	[p11l1366t2001r1473b2028],
10	breast	NN	O	breast	nn	11	SENT_173	[p11l1026t2036r1108b2062],
11	cancer	NN	O	cancer	appos	8	SENT_173	[p11l1118t2045r1213b2066],
12	;	:	O	;	_	0	SENT_173	[p11l1118t2045r1213b2066],
13	sarcoma	NN	O	sarcoma	dep	8	SENT_173	[p11l1225t2045r1340b2062],

1	Melanoma	NN	O	melanoma	_	0	SENT_174	[p11l977t2189r1128b2219],
2	;	:	O	;	_	0	SENT_174	[p11l977t2189r1128b2219],
3	colon	NN	O	colon	dep	1	SENT_174	[p11l1140t2189r1221b2219],
4	,	,	O	,	_	0	SENT_174	[p11l1140t2189r1221b2219],
5	thyroid	NN	O	thyroid	nn	7	SENT_174	[p11l1231t2189r1325b2222],
6	cancer	NN	O	cancer	nn	7	SENT_174	[p11l1337t2198r1426b2214],
7	Breast	NN	O	breast	appos	1	SENT_174	[p11l977t2249r1067b2277],
8	,	,	O	,	_	0	SENT_174	[p11l977t2249r1067b2277],
9	colon	NN	O	colon	nn	10	SENT_174	[p11l1078t2247r1151b2272],
10	cancer	NN	O	cancer	appos	7	SENT_174	[p11l1163t2256r1258b2277],
11	;	:	O	;	_	0	SENT_174	[p11l1163t2256r1258b2277],
12	leukemia	NN	O	leukemia	nn	13	SENT_174	[p11l1271t2247r1391b2272],
13	Breast	NN	O	breast	dep	7	SENT_174	[p11l977t2307r1065b2334],
14	,	,	O	,	_	0	SENT_174	[p11l977t2307r1065b2334],
15	lung	NN	O	lung	appos	13	SENT_174	[p11l1077t2305r1141b2338],
16	,	,	O	,	_	0	SENT_174	[p11l1077t2305r1141b2338],
17	colon	NN	O	colon	nn	18	SENT_174	[p11l1151t2305r1223b2330],
18	cancer	NN	O	cancer	appos	13	SENT_174	[p11l1234t2314r1327b2334],
19	;	:	O	;	_	0	SENT_174	[p11l1234t2314r1327b2334],
20	lymphoma	NN	O	lymphoma	nn	22	SENT_174	[p11l1339t2305r1480b2338],
21	Renal-cell	JJ	MISC	renal-cell	amod	22	SENT_174	[p11l977t2362r1104b2387],
22	carcinoma	NN	O	carcinoma	dep	7	SENT_174	[p11l1115t2365r1257b2387],
23	Colorectal	JJ	O	colorectal	dep	22	SENT_174	[p11l975t2420r1119b2450],
24	,	,	O	,	_	0	SENT_174	[p11l975t2420r1119b2450],
25	breast	NN	O	breast	appos	1	SENT_174	[p11l1131t2420r1220b2450],
26	,	,	O	,	_	0	SENT_174	[p11l1131t2420r1220b2450],
27	gastric	JJ	O	gastric	amod	28	SENT_174	[p11l1232t2423r1322b2453],
28	cancer	NN	O	cancer	appos	1	SENT_174	[p11l1332t2429r1427b2450],
29	;	:	O	;	_	0	SENT_174	[p11l1332t2429r1427b2450],

1	glioblastoma	NN	O	glioblastoma	_	0	SENT_175	[p11l1025t2458r1201b2491],

1	Breast	NN	O	breast	_	0	SENT_176	[p11l977t2575r1067b2603],
2	,	,	O	,	_	0	SENT_176	[p11l977t2575r1067b2603],
3	ovarian	JJ	O	ovarian	amod	4	SENT_176	[p11l1078t2575r1177b2598],
4	cancer	NN	O	cancer	appos	1	SENT_176	[p11l1188t2582r1277b2598],

1	*	RB	O	*	advmod	3	SENT_177	[p11l89t2660r104b2675],
2	PARP	NN	O	parp	nsubj	3	SENT_177	[p11l117t2660r189b2683],
3	denotes	VBZ	O	denote	_	0	SENT_177	[p11l200t2658r307b2683],
4	poly	NN	O	poly	nn	7	SENT_177	[p11l321t2658r529b2691],
5	(	NN	O	(	nn	7	SENT_177	[p11l321t2658r529b2691],
6	adenosine	NN	O	adenosine	nn	7	SENT_177	[p11l321t2658r529b2691],
7	diphosphate	NN	O	diphosphate	dobj	3	SENT_177	[p11l541t2658r822b2691],
8	—	CD	NUMBER	—	num	9	SENT_177	[p11l541t2658r822b2691],
9	ribose	NN	O	ribose	tmod	3	SENT_177	[p11l541t2658r822b2691],
10	)	CD	NUMBER	)	num	11	SENT_177	[p11l541t2658r822b2691],
11	polymerase	NN	O	polymerase	dep	9	SENT_177	[p11l838t2658r1000b2691],
12	.	.	O	.	_	0	SENT_177	[p11l838t2658r1000b2691],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_178	[p11l1663t696r1827b729],
2	Agent	NNP	O	Agent	_	0	SENT_178	[p11l1836t699r1917b729],

1	Geﬁtinib	NNP	PERSON	Geﬁtinib	_	0	SENT_179	[p11l1517t811r1641b841],
2	,	,	O	,	_	0	SENT_179	[p11l1517t811r1641b841],
3	erlotinib	JJ	O	erlotinib	amod	5	SENT_179	[p11l1652t812r1765b837],
4	Lapatinib	NNP	MISC	Lapatinib	nn	5	SENT_179	[p11l1519t870r1643b902],
5	PKC412	NN	O	pkc412	appos	1	SENT_179	[p11l1519t929r1629b957],
6	,	,	O	,	_	0	SENT_179	[p11l1519t929r1629b957],
7	BIBF-1120	NN	O	bibf-1120	nn	8	SENT_179	[p11l1643t929r1781b953],
8	PKC412	NN	O	pkc412	appos	1	SENT_179	[p11l1519t987r1629b1015],
9	,	,	O	,	_	0	SENT_179	[p11l1519t987r1629b1015],
10	BIBF-1120	NN	O	bibf-1120	nn	11	SENT_179	[p11l1643t987r1781b1011],
11	PKC412	NN	O	pkc412	appos	1	SENT_179	[p11l1519t1045r1629b1073],
12	,	,	O	,	_	0	SENT_179	[p11l1519t1045r1629b1073],
13	BIBF-1120	NN	O	bibf-1120	nn	14	SENT_179	[p11l1643t1045r1781b1068],
14	Sunitinib	NN	O	sunitinib	appos	1	SENT_179	[p11l1517t1101r1646b1131],
15	,	,	O	,	_	0	SENT_179	[p11l1517t1101r1646b1131],
16	sorafenib	NN	O	sorafenib	appos	1	SENT_179	[p11l1658t1101r1791b1131],
17	,	,	O	,	_	0	SENT_179	[p11l1658t1101r1791b1131],
18	imatinib	NN	O	imatinib	appos	1	SENT_179	[p11l1804t1101r1915b1126],

1	Sunitinib	NNP	PERSON	Sunitinib	_	0	SENT_180	[p11l1517t1196r1646b1226],
2	,	,	O	,	_	0	SENT_180	[p11l1517t1196r1646b1226],
3	sorafenib	NN	O	sorafenib	appos	1	SENT_180	[p11l1658t1196r1791b1226],
4	,	,	O	,	_	0	SENT_180	[p11l1658t1196r1791b1226],
5	imatinib	NN	O	imatinib	appos	1	SENT_180	[p11l1804t1196r1915b1221],
6	Crizotinib	NNP	O	Crizotinib	dep	5	SENT_180	[p11l1517t1254r1649b1279],

1	Crizotinib	NNP	O	Crizotinib	_	0	SENT_181	[p11l1517t1349r1657b1379],
2	,	,	O	,	_	0	SENT_181	[p11l1517t1349r1657b1379],
3	XL184	NN	O	xl184	appos	1	SENT_181	[p11l1667t1351r1758b1379],
4	,	,	O	,	_	0	SENT_181	[p11l1667t1351r1758b1379],
5	SU11274	NN	O	su11274	appos	1	SENT_181	[p11l1770t1351r1892b1375],

1	CP-751	NN	O	cp-751	_	0	SENT_182	[p11l1517t1446r1678b1474],
2	,871	CD	NUMBER	,871	num	1	SENT_182	[p11l1517t1446r1678b1474],
3	,	,	O	,	_	0	SENT_182	[p11l1517t1446r1678b1474],
4	AMG479	NN	O	amg479	appos	1	SENT_182	[p11l1688t1446r1809b1470],

1	Sunitinib	NNP	O	Sunitinib	_	0	SENT_183	[p11l1517t1540r1646b1569],
2	,	,	O	,	_	0	SENT_183	[p11l1517t1540r1646b1569],
3	imatinib	NN	O	imatinib	appos	1	SENT_183	[p11l1659t1540r1770b1565],

1	Lestaurtinib	NNP	O	Lestaurtinib	_	0	SENT_184	[p11l1519t1635r1686b1665],
2	,	,	O	,	_	0	SENT_184	[p11l1519t1635r1686b1665],
3	XL999	NN	O	xl999	nn	4	SENT_184	[p11l1697t1637r1781b1660],
4	XL184	NN	O	xl184	appos	1	SENT_184	[p11l1516t1694r1599b1718],

1	lmatinib	NN	O	lmatinib	_	0	SENT_185	[p11l1519t1846r1631b1871],
2	Lestaurtinib	NNP	O	Lestaurtinib	dep	1	SENT_185	[p11l1519t1904r1686b1933],
3	,	,	O	,	_	0	SENT_185	[p11l1519t1904r1686b1933],
4	|	CD	NUMBER	|	num	5	SENT_185	[p11l1700t1905r1870b1929],
5	NCB0l8424	NN	O	ncb0l8424	appos	2	SENT_185	[p11l1700t1905r1870b1929],

1	KX2	NN	O	kx2	nn	2	SENT_186	[p11l1519t1999r1925b2029],
2	—	NN	O	—	_	0	SENT_186	[p11l1519t1999r1925b2029],
3	391	CD	NUMBER	391	dep	2	SENT_186	[p11l1519t1999r1925b2029],
4	,	,	O	,	_	0	SENT_186	[p11l1519t1999r1925b2029],
5	dasatinib	NN	O	dasatinib	appos	3	SENT_186	[p11l1519t1999r1925b2029],
6	,	,	O	,	_	0	SENT_186	[p11l1519t1999r1925b2029],
7	AZD0530	NN	O	azd0530	appos	3	SENT_186	[p11l1519t1999r1925b2029],

1	SB-590885	NN	O	sb-590885	_	0	SENT_187	[p11l1517t2191r1668b2219],
2	,	,	O	,	_	0	SENT_187	[p11l1517t2191r1668b2219],
3	PLX	NN	O	plx	dep	1	SENT_187	[p11l1681t2191r1814b2219],
4	—	CD	NUMBER	—	number	5	SENT_187	[p11l1681t2191r1814b2219],
5	4032	CD	NUMBER	4032	dep	3	SENT_187	[p11l1681t2191r1814b2219],
6	,	,	O	,	_	0	SENT_187	[p11l1681t2191r1814b2219],
7	RAF265	NN	O	raf265	appos	3	SENT_187	[p11l1827t2191r1937b2219],
8	,	,	O	,	_	0	SENT_187	[p11l1827t2191r1937b2219],
9	XL281	NN	O	xl281	nn	10	SENT_187	[p11l1947t2191r2030b2215],
10	MK-5108	NN	O	mk-5108	appos	7	SENT_187	[p11l1518t2249r1638b2272],
11	(	CD	NUMBER	(	num	12	SENT_187	[p11l1651t2249r1765b2280],
12	VX-689	NN	O	vx-689	dep	10	SENT_187	[p11l1651t2249r1765b2280],
13	)	CD	NUMBER	)	num	14	SENT_187	[p11l1651t2249r1765b2280],
14	Bl2536	NN	O	bl2536	dep	10	SENT_187	[p11l1518t2307r1617b2334],
15	,	,	O	,	_	0	SENT_187	[p11l1518t2307r1617b2334],
16	GSK461364	NN	O	gsk461364	nn	17	SENT_187	[p11l1629t2307r1787b2330],
17	Temsirolimus	NN	O	temsirolimus	appos	3	SENT_187	[p11l1515t2362r1705b2388],
18	(	CD	NUMBER	(	num	20	SENT_187	[p11l1718t2364r1854b2395],
19	CCI-779	NN	O	cci-779	nn	20	SENT_187	[p11l1718t2364r1854b2395],
20	)	NN	O	)	dep	17	SENT_187	[p11l1718t2364r1854b2395],
21	,	,	O	,	_	0	SENT_187	[p11l1718t2364r1854b2395],
22	BEZ235	NN	O	bez235	nn	23	SENT_187	[p11l1867t2364r1969b2387],
23	BEZ235	NN	O	bez235	dep	1	SENT_187	[p11l1518t2422r1620b2445],

1	Olaparib	NNP	O	Olaparib	nsubj	8	SENT_188	[p11l1516t2573r1641b2606],
2	,	,	O	,	_	0	SENT_188	[p11l1516t2573r1641b2606],
3	M	NN	O	m	nn	4	SENT_188	[p11l1655t2575r1677b2598],
4	K-4827	NN	O	k-4827	nsubj	8	SENT_188	[p11l1684t2575r1774b2598],
5	(	CD	NUMBER	(	num	7	SENT_188	[p11l1787t2575r1871b2606],
6	PARP	NN	O	parp	nn	7	SENT_188	[p11l1787t2575r1871b2606],
7	inhibitors	NNS	O	inhibitor	dep	4	SENT_188	[p11l1882t2573r2020b2606],
8	)	VBP	O	)	_	0	SENT_188	[p11l1882t2573r2020b2606],

1	for	IN	O	for	_	0	SENT_189	[p11l378t2793r426b2824],
2	CML	NN	ORGANIZATION	cml	prep_for	30	SENT_189	[p11l442t2796r521b2824],
3	in	IN	O	in	_	0	SENT_189	[p11l537t2794r569b2823],
4	2001.25	CD	NUMBER	2001.25	prep_in	2	SENT_189	[p11l587t2796r705b2824],
5	In	IN	O	in	_	0	SENT_189	[p11l723t2796r757b2823],
6	a	DT	O	a	det	8	SENT_189	[p11l774t2804r792b2824],
7	2006	CD	DATE	2006	num	8	SENT_189	[p11l808t2796r889b2824],
8	study	NN	O	study	prep_in	30	SENT_189	[p11l907t2793r1001b2832],
9	,	,	O	,	_	0	SENT_189	[p11l907t2793r1001b2832],
10	the	DT	O	the	det	12	SENT_189	[p11l1021t2793r1072b2824],
11	overall	JJ	O	overall	amod	12	SENT_189	[p11l1090t2793r1201b2824],
12	rate	NN	O	rate	nsubj	30	SENT_189	[p11l378t2849r440b2873],
13	of	IN	O	of	_	0	SENT_189	[p11l454t2842r492b2873],
14	5-year	JJ	DURATION	5-year	amod	15	SENT_189	[p11l499t2845r600b2881],
15	survival	NN	O	survival	prep_of	12	SENT_189	[p11l613t2842r742b2873],
16	for	IN	O	for	_	0	SENT_189	[p11l755t2842r803b2873],
17	patients	NNS	O	patient	prep_for	15	SENT_189	[p11l814t2843r947b2881],
18	with	IN	O	with	_	0	SENT_189	[p11l959t2842r1035b2873],
19	newly	RB	O	newly	advmod	20	SENT_189	[p11l1048t2842r1145b2881],
20	diagnosed	VBN	O	diagnose	amod	22	SENT_189	[p11l1157t2842r1200b2873, p11l378t2891r516b2931],
21	chronic-phase	JJ	O	chronic-phase	amod	22	SENT_189	[p11l538t2891r773b2931],
22	CML	NN	ORGANIZATION	cml	prep_with	17	SENT_189	[p11l795t2894r874b2922],
23	who	WP	O	who	nsubjpass	25	SENT_189	[p11l893t2891r964b2923],
24	were	VBD	O	be	auxpass	25	SENT_189	[p11l985t2902r1063b2923],
25	treated	VBN	O	treat	rcmod	22	SENT_189	[p11l1085t2891r1200b2922],
26	with	IN	O	with	_	0	SENT_189	[p11l376t2941r452b2973],
27	imatinib	NN	O	imatinib	prep_with	25	SENT_189	[p11l465t2941r608b2972],
28	was	VBD	O	be	cop	30	SENT_189	[p11l620t2952r683b2973],
29	89	CD	NUMBER	89	number	30	SENT_189	[p11l698t2943r810b2973],
30	°	CD	NUMBER	°	_	0	SENT_189	[p11l698t2943r810b2973],
31	/	:	O	/	punct	32	SENT_189	[p11l698t2943r810b2973],
32	0.26	CD	NUMBER	0.26	dep	30	SENT_189	[p11l698t2943r810b2973],

1	The	DT	O	the	det	2	SENT_190	[p11l426t2991r489b3022],
2	success	NN	O	success	nsubjpass	9	SENT_190	[p11l507t3002r629b3022],
3	of	IN	O	of	_	0	SENT_190	[p11l647t2991r686b3022],
4	imatinib	NN	O	imatinib	prep_of	2	SENT_190	[p11l696t2991r839b3022],
5	in	IN	O	in	_	0	SENT_190	[p11l857t2992r889b3021],
6	CML	NN	ORGANIZATION	cml	prep_in	4	SENT_190	[p11l906t2994r985b3022],
7	was	VBD	O	be	auxpass	9	SENT_190	[p11l1000t3002r1063b3022],
8	quickly	RB	O	quickly	advmod	9	SENT_190	[p11l1082t2991r1202b3030],
9	extended	VBN	O	extend	_	0	SENT_190	[p11l378t3041r527b3071],
10	to	TO	O	to	_	0	SENT_190	[p11l559t3047r591b3071],
11	gastrointestinal	JJ	O	gastrointestinal	amod	13	SENT_190	[p11l623t3041r888b3080],
12	stromal	JJ	O	stromal	amod	13	SENT_190	[p11l920t3041r1049b3071],
13	tumors	NNS	O	tumor	prep_to	9	SENT_190	[p11l1080t3047r1200b3072],
14	(	VBP	O	(	rcmod	13	SENT_190	[p11l380t3093r494b3128],
15	GIST	NN	O	gist	nn	16	SENT_190	[p11l380t3093r494b3128],
16	)	NN	O	)	dobj	14	SENT_190	[p11l380t3093r494b3128],
17	,	,	O	,	_	0	SENT_190	[p11l380t3093r494b3128],
18	the	DT	O	the	det	19	SENT_190	[p11l517t3090r569b3121],
19	majority	NN	O	majority	appos	16	SENT_190	[p11l589t3091r729b3130],
20	of	IN	O	of	_	0	SENT_190	[p11l748t3090r787b3121],
21	which	WDT	O	which	det	22	SENT_190	[p11l799t3090r900b3122],
22	sport	NN	O	sport	rel	28	SENT_190	[p11l921t3097r1008b3130],
23	a	DT	O	a	det	27	SENT_190	[p11l1027t3101r1044b3121],
24	receptor	NN	O	receptor	nn	27	SENT_190	[p11l1064t3097r1202b3130],
25	tyrosine	NN	O	tyrosine	nn	27	SENT_190	[p11l378t3141r512b3180],
26	kinase	NN	O	kinase	nn	27	SENT_190	[p11l528t3140r636b3172],
27	(	NN	O	(	nsubj	28	SENT_190	[p11l653t3140r760b3176],
28	called	VBN	O	call	rcmod	19	SENT_190	[p11l653t3140r760b3176],
29	c-Kit	NN	O	c-kit	nn	30	SENT_190	[p11l776t3141r864b3176],
30	)	NN	O	)	dobj	28	SENT_190	[p11l776t3141r864b3176],
31	that	WDT	O	that	nsubjpass	33	SENT_190	[p11l881t3140r948b3171],
32	is	VBZ	O	be	auxpass	33	SENT_190	[p11l961t3141r987b3171],
33	activated	VBN	O	activate	rcmod	30	SENT_190	[p11l1003t3140r1149b3172],
34	by	IN	O	by	_	0	SENT_190	[p11l1165t3140r1202b3180],
35	mutation	NN	O	mutation	agent	33	SENT_190	[p11l1240t2794r1432b2824],
36	.	.	O	.	_	0	SENT_190	[p11l1240t2794r1432b2824],
37	"	''	O	"	punct	9	SENT_190	[p11l1240t2794r1432b2824],

1	Because	IN	O	because	mark	4	SENT_191	[p11l1454t2796r1588b2824],
2	imatinib	NN	O	imatinib	nsubj	4	SENT_191	[p11l1610t2793r1753b2824],
3	potently	RB	O	potently	advmod	4	SENT_191	[p11l1776t2794r1914b2832],
4	inhibits	VBZ	O	inhibit	_	0	SENT_191	[p11l1934t2793r2062b2824],
5	c	NN	O	c	dobj	4	SENT_191	[p11l1241t2843r1328b2880],
6	.	.	O	.	_	0	SENT_191	[p11l1241t2843r1328b2880],

1	—	NN	O	—	_	0	SENT_192	[p11l1241t2843r1328b2880],
2	.	.	O	.	_	0	SENT_192	[p11l1241t2843r1328b2880],

1	Kit	NN	O	kit	nsubjpass	9	SENT_193	[p11l1241t2843r1328b2880],
2	,	,	O	,	_	0	SENT_193	[p11l1241t2843r1328b2880],
3	its	PRP$	O	its	poss	5	SENT_193	[p11l1348t2843r1387b2873],
4	therapeutic	JJ	O	therapeutic	amod	5	SENT_193	[p11l1406t2842r1594b2881],
5	effect	NN	O	effect	appos	1	SENT_193	[p11l1612t2842r1706b2873],
6	on	IN	O	on	_	0	SENT_193	[p11l1723t2852r1764b2873],
7	GIST	NN	O	gist	prep_on	5	SENT_193	[p11l1782t2845r1867b2873],
8	was	VBD	O	be	auxpass	9	SENT_193	[p11l1882t2853r1945b2873],
9	tested	VBN	O	test	_	0	SENT_193	[p11l1965t2842r2063b2873],
10	in	IN	O	in	_	0	SENT_193	[p11l1240t2892r1272b2922],
11	clinical	JJ	O	clinical	amod	12	SENT_193	[p11l1288t2891r1410b2922],
12	trials	NNS	O	trial	prep_in	9	SENT_193	[p11l1425t2891r1519b2929],
13	,	,	O	,	_	0	SENT_193	[p11l1425t2891r1519b2929],
14	and	CC	O	and	_	0	SENT_193	[p11l1537t2891r1598b2922],
15	objective	JJ	O	objective	amod	17	SENT_193	[p11l1613t2891r1758b2931],
16	response	NN	O	response	nn	17	SENT_193	[p11l1773t2901r1921b2931],
17	rates	NNS	O	rate	nsubjpass	26	SENT_193	[p11l1936t2898r2015b2922],
18	of	IN	O	of	_	0	SENT_193	[p11l2031t2891r2070b2922],
19	more	JJR	O	more	mwe	20	SENT_193	[p11l1240t2951r1325b2972],
20	than	IN	O	than	quantmod	22	SENT_193	[p11l1343t2942r1419b2972],
21	50	CD	NUMBER	50	number	22	SENT_193	[p11l1436t2944r1508b2973],
22	°	CD	NUMBER	°	prep_of	17	SENT_193	[p11l1436t2944r1508b2973],
23	/	:	O	/	punct	24	SENT_193	[p11l1436t2944r1508b2973],
24	o	NN	O	o	dep	22	SENT_193	[p11l1436t2944r1508b2973],
25	were	VBD	O	be	auxpass	26	SENT_193	[p11l1523t2952r1601b2973],
26	obtained	VBN	O	obtain	conj_and	9	SENT_193	[p11l1619t2941r1805b2979],
27	,	,	O	,	_	0	SENT_193	[p11l1619t2941r1805b2979],
28	”	CD	NUMBER	”	dobj	26	SENT_193	[p11l1619t2941r1805b2979],
29	comparing	VBG	O	compare	partmod	28	SENT_193	[p11l1823t2942r2005b2981],
30	favorably	RB	O	favorably	advmod	29	SENT_193	[p11l2021t2941r2063b2972, p11l1239t2991r1360b3030],
31	to	TO	O	to	_	0	SENT_193	[p11l1378t2998r1410b3022],
32	a	DT	O	a	det	34	SENT_193	[p11l1430t3002r1447b3022],
33	response	NN	O	response	nn	34	SENT_193	[p11l1466t3001r1614b3030],
34	rate	NN	O	rate	prep_to	29	SENT_193	[p11l1634t2998r1696b3022],
35	of	IN	O	of	_	0	SENT_193	[p11l1716t2991r1755b3022],
36	less	JJR	O	less	mwe	37	SENT_193	[p11l1768t2991r1828b3022],
37	than	IN	O	than	quantmod	38	SENT_193	[p11l1849t2991r1925b3022],
38	5	CD	PERCENT	5	num	39	SENT_193	[p11l1946t2994r1997b3022],
39	%	NN	PERCENT	%	prep_of	34	SENT_193	[p11l1946t2994r1997b3022],
40	for	IN	O	for	_	0	SENT_193	[p11l2016t2991r2064b3022],
41	conventional	JJ	O	conventional	amod	42	SENT_193	[p11l1241t3041r1454b3072],
42	chemotherapy	NN	O	chemotherapy	prep_for	39	SENT_193	[p11l1470t3041r1742b3080],
43	.	.	O	.	_	0	SENT_193	[p11l1470t3041r1742b3080],

1	”	NN	O	”	_	0	SENT_194	[p11l1470t3041r1742b3080],
2	Although	IN	O	although	mark	6	SENT_194	[p11l1289t3090r1447b3130],
3	these	DT	O	these	nsubj	6	SENT_194	[p11l1472t3091r1558b3121],
4	are	VBP	O	be	cop	6	SENT_194	[p11l1583t3101r1633b3121],
5	important	JJ	O	important	amod	6	SENT_194	[p11l1657t3091r1828b3130],
6	examples	NNS	O	example	dep	1	SENT_194	[p11l1851t3090r2006b3130],
7	of	IN	O	of	_	0	SENT_194	[p11l2032t3090r2070b3121],
8	therapeutics	NNS	O	therapeutics	prep_of	6	SENT_194	[p11l1241t3141r1445b3180],
9	targeting	VBG	O	target	partmod	8	SENT_194	[p11l1464t3141r1619b3180],
10	the	DT	O	the	det	11	SENT_194	[p11l1636t3140r1688b3171],
11	products	NNS	O	product	dobj	9	SENT_194	[p11l1705t3140r1851b3180],
12	of	IN	O	of	_	0	SENT_194	[p11l1870t3140r1909b3171],
13	genomic	JJ	O	genomic	prep_of	11	SENT_194	[p11l1920t3141r2064b3180],

1	N	NN	O	n	nn	3	SENT_195	[p11l890t3265r903b3280],
2	ENGLJ	NN	O	englj	nn	3	SENT_195	[p11l918t3265r996b3287],
3	MED	NN	O	med	_	0	SENT_195	[p11l1011t3265r1063b3280],
4	364	CD	NUMBER	364	dep	3	SENT_195	[p11l1073t3259r1142b3287],
5	;	:	O	;	_	0	SENT_195	[p11l1073t3259r1142b3287],
6	4	CD	NUMBER	4	num	8	SENT_195	[p11l1073t3259r1142b3287],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_195	[p11l1176t3265r1300b3287],
8	JANUARY	NN	DATE	january	dep	3	SENT_195	[p11l1331t3265r1443b3287],
9	27	CD	DATE	27	dep	8	SENT_195	[p11l1453t3265r1487b3286],
10	,	,	DATE	,	_	0	SENT_195	[p11l1453t3265r1487b3286],
11	2011	CD	DATE	2011	appos	9	SENT_195	[p11l1499t3265r1550b3281],
12	The	DT	O	the	det	15	SENT_195	[p11l878t3322r929b3346],
13	New	NNP	O	New	nn	15	SENT_195	[p11l938t3323r1000b3346],
14	England	NNP	O	England	nn	15	SENT_195	[p11l1009t3322r1120b3353],
15	Journal	NNP	O	Journal	dep	3	SENT_195	[p11l1128t3322r1226b3346],
16	of	IN	O	of	_	0	SENT_195	[p11l1235t3322r1264b3346],
17	Medicine	NNP	O	Medicine	prep_of	15	SENT_195	[p11l1271t3322r1396b3346],

1	Downloaded	VBN	O	download	_	0	SENT_196	[p11l320t3363r490b3386],
2	from	IN	O	from	_	0	SENT_196	[p11l499t3363r563b3386],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_196	[p11l572t3363r690b3393],
4	at	IN	O	at	_	0	SENT_196	[p11l700t3367r723b3386],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_196	[p11l732t3363r914b3386],
6	on	IN	O	on	_	0	SENT_196	[p11l924t3370r956b3386],
7	January	NNP	DATE	January	prep_on	1	SENT_196	[p11l965t3363r1068b3393],
8	5	CD	DATE	5	num	7	SENT_196	[p11l1078t3363r1100b3391],
9	,	,	DATE	,	_	0	SENT_196	[p11l1078t3363r1100b3391],
10	2014	CD	DATE	2014	num	7	SENT_196	[p11l1111t3363r1183b3386],
11	.	.	O	.	_	0	SENT_196	[p11l1111t3363r1183b3386],

1	For	IN	O	for	_	0	SENT_197	[p11l1194t3363r1240b3386],
2	personal	JJ	O	personal	amod	3	SENT_197	[p11l1248t3363r1361b3393],
3	use	NN	O	use	pobj	1	SENT_197	[p11l1370t3370r1413b3386],
4	only	RB	O	only	advmod	3	SENT_197	[p11l1423t3363r1488b3393],
5	.	.	O	.	_	0	SENT_197	[p11l1423t3363r1488b3393],

1	No	DT	O	no	det	3	SENT_198	[p11l1498t3363r1538b3386],
2	other	JJ	O	other	amod	3	SENT_198	[p11l1548t3363r1616b3386],
3	uses	NNS	O	use	_	0	SENT_198	[p11l1624t3370r1680b3386],
4	without	IN	O	without	_	0	SENT_198	[p11l1690t3363r1792b3386],
5	permission	NN	O	permission	prep_without	3	SENT_198	[p11l1800t3363r1952b3393],
6	.	.	O	.	_	0	SENT_198	[p11l1800t3363r1952b3393],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_199	[p11l765t3447r923b3466],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_199	[p11l937t3447r1108b3466],

1	Before	IN	O	before	_	0	SENT_200	[p12l188t224r273b249],
2	treatment	NN	O	treatment	pobj	1	SENT_200	[p12l282t229r417b249],
3	;	:	O	;	_	0	SENT_200	[p12l716t217r738b259],
4	V	NN	O	v	dep	2	SENT_200	[p12l748t216r758b259],
5	‘	CD	NUMBER	‘	num	4	SENT_200	[p12l748t216r758b259],
6	I	PRP	O	I	rcmod	4	SENT_200	[p12l780t211r782b213],
7	r	NN	O	r	dep	6	SENT_200	[p12l794t215r806b225],
8	During	IN	O	during	dep	6	SENT_200	[p12l1697t225r1790b257],
9	treatment	NN	O	treatment	pobj	8	SENT_200	[p12l1799t229r1934b249],

1	Figure	NN	O	figure	_	0	SENT_201	[p12l122t1250r206b1282],
2	2	CD	NUMBER	2	dep	1	SENT_201	[p12l217t1252r241b1274],
3	.	.	O	.	_	0	SENT_201	[p12l217t1252r241b1274],

1	Targeting	NN	O	targeting	nn	2	SENT_202	[p12l251t1250r382b1282],
2	Treatment	NN	O	treatment	_	0	SENT_202	[p12l391t1252r534b1275],
3	to	TO	O	to	_	0	SENT_202	[p12l543t1254r570b1275],
4	a	DT	O	a	det	6	SENT_202	[p12l581t1258r595b1275],
5	Specific	JJ	MISC	specific	amod	6	SENT_202	[p12l606t1249r716b1282],
6	Variant	JJ	MISC	variant	prep_to	2	SENT_202	[p12l726t1250r824b1275],
7	in	IN	O	in	_	0	SENT_202	[p12l835t1250r858b1274],
8	the	DT	O	the	det	10	SENT_202	[p12l869t1249r913b1275],
9	Melanoma	NN	O	melanoma	nn	10	SENT_202	[p12l926t1249r1071b1275],
10	Gene	NN	O	gene	prep_in	2	SENT_202	[p12l1082t1251r1163b1275],
11	.	.	O	.	_	0	SENT_202	[p12l1082t1251r1163b1275],

1	Shown	VBN	O	show	csubj	4	SENT_203	[p12l120t1299r212b1325],
2	are	VBP	O	be	cop	4	SENT_203	[p12l225t1308r265b1325],
3	three-dimensional	JJ	O	three-dimensional	amod	4	SENT_203	[p12l276t1299r530b1325],
4	representations	NNS	O	representation	_	0	SENT_203	[p12l544t1302r760b1332],
5	of	IN	O	of	_	0	SENT_203	[p12l772t1299r802b1325],
6	glucose	NN	O	glucose	nn	7	SENT_203	[p12l809t1299r914b1333],
7	metabolism	NN	O	metabolism	prep_of	4	SENT_203	[p12l927t1299r1089b1325],
8	in	IN	O	in	_	0	SENT_203	[p12l1103t1302r1125b1324],
9	18F-fluorodeoxyglucos	NNP	O	18F-fluorodeoxyglucos	nn	10	SENT_203	[p12l1139t1299r1446b1333],
10	DG	NNS	O	dg	prep_in	7	SENT_203	[p12l1506t1301r1637b1332],
11	)	CD	NUMBER	)	dep	10	SENT_203	[p12l1506t1301r1637b1332],
12	.	.	O	.	_	0	SENT_203	[p12l1506t1301r1637b1332],

1	—	NN	O	—	_	0	SENT_204	[p12l1506t1301r1637b1332],
2	.	.	O	.	_	0	SENT_204	[p12l1506t1301r1637b1332],

1	PET	NN	O	pet	nn	2	SENT_205	[p12l1506t1301r1637b1332],
2	scans	NNS	O	scan	nsubj	3	SENT_205	[p12l1648t1308r1724b1325],
3	obtained	VBN	O	obtain	_	0	SENT_205	[p12l1736t1299r1857b1325],
4	at	IN	O	at	_	0	SENT_205	[p12l1870t1304r1894b1325],
5	baseline	NN	O	baseline	prep_at	3	SENT_205	[p12l1906t1299r2019b1325],
6	and	CC	O	and	_	0	SENT_205	[p12l120t1341r169b1366],
7	2	CD	DURATION	2	num	8	SENT_205	[p12l182t1343r196b1366],
8	weeks	NNS	NUMBER	week	prep_at	3	SENT_205	[p12l207t1341r290b1366],
9	after	IN	O	after	_	0	SENT_205	[p12l303t1341r366b1366],
10	the	DT	O	the	det	12	SENT_205	[p12l376t1341r419b1366],
11	initiation	NN	O	initiation	nn	12	SENT_205	[p12l432t1343r552b1366],
12	oftreatment	NN	O	oftreatment	nsubj	18	SENT_205	[p12l565t1341r738b1366],
13	in	IN	O	in	_	0	SENT_205	[p12l750t1343r772b1366],
14	a	DT	O	a	det	15	SENT_205	[p12l785t1350r798b1366],
15	patient	NN	O	patient	prep_in	12	SENT_205	[p12l811t1343r906b1374],
16	with	IN	O	with	_	0	SENT_205	[p12l916t1341r973b1366],
17	melanoma	NN	O	melanoma	prep_with	15	SENT_205	[p12l988t1341r1133b1366],
18	carrying	VBG	O	carry	prepc_after	3	SENT_205	[p12l1145t1343r1257b1374],
19	the	DT	O	the	det	22	SENT_205	[p12l1267t1341r1311b1366],
20	V600E	NN	O	v600e	nn	22	SENT_205	[p12l1321t1343r1410b1366],
21	BR	NN	O	br	nn	22	SENT_205	[p12l1423t1343r1459b1366],
22	mutation	NN	O	mutation	dobj	18	SENT_205	[p12l1510t1343r1643b1366],
23	.	.	O	.	_	0	SENT_205	[p12l1510t1343r1643b1366],

1	The	DT	O	the	det	2	SENT_206	[p12l1655t1341r1706b1366],
2	patient	NN	O	patient	nsubjpass	4	SENT_206	[p12l1719t1343r1814b1374],
3	was	VBD	O	be	auxpass	4	SENT_206	[p12l1824t1350r1876b1366],
4	treated	VBN	O	treat	_	0	SENT_206	[p12l1887t1341r1983b1366],
5	with	IN	O	with	_	0	SENT_206	[p12l119t1383r176b1408],
6	the	DT	O	the	det	9	SENT_206	[p12l188t1383r231b1408],
7	BRAF	NN	O	braf	nn	9	SENT_206	[p12l245t1384r319b1407],
8	inhibitor	NN	O	inhibitor	nn	9	SENT_206	[p12l332t1383r448b1408],
9	PLX4032	NN	O	plx4032	prep_with	4	SENT_206	[p12l461t1384r587b1408],
10	.	.	O	.	_	0	SENT_206	[p12l461t1384r587b1408],

1	Hypermetabolism	NN	O	hypermetabolism	nsubj	2	SENT_207	[p12l602t1383r850b1416],
2	ofinjected	VBD	O	ofinject	_	0	SENT_207	[p12l863t1382r1008b1416],
3	radioactive	JJ	O	radioactive	amod	4	SENT_207	[p12l1022t1383r1173b1408],
4	glucose	NN	O	glucose	nsubjpass	6	SENT_207	[p12l1185t1383r1289b1416],
5	is	VBZ	O	be	auxpass	6	SENT_207	[p12l1302t1385r1321b1408],
6	indicated	VBN	O	indicate	ccomp	2	SENT_207	[p12l1334t1383r1459b1408],
7	by	IN	O	by	_	0	SENT_207	[p12l1473t1383r1502b1416],
8	the	DT	O	the	det	15	SENT_207	[p12l1511t1383r1555b1408],
9	red	JJ	O	red	amod	15	SENT_207	[p12l1567t1383r1617b1412],
10	,	,	O	,	_	0	SENT_207	[p12l1567t1383r1617b1412],
11	green	JJ	O	green	amod	15	SENT_207	[p12l1630t1391r1714b1416],
12	,	,	O	,	_	0	SENT_207	[p12l1630t1391r1714b1416],
13	and	CC	O	and	_	0	SENT_207	[p12l1727t1383r1776b1408],
14	yellow	JJ	O	yellow	amod	15	SENT_207	[p12l1787t1383r1874b1416],
15	signals	NNS	O	signal	agent	6	SENT_207	[p12l1885t1383r1979b1416],
16	and	CC	O	and	_	0	SENT_207	[p12l1992t1383r2040b1408],
17	is	VBZ	O	be	cop	19	SENT_207	[p12l121t1427r140b1450],
18	a	DT	O	a	det	19	SENT_207	[p12l153t1433r165b1450],
19	feature	NN	O	feature	conj_and	2	SENT_207	[p12l177t1424r273b1450],
20	ofdividing	VBG	O	ofdivide	dep	19	SENT_207	[p12l284t1424r431b1458],
21	cancer	NN	O	cancer	nn	22	SENT_207	[p12l442t1433r533b1450],
22	cells	NNS	O	cell	dobj	20	SENT_207	[p12l543t1424r611b1454],
23	,	,	O	,	_	0	SENT_207	[p12l543t1424r611b1454],
24	as	RB	O	as	_	0	SENT_207	[p12l624t1433r652b1450],
25	well	RB	O	well	_	0	SENT_207	[p12l663t1424r715b1450],
26	as	IN	O	as	_	0	SENT_207	[p12l728t1433r756b1450],
27	being	VBG	O	be	aux	30	SENT_207	[p12l769t1424r844b1458],
28	a	DT	O	a	det	30	SENT_207	[p12l855t1433r868b1450],
29	normal	JJ	O	normal	amod	30	SENT_207	[p12l881t1424r977b1450],
30	feature	NN	O	feature	conj_and	20	SENT_207	[p12l989t1424r1086b1450],
31	of	IN	O	of	_	0	SENT_207	[p12l1097t1424r1127b1450],
32	brain	NN	O	brain	nn	35	SENT_207	[p12l1135t1424r1202b1450],
33	and	CC	O	and	_	0	SENT_207	[p12l1215t1424r1264b1450],
34	bladder	NN	O	bladder	conj_and	32	SENT_207	[p12l1278t1424r1382b1450],
35	metabolism	NN	O	metabolism	prep_of	30	SENT_207	[p12l1394t1424r1556b1450],
36	or	CC	O	or	_	0	SENT_207	[p12l1569t1433r1597b1450],
37	excretion	NN	O	excretion	conj_or	35	SENT_207	[p12l1607t1427r1741b1450],
38	.	.	O	.	_	0	SENT_207	[p12l1607t1427r1741b1450],

1	(	NN	O	(	nn	3	SENT_208	[p12l1756t1426r1865b1458],
2	Images	NNS	O	image	nn	3	SENT_208	[p12l1756t1426r1865b1458],
3	courtesy	NN	O	courtesy	nsubj	17	SENT_208	[p12l1877t1429r1995b1457],
4	of	IN	O	of	_	0	SENT_208	[p12l2006t1424r2036b1450],
5	Grant	NNP	PERSON	Grant	nn	6	SENT_208	[p12l120t1468r198b1491],
6	McArthur	NNP	PERSON	McArthur	prep_of	3	SENT_208	[p12l211t1466r437b1498],
7	,	,	O	,	_	0	SENT_208	[p12l211t1466r437b1498],
8	jason	NNP	PERSON	jason	nn	9	SENT_208	[p12l211t1466r437b1498],
9	Callahan	NNP	PERSON	Callahan	prep_of	3	SENT_208	[p12l450t1466r576b1496],
10	,	,	O	,	_	0	SENT_208	[p12l450t1466r576b1496],
11	and	CC	O	and	_	0	SENT_208	[p12l589t1466r637b1491],
12	Rod	NNP	PERSON	Rod	nn	16	SENT_208	[p12l652t1466r702b1491],
13	Hicks	NNP	PERSON	Hicks	nn	16	SENT_208	[p12l717t1466r792b1491],
14	ofthe	NNP	O	ofthe	nn	16	SENT_208	[p12l804t1466r883b1491],
15	Peter	NNP	PERSON	Peter	nn	16	SENT_208	[p12l897t1468r967b1491],
16	MacCa	NNP	PERSON	MacCa	conj_and	6	SENT_208	[p12l979t1466r1133b1491],
17	|	VBD	O	|	_	0	SENT_208	[p12l979t1466r1133b1491],
18	|	CD	NUMBER	|	num	20	SENT_208	[p12l979t1466r1133b1491],
19	um	NN	O	um	nn	20	SENT_208	[p12l979t1466r1133b1491],
20	Cancer	NN	O	cancer	dobj	17	SENT_208	[p12l1147t1468r1243b1491],
21	Centre	NNP	O	Centre	nn	23	SENT_208	[p12l1253t1468r1361b1499],
22	.	.	O	.	_	0	SENT_208	[p12l1253t1468r1361b1499],
23	)	NN	O	)	dep	20	SENT_208	[p12l1253t1468r1361b1499],

1	alterations	NNS	O	alteration	nsubjpass	14	SENT_209	[p12l11t1692r465b1771],
2	specific	JJ	O	specific	amod	1	SENT_209	[p12l523t1691r852b1792],
3	to	TO	O	to	_	0	SENT_209	[p12l907t1709r989b1771],
4	the	DT	O	the	det	5	SENT_209	[p12l1045t1692r1177b1770],
5	cancer	NN	O	cancer	prep_to	2	SENT_209	[p12l1233t1718r1532b1788],
6	,	,	O	,	_	0	SENT_209	[p12l1233t1718r1532b1788],
7	the	DT	O	the	det	9	SENT_209	[p12l1592t1692r1725b1770],
8	mutated	VBN	O	mutate	amod	9	SENT_209	[p12l1780t1692r2133b1772],
9	genes	NNS	O	gene	appos	5	SENT_209	[p12l11t1847r252b1922],
10	that	WDT	O	that	nsubjpass	12	SENT_209	[p12l311t1821r483b1899],
11	were	VBD	O	be	auxpass	12	SENT_209	[p12l531t1847r732b1900],
12	involved	VBN	O	involve	rcmod	9	SENT_209	[p12l788t1821r1140b1900],
13	were	VBD	O	be	auxpass	14	SENT_209	[p12l1192t1847r1394b1900],
14	discovered	VBN	O	discover	_	0	SENT_209	[p12l1451t1821r1905b1900],
15	well	RB	O	well	advmod	14	SENT_209	[p12l1956t1821r2134b1900],
16	before	IN	O	before	mark	23	SENT_209	[p12l12t1948r280b2028],
17	sequencing	NN	O	sequencing	nsubj	23	SENT_209	[p12l336t1950r822b2050],
18	of	IN	O	of	_	0	SENT_209	[p12l874t1948r973b2028],
19	the	DT	O	the	det	22	SENT_209	[p12l1010t1949r1142b2027],
20	reference	NN	O	reference	nn	22	SENT_209	[p12l1197t1948r1589b2027],
21	human	JJ	O	human	amod	22	SENT_209	[p12l1644t1949r1948b2028],
22	genome	NN	O	genome	prep_of	17	SENT_209	[p12l2002t1975r2132b2050, p12l11t2103r250b2156],
23	began	VBD	O	begin	advcl	14	SENT_209	[p12l306t2077r566b2178],
24	in	IN	O	in	_	0	SENT_209	[p12l622t2078r705b2155],
25	earnest	NN	O	earnest	prep_in	23	SENT_209	[p12l762t2094r1097b2156],
26	.	.	O	.	_	0	SENT_209	[p12l762t2094r1097b2156],

1	However	RB	O	however	advmod	16	SENT_210	[p12l1159t2085r1554b2173],
2	,	,	O	,	_	0	SENT_210	[p12l1159t2085r1554b2173],
3	increasingly	RB	O	increasingly	advmod	4	SENT_210	[p12l1614t2077r2138b2178],
4	extensive	JJ	O	extensive	amod	6	SENT_210	[p12l12t2206r399b2284],
5	systematic	JJ	O	systematic	amod	6	SENT_210	[p12l463t2206r912b2305],
6	sequencing	NN	O	sequencing	nsubj	16	SENT_210	[p12l974t2206r1460b2306],
7	of	IN	O	of	_	0	SENT_210	[p12l1519t2204r1619b2284],
8	cancer	NN	O	cancer	nn	9	SENT_210	[p12l1663t2231r1943b2283],
9	genomes	NNS	O	genome	prep_of	6	SENT_210	[p12l2002t2231r2132b2306, p12l11t2358r288b2411],
10	over	IN	O	over	_	0	SENT_210	[p12l356t2358r531b2412],
11	the	DT	DURATION	the	det	14	SENT_210	[p12l594t2332r724b2410],
12	past	JJ	DURATION	past	amod	14	SENT_210	[p12l787t2349r965b2432],
13	few	JJ	DURATION	few	amod	14	SENT_210	[p12l1026t2331r1177b2411],
14	years	NNS	DURATION	year	prep_over	9	SENT_210	[p12l1235t2358r1449b2432],
15	has	VBZ	O	have	aux	16	SENT_210	[p12l1517t2332r1659b2410],
16	identified	VBN	O	identify	_	0	SENT_210	[p12l1726t2331r2133b2411],
17	several	JJ	O	several	amod	18	SENT_210	[p12l12t2461r297b2540],
18	new	JJ	O	new	dobj	16	SENT_210	[p12l327t2487r505b2540],
19	mutated	VBN	O	mutate	partmod	18	SENT_210	[p12l533t2461r886b2540],
20	cancer	NN	O	cancer	nn	21	SENT_210	[p12l918t2487r1199b2539],
21	genes	NNS	O	gene	dobj	19	SENT_210	[p12l1227t2487r1493b2562],
22	.	.	O	.	_	0	SENT_210	[p12l1227t2487r1493b2562],

1	Some	DT	O	some	nsubj	4	SENT_211	[p12l1533t2467r1764b2540],
2	of	IN	O	of	_	0	SENT_211	[p12l1796t2460r1896b2540],
3	these	DT	O	these	prep_of	1	SENT_211	[p12l1909t2461r2133b2539],
4	recommend	VB	O	recommend	_	0	SENT_211	[p12l11t2589r517b2667],
5	the	DT	O	the	det	6	SENT_211	[p12l556t2589r686b2667],
6	proteins	NNS	O	protein	dobj	4	SENT_211	[p12l724t2590r1069b2688],
7	that	IN	O	that	complm	9	SENT_211	[p12l1111t2589r1280b2666],
8	they	PRP	O	they	nsubj	9	SENT_211	[p12l1314t2589r1493b2688],
9	encode	VBP	O	encode	ccomp	4	SENT_211	[p12l1528t2589r1822b2667],
10	as	IN	O	as	_	0	SENT_211	[p12l1860t2615r1945b2666],
11	targets	NNS	O	target	prep_as	9	SENT_211	[p12l1987t2606r2132b2666, p12l11t2734r183b2818],
12	for	IN	O	for	_	0	SENT_211	[p12l218t2716r341b2796],
13	new	JJ	O	new	amod	14	SENT_211	[p12l372t2743r550b2796],
14	therapeutics	NNS	O	therapeutics	prep_for	11	SENT_211	[p12l580t2717r1131b2817],
15	,	,	O	,	_	0	SENT_211	[p12l580t2717r1131b2817],
16	particularly	RB	O	particularly	advmod	11	SENT_211	[p12l1169t2717r1671b2817],
17	those	DT	O	those	dep	11	SENT_211	[p12l1700t2717r1932b2796],
18	that	WDT	O	that	nsubj	19	SENT_211	[p12l1966t2717r2138b2795],
19	encode	VBP	O	encode	rcmod	17	SENT_211	[p12l12t2845r312b2923],
20	enzymes	NNS	O	enzyme	dobj	19	SENT_211	[p12l361t2870r733b2944],
21	such	JJ	O	such	_	0	SENT_211	[p12l786t2845r980b2924],
22	as	IN	O	as	_	0	SENT_211	[p12l1028t2871r1114b2922],
23	kinases	NNS	O	kinase	prep_such_as	20	SENT_211	[p12l1165t2845r1486b2924],
24	and	CC	O	and	_	0	SENT_211	[p12l1537t2845r1694b2923],
25	in	IN	O	in	dep	29	SENT_211	[p12l1743t2846r1826b2922],
26	which	WDT	O	which	pobj	25	SENT_211	[p12l1871t2845r2133b2924],
27	the	DT	O	the	det	28	SENT_211	[p12l12t2974r144b3052],
28	mutations	NNS	O	mutation	nsubj	29	SENT_211	[p12l202t2975r636b3053],
29	result	VBP	O	result	ccomp	4	SENT_211	[p12l695t2974r938b3053],
30	in	IN	O	in	_	0	SENT_211	[p12l990t2975r1074b3052],
31	constitutive	JJ	O	constitutive	amod	32	SENT_211	[p12l1132t2975r1631b3053],
32	activation	NN	O	activation	prep_in	29	SENT_211	[p12l1688t2975r2128b3053],
33	.	.	O	.	_	0	SENT_211	[p12l1688t2975r2128b3053],

1	Examples	NNS	O	example	nsubj	2	SENT_212	[p12l9t3102r420b3201],
2	include	VBP	O	include	_	0	SENT_212	[p12l463t3102r773b3181],
3	BRAF	NN	O	braf	dobj	2	SENT_212	[p12l814t3108r1076b3197],
4	,	,	O	,	_	0	SENT_212	[p12l814t3108r1076b3197],
5	PIK3CA	NN	O	pik3ca	conj_and	3	SENT_212	[p12l1122t3108r1480b3197],
6	,	,	O	,	_	0	SENT_212	[p12l1122t3108r1480b3197],
7	FGFR2	NN	O	fgfr2	conj_and	3	SENT_212	[p12l1525t3108r1844b3197],
8	,	,	O	,	_	0	SENT_212	[p12l1525t3108r1844b3197],
9	JAK2	NN	O	jak2	conj_and	3	SENT_212	[p12l1881t3108r2128b3197],
10	,	,	O	,	_	0	SENT_212	[p12l1881t3108r2128b3197],
11	AKT1	NN	O	akt1	dobj	2	SENT_212	[p12l7t3235r278b3325],
12	,	,	O	,	_	0	SENT_212	[p12l7t3235r278b3325],
13	and	CC	O	and	_	0	SENT_212	[p12l322t3229r479b3308],
14	IDH1	NN	O	idh1	conj_and	3	SENT_212	[p12l517t3234r1047b3325],
15	,19	CD	NUMBER	,19	number	16	SENT_212	[p12l517t3234r1047b3325],
16	’	CD	NUMBER	’	nsubj	34	SENT_212	[p12l517t3234r1047b3325],
17	3	CD	NUMBER	3	num	18	SENT_212	[p12l517t3234r1047b3325],
18	°	NN	O	°	dep	16	SENT_212	[p12l517t3234r1047b3325],
19	'34	CD	NUMBER	'34	dep	16	SENT_212	[p12l517t3234r1047b3325],
20	and	CC	O	and	_	0	SENT_212	[p12l1085t3229r1243b3308],
21	searches	NNS	O	search	conj_and	16	SENT_212	[p12l1284t3229r1647b3307],
22	for	IN	O	for	_	0	SENT_212	[p12l1688t3228r1810b3308],
23	inhibitors	NNS	O	inhibitor	prep_for	21	SENT_212	[p12l1846t3229r2132b3308, p12l12t3374r174b3436],
24	of	IN	O	of	_	0	SENT_212	[p12l226t3356r326b3436],
25	the	DT	O	the	det	26	SENT_212	[p12l358t3357r491b3435],
26	proteins	NNS	O	protein	prep_of	23	SENT_212	[p12l539t3358r892b3457],
27	encoded	VBN	O	encode	partmod	26	SENT_212	[p12l945t3357r1301b3436],
28	by	IN	O	by	_	0	SENT_212	[p12l1352t3357r1449b3457],
29	many	JJ	O	many	agent	27	SENT_212	[p12l1494t3383r1733b3457],
30	of	IN	O	of	_	0	SENT_212	[p12l1779t3356r1879b3436],
31	these	DT	O	these	det	33	SENT_212	[p12l1911t3357r2134b3435],
32	mutated	VBN	O	mutate	amod	33	SENT_212	[p12l11t3486r364b3565],
33	genes	NNS	O	gene	prep_of	29	SENT_212	[p12l404t3512r645b3587],
34	are	VBP	O	be	rcmod	3	SENT_212	[p12l686t3512r815b3564],
35	in	IN	O	in	_	0	SENT_212	[p12l854t3487r937b3564],
36	progress	NN	O	progress	prep_in	34	SENT_212	[p12l975t3512r1371b3587],
37	.	.	O	.	_	0	SENT_212	[p12l975t3512r1371b3587],

1	A	DT	O	a	det	3	SENT_213	[p12l136t3621r202b3691],
2	notable	JJ	O	notable	amod	3	SENT_213	[p12l274t3613r591b3692],
3	example	NN	O	example	nsubj	14	SENT_213	[p12l667t3613r1022b3713],
4	of	IN	O	of	_	0	SENT_213	[p12l1098t3612r1198b3692],
5	a	DT	O	a	det	6	SENT_213	[p12l1254t3639r1298b3691],
6	protein	NN	O	protein	prep_of	3	SENT_213	[p12l1370t3614r1681b3713],
7	activated	VBN	O	activate	partmod	6	SENT_213	[p12l1756t3613r2134b3693],
8	through	IN	O	through	_	0	SENT_213	[p13l12t21r360b122],
9	somatic	JJ	O	somatic	amod	10	SENT_213	[p13l405t22r741b100],
10	mutation	NN	O	mutation	prep_through	7	SENT_213	[p13l784t22r1177b100],
11	in	IN	O	in	_	0	SENT_213	[p13l1220t22r1303b99],
12	cancer	NN	O	cancer	prep_in	10	SENT_213	[p13l1348t47r1629b99],
13	is	VBZ	O	be	cop	14	SENT_213	[p13l1669t22r1734b99],
14	BRAF	NNP	O	BRAF	_	0	SENT_213	[p13l1779t27r2041b117],
15	,	,	O	,	_	0	SENT_213	[p13l1779t27r2041b117],
16	a	DT	O	a	det	20	SENT_213	[p13l2090t47r2135b99],
17	serine	NN	O	serine	nn	20	SENT_213	[p13l12t149r750b228],
18	—	NN	O	—	nn	20	SENT_213	[p13l12t149r750b228],
19	threonine	NN	O	threonine	nn	20	SENT_213	[p13l12t149r750b228],
20	kinase	NN	O	kinase	appos	14	SENT_213	[p13l818t149r1120b228],
21	.	.	O	.	_	0	SENT_213	[p13l818t149r1120b228],

1	Activating	VBG	O	activate	amod	2	SENT_214	[p13l1190t150r1632b250],
2	mutations	NNS	O	mutation	nsubjpass	6	SENT_214	[p13l1697t150r2130b228],
3	in	IN	O	in	_	0	SENT_214	[p13l11t277r94b354],
4	BRAF	NN	O	braf	prep_in	2	SENT_214	[p13l125t282r349b356],
5	were	VBD	O	be	auxpass	6	SENT_214	[p13l372t302r573b356],
6	identified	VBN	O	identify	_	0	SENT_214	[p13l606t275r1023b355],
7	by	IN	O	by	_	0	SENT_214	[p13l1057t276r1154b376],
8	a	DT	O	a	det	10	SENT_214	[p13l1182t302r1226b354],
9	systematic	JJ	O	systematic	amod	10	SENT_214	[p13l1259t277r1709b376],
10	search	NN	O	search	agent	6	SENT_214	[p13l1743t276r2018b354],
11	of	IN	O	of	_	0	SENT_214	[p13l2052t275r2152b355],
12	candidate	NN	O	candidate	nn	14	SENT_214	[p13l12t405r428b484],
13	cancer	NN	O	cancer	nn	14	SENT_214	[p13l493t431r773b483],
14	genes	NNS	O	gene	prep_of	10	SENT_214	[p13l834t431r1075b506],
15	in	IN	O	in	_	0	SENT_214	[p13l1140t406r1224b483],
16	a	DT	O	a	det	17	SENT_214	[p13l1286t431r1331b483],
17	panel	NN	O	panel	prep_in	6	SENT_214	[p13l1391t405r1626b505],
18	of	IN	O	of	_	0	SENT_214	[p13l1690t404r1790b484],
19	diverse	JJ	O	diverse	amod	20	SENT_214	[p13l1836t405r2133b484],
20	cancers	NNS	O	cancer	prep_of	17	SENT_214	[p13l12t559r357b627],
21	;	:	O	;	_	0	SENT_214	[p13l12t559r357b627],
22	BRAF	NN	O	braf	nsubjpass	25	SENT_214	[p13l398t539r621b613],
23	was	VBD	O	be	auxpass	25	SENT_214	[p13l649t559r812b612],
24	then	RB	O	then	advmod	25	SENT_214	[p13l853t533r1043b611],
25	shown	VBN	O	show	parataxis	6	SENT_214	[p13l1083t533r1364b612],
26	to	TO	O	to	aux	28	SENT_214	[p13l1403t550r1484b612],
27	be	VB	O	be	auxpass	28	SENT_214	[p13l1525t533r1621b612],
28	mutated	VBN	O	mutate	xcomp	25	SENT_214	[p13l1659t533r2013b612],
29	in	IN	O	in	dep	28	SENT_214	[p13l2050t534r2134b610],
30	about	IN	O	about	_	0	SENT_214	[p13l11t661r255b740],
31	two	CD	NUMBER	two	num	32	SENT_214	[p13l318t678r475b740],
32	thirds	NNS	O	third	prep_about	28	SENT_214	[p13l545t661r799b740],
33	of	IN	O	of	_	0	SENT_214	[p13l870t660r969b740],
34	malignant	JJ	O	malignant	amod	35	SENT_214	[p13l1019t661r1469b762],
35	melanomas.-34	NN	O	melanomas.-34	prep_of	32	SENT_214	[p13l1531t661r2134b740],
36	Because	IN	O	because	mark	52	SENT_214	[p13l10t795r359b867],
37	of	IN	O	of	_	0	SENT_214	[p13l421t787r522b867],
38	the	DT	O	the	det	41	SENT_214	[p13l564t788r699b866],
39	limited	JJ	O	limited	amod	41	SENT_214	[p13l758t788r1073b867],
40	treatment	NN	O	treatment	nn	41	SENT_214	[p13l1134t805r1566b866],
41	options	NNS	O	option	prep_of	52	SENT_214	[p13l1622t789r1948b888],
42	for	IN	O	for	_	0	SENT_214	[p13l2011t787r2136b867],
43	metastatic	JJ	O	metastatic	amod	45	SENT_214	[p13l11t918r462b995],
44	malignant	JJ	O	malignant	amod	45	SENT_214	[p13l514t917r964b1018],
45	melanoma	NN	O	melanoma	prep_for	41	SENT_214	[p13l1011t917r1490b1013],
46	,	,	O	,	_	0	SENT_214	[p13l1011t917r1490b1013],
47	the	DT	O	the	det	48	SENT_214	[p13l1548t917r1681b995],
48	discovery	NN	O	discovery	nsubj	52	SENT_214	[p13l1734t917r2138b1017],
49	of	IN	O	of	_	0	SENT_214	[p13l12t1044r112b1124],
50	BRAF	NN	O	braf	nn	51	SENT_214	[p13l140t1051r363b1125],
51	mutations	NNS	O	mutation	prep_of	48	SENT_214	[p13l405t1046r839b1124],
52	triggered	VBD	O	trigger	advcl	28	SENT_214	[p13l890t1045r1283b1146],
53	multiple	JJ	O	multiple	amod	59	SENT_214	[p13l1330t1045r1686b1145],
54	drug	NN	O	drug	nn	59	SENT_214	[p13l1735t1045r2132b1146],
55	—	NN	O	—	nn	59	SENT_214	[p13l1735t1045r2132b1146],
56	dis	NN	O	di	nn	59	SENT_214	[p13l1735t1045r2132b1146],
57	—	NN	O	—	nn	59	SENT_214	[p13l1735t1045r2132b1146],
58	covery	NN	O	covery	nn	59	SENT_214	[p13l12t1199r286b1273],
59	programs	NNS	O	program	dobj	52	SENT_214	[p13l328t1199r746b1274],
60	in	IN	O	in	_	0	SENT_214	[p13l797t1174r880b1251],
61	the	DT	O	the	det	65	SENT_214	[p13l930t1173r1062b1251],
62	academic	JJ	O	academic	amod	65	SENT_214	[p13l1111t1173r1511b1252],
63	and	CC	O	and	_	0	SENT_214	[p13l1559t1173r1716b1252],
64	pharmaceutical	JJ	O	pharmaceutical	amod	65	SENT_214	[p13l1764t1173r2132b1273, p13l12t1300r342b1380],
65	sectors	NNS	O	sector	prep_in	59	SENT_214	[p13l385t1317r708b1379],
66	.	.	O	.	_	0	SENT_214	[p13l385t1317r708b1379],

1	Preliminary	JJ	O	preliminary	amod	2	SENT_215	[p13l754t1300r1269b1400],
2	results	NNS	O	result	nsubj	22	SENT_215	[p13l1306t1300r1589b1380],
3	from	IN	O	from	_	0	SENT_215	[p13l1633t1299r1844b1379],
4	phase	NN	O	phase	prep_from	2	SENT_215	[p13l1884t1300r2133b1400],
5	1	CD	NUMBER	1	num	7	SENT_215	[p13l15t1435r59b1507],
6	clinical	JJ	O	clinical	amod	7	SENT_215	[p13l108t1429r421b1507],
7	trials	NNS	O	trial	nsubj	15	SENT_215	[p13l469t1429r688b1507],
8	of	IN	O	of	_	0	SENT_215	[p13l739t1428r839b1508],
9	agents	NNS	O	agent	prep_of	7	SENT_215	[p13l868t1446r1144b1530],
10	emerging	VBG	O	emerge	partmod	9	SENT_215	[p13l1195t1430r1607b1530],
11	from	IN	O	from	_	0	SENT_215	[p13l1651t1428r1861b1508],
12	these	DT	O	these	det	13	SENT_215	[p13l1909t1429r2133b1507],
13	programs	NNS	O	program	prep_from	10	SENT_215	[p13l9t1583r417b1658],
14	have	VBP	O	have	aux	15	SENT_215	[p13l449t1557r634b1636],
15	shown	VBN	O	show	rcmod	4	SENT_215	[p13l665t1557r941b1636],
16	extraordinary	JJ	O	extraordinary	amod	17	SENT_215	[p13l971t1557r1541b1657],
17	activity	NN	O	activity	dobj	15	SENT_215	[p13l1565t1558r1946b1657],
18	,35	CD	NUMBER	,35	num	17	SENT_215	[p13l1565t1558r1946b1657],
19	and	CC	O	and	_	0	SENT_215	[p13l1979t1557r2134b1636],
20	further	JJ	O	further	amod	21	SENT_215	[p13l11t1684r312b1764],
21	trials	NNS	O	trial	conj_and	17	SENT_215	[p13l344t1685r557b1763],
22	are	VBP	O	be	_	0	SENT_215	[p13l593t1711r719b1763],
23	in	IN	O	in	_	0	SENT_215	[p13l754t1686r836b1763],
24	progress	NN	O	progress	nn	26	SENT_215	[p13l870t1711r1231b1786],
25	(	CD	NUMBER	(	num	26	SENT_215	[p13l1273t1686r1448b1786],
26	Fig	NN	O	fig	prep_in	22	SENT_215	[p13l1273t1686r1448b1786],
27	.	.	O	.	_	0	SENT_215	[p13l1273t1686r1448b1786],

1	2	CD	NUMBER	2	num	2	SENT_216	[p13l1488t1691r1585b1776],
2	)	CD	NUMBER	)	_	0	SENT_216	[p13l1488t1691r1585b1776],
3	.	.	O	.	_	0	SENT_216	[p13l1488t1691r1585b1776],

1	It	PRP	O	it	nsubj	3	SENT_217	[p13l1624t1693r1688b1763],
2	has	VBZ	O	have	aux	3	SENT_217	[p13l1717t1685r1859b1763],
3	taken	VBN	O	take	_	0	SENT_217	[p13l1896t1685r2134b1764],
4	less	JJR	DURATION	less	advmod	3	SENT_217	[p13l10t1813r166b1891],
5	than	IN	DURATION	than	_	0	SENT_217	[p13l204t1813r400b1891],
6	a	DT	DURATION	a	det	7	SENT_217	[p13l435t1839r480b1891],
7	decade	NN	DURATION	decade	prep_than	3	SENT_217	[p13l515t1813r807b1892],
8	to	TO	O	to	aux	9	SENT_217	[p13l843t1830r924b1892],
9	progress	VB	O	progress	xcomp	3	SENT_217	[p13l960t1839r1331b1914],
10	from	IN	O	from	_	0	SENT_217	[p13l1369t1812r1580b1892],
11	discovery	NN	O	discovery	prep_from	9	SENT_217	[p13l1616t1813r2019b1913],
12	of	IN	O	of	_	0	SENT_217	[p13l2051t1812r2152b1892],
13	mutated	VBN	O	mutate	amod	14	SENT_217	[p13l11t1941r365b2020],
14	BRAF	NN	ORGANIZATION	braf	prep_of	11	SENT_217	[p13l396t1947r620b2021],
15	in	IN	O	in	_	0	SENT_217	[p13l645t1942r728b2019],
16	melanoma	NN	O	melanoma	prep_in	14	SENT_217	[p13l761t1941r1218b2020],
17	to	TO	O	to	_	0	SENT_217	[p13l1250t1958r1332b2020],
18	targeted	VBN	O	target	amod	19	SENT_217	[p13l1366t1941r1721b2042],
19	therapies	NNS	O	therapy	prep_to	3	SENT_217	[p13l1754t1941r2131b2041],
20	showing	VBG	O	show	partmod	19	SENT_217	[p13l12t2069r371b2170],
21	promise	NN	O	promise	dobj	20	SENT_217	[p13l399t2070r741b2169],
22	in	IN	O	in	_	0	SENT_217	[p13l773t2070r854b2147],
23	clinical	JJ	O	clinical	amod	24	SENT_217	[p13l887t2069r1190b2147],
24	trials	NNS	O	trial	prep_in	20	SENT_217	[p13l1222t2069r1457b2165],
25	,	,	O	,	_	0	SENT_217	[p13l1222t2069r1457b2165],
26	illustrating	VBG	O	illustrate	partmod	20	SENT_217	[p13l1494t2069r1968b2170],
27	the	DT	O	the	det	29	SENT_217	[p13l2001t2069r2133b2147],
28	remarkable	JJ	O	remarkable	amod	29	SENT_217	[p13l11t2197r496b2276],
29	pace	NN	O	pace	dobj	26	SENT_217	[p13l561t2223r753b2297],
30	afforded	VBN	O	afford	partmod	29	SENT_217	[p13l818t2196r1185b2276],
31	by	IN	O	by	_	0	SENT_217	[p13l1251t2197r1349b2297],
32	the	DT	O	the	det	33	SENT_217	[p13l1411t2197r1543b2275],
33	coupling	NN	O	coupling	agent	30	SENT_217	[p13l1611t2197r1988b2298],
34	of	IN	O	of	_	0	SENT_217	[p13l2052t2196r2152b2276],
35	drug	NN	O	drug	nn	36	SENT_217	[p13l12t2325r216b2426],
36	development	NN	O	development	prep_of	33	SENT_217	[p13l252t2325r802b2425],
37	to	TO	O	to	_	0	SENT_217	[p13l836t2342r918b2404],
38	genomics	NNS	O	genomic	prep_to	30	SENT_217	[p13l959t2326r1370b2426],
39	and	CC	O	and	_	0	SENT_217	[p13l1411t2325r1569b2404],
40	biology	NN	O	biology	prep_to	30	SENT_217	[p13l1609t2325r1941b2426],
41	.	.	O	.	_	0	SENT_217	[p13l1609t2325r1941b2426],

1	Unfortunately	RB	O	unfortunately	advmod	9	SENT_218	[p13l140t2452r759b2553],
2	,	,	O	,	_	0	SENT_218	[p13l140t2452r759b2553],
3	many	JJ	O	many	nsubj	9	SENT_218	[p13l830t2479r1068b2553],
4	mutated	VBN	O	mutate	partmod	3	SENT_218	[p13l1128t2453r1482b2532],
5	cancer	NN	O	cancer	nn	6	SENT_218	[p13l1547t2479r1828b2531],
6	genes	NNS	O	gene	dobj	4	SENT_218	[p13l1890t2479r2131b2554],
7	do	VBP	O	do	aux	9	SENT_218	[p13l12t2581r114b2660],
8	not	RB	O	not	neg	9	SENT_218	[p13l160t2598r303b2660],
9	make	VB	O	make	_	0	SENT_218	[p13l342t2581r575b2660],
10	tractable	JJ	O	tractable	amod	11	SENT_218	[p13l620t2581r992b2660],
11	targets	NNS	O	target	dobj	9	SENT_218	[p13l1037t2598r1332b2682],
12	for	IN	O	for	_	0	SENT_218	[p13l1379t2580r1502b2660],
13	new	JJ	O	new	amod	16	SENT_218	[p13l1543t2581r1961b2682],
14	—	CD	NUMBER	—	tmod	13	SENT_218	[p13l1543t2581r1961b2682],
15	drug	NN	O	drug	nn	16	SENT_218	[p13l1543t2581r1961b2682],
16	development	NN	O	development	prep_for	9	SENT_218	[p13l2002t2581r2132b2660, p13l7t2708r478b2808],
17	.	.	O	.	_	0	SENT_218	[p13l2002t2581r2132b2660, p13l7t2708r478b2808],

1	In	IN	O	in	_	0	SENT_219	[p13l532t2716r620b2786],
2	this	DT	O	this	det	3	SENT_219	[p13l670t2708r830b2786],
3	context	NN	O	context	prep_in	17	SENT_219	[p13l882t2725r1219b2804],
4	,	,	O	,	_	0	SENT_219	[p13l882t2725r1219b2804],
5	the	DT	O	the	det	6	SENT_219	[p13l1275t2708r1408b2786],
6	development	NN	O	development	nsubj	17	SENT_219	[p13l1458t2708r2007b2808],
7	of	IN	O	of	_	0	SENT_219	[p13l2052t2707r2152b2787],
8	agents	NNS	O	agent	prep_of	6	SENT_219	[p13l11t2854r286b2938],
9	that	WDT	O	that	nsubj	10	SENT_219	[p13l329t2837r502b2915],
10	show	VBP	O	show	rcmod	8	SENT_219	[p13l539t2837r764b2916],
11	synthetic	JJ	O	synthetic	amod	12	SENT_219	[p13l803t2837r1191b2937],
12	lethality	NN	O	lethality	dobj	10	SENT_219	[p13l1230t2837r1586b2937],
13	with	IN	O	with	_	0	SENT_219	[p13l1618t2837r1813b2916],
14	mutated	VBN	O	mutate	amod	16	SENT_219	[p13l1854t2854r2132b2916, p13l12t2965r109b3044],
15	cancer	NN	O	cancer	nn	16	SENT_219	[p13l149t2991r430b3043],
16	genes	NNS	O	gene	prep_with	10	SENT_219	[p13l466t2991r708b3066],
17	seems	VBZ	O	seem	_	0	SENT_219	[p13l751t2991r1011b3043],
18	like	IN	O	like	_	0	SENT_219	[p13l1052t2965r1207b3044],
19	a	DT	O	a	det	21	SENT_219	[p13l1246t2991r1291b3043],
20	sensible	JJ	O	sensible	amod	21	SENT_219	[p13l1331t2965r1670b3044],
21	approach	NN	O	approach	prep_like	17	SENT_219	[p13l1710t2965r2128b3065],
22	.	.	O	.	_	0	SENT_219	[p13l1710t2965r2128b3065],

1	For	IN	O	for	_	0	SENT_220	[p13l9t3101r152b3172],
2	example	NN	O	example	prep_for	9	SENT_220	[p13l189t3093r567b3193],
3	,	,	O	,	_	0	SENT_220	[p13l189t3093r567b3193],
4	RAS	NN	O	ra	nn	7	SENT_220	[p13l609t3099r776b3173],
5	gene	NN	O	gene	nn	7	SENT_220	[p13l812t3119r1011b3194],
6	family	NN	O	family	nn	7	SENT_220	[p13l1050t3092r1325b3193],
7	members	NNS	O	member	nsubjpass	9	SENT_220	[p13l1360t3093r1756b3172],
8	are	VBP	O	be	auxpass	9	SENT_220	[p13l1797t3119r1925b3171],
9	mutated	VBN	O	mutate	_	0	SENT_220	[p13l1965t3119r2132b3172, p13l12t3221r225b3300],
10	and	CC	O	and	_	0	SENT_220	[p13l263t3221r421b3300],
11	activated	VBN	O	activate	conj_and	9	SENT_220	[p13l460t3221r838b3300],
12	in	IN	O	in	_	0	SENT_220	[p13l877t3222r960b3299],
13	10	CD	NUMBER	10	number	15	SENT_220	[p13l1003t3227r1096b3300],
14	to	TO	O	to	dep	15	SENT_220	[p13l1137t3238r1218b3300],
15	20	CD	PERCENT	20	num	16	SENT_220	[p13l1259t3226r1447b3300],
16	%	NN	PERCENT	%	prep_in	9	SENT_220	[p13l1259t3226r1447b3300],
17	of	IN	O	of	_	0	SENT_220	[p13l1486t3220r1586b3300],
18	human	JJ	O	human	amod	19	SENT_220	[p13l1608t3221r1912b3300],
19	canN	NN	O	cann	prep_of	16	SENT_220	[p13l1952t3247r2132b3299, p13l555t3385r569b3400],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_221	[p13l584t3385r662b3407],
2	MED	NNP	O	MED	_	0	SENT_221	[p13l676t3385r728b3400],
3	364	CD	NUMBER	364	dep	2	SENT_221	[p13l739t3379r808b3407],
4	;	:	O	;	_	0	SENT_221	[p13l739t3379r808b3407],
5	4	CD	NUMBER	4	num	7	SENT_221	[p13l739t3379r808b3407],
6	NEJM.oRG	NN	O	nejm.org	nn	7	SENT_221	[p13l842t3385r966b3407],
7	JANUARY2	NN	O	january2	dep	3	SENT_221	[p13l997t3385r1132b3407],
8	,2	CD	NUMBER	,2	num	9	SENT_221	[p13l1150t3385r1216b3405],
9	o11	NN	O	o11	dep	7	SENT_221	[p13l1150t3385r1216b3405],
10	345	CD	NUMBER	345	dep	2	SENT_221	[p13l1960t3375r2015b3398],

1	The	DT	O	the	det	4	SENT_222	[p13l702t3418r753b3442],
2	New	NNP	O	New	nn	4	SENT_222	[p13l762t3419r824b3442],
3	England	NNP	O	England	nn	4	SENT_222	[p13l833t3418r944b3449],
4	Joumal	NNP	O	Joumal	_	0	SENT_222	[p13l953t3418r1050b3442],
5	of	IN	O	of	prep	4	SENT_222	[p13l1060t3418r1089b3442],
6	e	SYM	O	e	dep	5	SENT_222	[p13l1125t3426r1139b3442],
7	icine	FW	O	icine	dep	4	SENT_222	[p13l1157t3418r1220b3442],

1	Downloaded	VBN	O	download	_	0	SENT_223	[p13l144t3459r314b3482],
2	from	IN	O	from	_	0	SENT_223	[p13l323t3459r387b3482],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_223	[p13l396t3459r514b3489],
4	at	IN	O	at	_	0	SENT_223	[p13l524t3463r547b3482],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_223	[p13l556t3459r739b3482],
6	on	IN	O	on	_	0	SENT_223	[p13l748t3466r780b3482],
7	January	NNP	DATE	January	prep_on	1	SENT_223	[p13l789t3459r892b3489],
8	5	CD	DATE	5	num	7	SENT_223	[p13l902t3459r924b3487],
9	,	,	DATE	,	_	0	SENT_223	[p13l902t3459r924b3487],
10	2014	CD	DATE	2014	num	7	SENT_223	[p13l935t3459r1007b3482],
11	.	.	O	.	_	0	SENT_223	[p13l935t3459r1007b3482],

1	For	IN	O	for	_	0	SENT_224	[p13l1018t3459r1064b3482],
2	personal	JJ	O	personal	amod	3	SENT_224	[p13l1072t3459r1185b3489],
3	use	NN	O	use	pobj	1	SENT_224	[p13l1194t3466r1237b3482],
4	only	RB	O	only	advmod	3	SENT_224	[p13l1247t3459r1312b3489],
5	.	.	O	.	_	0	SENT_224	[p13l1247t3459r1312b3489],

1	No	DT	O	no	det	3	SENT_225	[p13l1323t3459r1362b3482],
2	other	JJ	O	other	amod	3	SENT_225	[p13l1372t3459r1440b3482],
3	uses	NNS	O	use	_	0	SENT_225	[p13l1449t3466r1505b3482],
4	without	IN	O	without	_	0	SENT_225	[p13l1515t3459r1616b3482],
5	permission	NN	O	permission	prep_without	3	SENT_225	[p13l1624t3459r1777b3489],
6	.	.	O	.	_	0	SENT_225	[p13l1624t3459r1777b3489],

1	The	DT	O	the	det	4	SENT_226	[p13l673t3606r718b3627],
2	NEW	NNP	O	NEW	nn	4	SENT_226	[p13l737t3608r822b3627],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_226	[p13l841t3608r1029b3627],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_226	[p13l1048t3608r1227b3634],
5	of	IN	O	of	_	0	SENT_226	[p13l1247t3606r1275b3633],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_226	[p13l1287t3608r1486b3627],

1	cers	NNS	O	cer	_	0	SENT_227	[p14l12t131r203b184],
2	.	.	O	.	_	0	SENT_227	[p14l12t131r203b184],

1	Efforts	NNS	O	effort	nsubj	12	SENT_228	[p14l261t104r555b184],
2	to	TO	O	to	aux	3	SENT_228	[p14l611t122r692b184],
3	develop	VB	O	develop	infmod	1	SENT_228	[p14l748t105r1070b205],
4	drugs	NNS	O	drug	dobj	3	SENT_228	[p14l1126t105r1369b206],
5	that	WDT	O	that	nsubj	7	SENT_228	[p14l1425t105r1597b183],
6	directly	RB	O	directly	advmod	7	SENT_228	[p14l1646t105r1970b205],
7	inhibit	VBP	O	inhibit	rcmod	4	SENT_228	[p14l2018t106r2133b183, p14l12t233r212b312],
8	oncogenic	JJ	O	oncogenic	amod	9	SENT_228	[p14l274t234r713b334],
9	RAS	NNS	O	ra	dobj	7	SENT_228	[p14l777t239r957b316],
10	have	VBP	O	have	aux	12	SENT_228	[p14l1026t233r1216b312],
11	been	VBN	O	be	cop	12	SENT_228	[p14l1283t233r1484b312],
12	unsuccessful	JJ	O	unsuccessful	_	0	SENT_228	[p14l1551t232r2129b312],
13	.	.	O	.	_	0	SENT_228	[p14l1551t232r2129b312],

1	However	RB	O	however	advmod	32	SENT_229	[p14l11t368r406b456],
2	,	,	O	,	_	0	SENT_229	[p14l11t368r406b456],
3	the	DT	O	the	det	4	SENT_229	[p14l461t360r594b438],
4	introduction	NN	O	introduction	nsubj	32	SENT_229	[p14l643t360r1183b439],
5	of	IN	O	of	_	0	SENT_229	[p14l1233t359r1333b439],
6	libraries	NNS	O	library	prep_of	4	SENT_229	[p14l1363t360r1716b439],
7	of	IN	O	of	_	0	SENT_229	[p14l1768t359r1868b439],
8	small	JJ	O	small	amod	10	SENT_229	[p14l1900t360r2134b438],
9	interfering	VBG	O	interfere	amod	10	SENT_229	[p14l11t488r477b590],
10	RNAs	NNS	MISC	rna	prep_of	6	SENT_229	[p14l523t496r796b585],
11	,	,	O	,	_	0	SENT_229	[p14l523t496r796b585],
12	each	DT	O	each	nsubj	15	SENT_229	[p14l853t489r1045b567],
13	of	IN	O	of	_	0	SENT_229	[p14l1097t488r1196b568],
14	which	WDT	O	which	prep_of	12	SENT_229	[p14l1224t489r1487b568],
15	knocks	VBZ	O	knock	rcmod	4	SENT_229	[p14l1537t489r1843b568],
16	down	RP	O	down	prt	15	SENT_229	[p14l1896t489r2134b568],
17	the	DT	O	the	det	18	SENT_229	[p14l12t617r145b695],
18	expression	NN	O	expression	dobj	15	SENT_229	[p14l191t618r647b717],
19	of	IN	O	of	_	0	SENT_229	[p14l693t616r793b696],
20	one	CD	NUMBER	one	prep_of	18	SENT_229	[p14l820t643r971b696],
21	of	IN	O	of	_	0	SENT_229	[p14l1017t616r1117b696],
22	thousands	NNS	O	thousand	prep_of	18	SENT_229	[p14l1144t617r1589b696],
23	of	IN	O	of	_	0	SENT_229	[p14l1637t616r1737b696],
24	genes	NNS	O	gene	prep_of	22	SENT_229	[p14l1763t643r2004b718],
25	in	IN	O	in	_	0	SENT_229	[p14l2051t618r2134b695],
26	cancer	NN	O	cancer	nn	27	SENT_229	[p14l12t770r293b822],
27	cells	NNS	O	cell	prep_in	24	SENT_229	[p14l342t744r530b823],
28	in	FW	O	in	nn	29	SENT_229	[p14l582t745r666b822],
29	vitro	FW	O	vitro	dep	27	SENT_229	[p14l712t745r933b840],
30	,	,	O	,	_	0	SENT_229	[p14l712t745r933b840],
31	has	VBZ	O	have	aux	32	SENT_229	[p14l990t744r1133b822],
32	identified	VBN	O	identify	_	0	SENT_229	[p14l1187t743r1604b823],
33	an	DT	O	a	det	34	SENT_229	[p14l1654t770r1757b822],
34	interaction	NN	O	interaction	dobj	32	SENT_229	[p14l1808t745r2133b822, p14l12t873r181b951],
35	between	IN	O	between	_	0	SENT_229	[p14l248t872r605b952],
36	mutated	VBN	O	mutate	dep	57	SENT_229	[p14l670t872r1024b952],
37	KRAS	NNP	ORGANIZATION	KRAS	dobj	36	SENT_229	[p14l1088t878r1317b952],
38	and	CC	O	and	_	0	SENT_229	[p14l1379t872r1537b951],
39	a	DT	O	a	det	40	SENT_229	[p14l1601t898r1646b950],
40	couple	NN	O	couple	dobj	36	SENT_229	[p14l1711t872r1987b972],
41	of	IN	O	of	_	0	SENT_229	[p14l2053t871r2152b951],
42	protein	NN	O	protein	nn	43	SENT_229	[p14l11t1002r322b1100],
43	kinases	NNS	O	kinase	prep_of	40	SENT_229	[p14l393t1001r739b1096],
44	,	,	O	,	_	0	SENT_229	[p14l393t1001r739b1096],
45	STK33	NN	O	stk33	dep	52	SENT_229	[p14l817t1007r1092b1081],
46	and	CC	O	and	_	0	SENT_229	[p14l1166t1001r1324b1079],
47	TBK1	NN	O	tbk1	dep	52	SENT_229	[p14l1392t1005r1828b1081],
48	.36	CD	NUMBER	.36	num	47	SENT_229	[p14l1392t1005r1828b1081],
49	»	NN	O	»	dep	52	SENT_229	[p14l1392t1005r1828b1081],
50	37	CD	NUMBER	37	num	49	SENT_229	[p14l1392t1005r1828b1081],
51	Some	DT	O	some	det	52	SENT_229	[p14l1903t1007r2134b1079],
52	cells	NNS	O	cell	dep	57	SENT_229	[p14l12t1129r199b1207],
53	with	IN	O	with	_	0	SENT_229	[p14l235t1129r430b1208],
54	KRAS	NN	ORGANIZATION	kra	prep_with	52	SENT_229	[p14l467t1135r696b1208],
55	mutations	NNS	O	mutation	nsubj	57	SENT_229	[p14l732t1130r1167b1208],
56	are	VBP	O	be	cop	57	SENT_229	[p14l1206t1155r1335b1207],
57	dependent	JJ	O	dependent	prep_between	34	SENT_229	[p14l1374t1129r1824b1228],
58	on	IN	O	on	_	0	SENT_229	[p14l1858t1155r1964b1207],
59	the	DT	O	the	det	60	SENT_229	[p14l2002t1129r2134b1207],
60	expression	NN	O	expression	prep_on	57	SENT_229	[p14l12t1257r469b1356],
61	of	IN	O	of	_	0	SENT_229	[p14l541t1255r641b1335],
62	STK33	NN	O	stk33	prep_of	60	SENT_229	[p14l697t1262r972b1337],
63	and	CC	O	and	_	0	SENT_229	[p14l1045t1256r1203b1335],
64	TBK1	NN	O	tbk1	prep_between	34	SENT_229	[p14l1271t1262r1510b1337],
65	for	IN	O	for	_	0	SENT_229	[p14l1582t1255r1705b1335],
66	survival	NN	O	survival	prep_for	64	SENT_229	[p14l1774t1256r2129b1352],
67	,	,	O	,	_	0	SENT_229	[p14l1774t1256r2129b1352],
68	whereas	IN	O	whereas	mark	75	SENT_229	[p14l7t1385r359b1464],
69	cells	NNS	O	cell	nsubj	75	SENT_229	[p14l404t1385r591b1463],
70	with	IN	O	with	_	0	SENT_229	[p14l631t1385r826b1464],
71	normal	JJ	O	normal	amod	72	SENT_229	[p14l868t1385r1182b1464],
72	versions	NNS	O	version	prep_with	69	SENT_229	[p14l1219t1386r1569b1464],
73	of	IN	O	of	_	0	SENT_229	[p14l1614t1384r1714b1464],
74	KRAS	NNP	ORGANIZATION	KRAS	prep_of	72	SENT_229	[p14l1736t1391r1965b1465],
75	are	VBP	O	be	advcl	32	SENT_229	[p14l2005t1411r2134b1463],
76	not	RB	O	not	neg	75	SENT_229	[p14l12t1529r175b1591],
77	.	.	O	.	_	0	SENT_229	[p14l12t1529r175b1591],

1	Since	IN	O	since	mark	5	SENT_230	[p14l236t1514r459b1591],
2	these	DT	O	these	det	3	SENT_230	[p14l512t1513r736b1591],
3	kinases	NNS	O	kinase	nsubj	5	SENT_230	[p14l789t1513r1110b1592],
4	are	VBP	O	be	cop	5	SENT_230	[p14l1165t1539r1294b1591],
5	likely	JJ	O	likely	advcl	24	SENT_230	[p14l1347t1513r1578b1612],
6	to	TO	O	to	aux	11	SENT_230	[p14l1628t1530r1709b1591],
7	be	VB	O	be	cop	11	SENT_230	[p14l1765t1513r1861b1591],
8	more	RBR	O	more	advmod	9	SENT_230	[p14l1915t1539r2134b1591],
9	tractable	JJ	O	tractable	amod	11	SENT_230	[p14l12t1641r384b1720],
10	drug	NN	O	drug	nn	11	SENT_230	[p14l428t1641r632b1742],
11	targets	NNS	O	target	xcomp	5	SENT_230	[p14l671t1658r967b1742],
12	than	IN	O	than	_	0	SENT_230	[p14l1012t1641r1208b1719],
13	KRAS	NNP	ORGANIZATION	KRAS	prep_than	11	SENT_230	[p14l1250t1647r1500b1724],
14	itself	PRP	O	itself	advmod	13	SENT_230	[p14l1546t1640r1778b1737],
15	,	,	O	,	_	0	SENT_230	[p14l1546t1640r1778b1737],
16	the	DT	O	the	det	17	SENT_230	[p14l1827t1641r1960b1720],
17	development	NN	O	development	nsubj	24	SENT_230	[p14l2003t1641r2133b1720, p14l7t1768r458b1868],
18	of	IN	O	of	_	0	SENT_230	[p14l501t1767r602b1847],
19	inhibitors	NNS	O	inhibitor	prep_of	17	SENT_230	[p14l630t1768r1052b1847],
20	of	IN	O	of	_	0	SENT_230	[p14l1102t1767r1202b1847],
21	STK33	NN	O	stk33	prep_of	19	SENT_230	[p14l1234t1774r1509b1849],
22	and	CC	O	and	_	0	SENT_230	[p14l1560t1768r1717b1847],
23	TBK1	NN	O	tbk1	prep_of	19	SENT_230	[p14l1761t1774r2000b1849],
24	illustrates	VBZ	O	illustrate	_	0	SENT_230	[p14l2047t1768r2133b1846, p14l11t1897r375b1976],
25	a	DT	O	a	det	28	SENT_230	[p14l444t1923r488b1975],
26	potential	JJ	O	potential	amod	28	SENT_230	[p14l552t1897r940b1997],
27	therapeutic	JJ	O	therapeutic	amod	28	SENT_230	[p14l1007t1897r1492b1997],
28	strategy	NN	O	strategy	dobj	24	SENT_230	[p14l1560t1914r1904b1998],
29	that	WDT	O	that	nsubj	31	SENT_230	[p14l1967t1897r2139b1975],
30	may	MD	O	may	aux	31	SENT_230	[p14l12t2050r191b2124],
31	apply	VB	O	apply	rcmod	28	SENT_230	[p14l225t2024r454b2124],
32	to	TO	O	to	_	0	SENT_230	[p14l489t2041r571b2103],
33	a	DT	O	a	det	35	SENT_230	[p14l611t2050r655b2102],
34	broad	JJ	O	broad	amod	35	SENT_230	[p14l693t2024r937b2103],
35	spectrum	NN	O	spectrum	prep_to	31	SENT_230	[p14l978t2041r1384b2124],
36	of	IN	O	of	_	0	SENT_230	[p14l1424t2023r1524b2103],
37	tumors	NNS	O	tumor	prep_of	35	SENT_230	[p14l1546t2041r1878b2104],
38	.	.	O	.	_	0	SENT_230	[p14l1546t2041r1878b2104],

1	Large	JJ	O	large	amod	6	SENT_231	[p14l140t2153r629b2254],
2	—	NN	O	—	nn	6	SENT_231	[p14l140t2153r629b2254],
3	scale	NN	O	scale	nn	6	SENT_231	[p14l140t2153r629b2254],
4	cancer	NN	O	cancer	nn	6	SENT_231	[p14l684t2179r965b2231],
5	genome	NN	O	genome	nn	6	SENT_231	[p14l1017t2179r1356b2254],
6	studies	NNS	O	study	nsubj	23	SENT_231	[p14l1413t2153r1737b2249],
7	,	,	O	,	_	0	SENT_231	[p14l1413t2153r1737b2249],
8	such	JJ	O	such	_	0	SENT_231	[p14l1799t2153r1992b2232],
9	as	IN	O	as	_	0	SENT_231	[p14l2046t2179r2132b2231],
10	the	DT	O	the	det	14	SENT_231	[p14l12t2282r145b2360],
11	International	NNP	O	International	nn	14	SENT_231	[p14l206t2282r775b2361],
12	Cancer	NNP	O	Cancer	nn	14	SENT_231	[p14l836t2288r1135b2361],
13	Genome	NNP	O	Genome	nn	14	SENT_231	[p14l1195t2288r1555b2361],
14	Consortium	NNP	O	Consortium	prep_such_as	6	SENT_231	[p14l1618t2283r2134b2361],
15	and	CC	O	and	_	0	SENT_231	[p14l11t2410r169b2488],
16	the	DT	O	the	det	17	SENT_231	[p14l203t2410r336b2488],
17	Cancer	NN	O	cancer	prep_such_as	6	SENT_231	[p14l371t2416r670b2488],
18	Genome	NNP	O	Genome	nn	19	SENT_231	[p14l701t2416r1061b2488],
19	Atlas	NNP	O	Atlas	dep	6	SENT_231	[p14l1092t2410r1335b2505],
20	,	,	O	,	_	0	SENT_231	[p14l1092t2410r1335b2505],
21	are	VBP	O	be	aux	23	SENT_231	[p14l1374t2436r1503b2488],
22	already	RB	O	already	advmod	23	SENT_231	[p14l1537t2410r1848b2509],
23	applying	VBG	O	apply	ccomp	77	SENT_231	[p14l1877t2410r2133b2509, p14l11t2539r151b2639],
24	neXt	NN	O	next	nn	28	SENT_231	[p14l198t2539r870b2639],
25	—	NN	O	—	nn	28	SENT_231	[p14l198t2539r870b2639],
26	generation	NN	O	generation	nn	28	SENT_231	[p14l198t2539r870b2639],
27	sequencing	NN	O	sequencing	nn	28	SENT_231	[p14l922t2539r1408b2639],
28	technologies	NNS	O	technology	dobj	23	SENT_231	[p14l1454t2538r1999b2639],
29	to	TO	O	to	_	0	SENT_231	[p14l2051t2555r2133b2617],
30	tumors	NNS	O	tumor	prep_to	23	SENT_231	[p14l12t2683r320b2745],
31	from	IN	O	from	_	0	SENT_231	[p14l361t2665r571b2745],
32	50	CD	NUMBER	50	num	35	SENT_231	[p14l612t2672r709b2745],
33	different	JJ	O	different	amod	35	SENT_231	[p14l750t2665r1126b2745],
34	cancer	NN	O	cancer	nn	35	SENT_231	[p14l1160t2692r1441b2744],
35	types	NNS	O	type	prep_from	30	SENT_231	[p14l1478t2683r1701b2766],
36	to	TO	O	to	aux	37	SENT_231	[p14l1743t2683r1824b2745],
37	generate	VB	O	generate	xcomp	23	SENT_231	[p14l1864t2692r2133b2767, p14l11t2811r133b2872],
38	more	JJR	O	more	mwe	39	SENT_231	[p14l195t2820r414b2873],
39	than	IN	O	than	quantmod	40	SENT_231	[p14l476t2794r673b2872],
40	25,000	CD	NUMBER	25,000	num	42	SENT_231	[p14l734t2800r1020b2890],
41	cancer	NN	O	cancer	nn	42	SENT_231	[p14l1084t2820r1364b2873],
42	genomes	NNS	O	genome	dobj	37	SENT_231	[p14l1422t2820r1805b2895],
43	at	IN	O	at	_	0	SENT_231	[p14l1868t2811r1947b2872],
44	genomic	JJ	O	genomic	amod	50	SENT_231	[p14l2003t2820r2133b2895, p14l12t2923r303b3018],
45	,	,	O	,	_	0	SENT_231	[p14l2003t2820r2133b2895, p14l12t2923r303b3018],
46	epigenomic	JJ	O	epigenomic	amod	50	SENT_231	[p14l378t2923r897b3023],
47	,	,	O	,	_	0	SENT_231	[p14l378t2923r897b3023],
48	and	CC	O	and	_	0	SENT_231	[p14l971t2922r1128b3001],
49	transcriptomic	JJ	O	transcriptomic	conj_and	46	SENT_231	[p14l1197t2923r1835b3022],
50	levels	NNS	O	level	prep_at	37	SENT_231	[p14l1902t2922r2132b3001],
51	and	CC	O	and	_	0	SENT_231	[p14l11t3050r169b3129],
52	should	MD	O	should	aux	53	SENT_231	[p14l234t3050r522b3129],
53	generate	VB	O	generate	ccomp	77	SENT_231	[p14l585t3067r949b3151],
54	a	DT	O	a	det	56	SENT_231	[p14l1013t3076r1057b3128],
55	complete	JJ	O	complete	amod	56	SENT_231	[p14l1120t3050r1508b3150],
56	catalogue	NN	O	catalogue	dobj	53	SENT_231	[p14l1574t3050r1988b3151],
57	of	IN	O	of	_	0	SENT_231	[p14l2053t3049r2152b3129],
58	oncogenic	JJ	O	oncogenic	amod	59	SENT_231	[p14l12t3179r452b3279],
59	mutations	NNS	O	mutation	prep_of	56	SENT_231	[p14l492t3179r951b3274],
60	,	,	O	,	_	0	SENT_231	[p14l492t3179r951b3274],
61	some	DT	O	some	nsubj	65	SENT_231	[p14l1000t3204r1223b3257],
62	of	IN	O	of	_	0	SENT_231	[p14l1266t3177r1365b3257],
63	which	WDT	O	which	prep_of	61	SENT_231	[p14l1383t3178r1646b3257],
64	may	MD	O	may	aux	65	SENT_231	[p14l1688t3204r1867b3278],
65	prove	VB	O	prove	rcmod	59	SENT_231	[p14l1902t3204r2134b3278],
66	to	TO	O	to	aux	70	SENT_231	[p14l12t3323r94b3385],
67	be	VB	O	be	cop	70	SENT_231	[p14l164t3306r261b3385],
68	new	JJ	O	new	amod	70	SENT_231	[p14l329t3332r508b3385],
69	therapeutic	JJ	O	therapeutic	amod	70	SENT_231	[p14l573t3306r1058b3406],
70	targets	NNS	O	target	xcomp	65	SENT_231	[p14l1126t3311r1524b3407],
71	.33	CD	NUMBER	.33	dobj	23	SENT_231	[p14l1126t3311r1524b3407],
72	Intriguingly	RB	O	intriguingly	advmod	23	SENT_231	[p14l1593t3306r2129b3407],
73	,	,	O	,	_	0	SENT_231	[p14l1593t3306r2129b3407],
74	two	CD	NUMBER	two	num	76	SENT_231	[p14l12t3451r170b3513],
75	recent	JJ	O	recent	amod	76	SENT_231	[p14l216t3451r481b3513],
76	studies	NNS	O	study	nsubj	77	SENT_231	[p14l521t3434r821b3513],
77	suggest	VBP	O	suggest	_	0	SENT_231	[p14l870t3451r1197b3535],
78	that	IN	O	that	complm	80	SENT_231	[p14l1237t3434r1409b3512],
79	genomes	NNS	O	genome	nsubj	80	SENT_231	[p14l1449t3460r1831b3535],
80	evolve	VBP	O	evolve	ccomp	77	SENT_231	[p14l1879t3434r2133b3513],
81	as	IN	O	as	mark	84	SENT_231	[p14l11t3588r96b3640],
82	a	DT	O	a	det	83	SENT_231	[p14l138t3588r183b3640],
83	cancer	NN	O	cancer	nsubj	84	SENT_231	[p14l222t3588r502b3640],
84	progresses	VBZ	O	progress	advcl	80	SENT_231	[p14l538t3588r1025b3663],
85	.	.	O	.	_	0	SENT_231	[p14l538t3588r1025b3663],

1	Deep	JJ	O	deep	amod	2	SENT_232	[p14l1069t3569r1287b3662],
2	sequencing	NN	O	sequencing	_	0	SENT_232	[p14l1330t3563r1816b3663],
3	of	IN	O	of	_	0	SENT_232	[p14l1853t3561r1953b3641],
4	two	CD	NUMBER	two	num	7	SENT_232	[p14l1975t3579r2133b3641],
5	primary	JJ	O	primary	amod	7	SENT_232	[p14l11t3692r360b3790],
6	breast	NN	O	breast	nn	7	SENT_232	[p14l420t3691r682b3769],
7	cancers	NNS	O	cancer	prep_of	2	SENT_232	[p14l741t3717r1061b3769],
8	and	CC	O	and	_	0	SENT_232	[p14l1125t3691r1283b3769],
9	subsequent	JJ	O	subsequent	amod	10	SENT_232	[p14l1347t3691r1832b3790],
10	metastases	NNS	O	metastase	prep_of	2	SENT_232	[p14l1890t3708r2133b3769, p15l13t39r266b100],

1	showed	VBD	O	show	_	0	SENT_233	[p15l330t22r653b101],
2	novel	JJ	O	novel	amod	3	SENT_233	[p15l713t22r937b101],
3	mutations	NNS	O	mutation	dobj	1	SENT_233	[p15l997t23r1431b101],
4	or	CC	O	or	_	0	SENT_233	[p15l1495t48r1583b101],
5	enrichment	NN	O	enrichment	conj_or	3	SENT_233	[p15l1642t22r2139b101],
6	for	IN	O	for	_	0	SENT_233	[p15l12t148r135b228],
7	low	JJ	O	low	amod	10	SENT_233	[p15l180t148r790b249],
8	—	JJ	O	—	amod	10	SENT_233	[p15l180t148r790b249],
9	frequency	NN	O	frequency	nn	10	SENT_233	[p15l180t148r790b249],
10	mutations	NNS	O	mutation	prep_for	1	SENT_233	[p15l834t150r1269b228],
11	in	IN	O	in	_	0	SENT_233	[p15l1319t150r1402b227],
12	the	DT	O	the	det	13	SENT_233	[p15l1451t149r1583b227],
13	metastases	NNS	O	metastase	prep_in	10	SENT_233	[p15l1632t166r2129b245],
14	,	,	O	,	_	0	SENT_233	[p15l1632t166r2129b245],
15	pointing	VBG	O	point	partmod	1	SENT_233	[p15l11t279r384b379],
16	to	TO	O	to	_	0	SENT_233	[p15l418t295r499b357],
17	the	DT	O	the	det	18	SENT_233	[p15l538t278r670b356],
18	possibility	NN	O	possibility	prep_to	15	SENT_233	[p15l706t278r1156b378],
19	that	IN	O	that	complm	28	SENT_233	[p15l1189t278r1361b356],
20	analysis	NN	O	analysis	nsubj	28	SENT_233	[p15l1392t278r1732b378],
21	of	IN	O	of	_	0	SENT_233	[p15l1772t277r1872b357],
22	metastatic	JJ	O	metastatic	amod	23	SENT_233	[p15l1890t295r2133b356, p15l13t406r242b483],
23	tissues	NNS	O	tissue	prep_of	20	SENT_233	[p15l289t406r578b485],
24	of	IN	O	of	_	0	SENT_233	[p15l630t404r729b484],
25	some	DT	O	some	det	26	SENT_233	[p15l761t431r985b484],
26	cancers	NNS	O	cancer	prep_of	23	SENT_233	[p15l1035t431r1355b483],
27	may	MD	O	may	aux	28	SENT_233	[p15l1405t431r1585b505],
28	identify	VB	O	identify	ccomp	1	SENT_233	[p15l1628t404r1960b505],
29	additional	JJ	O	additional	amod	30	SENT_233	[p15l2004t405r2133b484, p15l12t534r346b613],
30	mutations	NNS	O	mutation	dobj	28	SENT_233	[p15l392t535r826b613],
31	that	WDT	O	that	nsubj	36	SENT_233	[p15l875t534r1047b612],
32	may	MD	O	may	aux	36	SENT_233	[p15l1088t560r1267b634],
33	be	VB	O	be	cop	36	SENT_233	[p15l1310t534r1405b613],
34	important	JJ	O	important	amod	36	SENT_233	[p15l1451t535r1893b634],
35	drug	NN	O	drug	nn	36	SENT_233	[p15l1934t534r2138b635],
36	targets.-39	NN	O	targets.-39	rcmod	30	SENT_233	[p15l12t666r508b761],
37	,40	CD	NUMBER	,40	nsubj	1	SENT_233	[p15l12t666r508b761],

1	ACQUIRED	VBN	O	acquire	_	0	SENT_234	[p15l29t957r620b1035],
2	RESISTANCE	NN	O	resistance	dobj	1	SENT_234	[p15l675t956r1364b1016],
3	TO	TO	O	to	dep	2	SENT_234	[p15l1412t956r1552b1016],
4	THERAPY	NN	O	therapy	dobj	3	SENT_234	[p15l1601t957r2119b1016],

1	The	DT	O	the	det	3	SENT_235	[p15l8t1226r169b1304],
2	rational	JJ	O	rational	amod	3	SENT_235	[p15l216t1226r551b1305],
3	use	NN	O	use	nsubj	14	SENT_235	[p15l598t1252r738b1305],
4	of	IN	O	of	_	0	SENT_235	[p15l786t1225r885b1305],
5	therapeutics	NNS	O	therapeutics	prep_of	3	SENT_235	[p15l914t1226r1440b1326],
6	that	WDT	O	that	nsubj	7	SENT_235	[p15l1490t1226r1662b1304],
7	target	VBP	O	target	rcmod	5	SENT_235	[p15l1704t1243r1960b1327],
8	the	DT	O	the	det	9	SENT_235	[p15l2002t1226r2134b1304],
9	products	NNS	O	product	dobj	7	SENT_235	[p15l11t1354r385b1454],
10	of	IN	O	of	_	0	SENT_235	[p15l426t1353r526b1433],
11	mutated	VBN	O	mutate	amod	12	SENT_235	[p15l546t1354r900b1433],
12	genes	NNS	O	gene	prep_of	9	SENT_235	[p15l937t1380r1178b1455],
13	has	VBZ	O	have	aux	14	SENT_235	[p15l1218t1354r1363b1432],
14	had	VBN	O	have	_	0	SENT_235	[p15l1402t1354r1559b1433],
15	considerable	JJ	O	considerable	amod	16	SENT_235	[p15l1597t1354r2134b1433],
16	success	NN	O	success	dobj	14	SENT_235	[p15l13t1508r353b1577],
17	,	,	O	,	_	0	SENT_235	[p15l13t1508r353b1577],
18	but	CC	O	but	_	0	SENT_235	[p15l387t1482r527b1561],
19	many	JJ	O	many	amod	20	SENT_235	[p15l550t1508r789b1581],
20	patients	NNS	O	patient	nsubj	21	SENT_235	[p15l811t1483r1152b1581],
21	have	VBP	O	have	conj_but	14	SENT_235	[p15l1182t1482r1372b1561],
22	a	DT	O	a	det	23	SENT_235	[p15l1400t1508r1444b1560],
23	relapse	NN	O	relapse	dobj	21	SENT_235	[p15l1471t1482r1773b1581],
24	because	IN	O	because	mark	28	SENT_235	[p15l1802t1482r2134b1561],
25	their	PRP$	O	they	poss	26	SENT_235	[p15l12t1610r216b1688],
26	tumors	NNS	O	tumor	nsubj	28	SENT_235	[p15l242t1627r549b1689],
27	become	VBP	O	become	cop	28	SENT_235	[p15l581t1610r910b1689],
28	resistant	JJ	O	resistant	dep	23	SENT_235	[p15l938t1611r1311b1688],
29	to	TO	O	to	_	0	SENT_235	[p15l1334t1627r1416b1689],
30	the	DT	O	the	det	31	SENT_235	[p15l1446t1610r1578b1688],
31	drugs	NNS	O	drug	prep_to	28	SENT_235	[p15l1608t1610r1954b1711],
32	.	.	O	.	_	0	SENT_235	[p15l1608t1610r1954b1711],

1	“	RB	O	“	advmod	15	SENT_236	[p15l1608t1610r1954b1711],
2	Genomic	JJ	O	genomic	amod	3	SENT_236	[p15l1982t1616r2133b1689, p15l12t1739r281b1817],
3	changes	NNS	O	change	nsubj	15	SENT_236	[p15l322t1738r694b1839],
4	,	,	O	,	_	0	SENT_236	[p15l322t1738r694b1839],
5	originally	RB	O	originally	advmod	6	SENT_236	[p15l742t1738r1159b1839],
6	present	JJ	DATE	present	amod	3	SENT_236	[p15l1194t1755r1514b1838],
7	in	IN	O	in	_	0	SENT_236	[p15l1549t1739r1632b1816],
8	small	JJ	O	small	amod	9	SENT_236	[p15l1675t1738r1910b1816],
9	subclones	NNS	O	subclone	prep_in	6	SENT_236	[p15l1952t1738r2132b1817, p15l13t1865r279b1944],
10	of	IN	O	of	_	0	SENT_236	[p15l337t1864r437b1944],
11	cancer	NN	O	cancer	nn	12	SENT_236	[p15l475t1891r755b1943],
12	cells	NNS	O	cell	prep_of	9	SENT_236	[p15l808t1865r1020b1961],
13	,	,	O	,	_	0	SENT_236	[p15l808t1865r1020b1961],
14	often	RB	O	often	advmod	15	SENT_236	[p15l1081t1864r1303b1944],
15	underlie	VBP	O	underlie	_	0	SENT_236	[p15l1359t1865r1710b1945],
16	acquired	VBN	O	acquire	amod	17	SENT_236	[p15l1765t1865r2134b1965],
17	resistance	NN	O	resistance	dobj	15	SENT_236	[p15l12t1995r440b2073],
18	in	IN	O	in	_	0	SENT_236	[p15l489t1995r572b2072],
19	these	DT	O	these	det	20	SENT_236	[p15l623t1994r847b2073],
20	circumstances	NNS	O	circumstance	prep_in	17	SENT_236	[p15l897t1995r1540b2073],
21	.	.	O	.	_	0	SENT_236	[p15l897t1995r1540b2073],

1	These	DT	O	these	det	2	SENT_237	[p15l1592t1994r1843b2073],
2	range	NN	O	range	_	0	SENT_237	[p15l1893t2020r2133b2095],
3	from	IN	O	from	dep	2	SENT_237	[p15l12t2120r222b2200],
4	an	DT	O	a	det	7	SENT_237	[p15l279t2147r381b2199],
5	additional	JJ	O	additional	amod	7	SENT_237	[p15l439t2121r875b2200],
6	point	NN	O	point	nn	7	SENT_237	[p15l931t2122r1161b2221],
7	mutation	NN	O	mutation	pobj	3	SENT_237	[p15l1213t2122r1606b2201],
8	within	IN	O	within	_	0	SENT_237	[p15l1659t2121r1943b2201],
9	the	DT	O	the	det	10	SENT_237	[p15l2002t2121r2134b2199],
10	gene	NN	O	gene	prep_within	7	SENT_237	[p15l12t2276r211b2351],
11	encoding	VBG	O	encode	partmod	10	SENT_237	[p15l270t2250r670b2351],
12	the	DT	O	the	det	13	SENT_237	[p15l725t2250r857b2328],
13	protein	NN	O	protein	dobj	11	SENT_237	[p15l915t2251r1226b2350],
14	to	TO	O	to	_	0	SENT_237	[p15l1284t2267r1365b2329],
15	which	WDT	O	which	rel	19	SENT_237	[p15l1421t2250r1683b2329],
16	the	DT	O	the	det	17	SENT_237	[p15l1742t2250r1875b2329],
17	drug	NN	O	drug	nsubjpass	19	SENT_237	[p15l1934t2250r2137b2351],
18	is	VBZ	O	be	auxpass	19	SENT_237	[p15l12t2379r77b2456],
19	targeted	VBN	O	target	rcmod	13	SENT_237	[p15l136t2378r491b2479],
20	—	RB	O	—	advmod	19	SENT_237	[p15l542t2423r650b2431],
21	such	JJ	O	such	_	0	SENT_237	[p15l703t2378r897b2457],
22	as	IN	O	as	_	0	SENT_237	[p15l952t2404r1038b2456],
23	ABL	NN	ORGANIZATION	abl	nn	24	SENT_237	[p15l1089t2384r1250b2456],
24	mutations	NNS	O	mutation	prep_such_as	19	SENT_237	[p15l1303t2379r1737b2457],
25	in	IN	O	in	_	0	SENT_237	[p15l1794t2379r1877b2456],
26	CML	NN	ORGANIZATION	cml	nn	29	SENT_237	[p15l1934t2384r2137b2457],
27	and	CC	O	and	_	0	SENT_237	[p15l11t2506r169b2585],
28	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_237	[p15l213t2512r422b2586],
29	mutations	NNS	O	mutation	prep_in	24	SENT_237	[p15l458t2507r884b2585],
30	in	IN	O	in	_	0	SENT_237	[p15l929t2507r1011b2584],
31	non	JJ	O	non	amod	39	SENT_237	[p15l1055t2506r1683b2585],
32	—	JJ	O	—	amod	39	SENT_237	[p15l1055t2506r1683b2585],
33	small	JJ	O	small	amod	39	SENT_237	[p15l1055t2506r1683b2585],
34	—	NN	O	—	nn	39	SENT_237	[p15l1055t2506r1683b2585],
35	cell	NN	O	cell	nn	39	SENT_237	[p15l1055t2506r1683b2585],
36	lung	NN	O	lung	nn	39	SENT_237	[p15l1725t2506r1915b2607],
37	cancer42	NN	O	cancer42	nn	39	SENT_237	[p15l1956t2532r2133b2584, p15l13t2638r301b2711],
38	'45	CD	NUMBER	'45	num	39	SENT_237	[p15l1956t2532r2133b2584, p15l13t2638r301b2711],
39	—	NN	O	—	prep_in	19	SENT_237	[p15l341t2678r448b2686],
40	to	TO	O	to	_	0	SENT_237	[p15l486t2650r567b2712],
41	amplification	NN	O	amplification	prep_to	19	SENT_237	[p15l609t2632r1194b2733],
42	of	IN	O	of	_	0	SENT_237	[p15l1236t2632r1336b2712],
43	an	DT	O	a	det	47	SENT_237	[p15l1359t2659r1461b2711],
44	entirely	RB	O	entirely	advmod	45	SENT_237	[p15l1503t2633r1826b2733],
45	different	JJ	O	different	amod	47	SENT_237	[p15l1864t2632r2133b2712, p15l12t2779r146b2840],
46	cancer	NN	O	cancer	nn	47	SENT_237	[p15l184t2788r465b2841],
47	gene	NN	O	gene	prep_of	41	SENT_237	[p15l504t2788r726b2863],
48	,	,	O	,	_	0	SENT_237	[p15l504t2788r726b2863],
49	such	JJ	O	such	_	0	SENT_237	[p15l775t2762r969b2841],
50	as	IN	O	as	_	0	SENT_237	[p15l1010t2788r1096b2840],
51	MET	NN	O	met	prep_such_as	10	SENT_237	[p15l1139t2768r1334b2841],
52	in	IN	O	in	_	0	SENT_237	[p15l1367t2763r1450b2840],
53	non	JJ	O	non	amod	58	SENT_237	[p15l1493t2762r2135b2841],
54	—	JJ	O	—	amod	58	SENT_237	[p15l1493t2762r2135b2841],
55	small	JJ	O	small	amod	58	SENT_237	[p15l1493t2762r2135b2841],
56	—	NN	O	—	nn	58	SENT_237	[p15l1493t2762r2135b2841],
57	cell	NN	O	cell	nn	58	SENT_237	[p15l1493t2762r2135b2841],
58	lung	NN	O	lung	prep_in	51	SENT_237	[p15l11t2890r204b2991],
59	cancer	NN	O	cancer	dep	10	SENT_237	[p15l236t2894r616b2969],
60	.46	CD	NUMBER	.46	num	59	SENT_237	[p15l236t2894r616b2969],

1	The	DT	O	the	det	2	SENT_238	[p15l135t3018r296b3097],
2	nature	NN	O	nature	nsubj	7	SENT_238	[p15l370t3035r648b3097],
3	of	IN	O	of	_	0	SENT_238	[p15l723t3017r823b3097],
4	the	DT	O	the	det	6	SENT_238	[p15l879t3018r1011b3096],
5	resistance	NN	O	resistance	nn	6	SENT_238	[p15l1086t3019r1515b3097],
6	mechanisms	NNS	O	mechanism	prep_of	2	SENT_238	[p15l1589t3018r2132b3096],
7	dictates	VBZ	O	dictate	_	0	SENT_238	[p15l10t3146r341b3224],
8	the	DT	O	the	det	10	SENT_238	[p15l396t3146r529b3224],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_238	[p15l582t3146r1068b3245],
10	approaches	NNS	O	approach	dobj	7	SENT_238	[p15l1119t3146r1603b3245],
11	adopted	VBN	O	adopt	partmod	10	SENT_238	[p15l1657t3146r2000b3245],
12	in	IN	O	in	_	0	SENT_238	[p15l2052t3147r2135b3223],
13	second	JJ	ORDINAL	second	amod	16	SENT_238	[p15l11t3274r502b3352],
14	—	NN	O	—	nn	16	SENT_238	[p15l11t3274r502b3352],
15	line	NN	O	line	nn	16	SENT_238	[p15l11t3274r502b3352],
16	therapy	NN	O	therapy	prep_in	11	SENT_238	[p15l556t3274r891b3373],
17	.	.	O	.	_	0	SENT_238	[p15l556t3274r891b3373],

1	These	DT	O	these	det	2	SENT_239	[p15l947t3274r1199b3352],
2	approaches	NNS	O	approach	nsubj	4	SENT_239	[p15l1252t3274r1736b3373],
3	may	MD	O	may	aux	4	SENT_239	[p15l1791t3300r1971b3373],
4	include	VB	O	include	_	0	SENT_239	[p15l2019t3275r2134b3351, p15l10t3402r232b3481],
5	the	DT	O	the	det	6	SENT_239	[p15l299t3402r431b3480],
6	use	NN	O	use	nsubj	12	SENT_239	[p15l497t3428r638b3481],
7	of	IN	O	of	_	0	SENT_239	[p15l704t3401r804b3481],
8	second	JJ	ORDINAL	second	amod	11	SENT_239	[p15l852t3402r1647b3503],
9	—	NN	O	—	nn	11	SENT_239	[p15l852t3402r1647b3503],
10	generation	NN	O	generation	nn	11	SENT_239	[p15l852t3402r1647b3503],
11	inhibitors	NNS	O	inhibitor	prep_of	6	SENT_239	[p15l1711t3402r2134b3481],
12	capable	JJ	O	capable	xcomp	4	SENT_239	[p15l10t3530r330b3630],
13	of	IN	O	of	_	0	SENT_239	[p15l385t3529r485b3609],
14	overcoming	VBG	O	overcome	prepc_of	12	SENT_239	[p15l520t3531r1029b3631],
15	resistance	NN	O	resistance	nn	16	SENT_239	[p15l1079t3531r1508b3608],
16	mutations	NNS	O	mutation	dobj	14	SENT_239	[p15l1562t3531r1997b3609],
17	in	IN	O	in	_	0	SENT_239	[p15l2052t3531r2135b3608],
18	target	NN	O	target	nn	19	SENT_239	[p15l10t3675r266b3759],
19	genes	NNS	O	gene	prep_in	14	SENT_239	[p15l313t3684r580b3759],
20	,	,	O	,	_	0	SENT_239	[p15l313t3684r580b3759],
21	as	RB	O	as	advmod	24	SENT_239	[p15l639t3684r723b3736],
22	is	VBZ	O	be	cop	24	SENT_239	[p15l778t3659r844b3736],
23	the	DT	O	the	det	24	SENT_239	[p15l900t3658r1032b3737],
24	case	NN	O	case	dep	19	SENT_239	[p15l1086t3684r1266b3737],
25	in	IN	O	in	_	0	SENT_239	[p15l1318t3659r1402b3736],
26	CML	NN	ORGANIZATION	cml	nn	30	SENT_239	[p15l1455t3664r1658b3737],
27	and	CC	O	and	_	0	SENT_239	[p15l1708t3658r1866b3737],
28	nonsmall	JJ	O	nonsmall	conj_and	26	SENT_239	[p15l1919t3684r2139b3737, p16l11t20r430b98],
29	—	NN	O	—	nn	30	SENT_239	[p15l1919t3684r2139b3737, p16l11t20r430b98],
30	cell	NN	O	cell	prep_in	24	SENT_239	[p15l1919t3684r2139b3737, p16l11t20r430b98],

1	lung	NN	O	lung	nn	2	SENT_240	[p16l461t20r655b121],
2	cancer	NN	O	cancer	_	0	SENT_240	[p16l684t46r984b116],
3	,	,	O	,	_	0	SENT_240	[p16l684t46r984b116],
4	or	CC	O	or	_	0	SENT_240	[p16l1023t46r1111b99],
5	combination	NN	O	combination	nn	6	SENT_240	[p16l1141t20r1688b99],
6	strategies	NNS	O	strategy	conj_or	2	SENT_240	[p16l1723t21r2133b121],
7	that	WDT	O	that	nsubj	8	SENT_240	[p16l10t148r183b226],
8	involve	VBP	O	involve	rcmod	6	SENT_240	[p16l237t148r533b227],
9	targeting	VBG	O	target	xcomp	8	SENT_240	[p16l594t149r993b249],
10	the	DT	O	the	det	12	SENT_240	[p16l1051t148r1184b226],
11	protein	NN	O	protein	nn	12	SENT_240	[p16l1243t149r1555b248],
12	products	NNS	O	product	dobj	9	SENT_240	[p16l1614t148r1990b248],
13	of	IN	O	of	prep	9	SENT_240	[p16l2054t147r2153b227],
14	both	CC	O	both	preconj	6	SENT_240	[p16l10t276r208b355],
15	the	DT	O	the	det	18	SENT_240	[p16l259t276r391b354],
16	primary	JJ	O	primary	amod	18	SENT_240	[p16l441t277r792b376],
17	mutated	VBN	O	mutate	amod	18	SENT_240	[p16l838t276r1192b355],
18	gene	NN	O	gene	conj	6	SENT_240	[p16l1242t302r1441b377],
19	and	CC	O	and	_	0	SENT_240	[p16l1491t276r1649b355],
20	additional	JJ	O	additional	amod	22	SENT_240	[p16l1698t276r2136b355],
21	mutated	VBN	O	mutate	amod	22	SENT_240	[p16l10t404r364b483],
22	genes	NNS	O	gene	conj	6	SENT_240	[p16l403t430r669b505],
23	.	.	O	.	_	0	SENT_240	[p16l403t430r669b505],

1	If	IN	O	if	mark	5	SENT_241	[p16l138t530r221b609],
2	resistant	JJ	O	resistant	amod	3	SENT_241	[p16l240t532r613b609],
3	clones	NNS	O	clone	nsubj	5	SENT_241	[p16l647t531r914b610],
4	are	VBP	O	be	cop	5	SENT_241	[p16l954t557r1082b609],
5	present	JJ	DATE	present	advcl	17	SENT_241	[p16l1119t548r1440b631],
6	at	IN	O	at	_	0	SENT_241	[p16l1472t548r1551b609],
7	low	JJ	O	low	amod	8	SENT_241	[p16l1583t531r1739b611],
8	frequency	NN	O	frequency	prep_at	5	SENT_241	[p16l1773t530r2134b631, p16l10t687r99b760],
9	in	IN	O	in	_	0	SENT_241	[p16l135t662r218b738],
10	the	DT	O	the	det	12	SENT_241	[p16l258t661r391b739],
11	primary	JJ	O	primary	amod	12	SENT_241	[p16l430t662r780b760],
12	tumor	NN	O	tumor	prep_in	8	SENT_241	[p16l816t677r1102b756],
13	,	,	O	,	_	0	SENT_241	[p16l816t677r1102b756],
14	an	DT	O	a	det	16	SENT_241	[p16l1147t687r1250b738],
15	important	JJ	O	important	amod	16	SENT_241	[p16l1289t662r1731b760],
16	question	NN	O	question	nsubj	17	SENT_241	[p16l1767t662r2135b760],
17	is	VBZ	O	be	_	0	SENT_241	[p16l9t790r75b867],
18	Whether	IN	O	whether	complm	22	SENT_241	[p16l130t789r486b868],
19	they	PRP	O	they	nsubjpass	22	SENT_241	[p16l541t789r724b888],
20	could	MD	O	could	aux	22	SENT_241	[p16l778t789r1013b868],
21	be	VB	O	be	auxpass	22	SENT_241	[p16l1071t789r1168b867],
22	detected	VBN	O	detect	dep	17	SENT_241	[p16l1226t789r1585b867],
23	at	IN	O	at	_	0	SENT_241	[p16l1641t805r1720b867],
24	an	DT	O	a	det	26	SENT_241	[p16l1772t815r1875b866],
25	early	JJ	O	early	amod	26	SENT_241	[p16l1934t789r2139b888],
26	stage	NN	O	stage	prep_at	22	SENT_241	[p16l11t934r254b1018],
27	,	,	O	,	_	0	SENT_241	[p16l11t934r254b1018],
28	thus	RB	O	thus	advmod	29	SENT_241	[p16l320t917r504b996],
29	influencing	VBG	O	influence	xcomp	22	SENT_241	[p16l565t916r1068b1018],
30	the	DT	O	the	det	31	SENT_241	[p16l1124t917r1257b996],
31	choice	NN	O	choice	dobj	29	SENT_241	[p16l1318t917r1588b996],
32	of	IN	O	of	_	0	SENT_241	[p16l1649t916r1749b996],
33	primary	JJ	O	primary	amod	34	SENT_241	[p16l1789t918r2140b1017],
34	therapy	NN	O	therapy	prep_of	31	SENT_241	[p16l10t1045r345b1145],
35	.	.	O	.	_	0	SENT_241	[p16l10t1045r345b1145],

1	Deep	JJ	O	deep	amod	2	SENT_242	[p16l394t1052r612b1145],
2	sequencing	NN	O	sequencing	nsubj	18	SENT_242	[p16l660t1046r1147b1146],
3	of	IN	O	of	_	0	SENT_242	[p16l1188t1044r1289b1124],
4	cancer	NN	O	cancer	nn	5	SENT_242	[p16l1316t1071r1596b1123],
5	genomes	NNS	O	genome	prep_of	2	SENT_242	[p16l1638t1071r2021b1146],
6	is	VBZ	O	be	cop	7	SENT_242	[p16l2067t1046r2133b1123],
7	capable	JJ	O	capable	_	0	SENT_242	[p16l10t1173r330b1273],
8	of	IN	O	of	_	0	SENT_242	[p16l374t1172r474b1252],
9	detecting	VBG	O	detect	prepc_of	7	SENT_242	[p16l499t1173r901b1274],
10	small	JJ	O	small	amod	11	SENT_242	[p16l942t1173r1177b1251],
11	numbers	NNS	O	number	dobj	9	SENT_242	[p16l1219t1173r1597b1252],
12	of	IN	O	of	_	0	SENT_242	[p16l1643t1172r1743b1252],
13	resistant	JJ	O	resistant	amod	14	SENT_242	[p16l1767t1174r2140b1251],
14	cells	NNS	O	cell	prep_of	11	SENT_242	[p16l10t1300r197b1378],
15	and	CC	O	and	_	0	SENT_242	[p16l235t1300r393b1379],
16	so	RB	O	so	advmod	18	SENT_242	[p16l431t1326r521b1379],
17	could	MD	O	could	aux	18	SENT_242	[p16l559t1300r793b1380],
18	inform	VB	O	inform	conj_and	7	SENT_242	[p16l829t1299r1129b1379],
19	up	RP	O	up	prt	18	SENT_242	[p16l1165t1299r1524b1400],
20	—	CD	NUMBER	—	num	23	SENT_242	[p16l1165t1299r1524b1400],
21	front	JJ	O	front	amod	23	SENT_242	[p16l1165t1299r1524b1400],
22	combinationtreatment	NN	O	combinationtreatment	nn	23	SENT_242	[p16l1555t1300r2134b1379, p16l10t1446r435b1508],
23	strategies	NNS	O	strategy	dobj	18	SENT_242	[p16l494t1430r904b1530],
24	that	WDT	O	that	nsubj	26	SENT_242	[p16l970t1429r1143b1507],
25	might	MD	O	might	aux	26	SENT_242	[p16l1201t1429r1461b1530],
26	minimize	VB	O	minimize	rcmod	23	SENT_242	[p16l1519t1430r1938b1508],
27	the	DT	O	the	det	28	SENT_242	[p16l2002t1429r2135b1507],
28	chances	NNS	O	chance	dobj	26	SENT_242	[p16l10t1557r350b1635],
29	of	IN	O	of	_	0	SENT_242	[p16l385t1556r485b1636],
30	the	DT	O	the	det	32	SENT_242	[p16l499t1557r632b1635],
31	resistant	JJ	O	resistant	amod	32	SENT_242	[p16l663t1558r1037b1635],
32	clones	NNS	O	clone	prep_of	28	SENT_242	[p16l1064t1557r1332b1636],
33	ever	RB	O	ever	advmod	34	SENT_242	[p16l1366t1583r1538b1636],
34	expanding	VBG	O	expand	partmod	32	SENT_242	[p16l1568t1557r2023b1658],
35	to	TO	O	to	aux	36	SENT_242	[p16l2052t1574r2134b1636],
36	dominate	VB	O	dominate	xcomp	34	SENT_242	[p16l10t1685r419b1763],
37	the	DT	O	the	det	41	SENT_242	[p16l459t1685r592b1763],
38	tumor	NN	O	tumor	nn	41	SENT_242	[p16l632t1685r1082b1764],
39	—	NN	O	—	nn	41	SENT_242	[p16l632t1685r1082b1764],
40	cell	NN	O	cell	nn	41	SENT_242	[p16l632t1685r1082b1764],
41	population	NN	O	population	dobj	36	SENT_242	[p16l1121t1685r1615b1784],
42	.	.	O	.	_	0	SENT_242	[p16l1121t1685r1615b1784],

1	MONITORING	VBG	O	monitor	_	0	SENT_243	[p16l77t2009r851b2068],
2	OF	IN	O	of	_	0	SENT_243	[p16l902t2009r1033b2068],
3	DISEASE	NN	O	disease	nn	4	SENT_243	[p16l1087t2010r1543b2068],
4	BURDEN	NN	O	burden	prep_of	1	SENT_243	[p16l1599t2010r2065b2068],

1	AND	CC	O	and	cc	3	SENT_244	[p16l340t2116r580b2175],
2	EARLY	NNP	O	EARLY	nn	3	SENT_244	[p16l636t2116r983b2175],
3	RECURRENCE	NNP	O	RECURRENCE	_	0	SENT_244	[p16l1033t2116r1799b2175],

1	For	IN	O	for	_	0	SENT_245	[p16l8t2319r151b2390],
2	most	JJS	O	most	amod	4	SENT_245	[p16l206t2328r422b2390],
3	solid	JJ	O	solid	amod	4	SENT_245	[p16l476t2311r681b2390],
4	tumors	NNS	O	tumor	prep_for	11	SENT_245	[p16l739t2328r1072b2407],
5	,	,	O	,	_	0	SENT_245	[p16l739t2328r1072b2407],
6	monitoring	NN	O	monitoring	nsubj	11	SENT_245	[p16l1135t2312r1629b2412],
7	of	IN	O	of	_	0	SENT_245	[p16l1684t2310r1784b2390],
8	disease	NN	O	disease	nn	9	SENT_245	[p16l1825t2311r2135b2390],
9	burden	NN	O	burden	prep_of	6	SENT_245	[p16l10t2439r313b2518],
10	is	VBZ	O	be	aux	11	SENT_245	[p16l387t2440r452b2517],
11	achieved	VBN	O	achieve	_	0	SENT_245	[p16l528t2439r896b2518],
12	through	IN	O	through	_	0	SENT_245	[p16l971t2439r1320b2540],
13	various	JJ	O	various	amod	15	SENT_245	[p16l1389t2440r1700b2518],
14	imaging	NN	O	imaging	nn	15	SENT_245	[p16l1776t2440r2138b2540],
15	methods	NNS	O	method	prep_through	11	SENT_245	[p16l10t2566r408b2662],
16	,	,	O	,	_	0	SENT_245	[p16l10t2566r408b2662],
17	supplemented	VBN	O	supplement	dep	11	SENT_245	[p16l450t2566r1050b2666],
18	in	IN	O	in	_	0	SENT_245	[p16l1085t2567r1168b2644],
19	a	DT	O	a	det	22	SENT_245	[p16l1202t2592r1246b2644],
20	few	JJ	O	few	amod	22	SENT_245	[p16l1280t2565r1435b2646],
21	cancer	NN	O	cancer	nn	22	SENT_245	[p16l1467t2592r1748b2644],
22	types	NNS	O	type	prep_in	17	SENT_245	[p16l1781t2583r2005b2666],
23	by	IN	O	by	_	0	SENT_245	[p16l2042t2566r2140b2666],
24	measurement	NN	O	measurement	prep_by	17	SENT_245	[p16l10t2712r598b2774],
25	of	IN	O	of	_	0	SENT_245	[p16l625t2694r725b2774],
26	circulating	VBG	O	circulate	prepc_of	24	SENT_245	[p16l738t2695r1206b2796],
27	tissue	NN	O	tissue	nn	28	SENT_245	[p16l1234t2694r1852b2795],
28	—	NN	O	—	dobj	26	SENT_245	[p16l1234t2694r1852b2795],
29	specific	JJ	O	specific	amod	30	SENT_245	[p16l1234t2694r1852b2795],
30	markers	NNS	O	marker	nsubj	31	SENT_245	[p16l1882t2695r2134b2774, p16l10t2849r131b2901],
31	(	VBP	O	(	rcmod	28	SENT_245	[p16l202t2830r397b2924],
32	e.g.	FW	O	e.g.	dobj	31	SENT_245	[p16l202t2830r397b2924],
33	,	,	O	,	_	0	SENT_245	[p16l202t2830r397b2924],
34	prostate	NN	O	prostate	nn	37	SENT_245	[p16l466t2822r1187b2923],
35	—	NN	O	—	nn	37	SENT_245	[p16l466t2822r1187b2923],
36	specif1c	NN	O	specif1c	nn	37	SENT_245	[p16l466t2822r1187b2923],
37	antigen	NN	O	antigen	dobj	11	SENT_245	[p16l1251t2824r1574b2924],
38	in	IN	O	in	_	0	SENT_245	[p16l1638t2824r1722b2901],
39	prostate	NN	O	prostate	nn	41	SENT_245	[p16l1785t2840r2135b2923],
40	cancer	NN	O	cancer	nn	41	SENT_245	[p16l10t2957r339b3041],
41	)	NN	O	)	prep_in	37	SENT_245	[p16l10t2957r339b3041],
42	.	.	O	.	_	0	SENT_245	[p16l10t2957r339b3041],

1	For	IN	O	for	_	0	SENT_246	[p16l379t2958r522b3029],
2	some	DT	O	some	det	3	SENT_246	[p16l556t2976r780b3029],
3	cancers	NNS	O	cancer	prep_for	19	SENT_246	[p16l816t2976r1162b3046],
4	,	,	O	,	_	0	SENT_246	[p16l816t2976r1162b3046],
5	however	RB	O	however	advmod	19	SENT_246	[p16l1203t2950r1578b3046],
6	,	,	O	,	_	0	SENT_246	[p16l1203t2950r1578b3046],
7	detection	NN	O	detection	nsubjpass	19	SENT_246	[p16l1620t2950r2017b3029],
8	of	IN	O	of	_	0	SENT_246	[p16l2053t2949r2153b3029],
9	tumor	NN	O	tumor	nn	13	SENT_246	[p16l10t3078r644b3179],
10	—	NN	O	—	nn	13	SENT_246	[p16l10t3078r644b3179],
11	specific	JJ	O	specific	amod	13	SENT_246	[p16l10t3078r644b3179],
12	genetic	JJ	O	genetic	amod	13	SENT_246	[p16l707t3080r1016b3180],
13	abnormalities	NNS	O	abnormality	prep_of	7	SENT_246	[p16l1080t3079r1678b3158],
14	in	IN	O	in	_	0	SENT_246	[p16l1744t3080r1827b3157],
15	blood	NN	O	blood	nn	16	SENT_246	[p16l1893t3079r2135b3158],
16	samples	NNS	O	sample	prep_in	13	SENT_246	[p16l11t3206r356b3306],
17	has	VBZ	O	have	aux	19	SENT_246	[p16l403t3206r547b3284],
18	been	VBN	O	be	auxpass	19	SENT_246	[p16l595t3206r796b3285],
19	used	VBN	O	use	_	0	SENT_246	[p16l840t3206r1038b3286],
20	to	TO	O	to	aux	21	SENT_246	[p16l1083t3223r1164b3285],
21	quantify	VB	O	quantify	xcomp	19	SENT_246	[p16l1211t3205r1576b3306],
22	tumor	NN	O	tumor	nn	23	SENT_246	[p16l1617t3223r1884b3286],
23	load	NN	O	load	dobj	21	SENT_246	[p16l1925t3206r2129b3285],
24	.	.	O	.	_	0	SENT_246	[p16l1925t3206r2129b3285],

1	This	DT	O	this	det	2	SENT_247	[p16l6t3335r194b3413],
2	strategy	NN	O	strategy	nsubj	6	SENT_247	[p16l229t3352r574b3436],
3	has	VBZ	O	have	aux	6	SENT_247	[p16l600t3335r745b3413],
4	been	VBN	O	be	cop	6	SENT_247	[p16l779t3335r980b3414],
5	particularly	RB	O	particularly	advmod	6	SENT_247	[p16l1011t3335r1514b3435],
6	fruitful	JJ	O	fruitful	_	0	SENT_247	[p16l1541t3334r1856b3414],
7	in	IN	O	in	_	0	SENT_247	[p16l1887t3336r1970b3413],
8	hematologic	JJ	O	hematologic	amod	9	SENT_247	[p16l2002t3335r2134b3414, p16l10t3463r440b3564],
9	cancers	NNS	O	cancer	prep_in	6	SENT_247	[p16l477t3489r823b3559],
10	,	,	O	,	_	0	SENT_247	[p16l477t3489r823b3559],
11	in	IN	O	in	_	0	SENT_247	[p16l865t3464r948b3541],
12	which	WDT	O	which	det	13	SENT_247	[p16l981t3463r1244b3542],
13	treatment	NN	O	treatment	rel	17	SENT_247	[p16l1281t3480r1706b3542],
14	decisions	NNS	O	decision	nsubjpass	17	SENT_247	[p16l1738t3463r2133b3542],
15	are	VBP	O	be	auxpass	17	SENT_247	[p16l9t3617r138b3669],
16	routinely	RB	O	routinely	advmod	17	SENT_247	[p16l186t3591r573b3691],
17	based	VBN	O	base	rcmod	9	SENT_247	[p16l617t3591r861b3670],
18	on	IN	O	on	_	0	SENT_247	[p16l910t3617r1016b3670],
19	the	DT	O	the	det	20	SENT_247	[p16l1064t3591r1197b3669],
20	levels	NNS	O	level	prep_on	17	SENT_247	[p16l1244t3591r1475b3670],
21	of	IN	O	of	_	0	SENT_247	[p16l1525t3590r1626b3670],
22	certain	JJ	O	certain	amod	23	SENT_247	[p16l1656t3592r1957b3669],
23	genetic	JJ	O	genetic	prep_of	20	SENT_247	[p16l2004t3617r2134b3692, p17l10t21r217b98],

1	alterations	NNS	O	alteration	_	0	SENT_248	[p17l259t20r740b98],
2	.	.	O	.	_	0	SENT_248	[p17l259t20r740b98],

1	This	DT	O	this	det	2	SENT_249	[p17l785t20r973b97],
2	success	NN	O	success	nsubj	4	SENT_249	[p17l1020t46r1335b99],
3	has	VBZ	O	have	aux	4	SENT_249	[p17l1380t20r1524b98],
4	depended	VBN	O	depend	_	0	SENT_249	[p17l1571t20r1985b119],
5	on	IN	O	on	_	0	SENT_249	[p17l2029t46r2135b98],
6	the	DT	O	the	det	9	SENT_249	[p17l10t148r143b226],
7	recurrent	JJ	O	recurrent	amod	9	SENT_249	[p17l170t165r571b227],
8	gene	NN	O	gene	nn	9	SENT_249	[p17l592t174r792b249],
9	rearrangements	NNS	O	rearrangement	prep_on	4	SENT_249	[p17l820t165r1502b249],
10	that	WDT	O	that	nsubjpass	12	SENT_249	[p17l1532t148r1704b226],
11	are	VBP	O	be	auxpass	12	SENT_249	[p17l1726t174r1855b226],
12	found	VBN	O	find	rcmod	9	SENT_249	[p17l1883t147r2135b227],
13	in	IN	O	in	_	0	SENT_249	[p17l9t277r93b354],
14	many	JJ	O	many	amod	16	SENT_249	[p17l153t302r392b376],
15	hematologic	JJ	O	hematologic	amod	16	SENT_249	[p17l449t276r983b377],
16	cancers	NNS	O	cancer	prep_in	12	SENT_249	[p17l1043t302r1389b355],
17	.	.	O	.	_	0	SENT_249	[p17l1043t302r1389b355],

1	Because	IN	O	because	_	0	SENT_250	[p17l1454t283r1798b355],
2	of	IN	O	of	_	0	SENT_250	[p17l1860t275r1959b355],
3	the	DT	O	the	det	4	SENT_250	[p17l2002t276r2135b354],
4	possibility	NN	O	possibility	prep_because_of	22	SENT_250	[p17l8t404r458b504],
5	of	IN	O	of	_	0	SENT_250	[p17l507t403r607b483],
6	designing	VBG	O	design	prepc_of	4	SENT_250	[p17l642t404r1069b505],
7	PCR	NN	O	pcr	nn	8	SENT_250	[p17l1117t410r1308b487],
8	primers	NNS	O	primer	dobj	6	SENT_250	[p17l1349t405r1684b504],
9	that	WDT	O	that	nsubj	11	SENT_250	[p17l1739t404r1911b482],
10	speciﬁcally	RB	O	speciﬁcally	advmod	11	SENT_250	[p17l1960t430r2134b504, p17l10t531r353b632],
11	amplify	VBP	O	amplify	rcmod	8	SENT_250	[p17l400t531r734b632],
12	the	DT	O	the	det	16	SENT_250	[p17l783t532r916b610],
13	abnormally	RB	O	abnormally	advmod	14	SENT_250	[p17l968t532r1463b632],
14	connected	VBN	O	connect	amod	16	SENT_250	[p17l1512t532r1952b611],
15	genomic	JJ	O	genomic	amod	16	SENT_250	[p17l2004t558r2134b633, p17l10t661r279b739],
16	segments	NNS	O	segment	dep	11	SENT_250	[p17l321t677r752b761],
17	,	,	O	,	_	0	SENT_250	[p17l321t677r752b761],
18	such	JJ	O	such	amod	19	SENT_250	[p17l800t660r994b739],
19	rearrangements	NNS	O	rearrangement	nsubj	22	SENT_250	[p17l1035t677r1718b761],
20	are	VBP	O	be	cop	22	SENT_250	[p17l1760t686r1890b738],
21	ideal	JJ	O	ideal	amod	22	SENT_250	[p17l1931t660r2135b739],
22	substrates	NNS	O	substrate	_	0	SENT_250	[p17l11t788r444b867],
23	for	IN	O	for	_	0	SENT_250	[p17l476t787r600b867],
24	technically	RB	O	technically	advmod	25	SENT_250	[p17l627t788r1098b888],
25	straightforward	JJ	O	straightforward	amod	31	SENT_250	[p17l1126t787r1830b889],
26	,	,	O	,	_	0	SENT_250	[p17l1126t787r1830b889],
27	highly	RB	O	highly	advmod	28	SENT_250	[p17l1866t788r2140b889],
28	sensitive	JJ	O	sensitive	conj_and	25	SENT_250	[p17l11t916r376b995],
29	and	CC	O	and	_	0	SENT_250	[p17l409t915r567b994],
30	specific	JJ	O	specific	conj_and	25	SENT_250	[p17l602t914r932b1015],
31	assays	NNS	O	assay	prep_for	22	SENT_250	[p17l965t941r1255b1015],
32	.	.	O	.	_	0	SENT_250	[p17l965t941r1255b1015],

1	For	IN	O	for	_	0	SENT_251	[p17l1294t923r1436b994],
2	example	NN	O	example	prep_for	26	SENT_251	[p17l1468t915r1847b1015],
3	,	,	O	,	_	0	SENT_251	[p17l1468t915r1847b1015],
4	in	IN	O	in	_	0	SENT_251	[p17l1886t916r1970b993],
5	patients	NNS	O	patient	prep_in	26	SENT_251	[p17l2002t941r2134b1015, p17l10t1045r246b1122],
6	with	IN	O	with	_	0	SENT_251	[p17l280t1044r475b1123],
7	CML	NN	ORGANIZATION	cml	prep_with	5	SENT_251	[p17l510t1050r713b1122],
8	who	WP	O	who	nsubj	9	SENT_251	[p17l741t1044r925b1123],
9	have	VBP	O	have	rcmod	5	SENT_251	[p17l960t1044r1151b1123],
10	a	DT	O	a	det	11	SENT_251	[p17l1185t1070r1230b1121],
11	reduction	NN	O	reduction	dobj	9	SENT_251	[p17l1263t1044r1673b1123],
12	in	IN	O	in	_	0	SENT_251	[p17l1707t1045r1790b1121],
13	quantitative	JJ	O	quantitative	amod	16	SENT_251	[p17l1826t1045r2134b1143, p17l10t1172r240b1250],
14	BCR-ABL	NN	O	bcr-abl	nn	16	SENT_251	[p17l268t1177r661b1255],
15	transcript	NN	O	transcript	nn	16	SENT_251	[p17l689t1172r1113b1271],
16	levels	NNS	O	level	prep_in	11	SENT_251	[p17l1136t1171r1368b1251],
17	by	IN	O	by	_	0	SENT_251	[p17l1400t1171r1497b1271],
18	a	DT	O	a	det	19	SENT_251	[p17l1521t1197r1565b1249],
19	factor	NN	O	factor	prep_by	9	SENT_251	[p17l1594t1170r1844b1250],
20	of	IN	O	of	_	0	SENT_251	[p17l1871t1170r1971b1250],
21	100	CD	NUMBER	100	prep_of	19	SENT_251	[p17l1986t1177r2134b1250],
22	after	IN	O	after	_	0	SENT_251	[p17l9t1298r212b1377],
23	treatment	NN	O	treatment	prep_after	21	SENT_251	[p17l259t1316r704b1395],
24	,	,	O	,	_	0	SENT_251	[p17l259t1316r704b1395],
25	there	EX	O	there	expl	26	SENT_251	[p17l760t1299r978b1377],
26	is	VBZ	O	be	_	0	SENT_251	[p17l1027t1300r1093b1377],
27	typically	RB	O	typically	advmod	26	SENT_251	[p17l1146t1299r1511b1399],
28	a	DT	O	a	det	48	SENT_251	[p17l1556t1325r1600b1377],
29	durable	JJ	O	durable	amod	48	SENT_251	[p17l1650t1299r1970b1379],
30	response	NN	O	response	nn	48	SENT_251	[p17l2021t1325r2134b1377, p17l11t1433r407b1528],
31	,47	CD	NUMBER	,47	num	30	SENT_251	[p17l2021t1325r2134b1377, p17l11t1433r407b1528],
32	and	CC	O	and	_	0	SENT_251	[p17l441t1428r599b1507],
33	rising	VBG	O	rise	conj_and	30	SENT_251	[p17l632t1429r882b1529],
34	levels	NNS	O	level	dobj	33	SENT_251	[p17l911t1428r1142b1507],
35	ofBCR-ABL	NN	O	ofbcr-abl	nn	36	SENT_251	[p17l1178t1427r1684b1511],
36	transcript	NN	O	transcript	nsubj	38	SENT_251	[p17l1716t1429r2140b1528],
37	often	RB	O	often	advmod	38	SENT_251	[p17l10t1555r233b1635],
38	indicate	VBP	O	indicate	rcmod	34	SENT_251	[p17l264t1556r606b1635],
39	the	DT	O	the	det	41	SENT_251	[p17l639t1556r771b1634],
40	accelerated	VBN	O	accelerate	amod	41	SENT_251	[p17l803t1556r1279b1635],
41	growth	NN	O	growth	dobj	38	SENT_251	[p17l1311t1556r1626b1657],
42	of	IN	O	of	_	0	SENT_251	[p17l1658t1555r1758b1635],
43	neoplastic	JJ	O	neoplastic	amod	44	SENT_251	[p17l1772t1556r2134b1656, p17l10t1685r113b1762],
44	clones	NNS	O	clone	prep_of	41	SENT_251	[p17l151t1684r418b1762],
45	that	WDT	O	that	nsubj	47	SENT_251	[p17l458t1684r630b1762],
46	have	VBP	O	have	aux	47	SENT_251	[p17l662t1684r852b1763],
47	developed	VBN	O	develop	rcmod	41	SENT_251	[p17l890t1684r1317b1783],
48	resistance	NN	O	resistance	nsubj	26	SENT_251	[p17l1355t1685r1784b1762],
49	to	TO	O	to	_	0	SENT_251	[p17l1821t1700r1903b1762],
50	imatinib	NN	O	imatinib	prep_to	48	SENT_251	[p17l1941t1685r2134b1761, p17l10t1812r234b1908],
51	,	,	O	,	_	0	SENT_251	[p17l1941t1685r2134b1761, p17l10t1812r234b1908],
52	triggering	VBG	O	trigger	partmod	48	SENT_251	[p17l271t1813r708b1913],
53	a	DT	O	a	det	54	SENT_251	[p17l735t1838r779b1890],
54	switch	NN	O	switch	dobj	52	SENT_251	[p17l810t1812r1087b1891],
55	to	TO	O	to	_	0	SENT_251	[p17l1119t1829r1200b1891],
56	alternative	JJ	O	alternative	amod	57	SENT_251	[p17l1232t1812r1683b1891],
57	therapies	NNS	O	therapy	prep_to	52	SENT_251	[p17l1715t1812r2130b1912],
58	.	.	O	.	_	0	SENT_251	[p17l1715t1812r2130b1912],

1	This	DT	O	this	det	2	SENT_252	[p17l135t1940r320b2018],
2	strategy	NN	O	strategy	nsubjpass	7	SENT_252	[p17l357t1957r695b2041],
3	has	VBZ	O	have	aux	7	SENT_252	[p17l724t1940r866b2018],
4	not	RB	O	not	neg	7	SENT_252	[p17l902t1957r1043b2019],
5	been	VBN	O	be	auxpass	7	SENT_252	[p17l1073t1940r1271b2019],
6	routinely	RB	O	routinely	advmod	7	SENT_252	[p17l1305t1940r1683b2040],
7	applied	VBN	O	apply	_	0	SENT_252	[p17l1712t1940r2019b2040],
8	to	TO	O	to	_	0	SENT_252	[p17l2053t1957r2134b2019],
9	the	DT	O	the	det	11	SENT_252	[p17l10t2068r143b2146],
10	clinical	JJ	O	clinical	amod	11	SENT_252	[p17l190t2068r504b2146],
11	management	NN	O	management	prep_to	7	SENT_252	[p17l550t2085r1117b2169],
12	of	IN	O	of	_	0	SENT_252	[p17l1159t2067r1259b2147],
13	most	JJS	O	most	amod	15	SENT_252	[p17l1286t2085r1503b2147],
14	solid	JJ	O	solid	amod	15	SENT_252	[p17l1546t2068r1750b2147],
15	tumors	NNS	O	tumor	prep_of	11	SENT_252	[p17l1796t2085r2129b2164],
16	,	,	O	,	_	0	SENT_252	[p17l1796t2085r2129b2164],

1	346	CD	NUMBER	346	num	2	SENT_253	[p17l149t2244r206b2268],
2	JANUARY	NN	DATE	january	_	0	SENT_253	[p17l1390t2255r1502b2277],
3	27	CD	DATE	27	dep	2	SENT_253	[p17l1512t2255r1546b2276],
4	,	,	DATE	,	_	0	SENT_253	[p17l1512t2255r1546b2276],
5	2011	CD	DATE	2011	appos	3	SENT_253	[p17l1557t2255r1609b2271],

1	GLJ	NN	O	glj	nn	2	SENT_254	[p17l1010t2255r1054b2277],
2	MED	NN	O	med	_	0	SENT_254	[p17l1069t2255r1121b2270],
3	364	CD	NUMBER	364	num	5	SENT_254	[p17l1131t2249r1200b2277],
4	;	:	O	;	_	0	SENT_254	[p17l1131t2249r1200b2277],
5	4	CD	NUMBER	4	dep	2	SENT_254	[p17l1131t2249r1200b2277],
6	NEjM	NNP	O	NEjM	nn	8	SENT_254	[p17l1235t2255r1359b2277],
7	,	,	O	,	_	0	SENT_254	[p17l1235t2255r1359b2277],
8	ORG	NNP	O	ORG	dep	2	SENT_254	[p17l1235t2255r1359b2277],

1	The	DT	O	the	det	4	SENT_255	[p17l936t2288r987b2312],
2	New	NNP	O	New	nn	4	SENT_255	[p17l996t2289r1058b2312],
3	England	NNP	O	England	nn	4	SENT_255	[p17l1067t2288r1178b2319],
4	Journal	NNP	O	Journal	_	0	SENT_255	[p17l1187t2288r1284b2312],
5	of	IN	O	of	_	0	SENT_255	[p17l1294t2288r1323b2312],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_255	[p17l1330t2288r1455b2312],

1	Downloaded	VBN	O	download	_	0	SENT_256	[p17l378t2329r548b2352],
2	from	IN	O	from	_	0	SENT_256	[p17l557t2329r622b2352],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_256	[p17l630t2329r749b2359],
4	at	IN	O	at	_	0	SENT_256	[p17l759t2333r782b2352],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_256	[p17l790t2329r973b2352],
6	on	IN	O	on	_	0	SENT_256	[p17l982t2336r1015b2352],
7	January	NNP	DATE	January	prep_on	1	SENT_256	[p17l1023t2329r1126b2359],
8	5	CD	DATE	5	num	7	SENT_256	[p17l1136t2329r1159b2356],
9	,	,	DATE	,	_	0	SENT_256	[p17l1136t2329r1159b2356],
10	2014	CD	DATE	2014	num	7	SENT_256	[p17l1169t2329r1242b2352],
11	.	.	O	.	_	0	SENT_256	[p17l1169t2329r1242b2352],

1	For	IN	O	for	_	0	SENT_257	[p17l1252t2329r1299b2352],
2	personal	JJ	O	personal	amod	3	SENT_257	[p17l1307t2329r1419b2359],
3	use	NN	O	use	pobj	1	SENT_257	[p17l1428t2336r1472b2352],
4	only	RB	O	only	advmod	3	SENT_257	[p17l1481t2329r1546b2359],
5	.	.	O	.	_	0	SENT_257	[p17l1481t2329r1546b2359],

1	No	DT	O	no	det	3	SENT_258	[p17l1557t2329r1596b2352],
2	other	JJ	O	other	amod	3	SENT_258	[p17l1606t2329r1674b2352],
3	uses	NNS	O	use	_	0	SENT_258	[p17l1683t2336r1739b2352],
4	without	IN	O	without	_	0	SENT_258	[p17l1749t2329r1850b2352],
5	permission	NN	O	permission	prep_without	3	SENT_258	[p17l1858t2329r2011b2359],
6	.	.	O	.	_	0	SENT_258	[p17l1858t2329r2011b2359],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_259	[p17l909t2476r1067b2495],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_259	[p17l1081t2476r1251b2495],

1	primarily	RB	O	primarily	advmod	3	SENT_260	[p17l8t2691r409b2791],
2	because	IN	O	because	mwe	3	SENT_260	[p17l439t2691r772b2771],
3	of	IN	O	of	_	0	SENT_260	[p17l807t2690r906b2770],
4	the	DT	O	the	det	5	SENT_260	[p17l922t2691r1053b2769],
5	absence	NN	O	absence	pobj	3	SENT_260	[p17l1087t2691r1421b2770],
6	of	IN	O	of	_	0	SENT_260	[p17l1456t2690r1555b2770],
7	known	JJ	O	known	amod	10	SENT_260	[p17l1570t2691r1866b2771],
8	recurrent	JJ	O	recurrent	amod	10	SENT_260	[p17l1900t2717r2148b2770, p17l10t2837r180b2899],
9	genetic	JJ	O	genetic	amod	10	SENT_260	[p17l234t2821r545b2921],
10	translocations	NNS	O	translocation	prep_of	5	SENT_260	[p17l605t2820r1222b2899],
11	or	CC	O	or	_	0	SENT_260	[p17l1286t2846r1375b2899],
12	rearrangements	NNS	O	rearrangement	conj_or	10	SENT_260	[p17l1432t2837r2144b2921],
13	.	.	O	.	_	0	SENT_260	[p17l1432t2837r2144b2921],

1	However	RB	O	however	advmod	23	SENT_261	[p17l10t2956r407b3044],
2	,	,	O	,	_	0	SENT_261	[p17l10t2956r407b3044],
3	since	IN	O	since	mark	10	SENT_261	[p17l450t2949r667b3026],
4	dying	VBG	O	die	amod	5	SENT_261	[p17l703t2948r945b3049],
5	cells	NNS	O	cell	nsubj	10	SENT_261	[p17l978t2948r1166b3026],
6	in	IN	O	in	_	0	SENT_261	[p17l1203t2949r1287b3026],
7	many	JJ	O	many	amod	9	SENT_261	[p17l1323t2974r1564b3048],
8	solid	JJ	O	solid	amod	9	SENT_261	[p17l1596t2948r1802b3027],
9	tumors	NNS	O	tumor	prep_in	5	SENT_261	[p17l1838t2965r2147b3027],
10	release	VBP	O	release	advcl	23	SENT_261	[p17l10t3076r305b3154],
11	naked	JJ	O	naked	amod	12	SENT_261	[p17l352t3076r613b3155],
12	DNA	NN	O	dna	dobj	10	SENT_261	[p17l657t3082r868b3155],
13	into	IN	O	into	_	0	SENT_261	[p17l910t3077r1080b3155],
14	the	DT	O	the	det	15	SENT_261	[p17l1128t3076r1262b3154],
15	circulation	NN	O	circulation	prep_into	10	SENT_261	[p17l1309t3076r1798b3172],
16	,	,	O	,	_	0	SENT_261	[p17l1309t3076r1798b3172],
17	the	DT	O	the	det	19	SENT_261	[p17l1851t3076r1984b3155],
18	tumor	NN	O	tumor	nn	19	SENT_261	[p17l2031t3093r2148b3155, p17l10t3231r188b3284],
19	burden	NN	O	burden	nsubjpass	23	SENT_261	[p17l225t3205r530b3284],
20	theoretically	RB	O	theoretically	advmod	23	SENT_261	[p17l570t3205r1113b3305],
21	could	MD	O	could	aux	23	SENT_261	[p17l1149t3205r1385b3284],
22	be	VB	O	be	auxpass	23	SENT_261	[p17l1425t3205r1522b3284],
23	monitored	VBN	O	monitor	_	0	SENT_261	[p17l1562t3205r2016b3284],
24	by	IN	O	by	_	0	SENT_261	[p17l2056t3205r2154b3305],
25	blood	NN	O	blood	nn	26	SENT_261	[p17l11t3334r256b3414],
26	sampling	NN	O	sampling	agent	23	SENT_261	[p17l291t3334r697b3436],
27	similar	JJ	O	similar	amod	26	SENT_261	[p17l729t3334r1037b3413],
28	to	TO	O	to	_	0	SENT_261	[p17l1069t3351r1152b3414],
29	that	DT	O	that	prep_to	27	SENT_261	[p17l1188t3334r1361b3413],
30	done	VBN	O	do	partmod	29	SENT_261	[p17l1391t3334r1599b3414],
31	for	IN	O	for	_	0	SENT_261	[p17l1634t3333r1758b3414],
32	hematologic	JJ	O	hematologic	amod	33	SENT_261	[p17l1789t3334r2148b3414, p17l9t3463r218b3565],
33	neoplasms	NNS	O	neoplasm	prep_for	30	SENT_261	[p17l279t3463r765b3564],
34	.	.	O	.	_	0	SENT_261	[p17l279t3463r765b3564],

1	Low	JJ	O	low	amod	2	SENT_262	[p17l830t3471r1016b3543],
2	levels	NNS	O	level	nsubjpass	11	SENT_262	[p17l1072t3463r1304b3543],
3	of	IN	O	of	_	0	SENT_262	[p17l1368t3462r1469b3543],
4	tumor	NN	O	tumor	nn	8	SENT_262	[p17l1512t3462r2150b3564],
5	—	NN	O	—	nn	8	SENT_262	[p17l1512t3462r2150b3564],
6	specific	JJ	O	specific	amod	8	SENT_262	[p17l1512t3462r2150b3564],
7	point	NN	O	point	nn	8	SENT_262	[p17l8t3593r240b3692],
8	mutations	NNS	O	mutation	prep_of	2	SENT_262	[p17l288t3593r725b3671],
9	have	VBP	O	have	aux	11	SENT_262	[p17l780t3592r971b3671],
10	been	VBN	O	be	auxpass	11	SENT_262	[p17l1024t3592r1227b3671],
11	detected	VBN	O	detect	_	0	SENT_262	[p17l1280t3592r1641b3671],
12	in	IN	O	in	_	0	SENT_262	[p17l1692t3593r1776b3670],
13	the	DT	O	the	det	14	SENT_262	[p17l1829t3592r1963b3670],
14	peripheral	JJ	O	peripheral	prep_in	11	SENT_262	[p17l2014t3618r2148b3692, p18l10t21r349b121],

1	blood	NN	O	blood	dep	8	SENT_263	[p18l401t21r646b100],
2	of	IN	O	of	_	0	SENT_263	[p18l699t20r799b100],
3	patients	NNS	O	patient	prep_of	1	SENT_263	[p18l830t22r1175b121],
4	with	IN	O	with	_	0	SENT_263	[p18l1224t21r1421b101],
5	solid	JJ	O	solid	amod	6	SENT_263	[p18l1474t21r1680b100],
6	tumors	NNS	O	tumor	prep_with	3	SENT_263	[p18l1732t26r2149b101],
7	.48	CD	NUMBER	.48	dep	8	SENT_263	[p18l1732t26r2149b101],
8	These	DT	O	these	dep	12	SENT_263	[p18l6t151r260b230],
9	mutations	NNS	O	mutation	dep	8	SENT_263	[p18l318t152r755b230],
10	have	VBP	O	have	aux	12	SENT_263	[p18l815t151r1006b230],
11	been	VBN	O	be	auxpass	12	SENT_263	[p18l1064t151r1267b230],
12	used	VBN	O	use	_	0	SENT_263	[p18l1324t151r1522b230],
13	to	TO	O	to	aux	14	SENT_263	[p18l1580t168r1662b230],
14	detect	VB	O	detect	xcomp	12	SENT_263	[p18l1722t151r1982b230],
15	relapse	NN	O	relapse	dobj	14	SENT_263	[p18l2034t177r2148b229, p18l9t278r229b378],

1	of	IN	O	of	dep	37	SENT_264	[p18l265t277r365b357],
2	colorectal	JJ	O	colorectal	amod	3	SENT_264	[p18l383t278r806b357],
3	cancers	NNS	O	cancer	pobj	1	SENT_264	[p18l842t304r1165b356],
4	and	CC	O	and	_	0	SENT_264	[p18l1201t278r1360b357],
5	also	RB	O	also	advmod	7	SENT_264	[p18l1394t278r1567b357],
6	the	DT	O	the	det	7	SENT_264	[p18l1604t278r1738b356],
7	presence	NN	O	presence	conj_and	1	SENT_264	[p18l1771t304r2149b378],
8	of	IN	O	of	_	0	SENT_264	[p18l11t405r111b485],
9	a	DT	O	a	det	12	SENT_264	[p18l146t432r191b484],
10	secondary	JJ	O	secondary	amod	12	SENT_264	[p18l244t406r685b506],
11	resistance	NN	O	resistance	nn	12	SENT_264	[p18l734t407r1166b484],
12	mutation	NN	O	mutation	prep_of	7	SENT_264	[p18l1219t407r1615b486],
13	in	IN	O	in	_	0	SENT_264	[p18l1668t407r1751b484],
14	patients	NNS	O	patient	prep_in	12	SENT_264	[p18l1803t407r2148b506],
15	with	IN	O	with	_	0	SENT_264	[p18l6t535r202b614],
16	non	JJ	O	non	amod	22	SENT_264	[p18l239t535r886b614],
17	—	JJ	O	—	amod	22	SENT_264	[p18l239t535r886b614],
18	small	JJ	O	small	amod	22	SENT_264	[p18l239t535r886b614],
19	—	NN	O	—	nn	22	SENT_264	[p18l239t535r886b614],
20	cell	NN	O	cell	nn	22	SENT_264	[p18l239t535r886b614],
21	lung	NN	O	lung	nn	22	SENT_264	[p18l920t535r1115b636],
22	cancer	NN	O	cancer	prep_with	14	SENT_264	[p18l1149t561r1432b613],
23	who	WP	O	who	nsubjpass	25	SENT_264	[p18l1461t535r1645b614],
24	are	VBP	O	be	auxpass	25	SENT_264	[p18l1682t561r1812b614],
25	treated	VBN	O	treat	rcmod	12	SENT_264	[p18l1848t535r2149b614],
26	with	IN	O	with	_	0	SENT_264	[p18l6t663r202b742],
27	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_264	[p18l233t669r491b746],
28	kinase	NN	O	kinase	nn	29	SENT_264	[p18l512t663r793b742],
29	inhibitors	NNS	O	inhibitor	prep_with	25	SENT_264	[p18l825t663r1453b742],
30	.49	CD	NUMBER	.49	number	31	SENT_264	[p18l825t663r1453b742],
31	’	CD	NUMBER	’	nsubj	37	SENT_264	[p18l825t663r1453b742],
32	5	CD	NUMBER	5	num	33	SENT_264	[p18l825t663r1453b742],
33	°	NN	O	°	dep	31	SENT_264	[p18l825t663r1453b742],
34	This	DT	O	this	det	35	SENT_264	[p18l1482t663r1671b741],
35	strategy	NN	O	strategy	dep	31	SENT_264	[p18l1707t680r2054b764],
36	is	VBZ	O	be	cop	37	SENT_264	[p18l2081t664r2147b741],
37	difficult	JJ	O	difficult	_	0	SENT_264	[p18l11t789r369b870],
38	to	TO	O	to	aux	39	SENT_264	[p18l401t807r483b869],
39	implement	VB	O	implement	xcomp	37	SENT_264	[p18l522t790r992b890],
40	widely	RB	O	widely	advmod	39	SENT_264	[p18l1020t790r1302b890],
41	in	IN	O	in	_	0	SENT_264	[p18l1335t791r1418b868],
42	clinical	JJ	O	clinical	amod	43	SENT_264	[p18l1457t790r1773b868],
43	practice	NN	O	practice	prep_in	39	SENT_264	[p18l1808t791r2149b890],
44	because	IN	O	because	mark	60	SENT_264	[p18l11t918r350b997],
45	the	DT	O	the	det	46	SENT_264	[p18l396t918r530b996],
46	detection	NN	O	detection	nsubj	60	SENT_264	[p18l577t918r977b997],
47	of	IN	O	of	_	0	SENT_264	[p18l1024t917r1124b997],
48	a	DT	O	a	det	50	SENT_264	[p18l1151t944r1196b996],
49	small	JJ	O	small	amod	50	SENT_264	[p18l1241t918r1478b996],
50	subpopulation	NN	O	subpopulation	prep_of	46	SENT_264	[p18l1525t918r2149b1018],
51	of	IN	O	of	_	0	SENT_264	[p18l11t1046r111b1127],
52	DNA	NN	O	dna	nn	53	SENT_264	[p18l136t1054r346b1127],
53	fragments	NNS	O	fragment	prep_of	50	SENT_264	[p18l387t1046r830b1149],
54	carrying	VBG	O	carry	partmod	53	SENT_264	[p18l877t1048r1244b1149],
55	a	DT	O	a	det	57	SENT_264	[p18l1284t1074r1329b1126],
56	point	NN	O	point	nn	57	SENT_264	[p18l1371t1048r1603b1148],
57	mutation	NN	O	mutation	dobj	54	SENT_264	[p18l1642t1048r2037b1127],
58	is	VBZ	O	be	cop	60	SENT_264	[p18l2081t1048r2148b1126],
59	technically	RB	O	technically	advmod	60	SENT_264	[p18l11t1176r474b1276],
60	challenging	JJ	O	challenging	advcl	39	SENT_264	[p18l516t1176r1036b1277],
61	.	.	O	.	_	0	SENT_264	[p18l516t1176r1036b1277],

1	However	RB	O	however	advmod	6	SENT_265	[p18l1087t1184r1477b1272],
2	,	,	O	,	_	0	SENT_265	[p18l1087t1184r1477b1272],
3	most	RBS	O	most	advmod	5	SENT_265	[p18l1528t1193r1743b1255],
4	solid	JJ	O	solid	amod	5	SENT_265	[p18l1786t1176r1986b1255],
5	tumors	NNS	O	tumor	nsubj	6	SENT_265	[p18l2033t1193r2148b1255, p18l10t1330r225b1383],
6	carry	VBP	O	carry	_	0	SENT_265	[p18l302t1330r521b1404],
7	genomic	JJ	O	genomic	amod	8	SENT_265	[p18l591t1305r957b1405],
8	rearrangements	NNS	O	rearrangement	dobj	6	SENT_265	[p18l1032t1321r1704b1405],
9	that	WDT	O	that	nsubj	11	SENT_265	[p18l1782t1304r1952b1382],
10	are	VBP	O	be	cop	11	SENT_265	[p18l2021t1330r2149b1382],
11	speciflc	NN	O	speciflc	rcmod	8	SENT_265	[p18l11t1430r336b1531],
12	to	TO	O	to	_	0	SENT_265	[p18l366t1448r448b1510],
13	each	DT	O	each	det	15	SENT_265	[p18l482t1431r676b1509],
14	individual	JJ	O	individual	amod	15	SENT_265	[p18l707t1431r1141b1511],
15	patient	NN	O	patient	prep_to	11	SENT_265	[p18l1171t1432r1496b1531],
16	.	.	O	.	_	0	SENT_265	[p18l1171t1432r1496b1531],

1	Indeed	RB	O	indeed	advmod	68	SENT_266	[p18l1532t1431r1851b1527],
2	,	,	O	,	_	0	SENT_266	[p18l1532t1431r1851b1527],
3	recent	JJ	O	recent	amod	4	SENT_266	[p18l1888t1448r2154b1509],
4	studies	NNS	O	study	nsubj	6	SENT_266	[p18l11t1560r314b1639],
5	have	VBP	O	have	aux	6	SENT_266	[p18l349t1560r541b1639],
6	shown	VBN	O	show	parataxis	68	SENT_266	[p18l575t1560r859b1639],
7	that	IN	O	that	complm	22	SENT_266	[p18l893t1560r1067b1638],
8	rearrangements	NNS	O	rearrangement	nsubjpass	22	SENT_266	[p18l1095t1577r1781b1661],
9	that	WDT	O	that	nsubjpass	11	SENT_266	[p18l1817t1560r1992b1638],
10	are	VBP	O	be	auxpass	11	SENT_266	[p18l2019t1586r2149b1638],
11	detected	VBN	O	detect	rcmod	8	SENT_266	[p18l11t1688r372b1767],
12	in	IN	O	in	_	0	SENT_266	[p18l421t1689r504b1766],
13	primary	JJ	O	primary	amod	14	SENT_266	[p18l553t1689r906b1788],
14	cancers	NNS	O	cancer	prep_in	11	SENT_266	[p18l952t1714r1275b1766],
15	by	IN	O	by	_	0	SENT_266	[p18l1328t1688r1426b1788],
16	neXt	NN	O	next	nn	19	SENT_266	[p18l1471t1689r2149b1789],
17	—	NN	O	—	nn	19	SENT_266	[p18l1471t1689r2149b1789],
18	generation	NN	O	generation	nn	19	SENT_266	[p18l1471t1689r2149b1789],
19	sequencing	NN	O	sequencing	agent	11	SENT_266	[p18l11t1817r501b1917],
20	can	MD	O	can	aux	22	SENT_266	[p18l565t1842r715b1894],
21	be	VB	O	be	auxpass	22	SENT_266	[p18l782t1816r879b1895],
22	used	VBN	O	use	ccomp	6	SENT_266	[p18l945t1816r1143b1895],
23	to	TO	O	to	aux	24	SENT_266	[p18l1210t1833r1292b1895],
24	detect	VB	O	detect	xcomp	22	SENT_266	[p18l1360t1816r1621b1895],
25	circulating	VBG	O	circulate	xcomp	24	SENT_266	[p18l1682t1816r2153b1917],
26	tumor	NN	O	tumor	nn	27	SENT_266	[p18l11t1962r280b2025],
27	DNA	NN	MISC	dna	dobj	25	SENT_266	[p18l327t1952r559b2042],
28	,	,	O	,	_	0	SENT_266	[p18l327t1952r559b2042],
29	the	DT	O	the	det	30	SENT_266	[p18l615t1945r749b2024],
30	levels	NNS	O	level	nsubj	68	SENT_266	[p18l799t1945r1031b2025],
31	of	IN	O	of	_	0	SENT_266	[p18l1085t1944r1185b2025],
32	which	WDT	O	which	nsubj	33	SENT_266	[p18l1213t1945r1478b2025],
33	correlate	VBP	O	correlate	prepc_of	30	SENT_266	[p18l1529t1945r1906b2025],
34	with	IN	O	with	_	0	SENT_266	[p18l1952t1945r2149b2025],
35	tumor	NN	O	tumor	nn	36	SENT_266	[p18l11t2091r280b2153],
36	load	NN	O	load	prep_with	33	SENT_266	[p18l346t2074r725b2153],
37	.51	CD	NUMBER	.51	num	38	SENT_266	[p18l346t2074r725b2153],
38	’52	CD	NUMBER	’52	npadvmod	39	SENT_266	[p18l346t2074r725b2153],
39	Thus	RB	O	thus	advmod	33	SENT_266	[p18l792t2074r1030b2170],
40	,	,	O	,	_	0	SENT_266	[p18l792t2074r1030b2170],
41	it	PRP	O	it	nsubj	44	SENT_266	[p18l1105t2075r1165b2152],
42	may	MD	O	may	aux	44	SENT_266	[p18l1229t2100r1409b2174],
43	be	VB	O	be	cop	44	SENT_266	[p18l1476t2074r1573b2153],
44	possible	JJ	O	possible	ccomp	33	SENT_266	[p18l1642t2074r1995b2174],
45	to	TO	O	to	aux	46	SENT_266	[p18l2065t2091r2148b2153],
46	monitor	VB	O	monitor	xcomp	44	SENT_266	[p18l10t2203r364b2281],
47	the	DT	O	the	det	49	SENT_266	[p18l396t2202r529b2280],
48	cancer	NN	O	cancer	nn	49	SENT_266	[p18l565t2228r848b2280],
49	burden	NN	O	burden	dobj	46	SENT_266	[p18l880t2202r1185b2282],
50	of	IN	O	of	_	0	SENT_266	[p18l1220t2201r1321b2281],
51	almost	RB	O	almost	quantmod	52	SENT_266	[p18l1337t2202r1636b2281],
52	all	DT	O	all	num	53	SENT_266	[p18l1665t2202r1770b2280],
53	patients	NNS	O	patient	prep_of	49	SENT_266	[p18l1803t2203r2147b2302],
54	with	IN	O	with	_	0	SENT_266	[p18l6t2331r202b2410],
55	solid	JJ	O	solid	amod	56	SENT_266	[p18l246t2331r452b2410],
56	tumors	NNS	O	tumor	prep_with	46	SENT_266	[p18l495t2348r805b2410],
57	in	IN	O	in	_	0	SENT_266	[p18l849t2332r933b2409],
58	a	DT	O	a	det	59	SENT_266	[p18l975t2357r1020b2409],
59	way	NN	O	way	prep_in	56	SENT_266	[p18l1056t2357r1226b2431],
60	similar	JJ	O	similar	amod	59	SENT_266	[p18l1265t2331r1573b2409],
61	to	TO	O	to	_	0	SENT_266	[p18l1613t2348r1695b2410],
62	that	DT	O	that	prep_to	60	SENT_266	[p18l1740t2331r1914b2409],
63	used	VBN	O	use	partmod	62	SENT_266	[p18l1951t2331r2149b2410],
64	in	IN	O	in	_	0	SENT_266	[p18l10t2461r93b2538],
65	monitoring	VBG	O	monitor	prepc_in	63	SENT_266	[p18l137t2461r634b2561],
66	hematologic	JJ	O	hematologic	amod	67	SENT_266	[p18l675t2460r1213b2561],
67	cancers	NNS	O	cancer	dobj	65	SENT_266	[p18l1257t2486r1579b2539],
68	(	VBP	O	(	_	0	SENT_266	[p18l1630t2461r1814b2561],
69	Fig	NN	O	fig	dobj	68	SENT_266	[p18l1630t2461r1814b2561],
70	.	.	O	.	_	0	SENT_266	[p18l1630t2461r1814b2561],

1	3	CD	NUMBER	3	_	0	SENT_267	[p18l1867t2466r1937b2556],
2	,	,	O	,	_	0	SENT_267	[p18l1867t2466r1937b2556],
3	and	CC	O	and	_	0	SENT_267	[p18l1989t2460r2150b2539],
4	an	DT	O	a	det	6	SENT_267	[p18l10t2614r114b2667],
5	interactive	JJ	O	interactive	amod	6	SENT_267	[p18l171t2589r631b2668],
6	graphic	JJ	O	graphic	conj_and	1	SENT_267	[p18l688t2588r1047b2690],
7	,	,	O	,	_	0	SENT_267	[p18l688t2588r1047b2690],
8	available	JJ	O	available	amod	1	SENT_267	[p18l1109t2588r1492b2668],
9	with	IN	O	with	_	0	SENT_267	[p18l1545t2588r1746b2668],
10	the	DT	O	the	det	12	SENT_267	[p18l1804t2588r1940b2667],
11	full	JJ	O	full	amod	12	SENT_267	[p18l1997t2587r2150b2668],
12	text	NN	O	text	prep_with	8	SENT_267	[p18l11t2734r175b2796],
13	of	IN	O	of	_	0	SENT_267	[p18l213t2716r315b2797],
14	this	DT	O	this	det	15	SENT_267	[p18l339t2717r503b2796],
15	article	NN	O	article	prep_of	12	SENT_267	[p18l546t2717r823b2796],
16	at	IN	O	at	_	0	SENT_267	[p18l864t2734r945b2796],
17	NEJM.org	NN	O	nejm.org	nn	18	SENT_267	[p18l979t2724r1468b2819],
18	)	NN	O	)	prep_at	15	SENT_267	[p18l979t2724r1468b2819],
19	.	.	O	.	_	0	SENT_267	[p18l979t2724r1468b2819],

1	At	IN	O	at	_	0	SENT_268	[p18l136t2853r236b2923],
2	present	JJ	DATE	present	prep_at	14	SENT_268	[p18l276t2862r619b2945],
3	,	,	O	,	_	0	SENT_268	[p18l276t2862r619b2945],
4	the	DT	O	the	det	5	SENT_268	[p18l672t2845r805b2923],
5	detection	NN	O	detection	nsubj	14	SENT_268	[p18l852t2845r1253b2924],
6	of	IN	O	of	_	0	SENT_268	[p18l1300t2844r1400b2924],
7	early	JJ	O	early	amod	8	SENT_268	[p18l1429t2845r1637b2945],
8	relapse	NN	O	relapse	prep_of	5	SENT_268	[p18l1678t2845r1982b2945],
9	for	IN	O	for	_	0	SENT_268	[p18l2029t2844r2153b2924],
10	most	JJS	O	most	amod	11	SENT_268	[p18l10t2991r228b3053],
11	cancers	NNS	O	cancer	prep_for	8	SENT_268	[p18l284t3000r607b3052],
12	does	VBZ	O	do	aux	14	SENT_268	[p18l670t2974r865b3053],
13	not	RB	O	not	neg	14	SENT_268	[p18l928t2991r1071b3053],
14	yield	VB	O	yield	_	0	SENT_268	[p18l1123t2974r1326b3074],
15	improvements	NNS	O	improvement	dobj	14	SENT_268	[p18l1385t2975r2003b3074],
16	in	IN	O	in	_	0	SENT_268	[p18l2065t2975r2149b3052],
17	survival	NN	O	survival	prep_in	14	SENT_268	[p18l11t3103r369b3199],
18	,	,	O	,	_	0	SENT_268	[p18l11t3103r369b3199],
19	and	CC	O	and	_	0	SENT_268	[p18l411t3103r570b3182],
20	this	DT	O	this	nsubj	22	SENT_268	[p18l608t3103r768b3181],
21	will	MD	O	will	aux	22	SENT_268	[p18l803t3103r969b3182],
22	continue	VB	O	continue	conj_and	14	SENT_268	[p18l1007t3104r1382b3182],
23	to	TO	O	to	aux	26	SENT_268	[p18l1420t3120r1502b3182],
24	be	VB	O	be	cop	26	SENT_268	[p18l1541t3103r1638b3182],
25	the	DT	O	the	det	26	SENT_268	[p18l1677t3103r1810b3181],
26	case	NN	O	case	xcomp	22	SENT_268	[p18l1848t3129r2029b3181],
27	in	IN	O	in	_	0	SENT_268	[p18l2066t3104r2150b3181],
28	the	DT	O	the	det	29	SENT_268	[p18l11t3231r144b3309],
29	absence	NN	O	absence	prep_in	26	SENT_268	[p18l218t3231r558b3310],
30	of	IN	O	of	_	0	SENT_268	[p18l634t3230r734b3310],
31	more	JJR	O	more	amod	33	SENT_268	[p18l790t3257r1011b3310],
32	effective	JJ	O	effective	amod	33	SENT_268	[p18l1086t3230r1447b3311],
33	therapies	NNS	O	therapy	prep_of	29	SENT_268	[p18l1522t3231r1939b3331],
34	.	.	O	.	_	0	SENT_268	[p18l1522t3231r1939b3331],

1	We	PRP	O	we	nsubj	3	SENT_269	[p18l2015t3239r2149b3309],
2	would	MD	O	would	aux	3	SENT_269	[p18l6t3359r274b3439],
3	hope	VB	O	hope	_	0	SENT_269	[p18l315t3359r525b3459],
4	that	IN	O	that	complm	8	SENT_269	[p18l568t3359r741b3437],
5	such	JJ	O	such	amod	6	SENT_269	[p18l779t3359r975b3439],
6	therapies	NNS	O	therapy	nsubj	8	SENT_269	[p18l1016t3359r1409b3459],
7	will	MD	O	will	aux	8	SENT_269	[p18l1449t3359r1614b3439],
8	result	VB	O	result	ccomp	3	SENT_269	[p18l1656t3359r1901b3439],
9	from	IN	O	from	_	0	SENT_269	[p18l1938t3358r2149b3438],
10	the	DT	O	the	det	11	SENT_269	[p18l11t3488r144b3567],
11	generation	NN	O	generation	prep_from	8	SENT_269	[p18l209t3489r672b3590],
12	of	IN	O	of	_	0	SENT_269	[p18l737t3487r837b3568],
13	catalogues	NNS	O	catalogue	prep_of	11	SENT_269	[p18l884t3488r1344b3590],
14	of	IN	O	of	_	0	SENT_269	[p18l1411t3487r1512b3568],
15	recurrent	JJ	O	recurrent	amod	17	SENT_269	[p18l1557t3505r1960b3568],
16	somatic	JJ	O	somatic	amod	17	SENT_269	[p18l2021t3514r2148b3568, p18l10t3618r252b3696],
17	mutations	NNS	O	mutation	prep_of	13	SENT_269	[p18l293t3618r732b3697],
18	among	IN	O	among	_	0	SENT_269	[p18l776t3643r1078b3719],
19	most	JJS	O	most	prep_among	8	SENT_269	[p18l1117t3634r1335b3697],
20	of	IN	O	of	_	0	SENT_269	[p18l1373t3616r1474b3697],
21	the	DT	O	the	det	23	SENT_269	[p18l1498t3617r1632b3696],
22	major	JJ	O	major	amod	23	SENT_269	[p18l1674t3618r1927b3718],
23	cancer	NN	O	cancer	prep_of	19	SENT_269	[p18l1967t3643r2148b3696, p19l11t46r139b98],

1	types	NNS	O	type	_	0	SENT_270	[p19l185t37r435b120],
2	.	.	O	.	_	0	SENT_270	[p19l185t37r435b120],

1	However	RB	O	however	advmod	7	SENT_271	[p19l489t28r887b116],
2	,	,	O	,	_	0	SENT_271	[p19l489t28r887b116],
3	early	JJ	O	early	amod	4	SENT_271	[p19l942t20r1149b120],
4	detection	NN	O	detection	nsubj	7	SENT_271	[p19l1195t20r1595b99],
5	is	VBZ	O	be	cop	7	SENT_271	[p19l1643t21r1709b98],
6	currently	RB	DATE	currently	advmod	7	SENT_271	[p19l1761t20r2154b120],
7	likely	JJ	O	likely	_	0	SENT_271	[p19l9t149r239b250],
8	to	TO	O	to	aux	10	SENT_271	[p19l270t166r351b229],
9	be	VB	O	be	cop	10	SENT_271	[p19l389t149r486b229],
10	important	JJ	O	important	xcomp	7	SENT_271	[p19l521t150r958b250],
11	for	IN	O	for	_	0	SENT_271	[p19l988t148r1110b229],
12	cancers	NNS	O	cancer	prep_for	10	SENT_271	[p19l1144t175r1460b228],
13	(	CD	NUMBER	(	tmod	10	SENT_271	[p19l1504t156r1694b251],
14	e.g.	FW	O	e.g.	tmod	10	SENT_271	[p19l1504t156r1694b251],
15	,	,	O	,	_	0	SENT_271	[p19l1504t156r1694b251],
16	colorectal	JJ	O	colorectal	amod	18	SENT_271	[p19l1736t149r2150b229],
17	cancer	NN	O	cancer	nn	18	SENT_271	[p19l11t285r317b370],
18	)	NN	O	)	appos	14	SENT_271	[p19l11t285r317b370],
19	for	IN	O	for	_	0	SENT_271	[p19l366t277r490b358],
20	which	WDT	O	which	rel	26	SENT_271	[p19l526t278r791b358],
21	surgical	JJ	O	surgical	amod	22	SENT_271	[p19l837t278r1180b380],
22	resection	NN	O	resection	nsubj	26	SENT_271	[p19l1224t279r1618b358],
23	of	IN	O	of	_	0	SENT_271	[p19l1662t277r1763b358],
24	relapsed	JJ	O	relapsed	amod	25	SENT_271	[p19l1788t278r2149b379],
25	disease	NN	O	disease	prep_of	22	SENT_271	[p19l11t407r323b486],
26	translates	VBZ	O	translate	rcmod	18	SENT_271	[p19l357t407r777b485],
27	into	IN	O	into	_	0	SENT_271	[p19l812t408r983b486],
28	substantial	JJ	O	substantial	amod	29	SENT_271	[p19l1019t407r1498b486],
29	improvements	NNS	O	improvement	prep_into	26	SENT_271	[p19l1530t408r2148b507],
30	in	IN	O	in	_	0	SENT_271	[p19l10t537r93b614],
31	survival	NN	O	survival	prep_in	29	SENT_271	[p19l143t536r500b616],
32	.	.	O	.	_	0	SENT_271	[p19l143t536r500b616],

1	The	DT	O	the	det	2	SENT_272	[p19l550t536r712b615],
2	utility	NN	O	utility	nsubj	6	SENT_272	[p19l760t536r1019b637],
3	of	IN	O	of	_	0	SENT_272	[p19l1063t535r1164b616],
4	this	DT	O	this	det	5	SENT_272	[p19l1194t536r1355b615],
5	strategy	NN	O	strategy	prep_of	2	SENT_272	[p19l1406t553r1754b638],
6	requires	VBZ	O	require	_	0	SENT_272	[p19l1796t537r2147b637],
7	stringent	JJ	O	stringent	amod	8	SENT_272	[p19l11t666r406b766],
8	evaluation	NN	O	evaluation	dobj	6	SENT_272	[p19l441t665r886b744],
9	through	IN	O	through	_	0	SENT_272	[p19l926t665r1277b766],
10	clinical	JJ	O	clinical	amod	11	SENT_272	[p19l1318t665r1634b743],
11	trials	NNS	O	trial	prep_through	6	SENT_272	[p19l1673t665r1919b744],
12	.	.	O	.	_	0	SENT_272	[p19l1673t665r1919b744],

1	GENOMICS	NNP	O	GENOMICS	_	0	SENT_273	[p19l314t1003r911b1064],
2	IN	IN	O	in	dep	1	SENT_273	[p19l967t1004r1092b1063],
3	THE	DT	O	the	det	4	SENT_273	[p19l1144t1004r1365b1062],
4	DESIGN	NN	O	design	pobj	2	SENT_273	[p19l1420t1003r1842b1063],

1	OF	IN	O	of	_	0	SENT_274	[p19l491t1112r623b1172],
2	CLINICAL	NNP	O	CLINICAL	nn	3	SENT_274	[p19l675t1112r1219b1172],
3	TRIALS	NNS	O	trial	pobj	1	SENT_274	[p19l1266t1112r1668b1172],

1	As	IN	O	as	mark	2	SENT_275	[p19l6t1354r113b1425],
2	described	VBN	O	describe	advcl	13	SENT_275	[p19l148t1346r562b1426],
3	earlier	RBR	O	earlier	advmod	2	SENT_275	[p19l595t1346r889b1443],
4	,	,	O	,	_	0	SENT_275	[p19l595t1346r889b1443],
5	the	DT	O	the	det	6	SENT_275	[p19l926t1346r1060b1425],
6	targets	NNS	O	target	nsubj	13	SENT_275	[p19l1093t1363r1390b1448],
7	of	IN	O	of	_	0	SENT_275	[p19l1424t1345r1525b1426],
8	many	JJ	O	many	amod	11	SENT_275	[p19l1538t1372r1779b1447],
9	new	JJ	O	new	amod	11	SENT_275	[p19l1806t1372r1985b1426],
10	anticancer	JJ	O	anticancer	amod	11	SENT_275	[p19l2012t1372r2148b1425, p19l11t1476r357b1554],
11	drugs	NNS	O	drug	prep_of	6	SENT_275	[p19l415t1475r660b1576],
12	are	VBP	O	be	cop	13	SENT_275	[p19l722t1501r853b1553],
13	proteins	NNS	O	protein	_	0	SENT_275	[p19l912t1476r1267b1575],
14	encoded	VBN	O	encode	partmod	13	SENT_275	[p19l1331t1475r1690b1554],
15	by	IN	O	by	_	0	SENT_275	[p19l1751t1475r1848b1575],
16	genes	NNS	O	gene	agent	14	SENT_275	[p19l1904t1501r2147b1576],
17	with	IN	O	with	_	0	SENT_275	[p19l6t1603r202b1682],
18	driver	NN	O	driver	nn	20	SENT_275	[p19l252t1603r502b1682],
19	somatic	JJ	O	somatic	amod	20	SENT_275	[p19l548t1604r887b1682],
20	mutations	NNS	O	mutation	prep_with	16	SENT_275	[p19l935t1604r1373b1682],
21	in	IN	O	in	_	0	SENT_275	[p19l1422t1604r1506b1681],
22	cancer	NN	O	cancer	prep_in	20	SENT_275	[p19l1556t1629r1856b1682],
23	.	.	O	.	_	0	SENT_275	[p19l1556t1629r1856b1682],

1	Thus	RB	O	thus	advmod	8	SENT_276	[p19l1907t1603r2144b1699],
2	,	,	O	,	_	0	SENT_276	[p19l1907t1603r2144b1699],
3	many	JJ	O	many	amod	5	SENT_276	[p19l10t1758r251b1833],
4	such	JJ	O	such	amod	5	SENT_276	[p19l294t1732r490b1812],
5	agents	NNS	O	agent	nsubj	8	SENT_276	[p19l535t1749r814b1834],
6	may	MD	O	may	aux	8	SENT_276	[p19l863t1758r1043b1833],
7	be	VB	O	be	cop	8	SENT_276	[p19l1086t1732r1183b1812],
8	efficacious	JJ	O	efficacious	_	0	SENT_276	[p19l1231t1731r1699b1812],
9	only	RB	O	only	advmod	8	SENT_276	[p19l1749t1732r1934b1833],
10	in	IN	O	in	_	0	SENT_276	[p19l1976t1733r2060b1810],
11	a	DT	O	a	det	12	SENT_276	[p19l2106t1759r2151b1811],
12	subgroup	NN	O	subgroup	prep_in	8	SENT_276	[p19l12t1861r418b1963],
13	of	IN	O	of	_	0	SENT_276	[p19l453t1860r554b1941],
14	patients	NNS	O	patient	prep_of	12	SENT_276	[p19l568t1862r911b1962],
15	Whose	WP$	O	whose	poss	16	SENT_276	[p19l943t1861r1219b1941],
16	tumors	NNS	O	tumor	nsubj	17	SENT_276	[p19l1253t1878r1563b1941],
17	harbor	VBP	O	harbor	rcmod	14	SENT_276	[p19l1599t1861r1893b1941],
18	these	DT	O	these	det	19	SENT_276	[p19l1924t1861r2149b1940],
19	mutations	NNS	O	mutation	dobj	17	SENT_276	[p19l10t2116r371b2177],
20	.	.	O	.	_	0	SENT_276	[p19l10t2116r371b2177],

1	Since	IN	O	since	mark	7	SENT_277	[p19l406t2116r580b2177],
2	this	DT	O	this	det	3	SENT_277	[p19l609t2115r734b2176],
3	subgroup	NN	O	subgroup	nsubj	7	SENT_277	[p19l765t2115r1082b2194],
4	may	MD	O	may	aux	7	SENT_277	[p19l1111t2135r1252b2193],
5	be	VB	O	be	cop	7	SENT_277	[p19l1277t2115r1353b2177],
6	relatively	RB	O	relatively	advmod	7	SENT_277	[p19l1381t2115r1684b2193],
7	small	JJ	O	small	advcl	17	SENT_277	[p19l11t2215r213b2290],
8	,	,	O	,	_	0	SENT_277	[p19l11t2215r213b2290],
9	the	DT	O	the	det	10	SENT_277	[p19l253t2215r357b2276],
10	effectiveness	NN	O	effectiveness	nsubjpass	17	SENT_277	[p19l393t2214r823b2277],
11	of	IN	O	of	_	0	SENT_277	[p19l861t2214r939b2277],
12	some	DT	O	some	det	13	SENT_277	[p19l961t2235r1137b2277],
13	drugs	NNS	O	drug	prep_of	10	SENT_277	[p19l1172t2215r1364b2294],
14	may	MD	O	may	aux	17	SENT_277	[p19l1400t2235r1541b2293],
15	not	RB	O	not	neg	17	SENT_277	[p19l1572t2228r1684b2277],
16	be	VB	O	be	auxpass	17	SENT_277	[p19l11t2315r86b2377],
17	detected	VBN	O	detect	_	0	SENT_277	[p19l127t2315r409b2377],
18	if	IN	O	if	mark	23	SENT_277	[p19l448t2314r509b2376],
19	the	DT	O	the	det	21	SENT_277	[p19l535t2315r640b2376],
20	study	NN	O	study	nn	21	SENT_277	[p19l681t2315r862b2393],
21	group	NN	O	group	nsubjpass	23	SENT_277	[p19l898t2335r1096b2394],
22	is	VBZ	O	be	auxpass	23	SENT_277	[p19l1137t2316r1189b2376],
23	composed	VBN	O	compose	advcl	17	SENT_277	[p19l1231t2315r1576b2393],
24	of	IN	O	of	_	0	SENT_277	[p19l1616t2314r1695b2377],
25	patients	NNS	O	patient	prep_of	23	SENT_277	[p19l9t2416r277b2493],
26	who	WP	O	who	nsubjpass	29	SENT_277	[p19l301t2415r445b2477],
27	are	VBP	O	be	auxpass	29	SENT_277	[p19l471t2435r572b2476],
28	not	RB	O	not	neg	29	SENT_277	[p19l598t2428r710b2477],
29	selected	VBN	O	select	rcmod	25	SENT_277	[p19l733t2415r1000b2477],
30	on	IN	O	on	_	0	SENT_277	[p19l1025t2435r1109b2477],
31	the	DT	O	the	det	32	SENT_277	[p19l1134t2415r1239b2476],
32	basis	NN	O	basis	prep_on	29	SENT_277	[p19l1265t2415r1431b2477],
33	of	IN	O	of	_	0	SENT_277	[p19l1458t2414r1537b2477],
34	mutation	NN	O	mutation	nn	35	SENT_277	[p19l1548t2435r1679b2477, p19l11t2516r209b2577],
35	status	NN	O	status	prep_of	32	SENT_277	[p19l239t2528r456b2577],
36	.	.	O	.	_	0	SENT_277	[p19l239t2528r456b2577],

1	This	DT	O	this	det	2	SENT_278	[p19l487t2515r634b2576],
2	finding	NN	O	finding	nsubj	4	SENT_278	[p19l665t2514r920b2594],
3	has	VBZ	O	have	aux	4	SENT_278	[p19l947t2515r1060b2576],
4	prompted	VBN	O	prompt	_	0	SENT_278	[p19l1089t2515r1420b2593],
5	changes	NNS	O	change	dobj	4	SENT_278	[p19l1450t2515r1679b2594, p19l11t2635r76b2676],
6	to	TO	O	to	_	0	SENT_278	[p19l111t2628r175b2677],
7	standard	JJ	O	standard	amod	9	SENT_278	[p19l210t2615r508b2677],
8	clinical-trial	JJ	O	clinical-trial	amod	9	SENT_278	[p19l541t2615r955b2676],
9	design	NN	O	design	prep_to	4	SENT_278	[p19l988t2615r1209b2694],
10	in	IN	O	in	_	0	SENT_278	[p19l1241t2616r1307b2676],
11	which	WDT	O	which	rel	16	SENT_278	[p19l1336t2615r1543b2677],
12	the	DT	O	the	det	14	SENT_278	[p19l1576t2615r1680b2676],
13	study	NN	O	study	nn	14	SENT_278	[p19l11t2715r192b2793],
14	population	NN	O	population	nsubjpass	16	SENT_278	[p19l211t2715r582b2793],
15	is	VBZ	O	be	auxpass	16	SENT_278	[p19l606t2716r658b2776],
16	enriched	VBN	O	enrich	rcmod	9	SENT_278	[p19l684t2715r976b2777],
17	with	IN	O	with	_	0	SENT_278	[p19l997t2715r1150b2777],
18	patients	NNS	O	patient	prep_with	16	SENT_278	[p19l1173t2716r1442b2793],
19	whose	WP$	O	whose	poss	20	SENT_278	[p19l1465t2715r1680b2777],
20	tumors	NNS	O	tumor	nsubj	21	SENT_278	[p19l11t2828r253b2877],
21	carry	VBP	O	carry	rcmod	18	SENT_278	[p19l284t2835r458b2893],
22	a	DT	O	a	det	24	SENT_278	[p19l483t2835r518b2876],
23	particular	JJ	O	particular	amod	24	SENT_278	[p19l544t2815r882b2893],
24	mutation	NN	O	mutation	dobj	21	SENT_278	[p19l909t2816r1236b2890],
25	,	,	O	,	_	0	SENT_278	[p19l909t2816r1236b2890],
26	set	NN	O	set	dobj	21	SENT_278	[p19l1270t2828r1365b2876],
27	of	IN	O	of	_	0	SENT_278	[p19l1390t2814r1469b2877],
28	mutations	NNS	O	mutation	prep_of	26	SENT_278	[p19l1483t2828r1679b2877, p19l11t2916r196b2990],
29	,	,	O	,	_	0	SENT_278	[p19l1483t2828r1679b2877, p19l11t2916r196b2990],
30	or	CC	O	or	_	0	SENT_278	[p19l240t2935r310b2977],
31	other	JJ	O	other	amod	32	SENT_278	[p19l348t2915r527b2977],
32	biomarker	NN	O	biomarker	dobj	21	SENT_278	[p19l565t2915r916b2977],
33	increasing	VBG	O	increase	partmod	32	SENT_278	[p19l952t2916r1306b2994],
34	the	DT	O	the	det	35	SENT_278	[p19l1343t2915r1447b2976],
35	likelihood	NN	O	likelihood	dobj	33	SENT_278	[p19l1486t2915r1679b2977, p19l10t3016r182b3078],
36	that	IN	O	that	complm	41	SENT_278	[p19l221t3016r356b3077],
37	such	JJ	O	such	amod	38	SENT_278	[p19l392t3016r545b3078],
38	tumors	NNS	O	tumor	nsubj	41	SENT_278	[p19l584t3029r826b3078],
39	will	MD	O	will	aux	41	SENT_278	[p19l863t3016r992b3078],
40	be	VB	O	be	cop	41	SENT_278	[p19l1031t3016r1107b3078],
41	sensitive	JJ	O	sensitive	ccomp	33	SENT_278	[p19l1147t3017r1433b3078],
42	to	TO	O	to	_	0	SENT_278	[p19l1472t3029r1536b3078],
43	the	DT	O	the	det	45	SENT_278	[p19l1576t3016r1681b3077],
44	intervention	NN	O	intervention	nn	45	SENT_278	[p19l10t3118r652b3179],
45	.2	NN	NUMBER	.2	prep_to	41	SENT_278	[p19l10t3118r652b3179],
46	°	CD	NUMBER	°	num	47	SENT_278	[p19l10t3118r652b3179],
47	>	JJR	O	>	dep	45	SENT_278	[p19l10t3118r652b3179],
48	21	CD	NUMBER	21	number	49	SENT_278	[p19l10t3118r652b3179],
49	’53	CD	NUMBER	’53	dep	47	SENT_278	[p19l10t3118r652b3179],

1	For	IN	O	for	_	0	SENT_279	[p19l110t3223r222b3279],
2	some	DT	O	some	det	3	SENT_279	[p19l251t3237r427b3279],
3	drugs	NNS	O	drug	prep_for	8	SENT_279	[p19l458t3217r669b3296],
4	,	,	O	,	_	0	SENT_279	[p19l458t3217r669b3296],
5	however	RB	O	however	advmod	8	SENT_279	[p19l703t3217r998b3292],
6	,	,	O	,	_	0	SENT_279	[p19l703t3217r998b3292],
7	there	EX	O	there	expl	8	SENT_279	[p19l1033t3217r1203b3278],
8	is	VBZ	O	be	_	0	SENT_279	[p19l1232t3218r1284b3278],
9	no	DT	O	no	det	12	SENT_279	[p19l1316t3237r1399b3279],
10	a	DT	O	a	det	11	SENT_279	[p19l1429t3237r1464b3278],
11	priori	FW	O	priori	nn	12	SENT_279	[p19l1491t3218r1681b3295],
12	indication	NN	O	indication	nsubj	8	SENT_279	[p19l10t3317r353b3379],
13	of	IN	O	of	_	0	SENT_279	[p19l385t3316r464b3379],
14	the	DT	O	the	det	16	SENT_279	[p19l481t3317r585b3378],
15	biologic	JJ	O	biologic	amod	16	SENT_279	[p19l617t3317r886b3396],
16	determinants	NNS	O	determinant	prep_of	12	SENT_279	[p19l917t3317r1371b3379],
17	underlying	VBG	O	underlie	partmod	16	SENT_279	[p19l1403t3317r1679b3395, p19l10t3418r120b3496],
18	the	DT	O	the	det	19	SENT_279	[p19l143t3417r247b3478],
19	responsiveness	NN	O	responsiveness	dobj	17	SENT_279	[p19l273t3418r777b3495],
20	of	IN	O	of	_	0	SENT_279	[p19l805t3416r884b3479],
21	a	DT	O	a	det	22	SENT_279	[p19l894t3437r929b3478],
22	subgroup	NN	O	subgroup	prep_of	19	SENT_279	[p19l955t3417r1272b3496],
23	of	IN	O	of	_	0	SENT_279	[p19l1299t3416r1378b3479],
24	patients	NNS	O	patient	prep_of	22	SENT_279	[p19l1388t3418r1676b3495],
25	,	,	O	,	_	0	SENT_279	[p19l1388t3418r1676b3495],
26	and	CC	O	and	_	0	SENT_279	[p19l10t3517r134b3579],
27	therefore	RB	O	therefore	advmod	31	SENT_279	[p19l177t3516r483b3579],
28	it	PRP	O	it	nsubj	31	SENT_279	[p19l525t3518r572b3578],
29	is	VBZ	O	be	cop	31	SENT_279	[p19l610t3518r662b3578],
30	not	RB	O	not	neg	31	SENT_279	[p19l706t3530r818b3579],
31	possible	JJ	O	possible	conj_and	8	SENT_279	[p19l856t3517r1132b3595],
32	to	TO	O	to	aux	33	SENT_279	[p19l1175t3530r1239b3579],
33	reconfigure	NN	O	reconfigure	xcomp	31	SENT_279	[p19l1283t3516r1680b3596],
34	trial	NN	O	trial	nn	35	SENT_279	[p19l11t3617r150b3678],
35	design	NN	O	design	dobj	33	SENT_279	[p19l202t3617r440b3696],
36	.	.	O	.	_	0	SENT_279	[p19l202t3617r440b3696],

1	Nevertheless	RB	O	nevertheless	advmod	11	SENT_280	[p19l494t3617r943b3692],
2	,	,	O	,	_	0	SENT_280	[p19l494t3617r943b3692],
3	currently	RB	DATE	currently	advmod	5	SENT_280	[p19l999t3617r1306b3695],
4	undiscovered	JJ	O	undiscovered	amod	5	SENT_280	[p19l1353t3617r1679b3679, p19l11t3717r153b3779],
5	determinants	NNS	O	determinant	nsubj	11	SENT_280	[p19l195t3717r648b3779],
6	of	IN	O	of	_	0	SENT_280	[p19l692t3716r771b3779],
7	sensitivity	NN	O	sensitivity	prep_of	5	SENT_280	[p19l799t3718r1140b3795],
8	and	CC	O	and	_	0	SENT_280	[p19l1177t3717r1301b3779],
9	resistance	NN	O	resistance	prep_of	5	SENT_280	[p19l1343t3718r1680b3778],
10	are	VBP	O	be	cop	11	SENT_280	[p20l10t38r111b79],
11	likely	JJ	O	likely	_	0	SENT_280	[p20l150t18r332b96],
12	to	TO	O	to	aux	14	SENT_280	[p20l369t31r433b80],
13	be	VB	O	be	auxpass	14	SENT_280	[p20l474t18r550b80],
14	buried	VBN	O	bury	xcomp	11	SENT_280	[p20l590t18r806b80],
15	within	IN	O	within	_	0	SENT_280	[p20l842t18r1067b80],
16	the	DT	O	the	det	17	SENT_280	[p20l1106t18r1211b79],
17	genome	NN	O	genome	prep_within	14	SENT_280	[p20l1250t38r1518b97],
18	and	CC	O	and	_	0	SENT_280	[p20l1557t18r1681b80],
19	transcriptome	NN	O	transcriptome	prep_within	14	SENT_280	[p20l11t119r489b196],
20	of	IN	O	of	_	0	SENT_280	[p20l524t117r602b180],
21	each	DT	O	each	det	22	SENT_280	[p20l623t118r774b179],
22	tumor	NN	O	tumor	prep_of	17	SENT_280	[p20l809t131r1033b180],
23	.	.	O	.	_	0	SENT_280	[p20l809t131r1033b180],

1	With	IN	O	with	_	0	SENT_281	[p20l1069t118r1237b179],
2	the	DT	O	the	det	3	SENT_281	[p20l1272t118r1376b179],
3	costs	NNS	O	cost	nsubj	7	SENT_281	[p20l1411t131r1580b180],
4	of	IN	O	of	_	0	SENT_281	[p20l1616t117r1695b180],
5	genome	NN	O	genome	nn	6	SENT_281	[p20l10t238r277b297],
6	sequencing	NN	O	sequencing	prep_of	3	SENT_281	[p20l314t219r697b297],
7	dropping	VBG	O	drop	prepc_with	12	SENT_281	[p20l731t218r1043b297],
8	precipitously	RB	O	precipitously	advmod	7	SENT_281	[p20l1075t218r1521b296],
9	,	,	O	,	_	0	SENT_281	[p20l1075t218r1521b296],
10	one	CD	NUMBER	one	nsubj	12	SENT_281	[p20l1561t238r1680b280],
11	could	MD	O	could	aux	12	SENT_281	[p20l11t319r195b381],
12	consider	VB	O	consider	_	0	SENT_281	[p20l230t319r517b381],
13	in	IN	O	in	_	0	SENT_281	[p20l549t320r614b380],
14	the	DT	O	the	det	20	SENT_281	[p20l649t319r754b381],
15	not	RB	O	not	neg	18	SENT_281	[p20l789t319r1304b381],
16	—	RB	O	—	advmod	18	SENT_281	[p20l789t319r1304b381],
17	too	RB	O	too	advmod	18	SENT_281	[p20l789t319r1304b381],
18	—	RB	O	—	amod	20	SENT_281	[p20l789t319r1304b381],
19	distant	JJ	O	distant	amod	20	SENT_281	[p20l789t319r1304b381],
20	future	NN	DATE	future	prep_in	12	SENT_281	[p20l1334t318r1541b381],
21	the	DT	O	the	det	23	SENT_281	[p20l1576t319r1680b380],
22	complete	JJ	O	complete	amod	23	SENT_281	[p20l11t419r316b497],
23	sequencing	NN	O	sequencing	dep	20	SENT_281	[p20l372t420r755b498],
24	of	IN	O	of	_	0	SENT_281	[p20l807t418r886b481],
25	cancer	NN	O	cancer	nn	26	SENT_281	[p20l927t439r1147b480],
26	genomes	NNS	O	genome	prep_of	23	SENT_281	[p20l1200t439r1500b498],
27	and	CC	O	and	_	0	SENT_281	[p20l1556t419r1680b481],
28	transcriptomes	NNS	O	transcriptome	prep_of	23	SENT_281	[p20l11t521r522b598],
29	as	IN	O	as	_	0	SENT_281	[p20l573t540r641b581],
30	routine	JJ	O	routine	amod	31	SENT_281	[p20l692t521r935b582],
31	accompaniments	NNS	O	accompaniment	prep_as	12	SENT_281	[p20l985t521r1563b598],
32	to	TO	O	to	_	0	SENT_281	[p20l1615t533r1679b582],
33	clinical	JJ	O	clinical	amod	34	SENT_281	[p20l11t620r257b681],
34	trials	NNS	O	trial	prep_to	31	SENT_281	[p20l290t620r463b681],
35	of	IN	O	of	_	0	SENT_281	[p20l499t619r577b682],
36	cancer	NN	O	cancer	nn	37	SENT_281	[p20l597t640r818b681],
37	drugs	NNS	O	drug	prep_of	34	SENT_281	[p20l849t620r1041b699],
38	in	IN	O	in	mark	41	SENT_281	[p20l1075t621r1141b681],
39	order	NN	O	order	dep	41	SENT_281	[p20l1175t620r1354b682],
40	to	TO	O	to	aux	41	SENT_281	[p20l1385t633r1449b682],
41	reveal	VB	O	reveal	purpcl	12	SENT_281	[p20l1484t620r1681b682],
42	these	DT	O	these	det	43	SENT_281	[p20l11t721r186b782],
43	determinants	NNS	O	determinant	dobj	41	SENT_281	[p20l218t721r691b783],
44	.	.	O	.	_	0	SENT_281	[p20l218t721r691b783],

1	SUSCEPTIBILITY	NN	O	susceptibility	_	0	SENT_282	[p20l218t955r938b1001],
2	TO	TO	O	to	infmod	1	SENT_282	[p20l971t954r1081b1001],
3	CANCER	NNP	O	CANCER	dep	1	SENT_282	[p20l1123t955r1479b1001],

1	Several	JJ	O	several	amod	4	SENT_283	[p20l12t1159r247b1222],
2	inherited	VBN	O	inherit	amod	4	SENT_283	[p20l285t1159r592b1222],
3	abnormal	JJ	O	abnormal	amod	4	SENT_283	[p20l629t1159r957b1222],
4	genes	NNS	O	gene	nsubjpass	24	SENT_283	[p20l995t1180r1185b1239],
5	that	WDT	O	that	nsubj	6	SENT_283	[p20l1225t1159r1361b1221],
6	confer	VBP	O	confer	rcmod	4	SENT_283	[p20l1396t1159r1611b1222],
7	a	DT	O	a	det	10	SENT_283	[p20l1647t1180r1682b1221],
8	substantially	RB	O	substantially	advmod	9	SENT_283	[p20l11t1260r447b1338],
9	elevated	JJ	O	elevated	amod	10	SENT_283	[p20l473t1260r742b1322],
10	risk	NN	O	risk	nsubj	16	SENT_283	[p20l770t1260r899b1322],
11	of	IN	O	of	_	0	SENT_283	[p20l925t1259r1004b1322],
12	cancer	NN	O	cancer	prep_of	10	SENT_283	[p20l1019t1280r1240b1321],
13	and	CC	O	and	_	0	SENT_283	[p20l1266t1260r1390b1322],
14	that	DT	O	that	prep_of	10	SENT_283	[p20l1419t1260r1554b1321],
15	are	VBP	O	be	cop	16	SENT_283	[p20l1579t1280r1680b1321],
16	present	JJ	DATE	present	ccomp	6	SENT_283	[p20l9t1373r260b1438],
17	in	IN	O	in	_	0	SENT_283	[p20l287t1361r353b1421],
18	families	NNS	O	family	prep_in	16	SENT_283	[p20l384t1359r656b1421],
19	with	IN	O	with	_	0	SENT_283	[p20l686t1360r839b1422],
20	multiple	JJ	O	multiple	amod	22	SENT_283	[p20l871t1360r1151b1438],
21	affected	JJ	O	affected	amod	22	SENT_283	[p20l1182t1359r1454b1422],
22	members	NNS	O	member	prep_with	18	SENT_283	[p20l1485t1380r1679b1421, p20l11t1461r150b1523],
23	were	VBD	O	be	auxpass	24	SENT_283	[p20l174t1481r333b1523],
24	discovered	VBN	O	discover	_	0	SENT_283	[p20l360t1461r717b1523],
25	in	IN	O	in	_	0	SENT_283	[p20l742t1462r808b1522],
26	the	DT	DATE	the	det	27	SENT_283	[p20l834t1461r938b1522],
27	decades	NNS	DATE	decade	prep_in	24	SENT_283	[p20l965t1461r1228b1523],
28	before	IN	DATE	before	_	0	SENT_283	[p20l1256t1460r1468b1523],
29	2000	CD	DATE	2000	prep_before	24	SENT_283	[p20l1494t1466r1676b1523],
30	.	.	O	.	_	0	SENT_283	[p20l1494t1466r1676b1523],

1	Examples	NNS	O	example	nsubj	3	SENT_284	[p20l9t1561r332b1640],
2	are	VBP	O	be	cop	3	SENT_284	[p20l364t1582r466b1622],
3	BRCA1	NN	O	brca1	_	0	SENT_284	[p20l496t1566r705b1624],
4	and	CC	O	and	_	0	SENT_284	[p20l737t1561r862b1623],
5	BRCA2	NN	O	brca2	conj_and	3	SENT_284	[p20l891t1566r1118b1635],
6	,	,	O	,	_	0	SENT_284	[p20l891t1566r1118b1635],
7	in	IN	O	in	_	0	SENT_284	[p20l1152t1562r1218b1622],
8	which	WDT	O	which	rel	10	SENT_284	[p20l1245t1561r1452b1623],
9	mutations	NNS	O	mutation	nsubj	10	SENT_284	[p20l1483t1574r1679b1623, p20l11t1663r177b1725],
10	confer	VBP	O	confer	rcmod	3	SENT_284	[p20l204t1662r420b1725],
11	an	DT	O	a	det	13	SENT_284	[p20l442t1683r523b1724],
12	increased	VBN	O	increase	amod	13	SENT_284	[p20l548t1662r869b1725],
13	risk	NN	O	risk	dobj	10	SENT_284	[p20l895t1662r1024b1725],
14	of	IN	O	of	_	0	SENT_284	[p20l1046t1662r1125b1725],
15	breast	NN	O	breast	nn	18	SENT_284	[p20l1136t1662r1342b1725],
16	and	CC	O	and	_	0	SENT_284	[p20l1363t1662r1487b1725],
17	ovarian	JJ	O	ovarian	nn	18	SENT_284	[p20l1513t1683r1679b1725, p20l10t1764r114b1824],
18	cancer	NN	O	cancer	prep_of	13	SENT_284	[p20l141t1783r376b1838],
19	,	,	O	,	_	0	SENT_284	[p20l141t1783r376b1838],
20	and	CC	O	and	_	0	SENT_284	[p20l405t1763r529b1825],
21	MLHI	NN	ORGANIZATION	mlhus	dobj	10	SENT_284	[p20l555t1768r748b1825],
22	and	CC	O	and	_	0	SENT_284	[p20l776t1763r900b1825],
23	MSH2	NN	O	msh2	conj_and	13	SENT_284	[p20l925t1768r1134b1837],
24	,	,	O	,	_	0	SENT_284	[p20l925t1768r1134b1837],
25	in	IN	O	in	_	0	SENT_284	[p20l1163t1764r1228b1824],
26	which	WDT	O	which	rel	28	SENT_284	[p20l1251t1763r1457b1825],
27	mutations	NNS	O	mutation	nsubj	28	SENT_284	[p20l1483t1776r1679b1825, p20l11t1865r177b1926],
28	confer	VBP	O	confer	rcmod	21	SENT_284	[p20l240t1863r456b1926],
29	an	DT	O	a	det	31	SENT_284	[p20l514t1884r595b1925],
30	increased	VBN	O	increase	amod	31	SENT_284	[p20l655t1864r977b1926],
31	risk	NN	O	risk	dobj	28	SENT_284	[p20l1037t1864r1166b1926],
32	of	IN	O	of	_	0	SENT_284	[p20l1224t1863r1303b1926],
33	colorectal	JJ	O	colorectal	amod	34	SENT_284	[p20l1350t1864r1681b1926],
34	cancer	NN	O	cancer	prep_of	31	SENT_284	[p20l11t1984r246b2026],
35	.	.	O	.	_	0	SENT_284	[p20l11t1984r246b2026],

1	Testing	VBG	O	test	csubj	20	SENT_285	[p20l296t1965r549b2043],
2	for	IN	O	for	_	0	SENT_285	[p20l594t1963r691b2026],
3	mutations	NNS	O	mutation	prep_for	1	SENT_285	[p20l737t1965r1079b2026],
4	in	IN	O	in	_	0	SENT_285	[p20l1128t1965r1194b2025],
5	these	DT	O	these	det	6	SENT_285	[p20l1242t1964r1418b2025],
6	genes	NNS	O	gene	prep_in	3	SENT_285	[p20l1467t1984r1676b2043],
7	,	,	O	,	_	0	SENT_285	[p20l1467t1984r1676b2043],
8	which	WDT	O	which	nsubj	10	SENT_285	[p20l7t2064r213b2126],
9	are	VBP	O	be	cop	10	SENT_285	[p20l235t2084r337b2125],
10	rare	JJ	O	rare	rcmod	6	SENT_285	[p20l360t2084r491b2125],
11	in	IN	O	in	_	0	SENT_285	[p20l513t2065r579b2125],
12	most	JJS	O	most	amod	13	SENT_285	[p20l602t2077r772b2126],
13	populations	NNS	O	population	prep_in	10	SENT_285	[p20l789t2064r1212b2142],
14	,	,	O	,	_	0	SENT_285	[p20l789t2064r1212b2142],
15	is	VBZ	O	be	cop	20	SENT_285	[p20l1238t2065r1290b2125],
16	now	RB	DATE	now	advmod	20	SENT_285	[p20l1314t2084r1459b2126],
17	a	DT	O	a	det	20	SENT_285	[p20l1479t2084r1513b2125],
18	conventional	JJ	O	conventional	amod	20	SENT_285	[p20l1535t2084r1679b2126, p20l7t2164r321b2226],
19	clinical	JJ	O	clinical	amod	20	SENT_285	[p20l353t2164r599b2225],
20	approach	NN	O	approach	_	0	SENT_285	[p20l630t2164r959b2242],
21	.	.	O	.	_	0	SENT_285	[p20l630t2164r959b2242],

1	The	DT	O	the	det	2	SENT_286	[p20l993t2164r1119b2225],
2	results	NNS	O	result	nsubj	6	SENT_286	[p20l1151t2164r1374b2226],
3	of	IN	O	of	_	0	SENT_286	[p20l1408t2163r1487b2226],
4	these	DT	O	these	det	5	SENT_286	[p20l1504t2164r1680b2225],
5	tests	NNS	O	test	prep_of	2	SENT_286	[p20l11t2277r163b2325],
6	influence	VBP	O	influence	_	0	SENT_286	[p20l210t2263r528b2326],
7	screening	NN	O	screening	dobj	6	SENT_286	[p20l575t2265r903b2343],
8	and	CC	O	and	_	0	SENT_286	[p20l946t2264r1070b2326],
9	other	JJ	O	other	amod	11	SENT_286	[p20l1116t2264r1295b2326],
10	preventive	JJ	O	preventive	amod	11	SENT_286	[p20l1338t2265r1680b2342],
11	measures	NNS	O	measure	dobj	6	SENT_286	[p20l10t2364r348b2406],
12	.	.	O	.	_	0	SENT_286	[p20l10t2364r348b2406],

1	Provision	NN	O	provision	nsubj	9	SENT_287	[p20l110t2445r426b2506],
2	of	IN	O	of	_	0	SENT_287	[p20l452t2443r531b2506],
3	the	DT	O	the	det	6	SENT_287	[p20l543t2444r648b2505],
4	human	JJ	O	human	amod	6	SENT_287	[p20l674t2444r913b2506],
5	genome	NN	O	genome	nn	6	SENT_287	[p20l939t2464r1206b2523],
6	sequence	NN	O	sequence	prep_of	1	SENT_287	[p20l1234t2464r1539b2522],
7	has	VBZ	O	have	aux	9	SENT_287	[p20l1566t2444r1679b2505],
8	recently	RB	DATE	recently	advmod	9	SENT_287	[p20l10t2544r278b2622],
9	allowed	VBN	O	allow	_	0	SENT_287	[p20l304t2544r567b2606],
10	cataloguing	NN	O	cataloguing	dobj	9	SENT_287	[p20l597t2544r1002b2623],
11	of	IN	O	of	_	0	SENT_287	[p20l1031t2543r1110b2606],
12	most	JJS	O	most	prep_of	10	SENT_287	[p20l1125t2557r1295b2606],
13	commonly	RB	O	commonly	advmod	14	SENT_287	[p20l1322t2544r1684b2622],
14	inherited	VBN	O	inherit	partmod	12	SENT_287	[p20l10t2644r317b2706],
15	DNA	NN	O	dna	nn	16	SENT_287	[p20l361t2649r525b2706],
16	variants	NNS	O	variant	dobj	14	SENT_287	[p20l565t2645r835b2706],
17	present	JJ	DATE	present	amod	16	SENT_287	[p20l880t2657r1132b2722],
18	in	IN	O	in	_	0	SENT_287	[p20l1172t2645r1238b2705],
19	the	DT	O	the	det	21	SENT_287	[p20l1284t2644r1389b2705],
20	normal	JJ	O	normal	amod	21	SENT_287	[p20l1434t2644r1681b2706],
21	population	NN	O	population	prep_in	17	SENT_287	[p20l9t2744r461b2822],
22	.	.	O	.	_	0	SENT_287	[p20l9t2744r461b2822],

1	“	NN	O	“	nn	3	SENT_288	[p20l9t2744r461b2822],
2	Such	JJ	O	such	amod	3	SENT_288	[p20l496t2744r655b2806],
3	work	NN	O	work	nsubj	5	SENT_288	[p20l685t2744r859b2806],
4	has	VBZ	O	have	aux	5	SENT_288	[p20l889t2744r1002b2805],
5	led	VBN	O	lead	_	0	SENT_288	[p20l1037t2744r1136b2806],
6	to	TO	O	to	_	0	SENT_288	[p20l1170t2757r1234b2806],
7	the	DT	O	the	det	8	SENT_288	[p20l1269t2744r1373b2805],
8	identification	NN	O	identification	prep_to	5	SENT_288	[p20l1407t2743r1679b2806, p20l11t2845r218b2906],
9	of	IN	O	of	_	0	SENT_288	[p20l256t2843r334b2906],
10	a	DT	O	a	det	13	SENT_288	[p20l357t2864r392b2905],
11	major	JJ	O	major	amod	13	SENT_288	[p20l428t2845r624b2922],
12	new	JJ	O	new	amod	13	SENT_288	[p20l660t2864r799b2906],
13	class	NN	O	class	prep_of	8	SENT_288	[p20l834t2844r994b2905],
14	of	IN	O	of	_	0	SENT_288	[p20l1034t2843r1113b2906],
15	variants	NNS	O	variant	prep_of	13	SENT_288	[p20l1132t2845r1402b2906],
16	conferring	VBG	O	confer	xcomp	5	SENT_288	[p20l1441t2843r1679b2906, p20l10t2945r150b3023],
17	cancer	NN	O	cancer	nn	18	SENT_288	[p20l181t2964r402b3005],
18	susceptibility	NN	O	susceptibility	dobj	16	SENT_288	[p20l433t2944r895b3022],
19	.	.	O	.	_	0	SENT_288	[p20l433t2944r895b3022],

1	Genomewide	JJ	MISC	genomewide	amod	3	SENT_289	[p20l932t2944r1379b3006],
2	association	NN	O	association	nn	3	SENT_289	[p20l1412t2945r1679b3006, p20l11t3045r144b3106],
3	studies	NNS	O	study	nsubjpass	29	SENT_289	[p20l187t3044r443b3119],
4	,	,	O	,	_	0	SENT_289	[p20l187t3044r443b3119],
5	which	WDT	O	which	nsubj	6	SENT_289	[p20l486t3044r693b3106],
6	compare	VBP	O	compare	rcmod	3	SENT_289	[p20l736t3064r1027b3122],
7	the	DT	O	the	det	8	SENT_289	[p20l1070t3044r1175b3105],
8	prevalence	NN	O	prevalence	dobj	6	SENT_289	[p20l1216t3044r1573b3122],
9	of	IN	O	of	_	0	SENT_289	[p20l1616t3043r1695b3106],
10	hundreds	NNS	O	hundred	dep	12	SENT_289	[p20l10t3145r328b3207],
11	of	IN	O	of	quantmod	12	SENT_289	[p20l362t3144r441b3207],
12	thousands	NNS	O	thousand	prep_of	8	SENT_289	[p20l458t3145r808b3207],
13	of	IN	O	of	_	0	SENT_289	[p20l842t3144r921b3207],
14	inherited	VBN	O	inherit	amod	15	SENT_289	[p20l938t3145r1245b3207],
15	variants	NNS	O	variant	prep_of	12	SENT_289	[p20l1273t3146r1543b3207],
16	between	IN	O	between	_	0	SENT_289	[p20l1577t3145r1679b3207, p20l11t3258r211b3307],
17	large	JJ	O	large	amod	18	SENT_289	[p20l247t3245r416b3324],
18	series	NN	O	series	prep_between	15	SENT_289	[p20l454t3246r642b3306],
19	of	IN	O	of	_	0	SENT_289	[p20l681t3244r760b3307],
20	patients	NNS	O	patient	prep_of	18	SENT_289	[p20l781t3246r1050b3323],
21	with	IN	O	with	_	0	SENT_289	[p20l1085t3245r1238b3307],
22	disease	NN	O	disease	nn	25	SENT_289	[p20l1276t3245r1520b3307],
23	and	CC	O	and	_	0	SENT_289	[p20l1556t3245r1680b3307],
24	control	JJ	O	control	nn	25	SENT_289	[p20l11t3345r252b3407],
25	subjects	NNS	O	subject	prep_with	20	SENT_289	[p20l300t3345r586b3423],
26	,	,	O	,	_	0	SENT_289	[p20l300t3345r586b3423],
27	have	VBP	O	have	aux	29	SENT_289	[p20l639t3345r788b3407],
28	been	VBN	O	be	auxpass	29	SENT_289	[p20l837t3345r995b3407],
29	applied	VBN	O	apply	_	0	SENT_289	[p20l1043t3345r1288b3423],
30	to	TO	O	to	_	0	SENT_289	[p20l1337t3358r1401b3407],
31	several	JJ	O	several	amod	33	SENT_289	[p20l1451t3345r1681b3407],
32	cancer	NN	O	cancer	nn	33	SENT_289	[p20l11t3465r232b3506],
33	types	NNS	O	type	prep_to	29	SENT_289	[p20l262t3458r458b3523],
34	.	.	O	.	_	0	SENT_289	[p20l262t3458r458b3523],

1	These	DT	O	these	det	2	SENT_290	[p20l492t3445r690b3506],
2	studies	NNS	O	study	nsubj	4	SENT_290	[p20l723t3445r959b3507],
3	have	VBP	O	have	aux	4	SENT_290	[p20l994t3445r1143b3507],
4	resulted	VBN	O	result	_	0	SENT_290	[p20l1175t3445r1446b3507],
5	in	IN	O	in	_	0	SENT_290	[p20l1477t3446r1543b3506],
6	the	DT	O	the	prep_in	4	SENT_290	[p20l1576t3445r1680b3506],

1	N	NN	O	n	nn	3	SENT_291	[p20l555t3608r569b3623],
2	ENGLJ	NN	O	englj	nn	3	SENT_291	[p20l584t3608r662b3630],
3	MED	NN	O	med	_	0	SENT_291	[p20l676t3608r728b3623],
4	364	CD	NUMBER	364	dep	3	SENT_291	[p20l738t3602r807b3630],
5	;	:	O	;	_	0	SENT_291	[p20l738t3602r807b3630],
6	4	CD	NUMBER	4	num	8	SENT_291	[p20l738t3602r807b3630],
7	NEjM.ORG	NN	O	nejm.org	nn	8	SENT_291	[p20l842t3608r966b3630],
8	JANUARY	NN	DATE	january	dep	3	SENT_291	[p20l997t3608r1109b3630],
9	27	CD	DATE	27	dep	8	SENT_291	[p20l1119t3608r1153b3629],
10	,	,	DATE	,	_	0	SENT_291	[p20l1119t3608r1153b3629],
11	2011	CD	DATE	2011	appos	9	SENT_291	[p20l1164t3608r1216b3624],
12	The	DT	O	the	det	15	SENT_291	[p20l702t3641r753b3665],
13	New	NNP	O	New	nn	15	SENT_291	[p20l762t3642r824b3665],
14	England	NNP	O	England	nn	15	SENT_291	[p20l833t3641r944b3672],
15	Journal	NNP	O	Journal	dep	3	SENT_291	[p20l952t3641r1050b3665],
16	of	IN	O	of	_	0	SENT_291	[p20l1059t3641r1088b3665],
17	Medicine	NNP	O	Medicine	prep_of	15	SENT_291	[p20l1095t3641r1220b3665],

1	I	PRP	O	I	nsubj	2	SENT_292	[p20l1777t1142r1892b1180],
2	:	:	O	:	_	0	SENT_292	[p20l1777t1142r1892b1180],
3	.	.	O	.	_	0	SENT_292	[p20l1777t1142r1892b1180],

1	I	PRP	O	I	_	0	SENT_293	[p20l1777t1142r1892b1180],

1	An	DT	O	a	det	3	SENT_294	[p20l1761t1302r1837b1347],
2	interactive	JJ	O	interactive	amod	3	SENT_294	[p20l1860t1299r2152b1348],
3	graphic	JJ	O	graphic	_	0	SENT_294	[p20l1763t1376r1972b1442],
4	on	IN	O	on	_	0	SENT_294	[p20l1991t1393r2056b1427],
5	monitoring	NN	O	monitoring	prep_on	3	SENT_294	[p20l1766t1458r2076b1522],
6	of	IN	O	of	_	0	SENT_294	[p20l1766t1535r1831b1601],
7	cancer	NN	O	cancer	nn	8	SENT_294	[p20l1835t1552r2017b1586],
8	burden	NN	O	burden	prep_of	5	SENT_294	[p20l1766t1615r1957b1666],
9	is	VBZ	O	be	cop	10	SENT_294	[p20l1980t1617r2018b1666],
10	available	JJ	O	available	rcmod	8	SENT_294	[p20l1766t1695r2008b1746],
11	at	IN	O	at	_	0	SENT_294	[p20l2027t1704r2082b1746],
12	Nl	NNP	O	Nl	prep_at	10	SENT_294	[p20l1768t1780r2034b1841],
13	:	:	O	:	_	0	SENT_294	[p20l1768t1780r2034b1841],
14	:	:	O	:	_	0	SENT_294	[p20l1768t1780r2034b1841],
15	IM.org	NN	O	im.org	dep	8	SENT_294	[p20l1768t1780r2034b1841],

1	Downloaded	VBN	O	download	_	0	SENT_295	[p20l144t3682r314b3705],
2	from	IN	O	from	_	0	SENT_295	[p20l323t3682r387b3705],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_295	[p20l396t3682r514b3712],
4	at	IN	O	at	_	0	SENT_295	[p20l524t3686r547b3705],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_295	[p20l556t3682r738b3705],
6	on	IN	O	on	_	0	SENT_295	[p20l748t3689r780b3705],
7	January	NNP	DATE	January	prep_on	1	SENT_295	[p20l789t3682r892b3712],
8	5	CD	DATE	5	num	7	SENT_295	[p20l902t3682r924b3710],
9	,	,	DATE	,	_	0	SENT_295	[p20l902t3682r924b3710],
10	2014	CD	DATE	2014	num	7	SENT_295	[p20l935t3682r1007b3705],
11	.	.	O	.	_	0	SENT_295	[p20l935t3682r1007b3705],

1	For	IN	O	for	_	0	SENT_296	[p20l1018t3682r1064b3705],
2	personal	JJ	O	personal	amod	3	SENT_296	[p20l1072t3682r1185b3712],
3	use	NN	O	use	pobj	1	SENT_296	[p20l1194t3689r1237b3705],
4	only	RB	O	only	advmod	3	SENT_296	[p20l1247t3682r1312b3712],
5	.	.	O	.	_	0	SENT_296	[p20l1247t3682r1312b3712],

1	No	DT	O	no	det	3	SENT_297	[p20l1322t3682r1362b3705],
2	other	JJ	O	other	amod	3	SENT_297	[p20l1372t3682r1440b3705],
3	uses	NNS	O	use	_	0	SENT_297	[p20l1448t3689r1504b3705],
4	without	IN	O	without	_	0	SENT_297	[p20l1515t3682r1616b3705],
5	permission	NN	O	permission	prep_without	3	SENT_297	[p20l1624t3682r1776b3712],
6	.	.	O	.	_	0	SENT_297	[p20l1624t3682r1776b3712],

1	The	DT	O	the	det	4	SENT_298	[p20l817t3765r862b3786],
2	NEW	NNP	O	NEW	nn	4	SENT_298	[p20l880t3767r965b3786],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_298	[p20l985t3767r1173b3786],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_298	[p20l1192t3767r1372b3793],
5	of	IN	O	of	_	0	SENT_298	[p20l1391t3765r1419b3792],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_298	[p20l1432t3767r1630b3786],

1	Resection	NN	O	resection	_	0	SENT_299	[p21l391t270r512b291],
2	of	IN	O	of	_	0	SENT_299	[p21l393t301r421b324],
3	cancer	NN	O	cancer	nn	5	SENT_299	[p21l427t309r510b324],
4	arly	JJ	O	arly	amod	5	SENT_299	[p21l1266t556r1310b587],
5	detection	NN	O	detection	prep_of	1	SENT_299	[p21l1319t556r1436b580],
6	asymptomatic	JJ	O	asymptomatic	amod	8	SENT_299	[p21l1269t592r1451b620],
7	recurrent	JJ	O	recurrent	amod	8	SENT_299	[p21l1286t627r1402b646],
8	disease	NN	O	disease	dep	1	SENT_299	[p21l1296t656r1391b680],

1	Tumor	NN	O	tumor	nn	2	SENT_300	[p21l180t603r203b695],
2	DNA	NN	O	dna	_	0	SENT_300	[p21l180t526r203b592],
3	(	NN	O	(	nn	6	SENT_300	[p21l178t425r211b515],
4	pg/ml	NN	O	pg/ml	nn	6	SENT_300	[p21l178t425r211b515],
5	ofserum	NN	O	ofserum	nn	6	SENT_300	[p21l178t284r211b414],
6	)	NN	O	)	dep	2	SENT_300	[p21l178t284r211b414],

1	Non	JJ	O	non	amod	3	SENT_301	[p21l511t1069r659b1092, p21l531t1102r571b1126],
2	—	NN	O	—	nn	3	SENT_301	[p21l511t1069r659b1092, p21l531t1102r571b1126],
3	smallcell	NN	O	smallcell	_	0	SENT_301	[p21l511t1069r659b1092, p21l531t1102r571b1126],
4	lung	NN	O	lung	nn	7	SENT_301	[p21l583t1102r638b1133],
5	1	CD	NUMBER	1	num	7	SENT_301	[p21l180t1140r192b1161],
6	Tumor	NN	O	tumor	nn	7	SENT_301	[p21l215t1138r302b1159],
7	resection	NN	O	resection	dep	3	SENT_301	[p21l311t1136r426b1159],
8	carcinoma	NN	O	carcinoma	dep	3	SENT_301	[p21l517t1138r650b1159],

1	5	CD	NUMBER	5	num	3	SENT_302	[p21l1521t1262r1534b1284],
2	PCR-based	JJ	O	pcr-based	amod	3	SENT_302	[p21l1560t1260r1695b1284],
3	assay	NN	O	assay	_	0	SENT_302	[p21l1705t1268r1775b1291],
4	of	IN	O	of	_	0	SENT_302	[p21l1784t1260r1813b1284],
5	DNA	NN	O	dna	prep_of	3	SENT_302	[p21l1819t1262r1881b1284],
6	containing	VBG	O	contain	partmod	5	SENT_302	[p21l1554t1294r1691b1324],
7	tumor-speciﬁc	JJ	O	tumor-speciﬁc	amod	8	SENT_302	[p21l1698t1293r1884b1324],
8	rearrangement	NN	O	rearrangement	dobj	6	SENT_302	[p21l1625t1331r1814b1357],

1	Primer	NN	O	primer	_	0	SENT_303	[p21l1538t1425r1621b1445],
2	l	NN	O	l	dep	1	SENT_303	[p21l1709t1415r1712b1432],
3	l	NN	O	l	tmod	2	SENT_303	[p21l1709t1448r1712b1465],

1	CGTACCGTAAGCTATTACGG	NN	O	cgtaccgtaagctattacgg	_	0	SENT_304	[p21l1520t1473r1900b1498],
2	'	''	O	'	_	0	SENT_304	[p21l1710t1515r1712b1532],

1	_	NN	O	_	nn	2	SENT_305	[p21l298t1564r303b1570],
2	I	NN	O	i	_	0	SENT_305	[p21l1709t1548r1712b1565],

1	2	CD	NUMBER	2	_	0	SENT_306	[p21l190t1564r204b1585],
2	Massively	RB	O	massively	dep	3	SENT_306	[p21l229t1564r354b1594],
3	Chr	NN	O	chr	dep	6	SENT_306	[p21l1570t1580r1614b1604],
4	1	CD	NUMBER	1	num	3	SENT_306	[p21l1625t1583r1635b1603],
5	I	PRP	O	I	nsubj	6	SENT_306	[p21l1710t1582r1712b1598],
6	CW4	VBP	O	cw4	dep	1	SENT_306	[p21l1783t1580r1850b1604],

1	I	PRP	O	I	_	0	SENT_307	[p21l1710t1615r1712b1632],
2	I	PRP	O	I	dep	1	SENT_307	[p21l1710t1648r1712b1659],

1	parallel	JJ	O	parallel	amod	3	SENT_308	[p21l249t1597r340b1627],
2	paired-end	JJ	O	paired-end	amod	3	SENT_308	[p21l223t1630r358b1661],
3	sequencing	NN	O	sequencing	_	0	SENT_308	[p21l217t1664r364b1694],
4	to	TO	O	to	aux	5	SENT_308	[p21l234t1701r259b1720],
5	detect	VB	O	detect	dep	3	SENT_308	[p21l268t1697r347b1720],
6	chromosomal	JJ	O	chromosomal	amod	7	SENT_308	[p21l202t1730r378b1754],
7	rearrangements	NNS	O	rearrangement	dobj	5	SENT_308	[p21l194t1768r396b1794],
8	3	CD	NUMBER	3	num	11	SENT_308	[p21l911t1755r924b1777],
9	Design	NN	O	design	nn	11	SENT_308	[p21l948t1753r1035b1783],
10	PCR	NN	O	pcr	nn	11	SENT_308	[p21l1048t1754r1099b1776],
11	primers	NNS	O	primer	tmod	5	SENT_308	[p21l1109t1753r1207b1783],
12	that	WDT	O	that	nsubj	13	SENT_308	[p21l1216t1753r1267b1776],
13	straddle	VBP	O	straddle	rcmod	11	SENT_308	[p21l1276t1752r1379b1776],
14	tumor-speciﬁc	JJ	O	tumor-speciﬁc	amod	15	SENT_308	[p21l970t1785r1156b1816],
15	rearrangement	NN	O	rearrangement	dobj	13	SENT_308	[p21l1166t1790r1355b1817],

1	Figure	NNP	O	Figure	_	0	SENT_309	[p21l122t2487r206b2519],
2	3	CD	NUMBER	3	dep	1	SENT_309	[p21l217t2489r239b2511],
3	.	.	O	.	_	0	SENT_309	[p21l217t2489r239b2511],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_310	[p21l252t2486r435b2512],
2	ofCancer-Speciﬁc	JJ	O	ofcancer-speciﬁc	amod	4	SENT_310	[p21l447t2486r701b2519],
3	Chromosomal	JJ	O	chromosomal	amod	4	SENT_310	[p21l710t2486r905b2512],
4	Rearrangements	NNS	O	rearrangement	dep	1	SENT_310	[p21l918t2489r1145b2519],
5	from	IN	O	from	_	0	SENT_310	[p21l1155t2486r1220b2512],
6	Sequencing	NN	O	sequencing	prep_from	4	SENT_310	[p21l1232t2487r1394b2519],
7	of	IN	O	of	_	0	SENT_310	[p21l1404t2486r1436b2512],
8	a	DT	O	a	det	10	SENT_310	[p21l1441t2495r1455b2512],
9	Cancer	NN	O	cancer	nn	10	SENT_310	[p21l1465t2488r1562b2512],
10	Genome	NNP	O	Genome	prep_of	6	SENT_310	[p21l1572t2488r1698b2512],
11	.	.	O	.	_	0	SENT_310	[p21l1572t2488r1698b2512],

1	On	IN	O	on	_	0	SENT_311	[p21l120t2538r160b2562],
2	the	DT	O	the	det	4	SENT_311	[p21l172t2536r216b2562],
3	basis	NN	O	basis	nn	4	SENT_311	[p21l228t2536r296b2562],
4	ofa	NN	O	ofa	prep_on	12	SENT_311	[p21l308t2536r358b2562],
5	tumor-biopsy	JJ	O	tumor-biopsy	amod	6	SENT_311	[p21l368t2536r556b2569],
6	sample	NN	O	sample	dep	4	SENT_311	[p21l567t2536r674b2569],
7	,	,	O	,	_	0	SENT_311	[p21l567t2536r674b2569],
8	massively	RB	O	massively	advmod	12	SENT_311	[p21l688t2536r820b2569],
9	parallel	JJ	O	parallel	amod	11	SENT_311	[p21l832t2536r930b2569],
10	paired-end	NN	O	paired-end	nn	11	SENT_311	[p21l944t2536r1092b2569],
11	sequencing	NN	O	sequencing	nsubj	12	SENT_311	[p21l1105t2539r1264b2570],
12	detects	VBZ	O	detect	_	0	SENT_311	[p21l1274t2536r1375b2562],
13	chromosomal	JJ	O	chromosomal	amod	14	SENT_311	[p21l1387t2536r1578b2562],
14	rearrangements	NNS	O	rearrangement	dobj	12	SENT_311	[p21l1592t2541r1812b2570],
15	that	WDT	O	that	nsubjpass	18	SENT_311	[p21l1823t2536r1878b2562],
16	can	MD	O	can	aux	18	SENT_311	[p21l1888t2545r1934b2562],
17	be	VB	O	be	auxpass	18	SENT_311	[p21l1948t2536r1979b2562],
18	used	VBN	O	use	rcmod	14	SENT_311	[p21l121t2578r184b2603],
19	to	TO	O	to	aux	20	SENT_311	[p21l196t2583r222b2603],
20	monitor	VB	O	monitor	xcomp	18	SENT_311	[p21l235t2580r346b2603],
21	relapse	NN	O	relapse	dobj	20	SENT_311	[p21l358t2578r455b2611],
22	or	CC	O	or	_	0	SENT_311	[p21l466t2587r494b2603],
23	response	NN	O	response	conj_or	21	SENT_311	[p21l506t2587r630b2611],
24	to	TO	O	to	_	0	SENT_311	[p21l641t2583r667b2603],
25	treatment	NN	O	treatment	prep_to	20	SENT_311	[p21l678t2583r816b2603],
26	from	IN	O	from	_	0	SENT_311	[p21l826t2578r891b2603],
27	serial	JJ	O	serial	amod	29	SENT_311	[p21l904t2578r975b2603],
28	blood	NN	O	blood	nn	29	SENT_311	[p21l989t2578r1065b2603],
29	samples	NNS	O	sample	prep_from	20	SENT_311	[p21l1079t2578r1192b2611],
30	from	IN	O	from	_	0	SENT_311	[p21l1204t2578r1268b2603],
31	the	DT	O	the	det	32	SENT_311	[p21l1280t2578r1324b2603],
32	patient	NN	O	patient	prep_from	29	SENT_311	[p21l1336t2580r1439b2611],
33	.	.	O	.	_	0	SENT_311	[p21l1336t2580r1439b2611],

1	348	CD	NUMBER	348	num	4	SENT_312	[p21l94t2722r150b2745],
2	N	NN	O	n	nn	4	SENT_312	[p21l893t2732r906b2748],
3	ENGLJ	NN	O	englj	nn	4	SENT_312	[p21l921t2732r999b2754],
4	MED	NN	O	med	_	0	SENT_312	[p21l1014t2732r1066b2747],
5	364	CD	NUMBER	364	dep	4	SENT_312	[p21l1076t2726r1145b2754],
6	;	:	O	;	_	0	SENT_312	[p21l1076t2726r1145b2754],
7	4	CD	NUMBER	4	num	9	SENT_312	[p21l1076t2726r1145b2754],
8	NEJM.ORG	NN	O	nejm.org	nn	9	SENT_312	[p21l1180t2732r1304b2754],
9	JANUARY	NN	DATE	january	dep	5	SENT_312	[p21l1334t2732r1447b2754],
10	27,2011	CD	NUMBER	27,2011	dep	9	SENT_312	[p21l1457t2732r1554b2753],

1	The	DT	O	the	det	4	SENT_313	[p21l881t2765r932b2788],
2	New	NNP	O	New	nn	4	SENT_313	[p21l941t2765r1003b2788],
3	England	NNP	O	England	nn	4	SENT_313	[p21l1012t2765r1123b2795],
4	Journal	NNP	O	Journal	_	0	SENT_313	[p21l1132t2765r1229b2788],
5	of	IN	O	of	_	0	SENT_313	[p21l1239t2765r1268b2788],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_313	[p21l1274t2765r1400b2788],

1	Downloaded	VBN	O	download	_	0	SENT_314	[p21l323t2805r493b2828],
2	from	IN	O	from	_	0	SENT_314	[p21l502t2805r566b2828],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_314	[p21l575t2805r693b2835],
4	at	IN	O	at	_	0	SENT_314	[p21l703t2809r726b2828],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_314	[p21l735t2805r918b2828],
6	on	IN	O	on	_	0	SENT_314	[p21l927t2812r959b2828],
7	January	NNP	DATE	January	prep_on	1	SENT_314	[p21l968t2805r1071b2835],
8	5	CD	DATE	5	num	7	SENT_314	[p21l1081t2805r1103b2833],
9	,	,	DATE	,	_	0	SENT_314	[p21l1081t2805r1103b2833],
10	2014	CD	DATE	2014	num	7	SENT_314	[p21l1114t2805r1186b2828],
11	.	.	O	.	_	0	SENT_314	[p21l1114t2805r1186b2828],

1	For	IN	O	for	_	0	SENT_315	[p21l1197t2805r1243b2828],
2	personal	JJ	O	personal	amod	3	SENT_315	[p21l1251t2805r1364b2835],
3	use	NN	O	use	pobj	1	SENT_315	[p21l1373t2812r1416b2828],
4	only	RB	O	only	advmod	3	SENT_315	[p21l1426t2805r1491b2835],
5	.	.	O	.	_	0	SENT_315	[p21l1426t2805r1491b2835],

1	No	DT	O	no	det	3	SENT_316	[p21l1502t2805r1541b2828],
2	other	JJ	O	other	amod	3	SENT_316	[p21l1551t2805r1619b2828],
3	uses	NNS	O	use	_	0	SENT_316	[p21l1628t2812r1684b2828],
4	without	IN	O	without	_	0	SENT_316	[p21l1694t2805r1795b2828],
5	permission	NN	O	permission	prep_without	3	SENT_316	[p21l1803t2805r1956b2835],
6	.	.	O	.	_	0	SENT_316	[p21l1803t2805r1956b2835],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_317	[p21l909t2952r1067b2971],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_317	[p21l1081t2952r1251b2971],

1	identification	NN	O	identification	_	0	SENT_318	[p21l11t3165r594b3245],
2	of	IN	O	of	_	0	SENT_318	[p21l628t3165r728b3245],
3	many	JJ	O	many	amod	6	SENT_318	[p21l743t3192r982b3266],
4	new	JJ	O	new	amod	6	SENT_318	[p21l1010t3192r1188b3246],
5	DNA	NN	O	dna	nn	6	SENT_318	[p21l1216t3173r1425b3245],
6	Variants	NNS	O	variant	prep_of	1	SENT_318	[p21l1450t3167r1794b3246],
7	conferring	VBG	O	confer	partmod	6	SENT_318	[p21l1829t3165r2132b3245, p21l11t3296r189b3396],
8	susceptibility	NN	O	susceptibility	dobj	7	SENT_318	[p21l241t3295r815b3395],
9	to	TO	O	to	_	0	SENT_318	[p21l864t3312r946b3374],
10	several	JJ	O	several	amod	12	SENT_318	[p21l1002t3295r1293b3374],
11	different	JJ	O	different	amod	12	SENT_318	[p21l1347t3294r1723b3374],
12	types	NNS	O	type	prep_to	7	SENT_318	[p21l1772t3312r1995b3396],
13	of	IN	O	of	_	0	SENT_318	[p21l2052t3294r2152b3374],
14	cancer	NN	O	cancer	prep_of	12	SENT_318	[p21l12t3449r310b3519],
15	,	,	O	,	_	0	SENT_318	[p21l12t3449r310b3519],
16	including	VBG	O	include	_	0	SENT_318	[p21l357t3423r768b3524],
17	cancer	NN	O	cancer	prep_including	12	SENT_318	[p21l807t3449r1088b3502],
18	of	IN	O	of	_	0	SENT_318	[p21l1127t3422r1227b3502],
19	the	DT	O	the	det	20	SENT_318	[p21l1250t3423r1383b3502],
20	breast	NN	O	breast	prep_of	17	SENT_318	[p21l1426t3423r1710b3519],
21	,	,	O	,	_	0	SENT_318	[p21l1426t3423r1710b3519],
22	prostate	NN	O	prostate	prep_of	17	SENT_318	[p21l1755t3440r2128b3523],
23	,	,	O	,	_	0	SENT_318	[p21l1755t3440r2128b3523],
24	colon	NN	O	colon	conj_and	20	SENT_318	[p21l12t3551r245b3630],
25	and	CC	O	and	_	0	SENT_318	[p21l293t3551r451b3630],
26	rectum	NN	O	rectum	conj_and	20	SENT_318	[p21l499t3568r828b3647],
27	,	,	O	,	_	0	SENT_318	[p21l499t3568r828b3647],
28	lung	NN	O	lung	conj_and	20	SENT_318	[p21l881t3551r1093b3652],
29	,	,	O	,	_	0	SENT_318	[p21l881t3551r1093b3652],
30	and	CC	O	and	_	0	SENT_318	[p21l1147t3551r1305b3630],
31	testis	NN	O	testis	conj_and	20	SENT_318	[p21l1353t3552r1602b3647],
32	,	,	O	,	_	0	SENT_318	[p21l1353t3552r1602b3647],
33	along	IN	O	along	_	0	SENT_318	[p21l1655t3551r1897b3652],
34	with	IN	O	with	_	0	SENT_318	[p21l1938t3551r2133b3630],
35	chronic	JJ	O	chronic	amod	37	SENT_318	[p21l12t3679r335b3757],
36	lymphocytic	JJ	O	lymphocytic	amod	37	SENT_318	[p21l396t3679r923b3778],
37	leukemia	NN	O	leukemia	prep_along_with	6	SENT_318	[p21l986t3679r1380b3758],
38	and	CC	O	and	_	0	SENT_318	[p21l1441t3679r1599b3757],
39	other	JJ	O	other	amod	40	SENT_318	[p21l1663t3679r1890b3757],
40	cancers	NNS	O	cancer	conj_and	37	SENT_318	[p21l1952t3704r2132b3757, p22l12t26r275b99],
41	.55	CD	NUMBER	.55	dep	6	SENT_318	[p21l1952t3704r2132b3757, p22l12t26r275b99],

1	The	DT	O	the	det	3	SENT_319	[p22l332t21r492b99],
2	inherited	VBN	O	inherit	amod	3	SENT_319	[p22l549t21r939b99],
3	variants	NNS	O	variant	nsubj	17	SENT_319	[p22l991t22r1334b100],
4	that	WDT	O	that	nsubjpass	7	SENT_319	[p22l1395t21r1567b99],
5	are	VBP	O	be	auxpass	7	SENT_319	[p22l1618t47r1747b99],
6	initially	RB	O	initially	advmod	7	SENT_319	[p22l1804t21r2138b120],
7	associated	VBN	O	associate	rcmod	3	SENT_319	[p22l11t149r455b227],
8	with	IN	O	with	_	0	SENT_319	[p22l516t149r712b228],
9	a	DT	O	a	det	10	SENT_319	[p22l777t175r822b227],
10	disease	NN	O	disease	prep_with	7	SENT_319	[p22l887t149r1198b227],
11	are	VBP	O	be	cop	17	SENT_319	[p22l1263t175r1392b227],
12	not	RB	O	not	dep	13	SENT_319	[p22l1458t166r1601b227],
13	necessarily	RB	O	necessarily	advmod	17	SENT_319	[p22l1662t149r2138b248],
14	themselves	PRP	O	themselves	advmod	17	SENT_319	[p22l12t277r482b356],
15	the	DT	O	the	det	17	SENT_319	[p22l530t277r662b355],
16	functional	JJ	O	functional	amod	17	SENT_319	[p22l708t276r1155b356],
17	changes	NNS	O	change	_	0	SENT_319	[p22l1201t277r1549b378],
18	but	CC	O	but	cc	21	SENT_319	[p22l1597t277r1737b356],
19	are	VBP	O	be	cop	21	SENT_319	[p22l1778t303r1906b355],
20	usually	RB	O	usually	advmod	21	SENT_319	[p22l1952t303r2132b356, p22l11t405r162b505],
21	located	JJ	O	located	dep	17	SENT_319	[p22l204t405r513b484],
22	adjacent	JJ	O	adjacent	advmod	21	SENT_319	[p22l559t405r912b505],
23	in	IN	O	in	_	0	SENT_319	[p22l953t406r1037b483],
24	the	DT	O	the	det	25	SENT_319	[p22l1084t405r1217b483],
25	genome	NN	O	genome	prep_in	22	SENT_319	[p22l1264t431r1604b506],
26	to	TO	O	to	_	0	SENT_319	[p22l1651t422r1733b484],
27	the	DT	O	the	det	30	SENT_319	[p22l1782t405r1915b483],
28	true	JJ	O	true	amod	30	SENT_319	[p22l1962t422r2133b484],
29	causative	JJ	O	causative	amod	30	SENT_319	[p22l12t507r399b584],
30	variants	NNS	O	variant	prep_to	25	SENT_319	[p22l434t507r802b584],
31	.	.	O	.	_	0	SENT_319	[p22l434t507r802b584],

1	In	IN	O	in	_	0	SENT_320	[p22l138t641r228b711],
2	general	JJ	O	general	prep_in	20	SENT_320	[p22l266t633r606b734],
3	,	,	O	,	_	0	SENT_320	[p22l266t633r606b734],
4	these	DT	O	these	det	7	SENT_320	[p22l651t633r874b711],
5	common	JJ	O	common	amod	7	SENT_320	[p22l915t659r1296b712],
6	susceptibility	NN	O	susceptibility	nn	7	SENT_320	[p22l1337t633r1911b733],
7	variants	NNS	O	variant	nsubj	20	SENT_320	[p22l1942t634r2132b712, p22l11t777r212b856],
8	,	,	O	,	_	0	SENT_320	[p22l1942t634r2132b712, p22l11t777r212b856],
9	which	WDT	O	which	nsubj	12	SENT_320	[p22l245t760r508b840],
10	may	MD	O	may	aux	12	SENT_320	[p22l540t786r719b860],
11	be	VB	O	be	cop	12	SENT_320	[p22l746t760r843b839],
12	present	JJ	DATE	present	rcmod	7	SENT_320	[p22l873t777r1192b860],
13	in	IN	O	in	_	0	SENT_320	[p22l1218t761r1302b838],
14	the	DT	O	the	det	15	SENT_320	[p22l1334t760r1466b838],
15	majority	NN	O	majority	prep_in	12	SENT_320	[p22l1498t761r1859b860],
16	of	IN	O	of	_	0	SENT_320	[p22l1887t759r1987b839],
17	the	DT	O	the	det	18	SENT_320	[p22l2001t760r2133b838],
18	population	NN	O	population	prep_of	15	SENT_320	[p22l9t888r504b988],
19	,	,	O	,	_	0	SENT_320	[p22l9t888r504b988],
20	confer	VB	O	confer	_	0	SENT_320	[p22l547t887r821b967],
21	a	DT	O	a	det	25	SENT_320	[p22l854t914r898b966],
22	very	RB	O	very	advmod	23	SENT_320	[p22l929t914r1107b988],
23	small	JJ	O	small	amod	25	SENT_320	[p22l1141t888r1374b966],
24	increased	VBN	O	increase	amod	25	SENT_320	[p22l1410t888r1818b967],
25	risk	NN	O	risk	dobj	20	SENT_320	[p22l1855t888r2019b968],
26	of	IN	O	of	_	0	SENT_320	[p22l2052t887r2152b967],
27	disease	NN	O	disease	prep_of	25	SENT_320	[p22l12t1017r345b1113],
28	,	,	O	,	_	0	SENT_320	[p22l12t1017r345b1113],
29	rendering	VBG	O	render	partmod	25	SENT_320	[p22l386t1017r807b1118],
30	them	PRP	O	they	nsubj	33	SENT_320	[p22l840t1017r1060b1095],
31	ofvery	JJ	O	ofvery	amod	33	SENT_320	[p22l1097t1016r1387b1117],
32	limited	JJ	O	limited	amod	33	SENT_320	[p22l1418t1017r1726b1096],
33	utility	NN	O	utility	xcomp	29	SENT_320	[p22l1762t1017r2019b1117],
34	in	IN	O	in	_	0	SENT_320	[p22l2050t1018r2133b1095],
35	clinical	JJ	O	clinical	amod	36	SENT_320	[p22l12t1145r325b1222],
36	practice	NN	O	practice	prep_in	33	SENT_320	[p22l368t1146r729b1244],
37	.	.	O	.	_	0	SENT_320	[p22l368t1146r729b1244],

1	However	RB	O	however	advmod	6	SENT_321	[p22l779t1152r1173b1240],
2	,	,	O	,	_	0	SENT_321	[p22l779t1152r1173b1240],
3	there	EX	O	there	expl	6	SENT_321	[p22l1225t1145r1441b1223],
4	may	MD	O	may	aux	6	SENT_321	[p22l1486t1171r1666b1244],
5	be	VB	O	be	cop	6	SENT_321	[p22l1707t1145r1803b1223],
6	opportunities	NNS	O	opportunity	_	0	SENT_321	[p22l1849t1171r2132b1244, p22l12t1274r336b1352],
7	in	IN	O	in	_	0	SENT_321	[p22l369t1274r453b1351],
8	the	DT	DATE	the	det	9	SENT_321	[p22l485t1273r618b1351],
9	future	NN	DATE	future	prep_in	6	SENT_321	[p22l650t1272r912b1352],
10	to	TO	O	to	aux	11	SENT_321	[p22l945t1290r1026b1352],
11	test	VB	O	test	infmod	9	SENT_321	[p22l1060t1290r1214b1351],
12	several	JJ	O	several	amod	14	SENT_321	[p22l1242t1273r1534b1352],
13	such	JJ	O	such	amod	14	SENT_321	[p22l1567t1273r1760b1352],
14	variants	NNS	O	variant	dobj	11	SENT_321	[p22l1788t1274r2131b1352],
15	together	RB	O	together	advmod	11	SENT_321	[p22l12t1401r374b1502],
16	at	IN	O	at	_	0	SENT_321	[p22l417t1418r496b1479],
17	a	DT	O	a	det	19	SENT_321	[p22l536t1427r581b1479],
18	population	NN	O	population	nn	19	SENT_321	[p22l623t1401r1095b1501],
19	level	NN	O	level	prep_at	11	SENT_321	[p22l1140t1401r1351b1497],
20	,	,	O	,	_	0	SENT_321	[p22l1140t1401r1351b1497],
21	perhaps	RB	O	perhaps	advmod	23	SENT_321	[p22l1402t1401r1742b1501],
22	to	TO	O	to	aux	23	SENT_321	[p22l1791t1418r1872b1480],
23	identify	VB	O	identify	xcomp	6	SENT_321	[p22l1919t1401r2132b1480, p22l12t1527r158b1628],
24	persons	NNS	O	person	dobj	23	SENT_321	[p22l186t1554r522b1628],
25	who	WP	O	who	nsubj	26	SENT_321	[p22l554t1528r736b1608],
26	are	VBP	O	be	rcmod	24	SENT_321	[p22l771t1554r900b1606],
27	at	IN	O	at	_	0	SENT_321	[p22l934t1545r1013b1606],
28	a	DT	O	a	det	31	SENT_321	[p22l1041t1554r1085b1606],
29	relatively	RB	O	relatively	advmod	31	SENT_321	[p22l1118t1528r1503b1628],
30	increased	VBN	O	increase	amod	31	SENT_321	[p22l1532t1528r1941b1607],
31	risk	NN	O	risk	prep_at	26	SENT_321	[p22l1974t1528r2138b1608],
32	for	IN	O	for	_	0	SENT_321	[p22l11t1656r134b1736],
33	entry	NN	O	entry	prep_for	31	SENT_321	[p22l175t1674r398b1757],
34	into	IN	O	into	_	0	SENT_321	[p22l436t1658r605b1736],
35	disease	NN	O	disease	nn	38	SENT_321	[p22l650t1657r1418b1758],
36	—	NN	O	—	nn	38	SENT_321	[p22l650t1657r1418b1758],
37	screening	NN	O	screening	nn	38	SENT_321	[p22l650t1657r1418b1758],
38	programs	NNS	O	program	prep_into	23	SENT_321	[p22l1458t1683r1876b1758],
39	or	CC	O	or	_	0	SENT_321	[p22l1922t1683r2010b1736],
40	in	IN	O	in	_	0	SENT_321	[p22l2050t1658r2134b1735],
41	the	DT	O	the	det	42	SENT_321	[p22l12t1785r144b1863],
42	context	NN	O	context	prep_in	23	SENT_321	[p22l193t1802r510b1864],
43	of	IN	O	of	_	0	SENT_321	[p22l553t1784r653b1864],
44	familial	JJ	O	familial	amod	45	SENT_321	[p22l683t1784r1020b1863],
45	disease	NN	O	disease	prep_of	42	SENT_321	[p22l1068t1785r1378b1864],
46	caused	VBN	O	cause	partmod	45	SENT_321	[p22l1427t1785r1717b1864],
47	by	IN	O	by	_	0	SENT_321	[p22l1765t1785r1862b1885],
48	highrisk	NN	O	highrisk	nn	50	SENT_321	[p22l1906t1785r2132b1886, p22l11t1912r175b1992],
49	susceptibility	NN	O	susceptibility	nn	50	SENT_321	[p22l231t1912r806b2012],
50	mutations	NNS	O	mutation	agent	46	SENT_321	[p22l861t1913r1320b2008],
51	,	,	O	,	_	0	SENT_321	[p22l861t1913r1320b2008],
52	with	IN	O	with	_	0	SENT_321	[p22l1381t1912r1576b1992],
53	the	DT	O	the	det	54	SENT_321	[p22l1637t1912r1769b1990],
54	aim	NN	O	aim	prep_with	46	SENT_321	[p22l1829t1913r1992b1990],
55	of	IN	O	of	_	0	SENT_321	[p22l2052t1911r2152b1991],
56	further	JJ	O	further	amod	59	SENT_321	[p22l11t2040r319b2120],
57	refining	NN	O	refining	nn	59	SENT_321	[p22l355t2040r710b2142],
58	risk	NN	O	risk	nn	59	SENT_321	[p22l746t2041r910b2120],
59	estimates	NNS	O	estimate	prep_of	54	SENT_321	[p22l946t2042r1377b2120],
60	.	.	O	.	_	0	SENT_321	[p22l946t2042r1377b2120],

1	Discoveries	NNS	O	discovery	nsubj	15	SENT_322	[p22l138t2170r624b2248],
2	made	VBN	O	make	partmod	1	SENT_322	[p22l673t2169r905b2248],
3	through	IN	O	through	_	0	SENT_322	[p22l952t2169r1301b2270],
4	application	NN	O	application	prep_through	2	SENT_322	[p22l1347t2169r1826b2269],
5	of	IN	O	of	_	0	SENT_322	[p22l1874t2168r1974b2248],
6	genomic	JJ	O	genomic	amod	7	SENT_322	[p22l2002t2195r2132b2270, p22l11t2298r279b2376],
7	technologies	NNS	O	technology	prep_of	4	SENT_322	[p22l322t2297r866b2398],
8	and	CC	O	and	_	0	SENT_322	[p22l910t2297r1067b2376],
9	the	DT	O	the	det	12	SENT_322	[p22l1110t2297r1243b2375],
10	human	JJ	O	human	amod	12	SENT_322	[p22l1285t2297r1589b2376],
11	genome	NN	O	genome	nn	12	SENT_322	[p22l1631t2323r1970b2398],
12	sequence	NN	O	sequence	prep_of	4	SENT_322	[p22l2015t2323r2132b2376, p22l12t2450r310b2524],
13	have	VBP	O	have	aux	15	SENT_322	[p22l372t2424r562b2503],
14	already	RB	O	already	advmod	15	SENT_322	[p22l623t2424r935b2524],
15	had	VBN	O	have	_	0	SENT_322	[p22l991t2424r1148b2503],
16	an	DT	O	a	det	17	SENT_322	[p22l1209t2450r1311b2502],
17	effect	NN	O	effect	dobj	15	SENT_322	[p22l1374t2423r1616b2502],
18	on	IN	O	on	_	0	SENT_322	[p22l1673t2450r1779b2503],
19	several	JJ	O	several	amod	20	SENT_322	[p22l1842t2424r2134b2503],
20	aspects	NNS	O	aspect	prep_on	17	SENT_322	[p22l11t2570r316b2653],
21	of	IN	O	of	_	0	SENT_322	[p22l353t2552r452b2632],
22	oncologic	JJ	O	oncologic	amod	23	SENT_322	[p22l469t2553r876b2654],
23	practice	NN	O	practice	prep_of	20	SENT_322	[p22l908t2554r1239b2653],
24	and	CC	O	and	_	0	SENT_322	[p22l1272t2553r1428b2632],
25	have	VBP	O	have	aux	26	SENT_322	[p22l1462t2553r1649b2632],
26	influenced	VBN	O	influence	conj_and	15	SENT_322	[p22l1683t2552r2134b2632],
27	the	DT	O	the	det	28	SENT_322	[p22l12t2681r144b2759],
28	design	NN	O	design	dobj	26	SENT_322	[p22l209t2681r490b2782],
29	of	IN	O	of	_	0	SENT_322	[p22l554t2680r654b2760],
30	clinical	JJ	O	clinical	amod	31	SENT_322	[p22l700t2681r1013b2759],
31	trials	NNS	O	trial	prep_of	28	SENT_322	[p22l1077t2681r1321b2760],
32	.	.	O	.	_	0	SENT_322	[p22l1077t2681r1321b2760],

1	In	IN	O	in	_	0	SENT_323	[p22l1389t2689r1478b2759],
2	the	DT	DURATION	the	det	5	SENT_323	[p22l1542t2681r1675b2759],
3	next	JJ	DURATION	next	amod	5	SENT_323	[p22l1739t2698r1924b2759],
4	few	JJ	DURATION	few	amod	5	SENT_323	[p22l1983t2680r2137b2760],
5	years	NNS	DURATION	year	prep_in	15	SENT_323	[p22l7t2835r251b2909],
6	,	,	O	,	_	0	SENT_323	[p22l7t2835r251b2909],
7	the	DT	O	the	det	8	SENT_323	[p22l296t2809r429b2887],
8	pace	NN	O	pace	nsubj	15	SENT_323	[p22l467t2835r659b2909],
9	of	IN	O	of	_	0	SENT_323	[p22l699t2808r799b2888],
10	research	NN	O	research	prep_of	8	SENT_323	[p22l821t2809r1182b2888],
11	into	IN	O	into	_	0	SENT_323	[p22l1221t2810r1390b2888],
12	cancer	NN	O	cancer	nn	13	SENT_323	[p22l1432t2835r1712b2887],
13	genomes	NNS	O	genome	prep_into	10	SENT_323	[p22l1749t2835r2131b2910],
14	will	MD	O	will	aux	15	SENT_323	[p22l7t2937r171b3016],
15	increase	VB	O	increase	_	0	SENT_323	[p22l218t2938r570b3016],
16	markedly	RB	O	markedly	advmod	15	SENT_323	[p22l618t2937r1035b3037],
17	.	.	O	.	_	0	SENT_323	[p22l618t2937r1035b3037],

1	Coordinated	VBN	O	coordinate	csubj	5	SENT_324	[p22l1089t2937r1626b3016],
2	global	JJ	O	global	amod	3	SENT_324	[p22l1673t2937r1941b3038],
3	initiatives	NNS	O	initiative	dobj	1	SENT_324	[p22l1987t2938r2132b3015, p22l12t3066r313b3144],
4	Will	MD	O	will	aux	5	SENT_324	[p22l359t3065r524b3144],
5	generate	VB	O	generate	_	0	SENT_324	[p22l572t3082r936b3166],
6	full	JJ	O	full	amod	8	SENT_324	[p22l984t3064r1133b3144],
7	genome	NN	O	genome	nn	8	SENT_324	[p22l1180t3091r1520b3166],
8	sequences	NNS	O	sequence	dobj	5	SENT_324	[p22l1570t3091r2001b3165],
9	of	IN	O	of	_	0	SENT_324	[p22l2052t3064r2152b3144],
10	tens	NNS	O	ten	dep	12	SENT_324	[p22l12t3210r185b3272],
11	of	IN	O	of	quantmod	12	SENT_324	[p22l230t3192r330b3272],
12	thousands	NNS	O	thousand	prep_of	8	SENT_324	[p22l354t3193r799b3272],
13	of	IN	O	of	_	0	SENT_324	[p22l844t3192r945b3272],
14	cancers	NNS	O	cancer	prep_of	12	SENT_324	[p22l969t3219r1314b3289],
15	,	,	O	,	_	0	SENT_324	[p22l969t3219r1314b3289],
16	yielding	VBG	O	yield	partmod	5	SENT_324	[p22l1357t3193r1705b3294],
17	complete	JJ	O	complete	amod	18	SENT_324	[p22l1744t3193r2133b3293],
18	catalogues	NNS	O	catalogue	dobj	16	SENT_324	[p22l12t3321r469b3422],
19	of	IN	O	of	_	0	SENT_324	[p22l530t3320r630b3400],
20	somatic	JJ	O	somatic	amod	21	SENT_324	[p22l671t3322r1008b3400],
21	mutations	NNS	O	mutation	prep_of	18	SENT_324	[p22l1066t3322r1500b3400],
22	in	IN	O	in	_	0	SENT_324	[p22l1560t3322r1643b3399],
23	each	DT	O	each	det	24	SENT_324	[p22l1703t3321r1894b3399],
24	one	CD	NUMBER	one	prep_in	16	SENT_324	[p22l1953t3347r2128b3400],
25	.	.	O	.	_	0	SENT_324	[p22l1953t3347r2128b3400],

1	These	DT	O	these	det	2	SENT_325	[p22l7t3448r252b3526],
2	studies	NNS	O	study	nsubj	4	SENT_325	[p22l288t3448r579b3528],
3	Will	MD	O	will	aux	4	SENT_325	[p22l610t3448r770b3528],
4	reveal	VB	O	reveal	_	0	SENT_325	[p22l803t3448r1046b3528],
5	essentially	RB	O	essentially	advmod	8	SENT_325	[p22l1080t3448r1518b3548],
6	the	DT	O	the	det	8	SENT_325	[p22l1547t3448r1677b3526],
7	full	JJ	O	full	amod	8	SENT_325	[p22l1711t3447r1854b3528],
8	repertoire	NN	O	repertoire	dobj	4	SENT_325	[p22l1888t3474r2132b3548, p22l12t3578r206b3656],
9	of	IN	O	of	_	0	SENT_325	[p22l246t3576r345b3656],
10	mutated	VBN	O	mutate	amod	12	SENT_325	[p22l367t3577r720b3656],
11	cancer	NN	O	cancer	nn	12	SENT_325	[p22l760t3603r1040b3655],
12	genes	NNS	O	gene	prep_of	8	SENT_325	[p22l1076t3603r1342b3678],
13	,	,	O	,	_	0	SENT_325	[p22l1076t3603r1342b3678],
14	moving	VBG	O	move	partmod	8	SENT_325	[p22l1387t3578r1714b3678],
15	us	PRP	O	we	nsubj	16	SENT_325	[p22l1749t3603r1841b3656],
16	closer	JJR	O	closer	xcomp	14	SENT_325	[p22l1884t3577r2137b3656],
17	to	TO	O	to	_	0	SENT_325	[p22l11t3722r92b3784],
18	establishing	VBG	O	establish	prepc_to	16	SENT_325	[p22l137t3705r664b3806],
19	a	DT	O	a	det	21	SENT_325	[p22l701t3731r746b3783],
20	central	JJ	O	central	amod	21	SENT_325	[p22l787t3705r1082b3783],
21	metric	NN	O	metric	dobj	18	SENT_325	[p22l1124t3706r1400b3784],
22	of	IN	O	of	_	0	SENT_325	[p22l1441t3704r1541b3784],
23	cancer	NN	O	cancer	nn	24	SENT_325	[p22l1565t3731r1846b3783],
24	development	NN	O	development	prep_of	21	SENT_325	[p22l1886t3705r2132b3784, p23l12t37r362b120],
25	:	:	O	:	_	0	SENT_325	[p22l1886t3705r2132b3784, p23l12t37r362b120],

1	how	WRB	O	how	advmod	2	SENT_326	[p23l419t20r603b100],
2	many	JJ	O	many	amod	5	SENT_326	[p23l652t46r891b120],
3	and	CC	O	and	_	0	SENT_326	[p23l938t20r1096b99],
4	what	WP	O	what	conj_and	2	SENT_326	[p23l1144t20r1360b100],
5	combinations	NNS	O	combination	nsubj	11	SENT_326	[p23l1408t20r1996b99],
6	of	IN	O	of	_	0	SENT_326	[p23l2052t19r2152b99],
7	mutated	VBN	O	mutate	amod	9	SENT_326	[p23l11t149r364b228],
8	cancer	NN	O	cancer	nn	9	SENT_326	[p23l408t175r688b227],
9	genes	NNS	O	gene	prep_of	5	SENT_326	[p23l728t175r969b250],
10	are	VBP	O	be	cop	11	SENT_326	[p23l1013t175r1142b227],
11	necessary	JJ	O	necessary	_	0	SENT_326	[p23l1185t175r1605b249],
12	to	TO	O	to	aux	13	SENT_326	[p23l1644t166r1725b228],
13	generate	VB	O	generate	xcomp	11	SENT_326	[p23l1769t166r2133b250],
14	an	DT	O	a	det	16	SENT_326	[p23l10t302r113b354],
15	individual	JJ	O	individual	amod	16	SENT_326	[p23l159t276r590b356],
16	cancer	NN	O	cancer	dobj	13	SENT_326	[p23l637t302r935b355],
17	.	.	O	.	_	0	SENT_326	[p23l637t302r935b355],

1	This	DT	O	this	nsubj	3	SENT_327	[p23l983t276r1171b354],
2	will	MD	O	will	aux	3	SENT_327	[p23l1215t276r1380b356],
3	clarify	VB	O	clarify	_	0	SENT_327	[p23l1426t275r1702b376],
4	the	DT	O	the	det	5	SENT_327	[p23l1744t276r1876b354],
5	challenges	NNS	O	challenge	dobj	3	SENT_327	[p23l1924t276r2132b354, p23l10t405r278b506],
6	that	IN	O	that	complm	8	SENT_327	[p23l315t405r488b483],
7	we	PRP	O	we	nsubj	8	SENT_327	[p23l512t431r630b484],
8	face	VBP	O	face	ccomp	3	SENT_327	[p23l665t404r833b483],
9	in	IN	O	in	_	0	SENT_327	[p23l866t406r950b483],
10	cancer	NN	O	cancer	nn	11	SENT_327	[p23l985t431r1266b483],
11	treatment	NN	O	treatment	prep_in	8	SENT_327	[p23l1297t422r1741b484],
12	.	.	O	.	_	0	SENT_327	[p23l1297t422r1741b484],

1	Coupled	VBN	O	couple	prep	21	SENT_328	[p23l1781t405r2134b505],
2	with	IN	O	with	pcomp	1	SENT_328	[p23l7t532r202b612],
3	these	DT	O	these	det	4	SENT_328	[p23l238t532r461b610],
4	advances	NNS	O	advance	pobj	2	SENT_328	[p23l497t532r904b628],
5	,	,	O	,	_	0	SENT_328	[p23l497t532r904b628],
6	more	JJR	O	more	dep	7	SENT_328	[p23l946t558r1165b611],
7	systematic	JJ	O	systematic	amod	9	SENT_328	[p23l1203t533r1652b632],
8	functional	JJ	O	functional	amod	9	SENT_328	[p23l1687t531r2134b612],
9	screening	NN	O	screening	nsubj	21	SENT_328	[p23l12t662r429b762],
10	of	IN	O	of	_	0	SENT_328	[p23l481t660r581b740],
11	living	VBG	O	live	prepc_of	9	SENT_328	[p23l615t661r860b762],
12	cancer	NN	O	cancer	nn	13	SENT_328	[p23l911t687r1191b739],
13	cells	NNS	O	cell	dobj	11	SENT_328	[p23l1244t661r1430b739],
14	to	TO	O	to	aux	15	SENT_328	[p23l1487t678r1568b740],
15	detect	VB	O	detect	xcomp	11	SENT_328	[p23l1624t661r1883b740],
16	their	PRP$	O	they	poss	18	SENT_328	[p23l1933t661r2136b740],
17	biologic	JJ	O	biologic	amod	18	SENT_328	[p23l12t789r353b890],
18	vulnerabilities	NNS	O	vulnerability	dobj	15	SENT_328	[p23l391t789r1007b868],
19	will	MD	O	will	aux	21	SENT_328	[p23l1048t789r1212b868],
20	undoubtedly	RB	O	undoubtedly	advmod	21	SENT_328	[p23l1254t789r1796b889],
21	lead	VB	O	lead	_	0	SENT_328	[p23l1833t789r2007b868],
22	to	TO	O	to	_	0	SENT_328	[p23l2050t806r2132b868],
23	new	JJ	O	new	amod	24	SENT_328	[p23l11t943r189b996],
24	directions	NNS	O	direction	prep_to	21	SENT_328	[p23l225t917r654b996],
25	in	IN	O	in	_	0	SENT_328	[p23l695t918r778b995],
26	targeted	VBN	O	target	amod	28	SENT_328	[p23l818t917r1173b1018],
27	drug	NN	O	drug	nn	28	SENT_328	[p23l1213t917r1417b1018],
28	discovery	NN	O	discovery	prep_in	24	SENT_328	[p23l1454t917r1870b1017],
29	.	.	O	.	_	0	SENT_328	[p23l1454t917r1870b1017],

1	The	DT	O	the	det	2	SENT_329	[p23l136t1045r297b1123],
2	technologies	NNS	O	technology	nsubjpass	9	SENT_329	[p23l329t1045r874b1146],
3	that	WDT	O	that	nsubj	6	SENT_329	[p23l907t1045r1080b1123],
4	are	VBP	O	be	cop	6	SENT_329	[p23l1106t1071r1235b1123],
5	research	NN	O	research	nn	6	SENT_329	[p23l1266t1045r1628b1124],
6	tools	NNS	O	tool	rcmod	2	SENT_329	[p23l1660t1045r1867b1124],
7	today	NN	DATE	today	tmod	6	SENT_329	[p23l1902t1045r2137b1145],
8	are	VBP	O	be	auxpass	9	SENT_329	[p23l10t1199r139b1252],
9	primed	VBN	O	prime	_	0	SENT_329	[p23l176t1173r487b1273],
10	to	TO	O	to	aux	13	SENT_329	[p23l525t1190r607b1252],
11	become	VB	O	become	cop	13	SENT_329	[p23l647t1173r977b1252],
12	the	DT	O	the	det	13	SENT_329	[p23l1016t1173r1149b1251],
13	diagnostics	NNS	O	diagnostic	xcomp	9	SENT_329	[p23l1188t1173r1679b1274],
14	of	IN	O	of	_	0	SENT_329	[p23l1721t1172r1821b1252],
15	tomorrow	NN	DATE	tomorrow	prep_of	13	SENT_329	[p23l1841t1190r2132b1252, p23l11t1327r189b1380],
16	.	.	O	.	_	0	SENT_329	[p23l1841t1190r2132b1252, p23l11t1327r189b1380],

1	We	PRP	O	we	nsubj	4	SENT_330	[p23l223t1309r357b1379],
2	have	VBP	O	have	aux	4	SENT_330	[p23l389t1301r579b1380],
3	already	RB	O	already	advmod	4	SENT_330	[p23l611t1301r923b1401],
4	seen	VBN	O	see	_	0	SENT_330	[p23l952t1327r1140b1380],
5	limited	JJ	O	limited	amod	7	SENT_330	[p23l1172t1301r1480b1380],
6	RNA	NN	O	rna	nn	7	SENT_330	[p23l1511t1308r1720b1384],
7	profiling	NN	O	profiling	dobj	4	SENT_330	[p23l1748t1300r2137b1402],
8	introduced	VBN	O	introduce	partmod	7	SENT_330	[p23l10t1429r478b1508],
9	into	IN	O	into	_	0	SENT_330	[p23l521t1430r690b1508],
10	clinical	JJ	O	clinical	amod	11	SENT_330	[p23l736t1429r1049b1507],
11	practice	NN	O	practice	prep_into	8	SENT_330	[p23l1092t1430r1429b1529],
12	and	CC	O	and	_	0	SENT_330	[p23l1473t1429r1631b1508],
13	testing	NN	O	testing	conj_and	11	SENT_330	[p23l1675t1430r1973b1530],
14	for	IN	O	for	_	0	SENT_330	[p23l2013t1428r2137b1508],
15	a	DT	O	a	det	17	SENT_330	[p23l10t1583r55b1635],
16	restricted	JJ	O	restricted	amod	17	SENT_330	[p23l91t1557r497b1636],
17	series	NN	O	series	prep_for	8	SENT_330	[p23l537t1558r776b1635],
18	of	IN	O	of	_	0	SENT_330	[p23l816t1556r916b1636],
19	somatic	JJ	O	somatic	amod	21	SENT_330	[p23l937t1558r1273b1636],
20	genetic	JJ	O	genetic	amod	21	SENT_330	[p23l1310t1558r1618b1658],
21	abnormalities	NNS	O	abnormality	prep_of	17	SENT_330	[p23l1654t1557r2132b1636, p23l11t1686r158b1763],
22	to	TO	O	to	aux	23	SENT_330	[p23l194t1702r274b1764],
23	select	VB	O	select	xcomp	8	SENT_330	[p23l311t1685r551b1763],
24	the	DT	O	the	det	27	SENT_330	[p23l580t1685r712b1763],
25	appropriate	JJ	O	appropriate	dep	26	SENT_330	[p23l746t1686r1240b1785],
26	targeted	VBN	O	target	amod	27	SENT_330	[p23l1274t1685r1629b1786],
27	therapy	NN	O	therapy	dobj	23	SENT_330	[p23l1663t1685r1984b1785],
28	for	IN	O	for	_	0	SENT_330	[p23l2013t1684r2136b1764],
29	individual	JJ	O	individual	amod	30	SENT_330	[p23l10t1812r442b1892],
30	patients	NNS	O	patient	prep_for	27	SENT_330	[p23l504t1813r870b1912],
31	.	.	O	.	_	0	SENT_330	[p23l504t1813r870b1912],

1	The	DT	O	the	det	3	SENT_331	[p23l936t1812r1097b1890],
2	rapid	JJ	O	rapid	amod	3	SENT_331	[p23l1161t1812r1378b1912],
3	development	NN	O	development	nsubj	11	SENT_331	[p23l1444t1812r1992b1912],
4	of	IN	O	of	_	0	SENT_331	[p23l2052t1811r2152b1891],
5	neXt	NN	O	next	nn	9	SENT_331	[p23l11t1943r684b2043],
6	—	NN	O	—	nn	9	SENT_331	[p23l11t1943r684b2043],
7	generation	NN	O	generation	nn	9	SENT_331	[p23l11t1943r684b2043],
8	sequencing	NN	O	sequencing	nn	9	SENT_331	[p23l737t1943r1223b2043],
9	technologies	NNS	O	technology	prep_of	3	SENT_331	[p23l1272t1942r1816b2043],
10	seems	VBZ	O	seem	cop	11	SENT_331	[p23l1872t1968r2131b2020],
11	likely	JJ	O	likely	_	0	SENT_331	[p23l10t2069r242b2169],
12	to	TO	O	to	aux	14	SENT_331	[p23l283t2086r364b2148],
13	be	VB	O	be	cop	14	SENT_331	[p23l411t2069r508b2148],
14	transformative	JJ	O	transformative	xcomp	11	SENT_331	[p23l553t2068r1211b2148],
15	.	.	O	.	_	0	SENT_331	[p23l553t2068r1211b2148],

1	Within	IN	O	within	_	0	SENT_332	[p23l1258t2069r1560b2147],
2	a	DT	DURATION	a	det	4	SENT_332	[p23l1605t2095r1649b2147],
3	few	JJ	DURATION	few	amod	4	SENT_332	[p23l1692t2068r1847b2149],
4	years	NNS	DURATION	year	prep_within	13	SENT_332	[p23l1883t2095r2128b2169],
5	,	,	O	,	_	0	SENT_332	[p23l1883t2095r2128b2169],
6	a	DT	O	a	det	10	SENT_332	[p23l10t2224r55b2276],
7	complete	JJ	O	complete	amod	10	SENT_332	[p23l95t2198r483b2298],
8	cancer	NN	O	cancer	nn	10	SENT_332	[p23l525t2224r806b2276],
9	genome	NN	O	genome	nn	10	SENT_332	[p23l844t2224r1183b2299],
10	sequence	NN	O	sequence	nsubj	20	SENT_332	[p23l1226t2224r1614b2298],
11	will	MD	O	will	aux	13	SENT_332	[p23l1651t2198r1815b2277],
12	be	VB	O	be	cop	13	SENT_332	[p23l1856t2198r1952b2277],
13	obtainable	JJ	O	obtainable	_	0	SENT_332	[p23l1995t2198r2132b2277, p23l11t2326r356b2405],
14	for	IN	O	for	_	0	SENT_332	[p23l389t2325r513b2405],
15	a	DT	O	a	det	18	SENT_332	[p23l542t2352r586b2404],
16	few	JJ	O	few	amod	18	SENT_332	[p23l618t2325r772b2405],
17	hundred	CD	MONEY	hundred	num	18	SENT_332	[p23l801t2326r1164b2405],
18	dollars	NNS	MONEY	dollar	prep_for	13	SENT_332	[p23l1197t2326r1490b2405],
19	or	CC	O	or	_	0	SENT_332	[p23l1526t2352r1614b2405],
20	less	JJR	O	less	conj_or	13	SENT_332	[p23l1644t2326r1824b2405],
21	.	.	O	.	_	0	SENT_332	[p23l1644t2326r1824b2405],

1	As	IN	O	as	mark	16	SENT_333	[p23l1859t2334r1965b2404],
2	the	DT	O	the	det	3	SENT_333	[p23l2001t2326r2133b2404],
3	number	NN	O	number	nsubj	16	SENT_333	[p23l11t2454r349b2533],
4	of	IN	O	of	_	0	SENT_333	[p23l390t2453r490b2533],
5	informative	JJ	O	informative	amod	7	SENT_333	[p23l514t2453r1014b2533],
6	genetic	JJ	O	genetic	amod	7	SENT_333	[p23l1058t2455r1366b2555],
7	abnormalities	NNS	O	abnormality	prep_of	3	SENT_333	[p23l1408t2454r2005b2533],
8	to	TO	O	to	aux	10	SENT_333	[p23l2050t2471r2132b2533],
9	be	VB	O	be	auxpass	10	SENT_333	[p23l12t2582r108b2661],
10	searched	VBN	O	search	infmod	3	SENT_333	[p23l156t2582r533b2661],
11	for	IN	O	for	prep	10	SENT_333	[p23l580t2581r703b2661],
12	in	IN	O	in	pcomp	11	SENT_333	[p23l746t2583r829b2660],
13	an	DT	O	a	det	15	SENT_333	[p23l875t2608r977b2660],
14	individual	JJ	O	individual	amod	15	SENT_333	[p23l1023t2582r1455b2661],
15	cancer	NN	O	cancer	pobj	12	SENT_333	[p23l1502t2608r1782b2660],
16	continues	VBZ	O	continue	_	0	SENT_333	[p23l1827t2583r2132b2661, p23l11t2736r149b2789],

1	to	TO	O	to	aux	2	SENT_334	[p23l189t2726r270b2788],
2	increase	VB	O	increase	purpcl	9	SENT_334	[p23l309t2711r683b2805],
3	,	,	O	,	_	0	SENT_334	[p23l309t2711r683b2805],
4	it	PRP	O	it	nsubj	9	SENT_334	[p23l725t2711r785b2787],
5	may	MD	O	may	aux	9	SENT_334	[p23l817t2736r996b2809],
6	ultimately	RB	O	ultimately	advmod	9	SENT_334	[p23l1028t2710r1466b2809],
7	be	VB	O	be	cop	9	SENT_334	[p23l1499t2710r1595b2788],
8	more	RBR	O	more	advmod	9	SENT_334	[p23l1633t2736r1853b2788],
9	parsimonious	JJ	O	parsimonious	_	0	SENT_334	[p23l1889t2711r2132b2809, p23l11t2839r385b2917],
10	to	TO	O	to	aux	11	SENT_334	[p23l436t2855r518b2917],
11	sequence	NN	O	sequence	xcomp	9	SENT_334	[p23l569t2864r957b2938],
12	the	DT	O	the	det	14	SENT_334	[p23l1006t2838r1139b2916],
13	whole	JJ	O	whole	amod	14	SENT_334	[p23l1183t2838r1440b2917],
14	genome	NN	O	genome	dobj	11	SENT_334	[p23l1489t2864r1828b2939],
15	rather	RB	O	rather	_	0	SENT_334	[p23l1877t2838r2137b2917],
16	than	IN	O	than	_	0	SENT_334	[p23l11t2966r207b3044],
17	do	VB	O	do	conj_negcc	9	SENT_334	[p23l256t2966r358b3045],
18	a	DT	O	a	det	20	SENT_334	[p23l407t2992r451b3044],
19	large	JJ	O	large	amod	20	SENT_334	[p23l496t2966r710b3067],
20	battery	NN	O	battery	dobj	17	SENT_334	[p23l759t2966r1060b3066],
21	of	IN	O	of	_	0	SENT_334	[p23l1103t2965r1203b3045],
22	directed	VBN	O	direct	amod	23	SENT_334	[p23l1233t2966r1581b3045],
23	tests	NNS	O	test	prep_of	20	SENT_334	[p23l1629t2983r1847b3045],
24	.	.	O	.	_	0	SENT_334	[p23l1629t2983r1847b3045],

1	However	RB	O	however	advmod	22	SENT_335	[p23l1899t2974r2132b3045, p23l12t3119r201b3189],
2	,	,	O	,	_	0	SENT_335	[p23l1899t2974r2132b3045, p23l12t3119r201b3189],
3	in	IN	O	in	mark	6	SENT_335	[p23l239t3094r323b3171],
4	order	NN	O	order	dep	6	SENT_335	[p23l357t3093r585b3172],
5	to	TO	O	to	aux	6	SENT_335	[p23l616t3110r697b3172],
6	exploit	VB	O	exploit	dep	22	SENT_335	[p23l733t3093r1023b3193],
7	the	DT	O	the	det	10	SENT_335	[p23l1052t3093r1185b3171],
8	full	JJ	O	full	amod	10	SENT_335	[p23l1218t3092r1367b3173],
9	clinical	JJ	O	clinical	amod	10	SENT_335	[p23l1401t3093r1714b3171],
10	potential	NN	O	potential	dobj	6	SENT_335	[p23l1746t3093r2133b3193],
11	of	IN	O	of	_	0	SENT_335	[p23l12t3221r112b3301],
12	information	NN	O	information	prep_of	10	SENT_335	[p23l128t3221r651b3301],
13	within	IN	O	within	_	0	SENT_335	[p23l681t3222r966b3301],
14	the	DT	O	the	det	16	SENT_335	[p23l1001t3222r1134b3300],
15	cancer	NN	O	cancer	nn	16	SENT_335	[p23l1170t3248r1451b3300],
16	genome	NN	O	genome	prep_within	6	SENT_335	[p23l1482t3248r1845b3323],
17	,	,	O	,	_	0	SENT_335	[p23l1482t3248r1845b3323],
18	it	PRP	O	it	nsubj	22	SENT_335	[p23l1885t3223r1944b3300],
19	will	MD	O	will	aux	22	SENT_335	[p23l1970t3222r2134b3301],
20	first	RB	ORDINAL	first	advmod	22	SENT_335	[p23l11t3348r195b3427],
21	be	VB	O	be	cop	22	SENT_335	[p23l232t3349r329b3428],
22	necessary	JJ	O	necessary	_	0	SENT_335	[p23l371t3375r790b3449],
23	to	TO	O	to	aux	24	SENT_335	[p23l828t3366r910b3428],
24	incorporate	VB	O	incorporate	xcomp	22	SENT_335	[p23l952t3350r1451b3449],
25	analysis	NN	O	analysis	dobj	24	SENT_335	[p23l1492t3349r1832b3449],
26	of	IN	O	of	_	0	SENT_335	[p23l1877t3348r1977b3428],
27	the	DT	O	the	det	28	SENT_335	[p23l2001t3349r2133b3427],
28	genome	NN	O	genome	prep_of	25	SENT_335	[p23l11t3504r350b3579],
29	and	CC	O	and	_	0	SENT_335	[p23l421t3478r579b3557],
30	transcriptome	NN	O	transcriptome	prep_of	25	SENT_335	[p23l651t3479r1258b3578],
31	more	RBR	O	more	advmod	32	SENT_335	[p23l1330t3504r1549b3557],
32	widely	RB	O	widely	dep	24	SENT_335	[p23l1617t3478r1897b3578],
33	into	IN	O	into	_	0	SENT_335	[p23l1962t3479r2132b3557],
34	clinical	JJ	O	clinical	amod	35	SENT_335	[p23l12t3606r310b3684],
35	trials	NNS	O	trial	prep_into	24	SENT_335	[p23l341t3606r572b3702],
36	,	,	O	,	_	0	SENT_335	[p23l341t3606r572b3702],
37	generating	VBG	O	generate	partmod	24	SENT_335	[p23l609t3607r1054b3707],
38	new	JJ	O	new	amod	41	SENT_335	[p23l1082t3632r1256b3685],
39	and	CC	O	and	_	0	SENT_335	[p23l1283t3606r1436b3685],
40	unexpected	JJ	O	unexpected	amod	41	SENT_335	[p23l1467t3606r1939b3706],
41	predictors	NNS	O	predictor	dobj	37	SENT_335	[p23l1969t3632r2132b3706, p24l12t21r305b100],

1	of	IN	O	of	_	0	SENT_336	[p24l347t20r447b100],
2	drug	NN	O	drug	nn	3	SENT_336	[p24l469t21r673b122],
3	responsiveness	NN	O	responsiveness	pobj	1	SENT_336	[p24l709t22r1349b121],
4	and	CC	O	and	_	0	SENT_336	[p24l1390t21r1547b100],
5	prognosis	NN	O	prognosis	conj_and	3	SENT_336	[p24l1586t22r2036b122],
6	.	.	O	.	_	0	SENT_336	[p24l1586t22r2036b122],

1	Disclosure	NN	O	disclosure	nsubj	2	SENT_337	[p24l95t317r442b377],
2	forms	VBZ	O	form	_	0	SENT_337	[p24l475t316r668b376],
3	provided	VBN	O	provide	csubj	8	SENT_337	[p24l701t317r988b392],
4	by	IN	O	by	_	0	SENT_337	[p24l1021t317r1095b392],
5	the	DT	O	the	det	6	SENT_337	[p24l1125t317r1226b375],
6	authors	NNS	O	author	prep_by	3	SENT_337	[p24l1258t317r1505b377],
7	are	VBP	O	be	cop	8	SENT_337	[p24l1539t336r1638b376],
8	available	JJ	O	available	ccomp	2	SENT_337	[p24l1671t317r1956b377],
9	With	IN	O	with	_	0	SENT_337	[p24l1985t317r2134b377],
10	the	DT	O	the	det	12	SENT_337	[p24l11t413r112b471],
11	full	JJ	O	full	amod	12	SENT_337	[p24l137t412r251b473],
12	text	NN	O	text	prep_with	8	SENT_337	[p24l276t425r399b471],
13	of	IN	O	of	_	0	SENT_337	[p24l421t412r497b472],
14	this	DT	O	this	det	15	SENT_337	[p24l509t413r631b471],
15	article	NN	O	article	prep_of	12	SENT_337	[p24l658t413r864b471],
16	at	IN	O	at	_	0	SENT_337	[p24l889t426r949b471],
17	NEJM.org	NN	O	nejm.org	prep_at	15	SENT_337	[p24l968t418r1308b488],
18	.	.	O	.	_	0	SENT_337	[p24l968t418r1308b488],

1	REFERENCES	NNS	O	reference	_	0	SENT_338	[p24l14t598r337b629],
2	1	CD	NUMBER	1	num	1	SENT_338	[p24l12t668r49b706],
3	.	.	O	.	_	0	SENT_338	[p24l12t668r49b706],

1	Lander	NNP	O	Lander	nn	2	SENT_339	[p24l106t662r280b706],
2	ES	NN	O	e	_	0	SENT_339	[p24l295t666r369b716],
3	,	,	O	,	_	0	SENT_339	[p24l295t666r369b716],
4	Linton	NNP	PERSON	Linton	nn	5	SENT_339	[p24l389t663r554b706],
5	LM	NNP	O	LM	appos	2	SENT_339	[p24l570t666r664b716],
6	,	,	O	,	_	0	SENT_339	[p24l570t666r664b716],
7	Birren	NNP	PERSON	Birren	nn	8	SENT_339	[p24l683t663r839b706],
8	B	NNP	PERSON	B	appos	2	SENT_339	[p24l856t666r903b716],
9	,	,	O	,	_	0	SENT_339	[p24l856t666r903b716],
10	et	FW	O	et	nn	11	SENT_339	[p24l924t671r968b706],
11	al.	FW	O	al.	appos	2	SENT_339	[p24l983t662r1039b706],
12	.	.	O	.	_	0	SENT_339	[p24l983t662r1039b706],

1	Initial	JJ	O	initial	amod	2	SENT_340	[p24l10t732r163b776],
2	sequencing	NN	O	sequencing	_	0	SENT_340	[p24l200t733r484b789],
3	and	CC	O	and	_	0	SENT_340	[p24l518t732r609b776],
4	analysis	NN	O	analysis	conj_and	2	SENT_340	[p24l645t732r844b788],
5	of	IN	O	of	_	0	SENT_340	[p24l882t732r939b777],
6	the	DT	O	the	det	8	SENT_340	[p24l965t732r1042b776],
7	human	JJ	O	human	amod	8	SENT_340	[p24l10t803r186b848],
8	genome	NN	O	genome	prep_of	2	SENT_340	[p24l224t817r435b860],
9	.	.	O	.	_	0	SENT_340	[p24l224t817r435b860],

1	Nature	NNP	O	Nature	_	0	SENT_341	[p24l475t807r646b848],
2	2001	CD	DATE	2001	num	1	SENT_341	[p24l685t807r1042b856, p24l11t878r110b919],
3	;	:	O	;	_	0	SENT_341	[p24l685t807r1042b856, p24l11t878r110b919],
4	409:860921	CD	NUMBER	409:860921	dep	1	SENT_341	[p24l685t807r1042b856, p24l11t878r110b919],
5	.	.	O	.	_	0	SENT_341	[p24l685t807r1042b856, p24l11t878r110b919],

1	2	LS	NUMBER	2	_	0	SENT_342	[p24l10t952r50b990],
2	.	.	O	.	_	0	SENT_342	[p24l10t952r50b990],

1	Stratton	NNP	PERSON	Stratton	nn	2	SENT_343	[p24l108t950r306b990],
2	MR	NN	PERSON	mr	_	0	SENT_343	[p24l322t950r422b1000],
3	,	,	O	,	_	0	SENT_343	[p24l322t950r422b1000],
4	Campbell	NNP	ORGANIZATION	Campbell	nn	5	SENT_343	[p24l443t946r678b1002],
5	PJ	NNP	ORGANIZATION	PJ	appos	2	SENT_343	[p24l695t950r753b1000],
6	,	,	O	,	_	0	SENT_343	[p24l695t950r753b1000],
7	Futreal	NNP	PERSON	Futreal	nn	8	SENT_343	[p24l773t946r946b991],
8	PA.	NNP	O	PA.	appos	5	SENT_343	[p24l963t950r1039b990],
9	.	.	O	.	_	0	SENT_343	[p24l963t950r1039b990],

1	The	DT	O	the	det	2	SENT_344	[p24l9t1016r100b1060],
2	cancer	NN	O	cancer	_	0	SENT_344	[p24l116t1031r276b1060],
3	genome	NN	O	genome	dep	2	SENT_344	[p24l290t1030r497b1073],
4	.	.	O	.	_	0	SENT_344	[p24l290t1030r497b1073],

1	Nature	NNP	O	Nature	_	0	SENT_345	[p24l515t1020r682b1061],
2	2009	CD	DATE	2009	num	1	SENT_345	[p24l698t1020r1042b1070, p24l11t1092r79b1132],
3	;	:	O	;	_	0	SENT_345	[p24l698t1020r1042b1070, p24l11t1092r79b1132],
4	458:71924	CD	NUMBER	458:71924	dep	1	SENT_345	[p24l698t1020r1042b1070, p24l11t1092r79b1132],
5	.	.	O	.	_	0	SENT_345	[p24l698t1020r1042b1070, p24l11t1092r79b1132],

1	3	LS	NUMBER	3	_	0	SENT_346	[p24l11t1165r48b1203],
2	.	.	O	.	_	0	SENT_346	[p24l11t1165r48b1203],

1	Pleasance	NNP	O	Pleasance	nn	2	SENT_347	[p24l106t1159r343b1203],
2	ED	NNP	O	ED	_	0	SENT_347	[p24l360t1163r443b1213],
3	,	,	O	,	_	0	SENT_347	[p24l360t1163r443b1213],
4	Stephens	NNP	PERSON	Stephens	nn	5	SENT_347	[p24l463t1159r682b1215],
5	PJ	NNP	PERSON	PJ	appos	2	SENT_347	[p24l699t1163r757b1213],
6	,	,	O	,	_	0	SENT_347	[p24l699t1163r757b1213],
7	O’Meara	NNP	O	O’Meara	nn	8	SENT_347	[p24l777t1163r984b1203],
8	S	NNP	O	S	appos	2	SENT_347	[p24l1001t1163r1039b1213],
9	,	,	O	,	_	0	SENT_347	[p24l1001t1163r1039b1213],
10	et	FW	O	et	nn	11	SENT_347	[p24l11t1238r55b1273],
11	al.	FW	O	al.	appos	2	SENT_347	[p24l85t1229r140b1273],
12	.	.	O	.	_	0	SENT_347	[p24l85t1229r140b1273],

1	A	DT	O	a	det	5	SENT_348	[p24l174t1233r211b1273],
2	small-cell	JJ	O	small-cell	amod	5	SENT_348	[p24l243t1229r483b1273],
3	lung	NN	O	lung	nn	5	SENT_348	[p24l515t1229r626b1286],
4	cancer	NN	O	cancer	nn	5	SENT_348	[p24l657t1243r817b1273],
5	genome	NN	O	genome	_	0	SENT_348	[p24l849t1243r1042b1286],
6	with	IN	O	with	_	0	SENT_348	[p24l8t1300r119b1345],
7	complex	JJ	O	complex	amod	8	SENT_348	[p24l138t1300r343b1356],
8	signatures	NNS	O	signature	prep_with	5	SENT_348	[p24l360t1301r615b1357],
9	of	IN	O	of	_	0	SENT_348	[p24l635t1300r691b1344],
10	tobacco	NN	O	tobacco	nn	11	SENT_348	[p24l699t1300r888b1344],
11	exposure	NN	O	exposure	prep_of	5	SENT_348	[p24l907t1314r1042b1356, p24l11t1386r126b1416],
12	.	.	O	.	_	0	SENT_348	[p24l907t1314r1042b1356, p24l11t1386r126b1416],

1	Nature	NNP	O	Nature	_	0	SENT_349	[p24l147t1375r315b1416],
2	2010	CD	DATE	2010	num	1	SENT_349	[p24l335t1375r753b1425],
3	;	:	O	;	_	0	SENT_349	[p24l335t1375r753b1425],
4	463:184	CD	NUMBER	463:184	number	5	SENT_349	[p24l335t1375r753b1425],
5	-90	CD	NUMBER	-90	dep	1	SENT_349	[p24l335t1375r753b1425],
6	.	.	O	.	_	0	SENT_349	[p24l335t1375r753b1425],

1	4	LS	NUMBER	4	_	0	SENT_350	[p24l9t1449r49b1487],
2	.	.	O	.	_	0	SENT_350	[p24l9t1449r49b1487],

1	Pleasance	NNP	O	Pleasance	nn	2	SENT_351	[p24l106t1443r339b1487],
2	ED	NNP	O	ED	_	0	SENT_351	[p24l354t1447r436b1497],
3	,	,	O	,	_	0	SENT_351	[p24l354t1447r436b1497],
4	Cheetham	NNP	PERSON	Cheetham	nn	5	SENT_351	[p24l456t1443r703b1487],
5	RK	NNP	O	RK	appos	2	SENT_351	[p24l718t1447r806b1497],
6	,	,	O	,	_	0	SENT_351	[p24l718t1447r806b1497],
7	Stephens	NNP	PERSON	Stephens	nn	9	SENT_351	[p24l827t1443r1041b1499],
8	P	NN	O	p	nn	9	SENT_351	[p24l10t1517r67b1567],
9	]	NN	O	]	appos	2	SENT_351	[p24l10t1517r67b1567],
10	,	,	O	,	_	0	SENT_351	[p24l10t1517r67b1567],
11	et	FW	O	et	nn	12	SENT_351	[p24l102t1522r146b1557],
12	al.	FW	O	al.	appos	2	SENT_351	[p24l174t1513r230b1557],
13	.	.	O	.	_	0	SENT_351	[p24l174t1513r230b1557],

1	A	DT	O	a	det	3	SENT_352	[p24l262t1517r299b1557],
2	comprehensive	JJ	O	comprehensive	amod	3	SENT_352	[p24l329t1513r695b1569],
3	catalogue	NN	O	catalogue	_	0	SENT_352	[p24l727t1513r964b1570],
4	of	IN	O	of	_	0	SENT_352	[p24l996t1513r1053b1557],
5	somatic	JJ	O	somatic	amod	6	SENT_352	[p24l11t1585r203b1629],
6	mutations	NNS	O	mutation	prep_of	3	SENT_352	[p24l226t1585r474b1629],
7	from	IN	O	from	_	0	SENT_352	[p24l498t1584r618b1628],
8	a	DT	O	a	det	11	SENT_352	[p24l640t1599r665b1628],
9	human	JJ	O	human	amod	11	SENT_352	[p24l687t1584r860b1629],
10	cancer	NN	O	cancer	nn	11	SENT_352	[p24l883t1598r1044b1628],
11	genome	NN	O	genome	prep_from	3	SENT_352	[p24l10t1669r217b1712],
12	.	.	O	.	_	0	SENT_352	[p24l10t1669r217b1712],

1	Nature	NNP	O	Nature	_	0	SENT_353	[p24l239t1659r407b1700],
2	2010	CD	DATE	2010	num	1	SENT_353	[p24l426t1659r811b1709],
3	;	:	O	;	_	0	SENT_353	[p24l426t1659r811b1709],
4	463:191	CD	NUMBER	463:191	number	5	SENT_353	[p24l426t1659r811b1709],
5	-6	CD	NUMBER	-6	dep	1	SENT_353	[p24l426t1659r811b1709],
6	.	.	O	.	_	0	SENT_353	[p24l426t1659r811b1709],

1	5	CD	NUMBER	5	_	0	SENT_354	[p24l11t1732r48b1770],
2	.	.	O	.	_	0	SENT_354	[p24l11t1732r48b1770],

1	Sotiriou	NNP	PERSON	Sotiriou	nn	2	SENT_355	[p24l108t1727r299b1771],
2	C	NNP	O	C	_	0	SENT_355	[p24l316t1730r363b1780],
3	,	,	O	,	_	0	SENT_355	[p24l316t1730r363b1780],
4	Pusztai	NNP	PERSON	Pusztai	nn	7	SENT_355	[p24l383t1727r559b1771],
5	L.	NNP	O	L.	nn	7	SENT_355	[p24l575t1730r617b1770],
6	Gene-expression	NNP	MISC	Gene-expression	nn	7	SENT_355	[p24l638t1727r1043b1782],
7	signatures	NNS	O	signature	appos	2	SENT_355	[p24l11t1798r266b1854],
8	in	IN	O	in	_	0	SENT_355	[p24l286t1798r334b1841],
9	breast	NN	O	breast	nn	10	SENT_355	[p24l354t1797r504b1842],
10	cancer	NN	O	cancer	prep_in	7	SENT_355	[p24l521t1811r693b1841],
11	.	.	O	.	_	0	SENT_355	[p24l521t1811r693b1841],

1	N	NN	O	n	nn	2	SENT_356	[p24l714t1801r756b1842],
2	EnglJ	NN	O	englj	nsubj	3	SENT_356	[p24l774t1797r920b1854],
3	Med	VBD	O	med	_	0	SENT_356	[p24l937t1797r1042b1841],
4	2009	CD	DATE	2009	dobj	3	SENT_356	[p24l11t1872r465b1922],
5	;	:	O	;	_	0	SENT_356	[p24l11t1872r465b1922],
6	360:790	CD	NUMBER	360:790	num	7	SENT_356	[p24l11t1872r465b1922],
7	-800	CD	NUMBER	-800	dep	4	SENT_356	[p24l11t1872r465b1922],
8	.	.	O	.	_	0	SENT_356	[p24l11t1872r465b1922],

1	6	CD	NUMBER	6	_	0	SENT_357	[p24l10t1946r49b1984],
2	.	.	O	.	_	0	SENT_357	[p24l10t1946r49b1984],

1	Sorlie	NNP	PERSON	Sorlie	nn	2	SENT_358	[p24l108t1940r242b1990],
2	T	NN	PERSON	t	_	0	SENT_358	[p24l258t1944r301b1994],
3	,	,	O	,	_	0	SENT_358	[p24l258t1944r301b1994],
4	Perou	NNP	ORGANIZATION	Perou	nn	5	SENT_358	[p24l321t1944r458b1985],
5	CM	NN	ORGANIZATION	cm	appos	2	SENT_358	[p24l475t1944r570b1994],
6	,	,	O	,	_	0	SENT_358	[p24l475t1944r570b1994],
7	Tibshirani	JJ	PERSON	tibshirani	amod	8	SENT_358	[p24l589t1940r841b1984],
8	R	NN	PERSON	r	appos	2	SENT_358	[p24l857t1944r906b1994],
9	,	,	O	,	_	0	SENT_358	[p24l857t1944r906b1994],
10	et	FW	O	et	nn	11	SENT_358	[p24l927t1949r971b1984],
11	al.	FW	O	al.	appos	2	SENT_358	[p24l985t1940r1040b1984],
12	.	.	O	.	_	0	SENT_358	[p24l985t1940r1040b1984],

1	Gene	NN	O	gene	nn	3	SENT_359	[p24l10t2014r136b2055],
2	expression	NN	O	expression	nn	3	SENT_359	[p24l159t2011r420b2066],
3	patterns	NNS	O	pattern	nsubj	7	SENT_359	[p24l442t2019r644b2066],
4	of	IN	O	of	_	0	SENT_359	[p24l668t2010r725b2055],
5	breast	NN	O	breast	nn	6	SENT_359	[p24l737t2010r888b2054],
6	carcinomas	NNS	O	carcinoma	prep_of	3	SENT_359	[p24l907t2011r1042b2054, p24l10t2095r172b2125],
7	distinguish	VBP	O	distinguish	_	0	SENT_359	[p24l192t2081r472b2138],
8	tumor	NN	O	tumor	nn	9	SENT_359	[p24l489t2091r642b2126],
9	subclasses	NNS	O	subclass	dobj	7	SENT_359	[p24l659t2081r915b2126],
10	with	IN	O	with	_	0	SENT_359	[p24l931t2081r1043b2126],
11	clinical	JJ	O	clinical	amod	12	SENT_359	[p24l1118t662r1298b706],
12	implications	NNS	O	implication	prep_with	7	SENT_359	[p24l1324t662r1645b718],
13	.	.	O	.	_	0	SENT_359	[p24l1324t662r1645b718],

1	Proc	NNP	O	Proc	nn	7	SENT_360	[p24l1673t666r1782b706],
2	Natl	NNP	O	Natl	nn	7	SENT_360	[p24l1806t662r1911b707],
3	Acad	NNP	O	Acad	nn	7	SENT_360	[p24l1934t662r2055b707],
4	Sci	NNP	O	Sci	nn	7	SENT_360	[p24l2082t663r2150b706],
5	U	NNP	O	U	nn	7	SENT_360	[p24l1117t736r1156b776],
6	S	NNP	O	S	nn	7	SENT_360	[p24l1176t736r1200b777],
7	A	NNP	O	A	_	0	SENT_360	[p24l1219t736r1256b776],
8	2001	CD	DATE	2001	num	7	SENT_360	[p24l1273t736r1714b786],
9	;	:	O	;	_	0	SENT_360	[p24l1273t736r1714b786],
10	98:10869	CD	NUMBER	98:10869	number	11	SENT_360	[p24l1273t736r1714b786],
11	—	CD	NUMBER	—	dep	7	SENT_360	[p24l1273t736r1714b786],
12	74	CD	NUMBER	74	dep	11	SENT_360	[p24l1273t736r1714b786],
13	.	.	O	.	_	0	SENT_360	[p24l1273t736r1714b786],

1	7	CD	NUMBER	7	_	0	SENT_361	[p24l1119t809r1152b847],
2	.	.	O	.	_	0	SENT_361	[p24l1119t809r1152b847],

1	van	NNP	O	van	nn	5	SENT_362	[p24l1212t818r1297b848],
2	de	NNP	O	de	nn	5	SENT_362	[p24l1315t803r1369b847],
3	Vijver	NNP	O	Vijver	nn	5	SENT_362	[p24l1385t804r1523b859],
4	M	NN	O	m	nn	5	SENT_362	[p24l1537t807r1616b857],
5	]	NN	O	]	_	0	SENT_362	[p24l1537t807r1616b857],
6	,	,	O	,	_	0	SENT_362	[p24l1537t807r1616b857],
7	He	PRP	O	he	nsubj	8	SENT_362	[p24l1636t807r1702b847],
8	YD	VBD	O	yd	dep	5	SENT_362	[p24l1718t807r1802b857],
9	,	,	O	,	_	0	SENT_362	[p24l1718t807r1802b857],
10	Van	NNP	PERSON	Van	nn	12	SENT_362	[p24l1820t817r1905b848],
11	’	CD	NUMBER	’	num	12	SENT_362	[p24l1925t807r1955b847],
12	t	NN	O	t	appos	5	SENT_362	[p24l1925t807r1955b847],
13	Veer	NN	O	veer	nn	15	SENT_362	[p24l1968t807r2075b847],
14	L	NN	O	l	nn	15	SENT_362	[p24l2090t807r2147b857],
15	]	NN	O	]	dep	12	SENT_362	[p24l2090t807r2147b857],
16	,	,	O	,	_	0	SENT_362	[p24l2090t807r2147b857],
17	et	FW	O	et	nn	18	SENT_362	[p24l1118t884r1162b918],
18	al.	FW	O	al.	appos	5	SENT_362	[p24l1192t874r1247b918],
19	.	.	O	.	_	0	SENT_362	[p24l1192t874r1247b918],

1	A	DT	O	a	det	3	SENT_363	[p24l1281t878r1318b918],
2	gene-expression	NN	O	gene-expression	nn	3	SENT_363	[p24l1349t875r1748b931],
3	signature	NN	O	signature	_	0	SENT_363	[p24l1782t875r2012b931],
4	as	IN	O	as	_	0	SENT_363	[p24l2044t889r2093b918],
5	a	DT	O	a	det	6	SENT_363	[p24l2126t889r2151b918],
6	predictor	NN	O	predictor	prep_as	3	SENT_363	[p24l1117t946r1349b1002],
7	of	IN	O	of	_	0	SENT_363	[p24l1384t946r1441b990],
8	survival	NN	O	survival	prep_of	6	SENT_363	[p24l1469t946r1663b991],
9	in	IN	O	in	_	0	SENT_363	[p24l1699t947r1747b990],
10	breast	NN	O	breast	nn	11	SENT_363	[p24l1785t946r1938b990],
11	cancer	NN	O	cancer	prep_in	3	SENT_363	[p24l1972t960r2147b990],
12	.	.	O	.	_	0	SENT_363	[p24l1972t960r2147b990],

1	N	NN	O	n	nn	2	SENT_364	[p24l1117t1020r1159b1061],
2	EnglJ	NN	O	englj	nsubj	3	SENT_364	[p24l1178t1016r1323b1073],
3	Med	VBD	O	med	_	0	SENT_364	[p24l1339t1016r1445b1060],
4	2002	CD	DATE	2002	dobj	3	SENT_364	[p24l1464t1020r1966b1069],
5	;	:	O	;	_	0	SENT_364	[p24l1464t1020r1966b1069],
6	347:1999	CD	DURATION	347:1999	num	7	SENT_364	[p24l1464t1020r1966b1069],
7	-2009	CD	DURATION	-2009	dep	4	SENT_364	[p24l1464t1020r1966b1069],
8	.	.	O	.	_	0	SENT_364	[p24l1464t1020r1966b1069],

1	8	CD	NUMBER	8	_	0	SENT_365	[p24l1117t1093r1157b1133],
2	.	.	O	.	_	0	SENT_365	[p24l1117t1093r1157b1133],

1	Bender	NNP	PERSON	Bender	nn	2	SENT_366	[p24l1214t1088r1386b1132],
2	RA	NN	O	ra	_	0	SENT_366	[p24l1413t1092r1501b1142],
3	,	,	O	,	_	0	SENT_366	[p24l1413t1092r1501b1142],
4	Erlander	NNP	PERSON	Erlander	nn	5	SENT_366	[p24l1533t1088r1743b1132],
5	MG	NN	O	mg	appos	2	SENT_366	[p24l1769t1092r1872b1132],
6	.	.	O	.	_	0	SENT_366	[p24l1769t1092r1872b1132],

1	Molecular	JJ	O	molecular	amod	2	SENT_367	[p24l1903t1088r2152b1133],
2	classification	NN	O	classification	_	0	SENT_367	[p24l1118t1159r1447b1203],
3	of	IN	O	of	_	0	SENT_367	[p24l1477t1159r1534b1203],
4	unknown	JJ	O	unknown	amod	6	SENT_367	[p24l1554t1159r1789b1204],
5	primary	JJ	O	primary	amod	6	SENT_367	[p24l1818t1160r2018b1215],
6	cancer	NN	O	cancer	prep_of	2	SENT_367	[p24l2046t1174r2149b1203, p24l1118t1244r1201b1273],
7	.	.	O	.	_	0	SENT_367	[p24l2046t1174r2149b1203, p24l1118t1244r1201b1273],

1	Semin	NNP	O	Semin	nn	2	SENT_368	[p24l1225t1230r1378b1274],
2	Oncol	NNP	O	Oncol	_	0	SENT_368	[p24l1397t1229r1542b1273],
3	2009	CD	DATE	2009	num	2	SENT_368	[p24l1561t1233r1923b1282],
4	;	:	O	;	_	0	SENT_368	[p24l1561t1233r1923b1282],
5	36:38	CD	NUMBER	36:38	number	6	SENT_368	[p24l1561t1233r1923b1282],
6	—	CD	NUMBER	—	dep	2	SENT_368	[p24l1561t1233r1923b1282],
7	43	CD	NUMBER	43	dep	6	SENT_368	[p24l1561t1233r1923b1282],
8	.	.	O	.	_	0	SENT_368	[p24l1561t1233r1923b1282],

1	9	CD	NUMBER	9	_	0	SENT_369	[p24l1118t1305r1155b1344],
2	.	.	O	.	_	0	SENT_369	[p24l1118t1305r1155b1344],

1	van	NN	O	van	nn	3	SENT_370	[p24l1212t1314r1297b1345],
2	’	CD	NUMBER	’	num	3	SENT_370	[p24l1318t1304r1348b1344],
3	t	NN	O	t	_	0	SENT_370	[p24l1318t1304r1348b1344],
4	Veer	NNP	O	Veer	nn	5	SENT_370	[p24l1362t1304r1469b1344],
5	LJ	NNP	O	LJ	dep	3	SENT_370	[p24l1485t1304r1542b1354],
6	,	,	O	,	_	0	SENT_370	[p24l1485t1304r1542b1354],
7	Dai	NNP	PERSON	Dai	nn	8	SENT_370	[p24l1564t1301r1648b1344],
8	H	NNP	PERSON	H	appos	5	SENT_370	[p24l1666t1304r1720b1354],
9	,	,	O	,	_	0	SENT_370	[p24l1666t1304r1720b1354],
10	van	NNP	O	van	nn	12	SENT_370	[p24l1740t1314r1825b1345],
11	de	IN	O	de	amod	12	SENT_370	[p24l1844t1300r1898b1344],
12	Vijver	NNP	O	Vijver	appos	5	SENT_370	[p24l1915t1301r2054b1356],
13	M	NN	O	m	nn	14	SENT_370	[p24l2069t1304r2147b1354],
14	]	NN	O	]	dep	12	SENT_370	[p24l2069t1304r2147b1354],
15	,	,	O	,	_	0	SENT_370	[p24l2069t1304r2147b1354],
16	et	FW	O	et	nn	17	SENT_370	[p24l1118t1381r1162b1415],
17	al.	FW	O	al.	appos	5	SENT_370	[p24l1185t1371r1240b1415],
18	.	.	O	.	_	0	SENT_370	[p24l1185t1371r1240b1415],

1	Gene	NN	PERSON	gene	nn	2	SENT_371	[p24l1269t1375r1394b1416],
2	expression	NN	O	expression	nsubj	4	SENT_371	[p24l1421t1372r1682b1427],
3	profiling	VBG	O	profile	partmod	2	SENT_371	[p24l1707t1371r1929b1428],
4	predicts	VBZ	O	predict	_	0	SENT_371	[p24l1952t1371r2149b1427],
5	clinical	JJ	O	clinical	amod	6	SENT_371	[p24l1118t1443r1298b1487],
6	outcome	NN	O	outcome	dobj	4	SENT_371	[p24l1319t1453r1530b1488],
7	of	IN	O	of	_	0	SENT_371	[p24l1551t1443r1608b1487],
8	breast	NN	O	breast	nn	9	SENT_371	[p24l1619t1443r1769b1487],
9	cancer	NN	O	cancer	prep_of	6	SENT_371	[p24l1788t1457r1959b1487],
10	.	.	O	.	_	0	SENT_371	[p24l1788t1457r1959b1487],

1	Nature	NNP	O	Nature	_	0	SENT_372	[p24l1982t1447r2150b1488],
2	2002	CD	DATE	2002	num	1	SENT_372	[p24l1118t1517r1507b1567],
3	;	:	O	;	_	0	SENT_372	[p24l1118t1517r1507b1567],
4	415:530	CD	NUMBER	415:530	number	5	SENT_372	[p24l1118t1517r1507b1567],
5	-6	CD	NUMBER	-6	dep	1	SENT_372	[p24l1118t1517r1507b1567],
6	.	.	O	.	_	0	SENT_372	[p24l1118t1517r1507b1567],

1	10	CD	NUMBER	10	_	0	SENT_373	[p24l1120t1589r1183b1628],
2	.	.	O	.	_	0	SENT_373	[p24l1120t1589r1183b1628],

1	Paik	NNP	PERSON	Paik	nn	2	SENT_374	[p24l1214t1584r1321b1629],
2	S	NNP	PERSON	S	_	0	SENT_374	[p24l1339t1588r1377b1638],
3	,	,	O	,	_	0	SENT_374	[p24l1339t1588r1377b1638],
4	Shak	NNP	PERSON	Shak	nn	5	SENT_374	[p24l1400t1584r1520b1629],
5	S	NNP	O	S	appos	2	SENT_374	[p24l1537t1588r1576b1638],
6	,	,	O	,	_	0	SENT_374	[p24l1537t1588r1576b1638],
7	Tang	NNP	PERSON	Tang	nn	8	SENT_374	[p24l1596t1588r1720b1641],
8	G	NNP	PERSON	G	appos	2	SENT_374	[p24l1737t1588r1789b1638],
9	,	,	O	,	_	0	SENT_374	[p24l1737t1588r1789b1638],
10	et	FW	O	et	nn	11	SENT_374	[p24l1812t1594r1856b1628],
11	al.	FW	O	al.	appos	2	SENT_374	[p24l1871t1584r1927b1628],
12	.	.	O	.	_	0	SENT_374	[p24l1871t1584r1927b1628],

1	A	DT	O	a	det	3	SENT_375	[p24l1947t1588r1984b1628],
2	multigene	JJ	O	multigene	amod	3	SENT_375	[p24l2000t1584r2149b1629, p24l1118t1669r1229b1712],
3	assay	NN	O	assay	nsubj	5	SENT_375	[p24l1248t1670r1376b1711],
4	to	TO	O	to	aux	5	SENT_375	[p24l1392t1664r1438b1699],
5	predict	VB	O	predict	_	0	SENT_375	[p24l1457t1655r1627b1711],
6	recurrence	NN	O	recurrence	dobj	5	SENT_375	[p24l1643t1670r1899b1700],
7	of	IN	O	of	_	0	SENT_375	[p24l1918t1655r1974b1699],
8	tamoxifen-treated	JJ	O	tamoxifen-treated	amod	12	SENT_375	[p24l1983t1664r2149b1699, p24l1117t1726r1417b1780],
9	,	,	O	,	_	0	SENT_375	[p24l1983t1664r2149b1699, p24l1117t1726r1417b1780],
10	node-negative	JJ	O	node-negative	amod	12	SENT_375	[p24l1442t1726r1785b1783],
11	breast	NN	O	breast	nn	12	SENT_375	[p24l1807t1726r1957b1771],
12	cancer	NN	O	cancer	prep_of	6	SENT_375	[p24l1976t1740r2147b1770],
13	.	.	O	.	_	0	SENT_375	[p24l1976t1740r2147b1770],

1	N	NN	O	n	nn	2	SENT_376	[p24l1117t1801r1159b1842],
2	EnglJ	NN	O	englj	nsubj	3	SENT_376	[p24l1176t1797r1322b1854],
3	Med	VBD	O	med	_	0	SENT_376	[p24l1338t1797r1444b1841],
4	2004	CD	DATE	2004	dobj	3	SENT_376	[p24l1463t1801r1903b1850],
5	;	:	O	;	_	0	SENT_376	[p24l1463t1801r1903b1850],
6	351:2817	CD	NUMBER	351:2817	num	7	SENT_376	[p24l1463t1801r1903b1850],
7	-26	CD	NUMBER	-26	dep	4	SENT_376	[p24l1463t1801r1903b1850],
8	.	.	O	.	_	0	SENT_376	[p24l1463t1801r1903b1850],

1	11	CD	NUMBER	11	_	0	SENT_377	[p24l1120t1874r1183b1912],
2	.	.	O	.	_	0	SENT_377	[p24l1120t1874r1183b1912],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_378	[p24l1212t1872r1355b1925],
2	Y	NN	PERSON	y	_	0	SENT_378	[p24l1367t1872r1408b1922],
3	,	,	O	,	_	0	SENT_378	[p24l1367t1872r1408b1922],
4	Klijn	NNP	O	Klijn	nn	5	SENT_378	[p24l1426t1868r1543b1924],
5	JG	NNP	O	JG	appos	2	SENT_378	[p24l1554t1872r1628b1922],
6	,	,	O	,	_	0	SENT_378	[p24l1554t1872r1628b1922],
7	Zhang	NNP	PERSON	Zhang	nn	8	SENT_378	[p24l1646t1868r1804b1925],
8	Y	NN	PERSON	y	appos	2	SENT_378	[p24l1816t1872r1856b1922],
9	,	,	O	,	_	0	SENT_378	[p24l1816t1872r1856b1922],
10	et	FW	O	et	nn	11	SENT_378	[p24l1876t1878r1919b1912],
11	al.	FW	O	al.	appos	2	SENT_378	[p24l1932t1868r1988b1912],
12	.	.	O	.	_	0	SENT_378	[p24l1932t1868r1988b1912],

1	Geneexpression	NN	O	geneexpression	nn	2	SENT_379	[p24l2006t1872r2149b1913, p24l1118t1941r1375b1996],
2	proﬁles	NNS	O	proﬁles	nsubj	4	SENT_379	[p24l1397t1940r1582b1996],
3	to	TO	O	to	aux	4	SENT_379	[p24l1607t1950r1652b1984],
4	predict	VB	O	predict	_	0	SENT_379	[p24l1675t1940r1846b1996],
5	distant	JJ	O	distant	amod	6	SENT_379	[p24l1867t1940r2036b1984],
6	metastasis	NN	O	metastasis	dobj	4	SENT_379	[p24l2057t1955r2149b1984, p24l1118t2011r1301b2054],
7	of	IN	O	of	_	0	SENT_379	[p24l1332t2010r1388b2055],
8	lymph-node-negative	JJ	O	lymph-node-negative	amod	11	SENT_379	[p24l1407t2010r1924b2067],
9	primary	JJ	O	primary	amod	11	SENT_379	[p24l1953t2011r2152b2066],
10	breast	NN	O	breast	nn	11	SENT_379	[p24l1118t2081r1269b2126],
11	cancer	NN	O	cancer	prep_of	6	SENT_379	[p24l1286t2096r1457b2125],
12	.	.	O	.	_	0	SENT_379	[p24l1286t2096r1457b2125],

1	Lancet	NNP	O	Lancet	_	0	SENT_380	[p24l1479t2085r1643b2125],
2	2005	CD	DATE	2005	num	1	SENT_380	[p24l1659t2085r2041b2134],
3	;	:	O	;	_	0	SENT_380	[p24l1659t2085r2041b2134],
4	365:671	CD	NUMBER	365:671	number	5	SENT_380	[p24l1659t2085r2041b2134],
5	-9	CD	NUMBER	-9	dep	1	SENT_380	[p24l1659t2085r2041b2134],
6	.	.	O	.	_	0	SENT_380	[p24l1659t2085r2041b2134],

1	12	CD	NUMBER	12	_	0	SENT_381	[p24l14t2449r146b2529],
2	.	.	O	.	_	0	SENT_381	[p24l14t2449r146b2529],

1	Lo	NNP	O	Lo	nn	2	SENT_382	[p24l207t2445r329b2529],
2	SS	NNP	O	SS	_	0	SENT_382	[p24l369t2445r509b2549],
3	,	,	O	,	_	0	SENT_382	[p24l369t2445r509b2549],
4	Mumby	NNP	ORGANIZATION	Mumby	nn	5	SENT_382	[p24l548t2437r936b2553],
5	PB	NN	ORGANIZATION	pb	appos	2	SENT_382	[p24l964t2445r1120b2549],
6	,	,	O	,	_	0	SENT_382	[p24l964t2445r1120b2549],
7	Norton	NNP	PERSON	Norton	nn	8	SENT_382	[p24l1159t2445r1527b2529],
8	J	NNP	PERSON	J	appos	2	SENT_382	[p24l1550t2447r1618b2549],
9	,	,	O	,	_	0	SENT_382	[p24l1550t2447r1618b2549],
10	et	FW	O	et	nn	11	SENT_382	[p24l1660t2457r1750b2529],
11	al.	FW	O	al.	appos	2	SENT_382	[p24l1780t2437r1894b2529],
12	.	.	O	.	_	0	SENT_382	[p24l1780t2437r1894b2529],

1	Prospective	JJ	O	prospective	amod	3	SENT_383	[p24l1935t2445r2145b2529, p24l10t2589r411b2703],
2	multicenter	JJ	O	multicenter	amod	3	SENT_383	[p24l469t2587r1058b2679],
3	study	NN	O	study	_	0	SENT_383	[p24l1113t2587r1385b2703],
4	of	IN	O	of	_	0	SENT_383	[p24l1436t2587r1554b2679],
5	the	DT	O	the	det	6	SENT_383	[p24l1588t2587r1746b2679],
6	impact	NN	O	impact	prep_of	3	SENT_383	[p24l1802t2589r2153b2703],
7	of	IN	O	of	_	0	SENT_383	[p24l10t2737r128b2829],
8	the	DT	O	the	det	12	SENT_383	[p24l156t2737r313b2829],
9	21-gene	JJ	O	21-gene	amod	12	SENT_383	[p24l363t2745r754b2855],
10	recurrence	NN	O	recurrence	nn	12	SENT_383	[p24l806t2767r1345b2829],
11	score	NN	NUMBER	score	nn	12	SENT_383	[p24l1397t2767r1658b2829],
12	assay	NN	O	assay	prep_of	3	SENT_383	[p24l1708t2767r1977b2853],
13	on	IN	O	on	_	0	SENT_383	[p24l2023t2767r2147b2829],
14	medical	JJ	O	medical	amod	15	SENT_383	[p24l10t2887r411b2979],
15	oncologist	NN	O	oncologist	prep_on	12	SENT_383	[p24l473t2887r1009b3005],
16	and	CC	O	and	_	0	SENT_383	[p24l1063t2887r1249b2979],
17	patient	NN	O	patient	conj_and	12	SENT_383	[p24l1309t2889r1668b3003],
18	adjuvant	JJ	O	adjuvant	amod	22	SENT_383	[p24l1724t2887r2153b3003],
19	breast	NN	O	breast	nn	22	SENT_383	[p24l10t3037r321b3129],
20	cancer	NN	O	cancer	nn	22	SENT_383	[p24l373t3067r705b3129],
21	treatment	NN	O	treatment	nn	22	SENT_383	[p24l758t3057r1259b3129],
22	selection	NN	O	selection	dep	17	SENT_383	[p24l1313t3037r1790b3129],
23	.	.	O	.	_	0	SENT_383	[p24l1313t3037r1790b3129],

1	J	NNP	O	J	nn	2	SENT_384	[p24l1841t3047r1885b3143],
2	Clin	NNP	O	Clin	_	0	SENT_384	[p24l1939t3037r2147b3129],

1	Oncol	NNP	O	Oncol	_	0	SENT_385	[p24l8t3187r309b3279],
2	2010	CD	DATE	2010	num	1	SENT_385	[p24l349t3195r1142b3297],
3	;	:	O	;	_	0	SENT_385	[p24l349t3195r1142b3297],
4	28:1671	CD	NUMBER	28:1671	number	5	SENT_385	[p24l349t3195r1142b3297],
5	-6	CD	NUMBER	-6	dep	1	SENT_385	[p24l349t3195r1142b3297],
6	.	.	O	.	_	0	SENT_385	[p24l349t3195r1142b3297],

1	13	CD	NUMBER	13	_	0	SENT_386	[p24l14t3349r140b3429],
2	.	.	O	.	_	0	SENT_386	[p24l14t3349r140b3429],

1	Kerr	NNP	PERSON	Kerr	nn	2	SENT_387	[p24l207t3345r425b3431],
2	D	NNP	O	D	_	0	SENT_387	[p24l455t3345r557b3449],
3	,	,	O	,	_	0	SENT_387	[p24l455t3345r557b3449],
4	Gray	NNP	ORGANIZATION	Gray	nn	5	SENT_387	[p24l597t3345r832b3453],
5	R	NNP	ORGANIZATION	R	appos	2	SENT_387	[p24l860t3345r960b3449],
6	,	,	O	,	_	0	SENT_387	[p24l860t3345r960b3449],
7	Quirke	NNP	PERSON	Quirke	nn	8	SENT_387	[p24l1000t3337r1341b3451],
8	P	NN	O	p	appos	2	SENT_387	[p24l1373t3345r1449b3449],
9	,	,	O	,	_	0	SENT_387	[p24l1373t3345r1449b3449],
10	et	FW	O	et	nn	11	SENT_387	[p24l1489t3357r1579b3429],
11	al.	FW	O	al.	appos	2	SENT_387	[p24l1606t3337r1718b3429],
12	.	.	O	.	_	0	SENT_387	[p24l1606t3337r1718b3429],

1	A	DT	O	a	det	5	SENT_388	[p24l1754t3345r1830b3427],
2	quantitative	JJ	O	quantitative	amod	5	SENT_388	[p24l1861t3367r2145b3453, p24l10t3489r349b3579],
3	multigene	JJ	O	multigene	amod	5	SENT_388	[p24l383t3487r884b3605],
4	RT-PCR	NN	O	rt-pcr	nn	5	SENT_388	[p24l918t3495r1309b3585],
5	assay	NN	O	assay	_	0	SENT_388	[p24l1333t3517r1596b3603],
6	for	IN	O	for	_	0	SENT_388	[p24l1626t3487r1768b3579],
7	prediction	NN	O	prediction	prep_for	5	SENT_388	[p24l1798t3487r2145b3603, p24l10t3639r206b3729],
8	of	IN	O	of	_	0	SENT_388	[p24l245t3637r361b3729],
9	recurrence	NN	O	recurrence	prep_of	5	SENT_388	[p24l377t3667r906b3729],
10	in	IN	O	in	_	0	SENT_388	[p24l942t3639r1040b3727],
11	stage	NN	O	stage	nn	14	SENT_388	[p24l1078t3657r1333b3755],
12	H	NN	O	h	nn	14	SENT_388	[p24l1369t3645r1447b3727],
13	colon	NN	O	colon	nn	14	SENT_388	[p24l1483t3637r1754b3729],
14	cancer	NN	O	cancer	prep_in	5	SENT_388	[p24l1792t3667r2143b3729],
15	:	:	O	:	_	0	SENT_388	[p24l1792t3667r2143b3729],

1	selection	NN	O	selection	nsubj	16	SENT_389	[p25l10t23r451b115],
2	of	IN	O	of	_	0	SENT_389	[p25l489t23r605b115],
3	the	DT	O	the	det	4	SENT_389	[p25l622t23r776b115],
4	genes	NNS	O	gene	prep_of	1	SENT_389	[p25l812t53r1094b141],
5	in	IN	O	in	_	0	SENT_389	[p25l1133t25r1229b113],
6	four	CD	NUMBER	four	num	8	SENT_389	[p25l1267t23r1477b115],
7	large	JJ	O	large	amod	8	SENT_389	[p25l1509t23r1758b141],
8	studies	NNS	O	study	prep_in	4	SENT_389	[p25l1797t23r2145b115],
9	and	CC	O	and	_	0	SENT_389	[p25l8t173r192b265],
10	results	NNS	O	result	prep_in	4	SENT_389	[p25l249t173r579b265],
11	of	IN	O	of	_	0	SENT_389	[p25l640t173r756b265],
12	the	DT	O	the	det	13	SENT_389	[p25l794t173r948b265],
13	independent	JJ	O	independent	prep_of	8	SENT_389	[p25l1005t173r1654b289],
14	,	,	O	,	_	0	SENT_389	[p25l1005t173r1654b289],
15	prospectively	RB	O	prospectively	advmod	16	SENT_389	[p25l1718t203r2145b289, p25l10t323r269b439],
16	designed	VBN	O	design	_	0	SENT_389	[p25l301t323r745b441],
17	QUASAR	NN	O	quasar	nn	19	SENT_389	[p25l780t331r1239b437],
18	validation	NN	O	validation	nn	19	SENT_389	[p25l1257t323r1754b415],
19	study	NN	O	study	dobj	16	SENT_389	[p25l1794t323r2075b439],
20	.	.	O	.	_	0	SENT_389	[p25l1794t323r2075b439],

1	J	NNP	O	J	nn	3	SENT_390	[p25l2107t333r2149b429],
2	Clin	NNP	O	Clin	nn	3	SENT_390	[p25l10t473r214b565],
3	Oncol	NNP	O	Oncol	_	0	SENT_390	[p25l251t473r547b565],
4	2009	CD	DATE	2009	num	6	SENT_390	[p25l584t473r1567b589],
5	;	:	O	;	_	0	SENT_390	[p25l584t473r1567b589],
6	27	CD	NUMBER	27	dep	3	SENT_390	[p25l584t473r1567b589],
7	:	:	O	:	_	0	SENT_390	[p25l584t473r1567b589],
8	Suppl	NNP	O	Suppl	dep	3	SENT_390	[p25l584t473r1567b589],
9	:169	CD	NUMBER	:169	num	10	SENT_390	[p25l584t473r1567b589],
10	s.	NN	O	s.	npadvmod	11	SENT_390	[p25l584t473r1567b589],
11	abstract	JJ	O	abstract	amod	8	SENT_390	[p25l1610t473r2035b565],
12	.	.	O	.	_	0	SENT_390	[p25l1610t473r2035b565],

1	14	CD	NUMBER	14	_	0	SENT_391	[p25l14t635r146b715],
2	.	.	O	.	_	0	SENT_391	[p25l14t635r146b715],

1	Rosenwald	NNP	PERSON	Rosenwald	nn	2	SENT_392	[p25l207t623r774b721],
2	A	NNP	O	A	_	0	SENT_392	[p25l832t633r936b735],
3	,	,	O	,	_	0	SENT_392	[p25l832t633r936b735],
4	Wright	NNP	PERSON	Wright	nn	5	SENT_392	[p25l1001t623r1367b741],
5	G	NNP	PERSON	G	appos	2	SENT_392	[p25l1424t631r1534b733],
6	,	,	O	,	_	0	SENT_392	[p25l1424t631r1534b733],
7	Chan	NNP	O	Chan	nn	8	SENT_392	[p25l1602t623r1872b715],
8	WC	NNP	O	WC	appos	2	SENT_392	[p25l1929t631r2141b735],
9	,	,	O	,	_	0	SENT_392	[p25l1929t631r2141b735],
10	et	FW	O	et	nn	11	SENT_392	[p25l10t793r102b865],
11	al.	FW	O	al.	appos	2	SENT_392	[p25l157t773r274b865],
12	.	.	O	.	_	0	SENT_392	[p25l157t773r274b865],

1	The	DT	O	the	det	2	SENT_393	[p25l339t773r527b865],
2	use	NN	O	use	_	0	SENT_393	[p25l586t803r752b865],
3	of	IN	O	of	_	0	SENT_393	[p25l812t773r930b865],
4	molecular	JJ	O	molecular	amod	5	SENT_393	[p25l966t773r1479b865],
5	profiling	NN	O	profiling	prep_of	2	SENT_393	[p25l1533t773r1995b891],
6	to	TO	O	to	aux	7	SENT_393	[p25l2049t793r2145b865],
7	predict	VB	O	predict	infmod	2	SENT_393	[p25l8t923r367b1039],
8	survival	NN	O	survival	dobj	7	SENT_393	[p25l437t923r830b1015],
9	after	IN	O	after	_	0	SENT_393	[p25l904t923r1143b1015],
10	chemotherapy	NN	O	chemotherapy	prep_after	7	SENT_393	[p25l1213t923r1937b1039],
11	for	IN	O	for	_	0	SENT_393	[p25l2005t923r2151b1015],
12	diffuse	JJ	O	diffuse	amod	13	SENT_393	[p25l10t1073r367b1165],
13	large	JJ	O	large	prep_for	10	SENT_393	[p25l423t1073r1010b1191],
14	.	.	O	.	_	0	SENT_393	[p25l423t1073r1010b1191],

1	—	NN	O	—	_	0	SENT_394	[p25l423t1073r1010b1191],
2	.	.	O	.	_	0	SENT_394	[p25l423t1073r1010b1191],

1	B-cell	NN	O	b-cell	_	0	SENT_395	[p25l423t1073r1010b1191],
2	lymphoma	NN	O	lymphoma	dep	1	SENT_395	[p25l1064t1073r1634b1189],
3	.	.	O	.	_	0	SENT_395	[p25l1064t1073r1634b1189],

1	N	NN	O	n	nn	2	SENT_396	[p25l1694t1081r1782b1165],
2	EnglJ	NN	O	englj	nsubj	3	SENT_396	[p25l1833t1073r2149b1191],
3	Med	VBD	O	med	_	0	SENT_396	[p25l6t1223r226b1315],
4	2002	CD	DATE	2002	dobj	3	SENT_396	[p25l265t1231r1173b1333],
5	;	:	O	;	_	0	SENT_396	[p25l265t1231r1173b1333],
6	346:1937	CD	NUMBER	346:1937	number	7	SENT_396	[p25l265t1231r1173b1333],
7	—	CD	NUMBER	—	dep	4	SENT_396	[p25l265t1231r1173b1333],
8	47	CD	NUMBER	47	dep	7	SENT_396	[p25l265t1231r1173b1333],
9	.	.	O	.	_	0	SENT_396	[p25l265t1231r1173b1333],

1	15	CD	NUMBER	15	_	0	SENT_397	[p25l14t1385r142b1465],
2	.	.	O	.	_	0	SENT_397	[p25l14t1385r142b1465],

1	Dave	NNP	PERSON	Dave	nn	2	SENT_398	[p25l207t1381r449b1465],
2	SS	NNP	O	SS	_	0	SENT_398	[p25l495t1381r635b1485],
3	,	,	O	,	_	0	SENT_398	[p25l495t1381r635b1485],
4	Fu	NNP	PERSON	Fu	nn	5	SENT_398	[p25l684t1381r806b1465],
5	K	NNP	PERSON	K	appos	2	SENT_398	[p25l848t1383r950b1485],
6	,	,	O	,	_	0	SENT_398	[p25l848t1383r950b1485],
7	Wright	NNP	PERSON	Wright	nn	8	SENT_398	[p25l996t1373r1355b1491],
8	GW	NNP	O	GW	appos	2	SENT_398	[p25l1393t1381r1602b1483],
9	,	,	O	,	_	0	SENT_398	[p25l1393t1381r1602b1483],
10	et	FW	O	et	nn	11	SENT_398	[p25l1652t1393r1744b1465],
11	al.	FW	O	al.	appos	2	SENT_398	[p25l1780t1373r1896b1465],
12	.	.	O	.	_	0	SENT_398	[p25l1780t1373r1896b1465],

1	Molecular	JJ	O	molecular	amod	2	SENT_399	[p25l1942t1381r2145b1465, p25l8t1523r355b1615],
2	diagnosis	NN	O	diagnosis	_	0	SENT_399	[p25l403t1523r888b1641],
3	of	IN	O	of	_	0	SENT_399	[p25l942t1523r1058b1615],
4	Burkitt	NN	PERSON	burkitt	poss	6	SENT_399	[p25l1085t1523r1520b1615],
5	’s	POS	O	’s	_	0	SENT_399	[p25l1085t1523r1520b1615],
6	lymphoma	NN	O	lymphoma	prep_of	2	SENT_399	[p25l1570t1523r2141b1639],
7	.	.	O	.	_	0	SENT_399	[p25l1570t1523r2141b1639],

1	N	NN	O	n	nn	2	SENT_400	[p25l6t1681r94b1765],
2	EnglJ	NN	O	englj	nsubj	3	SENT_400	[p25l130t1673r431b1791],
3	Med	VBD	O	med	_	0	SENT_400	[p25l465t1673r684b1765],
4	2006	CD	DATE	2006	dobj	3	SENT_400	[p25l724t1681r1644b1783],
5	.	.	O	.	_	0	SENT_400	[p25l724t1681r1644b1783],

1	’	NN	O	’	_	0	SENT_401	[p25l724t1681r1644b1783],
2	-.354:2431	CD	NUMBER	-.354:2431	num	1	SENT_401	[p25l724t1681r1644b1783],
3	—	CD	NUMBER	—	number	4	SENT_401	[p25l724t1681r1644b1783],
4	42	CD	NUMBER	42	num	1	SENT_401	[p25l724t1681r1644b1783],
5	.	.	O	.	_	0	SENT_401	[p25l724t1681r1644b1783],

1	one	CD	NUMBER	one	nsubj	11	SENT_402	[p25l916t1876r966b1892],
2	JAN	NNP	DATE	JAN	nn	3	SENT_402	[p25l997t1876r1041b1898],
3	UARY	NNP	DATE	UARY	dep	1	SENT_402	[p25l1048t1876r1109b1892],
4	27	CD	DATE	27	num	3	SENT_402	[p25l1119t1876r1153b1897],
5	,	,	DATE	,	_	0	SENT_402	[p25l1119t1876r1153b1897],
6	2011	CD	DATE	2011	num	3	SENT_402	[p25l1164t1876r1216b1892],
7	and	CC	O	and	_	0	SENT_402	[p25l897t1909r944b1933],
8	Journal	NNP	O	Journal	conj_and	1	SENT_402	[p25l952t1909r1050b1933],
9	of	IN	O	of	_	0	SENT_402	[p25l1059t1909r1088b1933],
10	Medicine	NNP	O	Medicine	prep_of	8	SENT_402	[p25l1095t1909r1220b1933],
11	ed	VBD	O	ed	_	0	SENT_402	[p25l283t1950r314b1973],
12	from	IN	O	from	_	0	SENT_402	[p25l323t1950r387b1973],
13	nejm.org	NN	O	nejm.org	prep_from	11	SENT_402	[p25l396t1950r514b1980],
14	at	IN	O	at	_	0	SENT_402	[p25l524t1954r547b1973],
15	UW-Madison	NN	O	uw-madison	prep_at	11	SENT_402	[p25l556t1950r738b1973],
16	on	IN	O	on	_	0	SENT_402	[p25l748t1957r780b1973],
17	January	NNP	DATE	January	prep_on	15	SENT_402	[p25l789t1950r892b1980],
18	5	CD	DATE	5	num	17	SENT_402	[p25l902t1950r924b1978],
19	,	,	DATE	,	_	0	SENT_402	[p25l902t1950r924b1978],
20	2014	CD	DATE	2014	num	17	SENT_402	[p25l935t1950r1007b1973],
21	.	.	O	.	_	0	SENT_402	[p25l935t1950r1007b1973],

1	For	IN	O	for	_	0	SENT_403	[p25l1018t1950r1064b1973],
2	personal	JJ	O	personal	amod	3	SENT_403	[p25l1072t1950r1185b1980],
3	use	NN	O	use	pobj	1	SENT_403	[p25l1194t1957r1237b1973],
4	only	RB	O	only	advmod	3	SENT_403	[p25l1247t1950r1312b1980],
5	.	.	O	.	_	0	SENT_403	[p25l1247t1950r1312b1980],

1	No	DT	O	no	det	3	SENT_404	[p25l1322t1950r1362b1973],
2	other	JJ	O	other	amod	3	SENT_404	[p25l1372t1950r1440b1973],
3	uses	NNS	O	use	_	0	SENT_404	[p25l1448t1957r1504b1973],
4	without	IN	O	without	_	0	SENT_404	[p25l1515t1950r1616b1973],
5	permission	NN	O	permission	prep_without	3	SENT_404	[p25l1624t1950r1776b1980],
6	.	.	O	.	_	0	SENT_404	[p25l1624t1950r1776b1980],
7	'	''	O	'	_	0	SENT_404	[p25l579t1991r583b1995],

1	©	RB	O	©	advmod	2	SENT_405	[p25l638t1991r661b2015],
2	2011	CD	DATE	2011	_	0	SENT_405	[p25l671t1991r734b2015],
3	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	5	SENT_405	[p25l746t1991r937b2015],
4	Medical	NNP	ORGANIZATION	Medical	nn	5	SENT_405	[p25l947t1991r1055b2015],
5	Society	NNP	ORGANIZATION	Society	dep	2	SENT_405	[p25l1065t1991r1170b2022],
6	.	.	O	.	_	0	SENT_405	[p25l1065t1991r1170b2022],

1	All	DT	O	all	det	2	SENT_406	[p25l1181t1991r1223b2015],
2	rights	NNS	O	rights	nsubj	3	SENT_406	[p25l1232t1991r1306b2022],
3	reserved	VBN	O	reserve	_	0	SENT_406	[p25l1316t1991r1435b2015],
4	.	.	O	.	_	0	SENT_406	[p25l1316t1991r1435b2015],

1	16	CD	NUMBER	16	_	0	SENT_407	[p25l23t2329r156b2410],
2	.	.	O	.	_	0	SENT_407	[p25l23t2329r156b2410],

1	O’Connell	NN	O	o’connell	nn	3	SENT_408	[p25l217t2319r738b2410],
2	M	NN	O	m	nn	3	SENT_408	[p25l803t2327r965b2430],
3	]	NN	O	]	_	0	SENT_408	[p25l803t2327r965b2430],
4	,	,	O	,	_	0	SENT_408	[p25l803t2327r965b2430],
5	Lavery	NNP	PERSON	Lavery	nn	6	SENT_408	[p25l1040t2327r1373b2434],
6	I	NNP	O	I	appos	3	SENT_408	[p25l1434t2327r1498b2428],
7	,	,	O	,	_	0	SENT_408	[p25l1434t2327r1498b2428],
8	Yothers	NNP	PERSON	Yothers	nn	9	SENT_408	[p25l1569t2319r1953b2410],
9	G	NNP	O	G	appos	3	SENT_408	[p25l2026t2325r2135b2428],
10	,	,	O	,	_	0	SENT_408	[p25l2026t2325r2135b2428],
11	et	FW	O	et	nn	12	SENT_408	[p25l21t2488r112b2559],
12	al.	FW	O	al.	appos	3	SENT_408	[p25l169t2468r286b2559],
13	.	.	O	.	_	0	SENT_408	[p25l169t2468r286b2559],

1	Relationship	NN	O	relationship	nsubj	19	SENT_409	[p25l352t2468r993b2583],
2	between	IN	O	between	_	0	SENT_409	[p25l1056t2468r1476b2559],
3	tumor	NN	O	tumor	nn	5	SENT_409	[p25l1537t2488r1850b2559],
4	gene	NN	O	gene	nn	5	SENT_409	[p25l1907t2498r2141b2585],
5	expression	NN	O	expression	prep_between	1	SENT_409	[p25l20t2619r546b2732],
6	and	CC	O	and	_	0	SENT_409	[p25l577t2617r758b2708],
7	recurrence	NN	O	recurrence	prep_between	1	SENT_409	[p25l789t2647r1314b2708],
8	in	IN	O	in	_	0	SENT_409	[p25l1343t2619r1440b2706],
9	four	CD	NUMBER	four	num	11	SENT_409	[p25l1470t2617r1678b2708],
10	independent	JJ	O	independent	amod	11	SENT_409	[p25l1705t2617r2139b2732, p25l21t2766r237b2857],
11	studies	NNS	O	study	prep_in	7	SENT_409	[p25l294t2766r640b2857],
12	of	IN	O	of	_	0	SENT_409	[p25l705t2766r821b2857],
13	patients	NNS	O	patient	prep_of	11	SENT_409	[p25l858t2768r1252b2881],
14	with	IN	O	with	_	0	SENT_409	[p25l1311t2766r1536b2857],
15	stage	NN	O	stage	nn	18	SENT_409	[p25l1599t2786r1852b2883],
16	II/III	CD	NUMBER	ii/iii	num	18	SENT_409	[p25l1912t2772r2141b2869],
17	colon	NN	O	colon	nn	18	SENT_409	[p25l21t2915r294b3006],
18	cancer	NN	O	cancer	prep_with	13	SENT_409	[p25l328t2945r657b3005],
19	treated	VBN	O	treat	_	0	SENT_409	[p25l688t2915r1039b3006],
20	with	IN	O	with	_	0	SENT_409	[p25l1066t2915r1294b3006],
21	surgery	NN	O	surgery	prep_with	19	SENT_409	[p25l1329t2945r1709b3032],
22	alone	RB	O	alone	advmod	21	SENT_409	[p25l1735t2915r2006b3006],
23	or	CC	O	or	_	0	SENT_409	[p25l2040t2945r2145b3006],
24	surgery	NN	O	surgery	conj_or	21	SENT_409	[p25l21t3094r399b3181],
25	plus	CC	O	plus	prep	24	SENT_409	[p25l470t3064r676b3179],
26	adjuvant	JJ	O	adjuvant	amod	27	SENT_409	[p25l755t3064r1183b3179],
27	fluorouracil	NN	O	fluorouracil	dep	25	SENT_409	[p25l1254t3064r1856b3155],
28	plus	CC	O	plus	prep	27	SENT_409	[p25l1931t3064r2137b3179],
29	leucovorin	NN	O	leucovorin	dep	28	SENT_409	[p25l17t3213r573b3304],
30	.	.	O	.	_	0	SENT_409	[p25l17t3213r573b3304],

1	J	NNP	O	J	nn	3	SENT_410	[p25l609t3221r652b3318],
2	Clin	NNP	O	Clin	nn	3	SENT_410	[p25l690t3213r896b3304],
3	Oncol	NNP	O	Oncol	_	0	SENT_410	[p25l936t3213r1234b3304],
4	2010	CD	DATE	2010	num	3	SENT_410	[p25l1274t3219r2123b3322],
5	;	:	O	;	_	0	SENT_410	[p25l1274t3219r2123b3322],
6	28:3937	CD	NUMBER	28:3937	number	7	SENT_410	[p25l1274t3219r2123b3322],
7	—	CD	NUMBER	—	dep	3	SENT_410	[p25l1274t3219r2123b3322],
8	44	CD	NUMBER	44	dep	7	SENT_410	[p25l1274t3219r2123b3322],
9	.	.	O	.	_	0	SENT_410	[p25l1274t3219r2123b3322],

1	17	CD	NUMBER	17	_	0	SENT_411	[p25l23t3374r144b3453],
2	.	.	O	.	_	0	SENT_411	[p25l23t3374r144b3453],

1	Mass	JJ	O	mass	amod	2	SENT_412	[p25l213t3370r470b3452],
2	RD	NN	O	rd	_	0	SENT_412	[p25l508t3370r690b3471],
3	,	,	O	,	_	0	SENT_412	[p25l508t3370r690b3471],
4	Press	NNP	O	Press	nn	5	SENT_412	[p25l732t3370r993b3453],
5	MF	NN	O	mf	appos	2	SENT_412	[p25l1027t3370r1211b3471],
6	,	,	O	,	_	0	SENT_412	[p25l1027t3370r1211b3471],
7	Anderson	NNP	PERSON	Anderson	nn	8	SENT_412	[p25l1248t3362r1739b3453],
8	S	NNP	O	S	appos	2	SENT_412	[p25l1777t3368r1856b3471],
9	,	,	O	,	_	0	SENT_412	[p25l1777t3368r1856b3471],
10	et	FW	O	et	nn	11	SENT_412	[p25l1900t3382r1991b3452],
11	al.	FW	O	al.	appos	2	SENT_412	[p25l2020t3362r2133b3453],
12	.	.	O	.	_	0	SENT_412	[p25l2020t3362r2133b3453],

1	Evaluation	NN	O	evaluation	_	0	SENT_413	[p25l17t3511r549b3602],
2	of	IN	O	of	_	0	SENT_413	[p25l585t3511r702b3602],
3	clinical	JJ	O	clinical	amod	4	SENT_413	[p25l717t3511r1086b3601],
4	outcomes	NNS	O	outcome	prep_of	1	SENT_413	[p25l1123t3531r1605b3602],
5	according	VBG	O	accord	_	0	SENT_413	[p25l1642t3511r2145b3628],
6	to	TO	O	to	prepc_according_to	4	SENT_413	[p25l19t3680r114b3751],
7	HER2	NN	O	her2	nn	8	SENT_413	[p25l155t3666r447b3757],
8	detection	NN	O	detection	pobj	4	SENT_413	[p25l490t3660r957b3751],
9	by	IN	O	by	_	0	SENT_413	[p25l997t3660r1110b3775],
10	fluorescence	NN	O	fluorescence	prep_by	1	SENT_413	[p25l1145t3660r1783b3751],
11	in	FW	O	in	nn	12	SENT_413	[p25l1822t3662r1919b3749],
12	situ	FW	O	situ	advmod	13	SENT_413	[p25l1961t3662r2141b3751],
13	hybridization	NN	O	hybridization	rcmod	10	SENT_413	[p26l19t24r698b139],
14	in	IN	O	in	_	0	SENT_413	[p26l755t26r853b113],
15	women	NNS	O	woman	prep_in	13	SENT_413	[p26l906t54r1276b115],
16	with	IN	O	with	_	0	SENT_413	[p26l1329t24r1557b115],
17	metastatic	JJ	O	metastatic	amod	19	SENT_413	[p26l1616t26r2141b114],
18	breast	NN	O	breast	nn	19	SENT_413	[p26l19t172r330b263],
19	cancer	NN	O	cancer	prep_with	1	SENT_413	[p26l383t202r712b263],
20	treated	VBN	O	treat	partmod	1	SENT_413	[p26l769t172r1120b263],
21	With	IN	O	with	_	0	SENT_413	[p26l1175t172r1403b263],
22	trastuzumab	NN	O	trastuzumab	prep_with	20	SENT_413	[p26l1462t172r2133b263],
23	.	.	O	.	_	0	SENT_413	[p26l1462t172r2133b263],

1	Clin	NNP	O	Clin	nn	3	SENT_414	[p26l19t321r227b412],
2	Breast	NN	O	breast	nn	3	SENT_414	[p26l264t329r581b412],
3	Cancer	NN	O	cancer	_	0	SENT_414	[p26l615t327r967b412],
4	2005	CD	DATE	2005	dep	3	SENT_414	[p26l1003t327r1690b430],
5	;	:	O	;	_	0	SENT_414	[p26l1003t327r1690b430],
6	6:240	CD	NUMBER	6:240	num	7	SENT_414	[p26l1003t327r1690b430],
7	-6	CD	NUMBER	-6	dep	3	SENT_414	[p26l1003t327r1690b430],
8	.	.	O	.	_	0	SENT_414	[p26l1003t327r1690b430],

1	18	CD	NUMBER	18	_	0	SENT_415	[p26l23t480r156b561],
2	.	.	O	.	_	0	SENT_415	[p26l23t480r156b561],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_416	[p26l215t470r512b585],
2	T	NN	O	t	nn	3	SENT_416	[p26l563t478r694b581],
3	]	NN	O	]	_	0	SENT_416	[p26l563t478r694b581],
4	,	,	O	,	_	0	SENT_416	[p26l563t478r694b581],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_416	[p26l753t470r945b561],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_416	[p26l997t478r1199b581],
7	,	,	O	,	_	0	SENT_416	[p26l997t478r1199b581],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_416	[p26l1262t470r1670b561],
9	R	NNP	PERSON	R	appos	3	SENT_416	[p26l1721t478r1821b579],
10	,	,	O	,	_	0	SENT_416	[p26l1721t478r1821b579],
11	et	FW	O	et	nn	12	SENT_416	[p26l1882t490r1973b560],
12	al.	FW	O	al.	appos	3	SENT_416	[p26l2020t470r2134b561],
13	.	.	O	.	_	0	SENT_416	[p26l2020t470r2134b561],

1	Activating	VBG	O	activate	amod	2	SENT_417	[p26l15t621r536b736],
2	mutations	NNS	O	mutation	_	0	SENT_417	[p26l615t621r1126b710],
3	in	IN	O	in	_	0	SENT_417	[p26l1211t621r1308b708],
4	the	DT	O	the	det	7	SENT_417	[p26l1393t619r1548b710],
5	epidermal	JJ	O	epidermal	amod	7	SENT_417	[p26l1634t619r2141b734],
6	growth	NN	O	growth	nn	7	SENT_417	[p26l19t768r381b885],
7	factor	NN	O	factor	prep_in	2	SENT_417	[p26l421t768r710b859],
8	receptor	NN	O	receptor	nn	10	SENT_417	[p26l747t788r1157b883],
9	underlying	VBG	O	underlie	amod	10	SENT_417	[p26l1193t768r1731b885],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_417	[p26l1767t798r2139b883, p26l21t919r423b1008],
11	of	IN	O	of	_	0	SENT_417	[p26l476t917r591b1008],
12	non	JJ	O	non	amod	18	SENT_417	[p26l619t917r1349b1008],
13	—	JJ	O	—	amod	18	SENT_417	[p26l619t917r1349b1008],
14	small	JJ	O	small	amod	18	SENT_417	[p26l619t917r1349b1008],
15	—	NN	O	—	nn	18	SENT_417	[p26l619t917r1349b1008],
16	cell	NN	O	cell	nn	18	SENT_417	[p26l619t917r1349b1008],
17	lung	NN	O	lung	nn	18	SENT_417	[p26l1396t917r1623b1034],
18	cancer	NN	O	cancer	prep_of	10	SENT_417	[p26l1668t947r1999b1007],
19	to	TO	O	to	_	0	SENT_417	[p26l2044t937r2139b1008],
20	gefitinib	NN	O	gefitinib	prep_to	10	SENT_417	[p26l19t1066r484b1183],
21	.	.	O	.	_	0	SENT_417	[p26l19t1066r484b1183],

1	N	NN	O	n	nn	3	SENT_418	[p26l523t1074r609b1157],
2	Engl	NNP	O	Engl	nn	3	SENT_418	[p26l640t1066r933b1183],
3	]	NNP	O	]	nsubj	4	SENT_418	[p26l640t1066r933b1183],
4	Med	VBD	O	med	_	0	SENT_418	[p26l961t1066r1179b1157],
5	2004	CD	DATE	2004	dobj	4	SENT_418	[p26l1214t1072r2134b1175],
6	;	:	O	;	_	0	SENT_418	[p26l1214t1072r2134b1175],
7	350:2129	CD	NUMBER	350:2129	number	8	SENT_418	[p26l1214t1072r2134b1175],
8	—	CD	NUMBER	—	dep	5	SENT_418	[p26l1214t1072r2134b1175],
9	39	CD	NUMBER	39	dep	8	SENT_418	[p26l1214t1072r2134b1175],
10	.	.	O	.	_	0	SENT_418	[p26l1214t1072r2134b1175],

1	19	CD	NUMBER	19	_	0	SENT_419	[p26l23t1225r150b1306],
2	.	.	O	.	_	0	SENT_419	[p26l23t1225r150b1306],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_420	[p26l215t1223r441b1305],
2	JG	NNP	O	JG	_	0	SENT_420	[p26l470t1221r623b1326],
3	,	,	O	,	_	0	SENT_420	[p26l470t1221r623b1326],
4	Jéinne	NNP	ORGANIZATION	Jéinne	nn	5	SENT_420	[p26l658t1223r946b1320],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_420	[p26l985t1223r1141b1324],
6	,	,	O	,	_	0	SENT_420	[p26l985t1223r1141b1324],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_420	[p26l1185t1223r1355b1306],
8	JC	NNP	PERSON	JC	appos	2	SENT_420	[p26l1383t1221r1526b1324],
9	,	,	O	,	_	0	SENT_420	[p26l1383t1221r1526b1324],
10	et	FW	O	et	nn	11	SENT_420	[p26l1573t1235r1664b1306],
11	al.	FW	O	al.	appos	2	SENT_420	[p26l1696t1215r1811b1306],
12	.	.	O	.	_	0	SENT_420	[p26l1696t1215r1811b1306],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_421	[p26l1854t1221r2153b1312],
2	mutations	NNS	O	mutation	_	0	SENT_421	[p26l19t1366r520b1455],
3	in	IN	O	in	_	0	SENT_421	[p26l559t1366r656b1453],
4	lung	NN	O	lung	nn	5	SENT_421	[p26l692t1364r916b1481],
5	cancer	NN	O	cancer	prep_in	2	SENT_421	[p26l951t1394r1298b1455],
6	:	:	O	:	_	0	SENT_421	[p26l951t1394r1298b1455],
7	correlation	NN	O	correlation	dep	2	SENT_421	[p26l1341t1364r1882b1455],
8	with	IN	O	with	_	0	SENT_421	[p26l1915t1364r2141b1455],
9	clinical	JJ	O	clinical	amod	10	SENT_421	[p26l20t1513r389b1603],
10	response	NN	O	response	prep_with	7	SENT_421	[p26l426t1543r874b1628],
11	to	TO	O	to	_	0	SENT_421	[p26l912t1533r1007b1604],
12	gefitinib	NN	O	gefitinib	nn	13	SENT_421	[p26l1044t1513r1482b1630],
13	therapy	NN	O	therapy	prep_to	10	SENT_421	[p26l1521t1513r1916b1628],
14	.	.	O	.	_	0	SENT_421	[p26l1521t1513r1916b1628],

1	Science	NNP	O	Science	_	0	SENT_422	[p26l1963t1515r2139b1604, p26l21t1692r241b1753],
2	2004	CD	DATE	2004	num	1	SENT_422	[p26l282t1670r1256b1771],
3	;	:	O	;	_	0	SENT_422	[p26l282t1670r1256b1771],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_422	[p26l282t1670r1256b1771],
5	—	CD	NUMBER	—	dep	1	SENT_422	[p26l282t1670r1256b1771],
6	500	CD	NUMBER	500	dep	5	SENT_422	[p26l282t1670r1256b1771],
7	.	.	O	.	_	0	SENT_422	[p26l282t1670r1256b1771],

1	20	CD	NUMBER	20	_	0	SENT_423	[p26l17t1821r154b1902],
2	.	.	O	.	_	0	SENT_423	[p26l17t1821r154b1902],

1	Mok	NN	O	mok	nn	2	SENT_424	[p26l213t1811r440b1902],
2	TS	NN	O	t	_	0	SENT_424	[p26l466t1819r619b1922],
3	,	,	O	,	_	0	SENT_424	[p26l466t1819r619b1922],
4	Wu	NNP	PERSON	Wu	nn	5	SENT_424	[p26l656t1819r823b1902],
5	Y-L	NNP	PERSON	Y-L	appos	2	SENT_424	[p26l854t1819r1035b1922],
6	,	,	O	,	_	0	SENT_424	[p26l854t1819r1035b1922],
7	Thongprasert	NNP	O	Thongprasert	nn	8	SENT_424	[p26l1072t1811r1753b1928],
8	S	NNP	O	S	appos	2	SENT_424	[p26l1785t1817r1862b1922],
9	,	,	O	,	_	0	SENT_424	[p26l1785t1817r1862b1922],
10	et	FW	O	et	nn	11	SENT_424	[p26l1905t1831r1995b1901],
11	al.	FW	O	al.	appos	2	SENT_424	[p26l2022t1811r2135b1902],
12	.	.	O	.	_	0	SENT_424	[p26l2022t1811r2135b1902],

1	Gefitinib	NN	O	gefitinib	_	0	SENT_425	[p26l19t1960r472b2051],
2	or	CC	O	or	_	0	SENT_425	[p26l517t1990r619b2051],
3	carboplatin	NN	O	carboplatin	conj_or	1	SENT_425	[p26l660t1960r1765b2075],
4	—	CD	NUMBER	—	num	5	SENT_425	[p26l660t1960r1765b2075],
5	paclitaxel	NN	O	paclitaxel	dep	1	SENT_425	[p26l660t1960r1765b2075],
6	in	IN	O	in	_	0	SENT_425	[p26l1808t1962r1904b2049],
7	pulmonary	JJ	O	pulmonary	amod	8	SENT_425	[p26l1945t1960r2139b2075, p26l19t2139r411b2224],
8	adenocarcinoma	NN	O	adenocarcinoma	prep_in	5	SENT_425	[p26l468t2109r1334b2200],
9	.	.	O	.	_	0	SENT_425	[p26l468t2109r1334b2200],

1	N	NN	O	n	nn	3	SENT_426	[p26l1401t2117r1486b2200],
2	Engl	NNP	O	Engl	nn	3	SENT_426	[p26l1545t2109r1773b2226],
3	J	NNP	O	J	nsubj	4	SENT_426	[p26l1824t2117r1866b2214],
4	Med	VBD	O	med	_	0	SENT_426	[p26l1923t2109r2141b2200],
5	2009	CD	DATE	2009	dobj	4	SENT_426	[p26l19t2264r856b2367],
6	;	:	O	;	_	0	SENT_426	[p26l19t2264r856b2367],
7	361:947	CD	NUMBER	361:947	number	8	SENT_426	[p26l19t2264r856b2367],
8	—	CD	NUMBER	—	dep	5	SENT_426	[p26l19t2264r856b2367],
9	57	CD	NUMBER	57	dep	8	SENT_426	[p26l19t2264r856b2367],
10	.	.	O	.	_	0	SENT_426	[p26l19t2264r856b2367],

1	21	CD	NUMBER	21	_	0	SENT_427	[p26l17t2419r152b2498],
2	.	.	O	.	_	0	SENT_427	[p26l17t2419r152b2498],

1	Fong	NNP	O	Fong	nn	2	SENT_428	[p26l215t2415r463b2524],
2	PC	NNP	O	PC	_	0	SENT_428	[p26l488t2413r649b2518],
3	,	,	O	,	_	0	SENT_428	[p26l488t2413r649b2518],
4	Boss	NNP	O	Boss	nn	5	SENT_428	[p26l684t2415r910b2498],
5	DS	NN	O	d	appos	2	SENT_428	[p26l943t2413r1106b2518],
6	,	,	O	,	_	0	SENT_428	[p26l943t2413r1106b2518],
7	Yap	NNP	PERSON	Yap	nn	8	SENT_428	[p26l1139t2415r1313b2522],
8	TA	NNP	O	TA	appos	2	SENT_428	[p26l1341t2415r1508b2518],
9	,	,	O	,	_	0	SENT_428	[p26l1341t2415r1508b2518],
10	et	FW	O	et	nn	11	SENT_428	[p26l1545t2427r1635b2498],
11	al.	FW	O	al.	appos	2	SENT_428	[p26l1660t2407r1769b2498],
12	.	.	O	.	_	0	SENT_428	[p26l1660t2407r1769b2498],

1	Inhibition	NN	O	inhibition	nsubj	7	SENT_429	[p26l1806t2407r2139b2498, p26l19t2558r215b2647],
2	of	IN	O	of	_	0	SENT_429	[p26l254t2556r369b2647],
3	poly	NN	O	poly	nn	5	SENT_429	[p26l385t2556r1223b2671],
4	(	CD	NUMBER	(	num	5	SENT_429	[p26l385t2556r1223b2671],
5	ADP	NN	O	adp	prep_of	1	SENT_429	[p26l385t2556r1223b2671],
6	—	CD	NUMBER	—	num	5	SENT_429	[p26l385t2556r1223b2671],
7	ribose	NN	O	ribose	_	0	SENT_429	[p26l385t2556r1223b2671],
8	)	CD	NUMBER	)	num	9	SENT_429	[p26l385t2556r1223b2671],
9	polymerase	NN	O	polymerase	dobj	7	SENT_429	[p26l1266t2556r1832b2671],
10	in	IN	O	in	_	0	SENT_429	[p26l1870t2558r1965b2645],
11	tumors	NNS	O	tumor	prep_in	9	SENT_429	[p26l2005t2576r2139b2647, p26l19t2735r268b2796],
12	from	IN	O	from	_	0	SENT_429	[p26l306t2705r549b2796],
13	BRCA	NN	O	brca	nn	15	SENT_429	[p26l583t2711r835b2796],
14	mutation	NN	O	mutation	nn	15	SENT_429	[p26l866t2707r1318b2796],
15	carriers	NNS	O	carrier	prep_from	7	SENT_429	[p26l1355t2707r1757b2796],
16	.	.	O	.	_	0	SENT_429	[p26l1355t2707r1757b2796],

1	N	NN	O	n	nn	3	SENT_430	[p26l1798t2713r1884b2796],
2	Engl	NNP	O	Engl	nn	3	SENT_430	[p26l1917t2705r2141b2822],
3	J	NNP	O	J	nsubj	4	SENT_430	[p26l7t2862r51b2959],
4	Med	VBD	O	med	_	0	SENT_430	[p26l84t2854r302b2945],
5	2009	CD	DATE	2009	dobj	4	SENT_430	[p26l342t2860r1203b2963],
6	;	:	O	;	_	0	SENT_430	[p26l342t2860r1203b2963],
7	361:123	CD	NUMBER	361:123	number	8	SENT_430	[p26l342t2860r1203b2963],
8	—	CD	NUMBER	—	dep	5	SENT_430	[p26l342t2860r1203b2963],
9	34	CD	NUMBER	34	dep	8	SENT_430	[p26l342t2860r1203b2963],
10	.	.	O	.	_	0	SENT_430	[p26l342t2860r1203b2963],

1	22	CD	NUMBER	22	_	0	SENT_431	[p26l17t3015r158b3094],
2	.	.	O	.	_	0	SENT_431	[p26l17t3015r158b3094],

1	McCabe	NNP	PERSON	McCabe	nn	2	SENT_432	[p26l213t3003r617b3094],
2	N	NNP	O	N	_	0	SENT_432	[p26l660t3011r769b3112],
3	,	,	O	,	_	0	SENT_432	[p26l660t3011r769b3112],
4	Turner	NNP	ORGANIZATION	Turner	nn	5	SENT_432	[p26l815t3011r1157b3094],
5	NC	NNP	ORGANIZATION	NC	appos	2	SENT_432	[p26l1197t3011r1383b3112],
6	,	,	O	,	_	0	SENT_432	[p26l1197t3011r1383b3112],
7	Lord	NNP	O	Lord	nn	9	SENT_432	[p26l1432t3003r1664b3094],
8	C	NNP	O	C	nn	9	SENT_432	[p26l1709t3011r1840b3112],
9	]	NN	O	]	appos	2	SENT_432	[p26l1709t3011r1840b3112],
10	,	,	O	,	_	0	SENT_432	[p26l1709t3011r1840b3112],
11	et	FW	O	et	nn	12	SENT_432	[p26l1891t3022r1981b3093],
12	al.	FW	O	al.	appos	2	SENT_432	[p26l2020t3003r2133b3094],
13	.	.	O	.	_	0	SENT_432	[p26l2020t3003r2133b3094],

1	Deficiency	NN	O	deficiency	_	0	SENT_433	[p26l17t3152r554b3267],
2	in	IN	O	in	_	0	SENT_433	[p26l601t3154r698b3241],
3	the	DT	O	the	det	4	SENT_433	[p26l749t3152r906b3243],
4	repair	NN	O	repair	prep_in	1	SENT_433	[p26l957t3154r1258b3267],
5	of	IN	O	of	_	0	SENT_433	[p26l1308t3152r1425b3243],
6	DNA	NN	O	dna	nn	7	SENT_433	[p26l1454t3160r1696b3243],
7	damage	NN	O	damage	prep_of	1	SENT_433	[p26l1745t3152r2141b3269],
8	by	IN	O	by	_	0	SENT_433	[p26l19t3301r134b3416],
9	homologous	JJ	O	homologous	amod	10	SENT_433	[p26l169t3301r797b3418],
10	recombination	NN	O	recombination	prep_by	7	SENT_433	[p26l840t3301r1583b3392],
11	and	CC	O	and	_	0	SENT_433	[p26l1624t3301r1809b3392],
12	sensitivity	NN	O	sensitivity	prep_of	1	SENT_433	[p26l1852t3303r2139b3391, p26l19t3452r274b3565],
13	to	TO	O	to	_	0	SENT_433	[p26l320t3470r415b3541],
14	poly	NN	O	poly	nn	16	SENT_433	[p26l466t3450r1322b3565],
15	(	CD	NUMBER	(	num	16	SENT_433	[p26l466t3450r1322b3565],
16	ADP	NN	O	adp	prep_to	12	SENT_433	[p26l466t3450r1322b3565],
17	—	CD	NUMBER	—	num	16	SENT_433	[p26l466t3450r1322b3565],
18	ribose	NN	O	ribose	nn	21	SENT_433	[p26l466t3450r1322b3565],
19	)	CD	NUMBER	)	num	21	SENT_433	[p26l466t3450r1322b3565],
20	polymerase	NN	O	polymerase	nn	21	SENT_433	[p26l1377t3450r1953b3565],
21	inhibition	NN	O	inhibition	dep	12	SENT_433	[p26l2004t3452r2139b3539, p26l19t3599r446b3690],
22	.	.	O	.	_	0	SENT_433	[p26l2004t3452r2139b3539, p26l19t3599r446b3690],

1	Cancer	NN	O	cancer	_	0	SENT_434	[p26l492t3605r843b3690],
2	Res	NNP	O	Res	dep	1	SENT_434	[p26l878t3607r1053b3694],
3	2006	CD	DATE	2006	num	2	SENT_434	[p26l1096t3605r1955b3708],
4	;	:	O	;	_	0	SENT_434	[p26l1096t3605r1955b3708],
5	66:8109	CD	NUMBER	66:8109	num	6	SENT_434	[p26l1096t3605r1955b3708],
6	-15	CD	NUMBER	-15	dep	1	SENT_434	[p26l1096t3605r1955b3708],
7	.	.	O	.	_	0	SENT_434	[p26l1096t3605r1955b3708],

1	23	CD	NUMBER	23	_	0	SENT_435	[p27l17t39r154b118],
2	.	.	O	.	_	0	SENT_435	[p27l17t39r154b118],

1	Wood	NNP	O	Wood	nn	2	SENT_436	[p27l213t27r508b118],
2	LD	NNP	O	LD	_	0	SENT_436	[p27l549t35r716b136],
3	,	,	O	,	_	0	SENT_436	[p27l549t35r716b136],
4	Parsons	NNP	PERSON	Parsons	nn	5	SENT_436	[p27l765t35r1159b118],
5	DW	NNP	O	DW	appos	2	SENT_436	[p27l1203t35r1407b136],
6	,	,	O	,	_	0	SENT_436	[p27l1203t35r1407b136],
7	Jones	NNP	PERSON	Jones	nn	8	SENT_436	[p27l1444t35r1718b132],
8	S	NNP	O	S	appos	2	SENT_436	[p27l1765t33r1844b136],
9	,	,	O	,	_	0	SENT_436	[p27l1765t33r1844b136],
10	et	FW	O	et	nn	11	SENT_436	[p27l1894t46r1985b118],
11	al.	FW	O	al.	appos	2	SENT_436	[p27l2020t27r2135b118],
12	.	.	O	.	_	0	SENT_436	[p27l2020t27r2135b118],

1	The	DT	O	the	det	3	SENT_437	[p27l15t176r203b266],
2	genomic	JJ	O	genomic	amod	3	SENT_437	[p27l242t178r676b293],
3	landscapes	NNS	O	landscape	_	0	SENT_437	[p27l712t176r1266b291],
4	of	IN	O	of	_	0	SENT_437	[p27l1309t176r1425b267],
5	human	JJ	O	human	amod	6	SENT_437	[p27l1442t176r1799b267],
6	breast	NN	O	breast	prep_of	3	SENT_437	[p27l1838t176r2147b267],
7	and	CC	O	and	_	0	SENT_437	[p27l19t325r203b416],
8	colorectal	JJ	O	colorectal	amod	9	SENT_437	[p27l248t325r744b416],
9	cancers	NNS	O	cancer	prep_of	3	SENT_437	[p27l791t355r1197b416],
10	.	.	O	.	_	0	SENT_437	[p27l791t355r1197b416],

1	Science	NNP	O	Science	_	0	SENT_438	[p27l1250t327r1619b416],
2	2007	CD	DATE	2007	num	1	SENT_438	[p27l1664t331r2135b434],
3	;	:	O	;	_	0	SENT_438	[p27l1664t331r2135b434],
4	318	CD	NUMBER	318	num	6	SENT_438	[p27l1664t331r2135b434],
5	:	:	O	:	_	0	SENT_438	[p27l1664t331r2135b434],
6	1108-13	CD	NUMBER	1108-13	dep	1	SENT_438	[p27l23t479r439b564],
7	.	.	O	.	_	0	SENT_438	[p27l23t479r439b564],

1	24	CD	NUMBER	24	_	0	SENT_439	[p27l17t634r156b713],
2	.	.	O	.	_	0	SENT_439	[p27l17t634r156b713],

1	Nowell	NNP	PERSON	Nowell	nn	2	SENT_440	[p27l215t622r571b713],
2	P	NN	PERSON	p	_	0	SENT_440	[p27l642t630r718b733],
3	,	,	O	,	_	0	SENT_440	[p27l642t630r718b733],
4	Hungerford	NNP	PERSON	Hungerford	nn	8	SENT_440	[p27l797t622r1391b739],
5	D.	NNP	O	D.	nn	8	SENT_440	[p27l1460t630r1565b713],
6	A	NNP	DURATION	A	nn	8	SENT_440	[p27l1640t630r1716b711],
7	minute	NN	DURATION	minute	nn	8	SENT_440	[p27l1783t624r2141b713],
8	chromosome	NN	O	chromosome	appos	2	SENT_440	[p27l21t771r680b862],
9	in	IN	O	in	_	0	SENT_440	[p27l727t773r825b860],
10	human	JJ	O	human	amod	13	SENT_440	[p27l872t771r1228b862],
11	chronic	JJ	O	chronic	amod	13	SENT_440	[p27l1276t771r1656b862],
12	granulo	NN	O	granulo	nn	13	SENT_440	[p27l1703t771r2139b888],
13	—	NN	O	—	prep_in	8	SENT_440	[p27l1703t771r2139b888],
14	cytic	JJ	O	cytic	amod	15	SENT_440	[p27l21t922r247b1035],
15	leukemia	NN	O	leukemia	dep	13	SENT_440	[p27l286t920r765b1011],
16	.	.	O	.	_	0	SENT_440	[p27l286t920r765b1011],

1	Science	NNP	O	Science	_	0	SENT_441	[p27l815t922r1175b1011],
2	1960	CD	DATE	1960	num	1	SENT_441	[p27l1220t926r1939b1029],
3	;	:	O	;	_	0	SENT_441	[p27l1220t926r1939b1029],
4	132:1497	CD	NUMBER	132:1497	dep	1	SENT_441	[p27l1220t926r1939b1029],
5	.	.	O	.	_	0	SENT_441	[p27l1220t926r1939b1029],

1	abstract	JJ	O	abstract	_	0	SENT_442	[p27l1986t920r2139b1011, p27l21t1088r328b1159],
2	.	.	O	.	_	0	SENT_442	[p27l1986t920r2139b1011, p27l21t1088r328b1159],

1	25	CD	NUMBER	25	_	0	SENT_443	[p27l17t1229r150b1308],
2	.	.	O	.	_	0	SENT_443	[p27l17t1229r150b1308],

1	O’Brien	NNP	O	O’Brien	nn	2	SENT_444	[p27l217t1219r587b1308],
2	SG	NNP	O	SG	_	0	SENT_444	[p27l619t1223r781b1328],
3	,	,	O	,	_	0	SENT_444	[p27l619t1223r781b1328],
4	Guilhot	NNP	O	Guilhot	nn	5	SENT_444	[p27l817t1217r1199b1308],
5	F	NN	O	f	appos	2	SENT_444	[p27l1222t1225r1298b1326],
6	,	,	O	,	_	0	SENT_444	[p27l1222t1225r1298b1326],
7	Larson	NNP	PERSON	Larson	nn	8	SENT_444	[p27l1333t1225r1670b1308],
8	RA	NN	O	ra	appos	2	SENT_444	[p27l1699t1225r1876b1326],
9	,	,	O	,	_	0	SENT_444	[p27l1699t1225r1876b1326],
10	et	FW	O	et	nn	11	SENT_444	[p27l1912t1237r2001b1308],
11	al.	FW	O	al.	appos	2	SENT_444	[p27l2024t1217r2135b1308],
12	.	.	O	.	_	0	SENT_444	[p27l2024t1217r2135b1308],

1	Imatinib	NN	O	imatinib	_	0	SENT_445	[p27l17t1366r457b1457],
2	compared	VBN	O	compare	_	0	SENT_445	[p27l526t1366r1026b1481],
3	with	IN	O	with	prepc_compared_with	1	SENT_445	[p27l1088t1366r1316b1457],
4	interferon	NN	O	interferon	pobj	1	SENT_445	[p27l1383t1366r1890b1457],
5	and	CC	O	and	_	0	SENT_445	[p27l1957t1366r2141b1457],
6	low-dose	JJ	O	low-dose	amod	7	SENT_445	[p27l17t1515r471b1606],
7	cytarabine	NN	O	cytarabine	conj_and	4	SENT_445	[p27l520t1515r1046b1630],
8	for	IN	O	for	prep	1	SENT_445	[p27l1094t1515r1239b1606],
9	newly	RB	O	newly	pcomp	8	SENT_445	[p27l1284t1515r1577b1630],
10	diagnosed	VBN	O	diagnose	partmod	1	SENT_445	[p27l1620t1515r2141b1632],
11	chronic	JJ	O	chronic	amod	13	SENT_445	[p27l21t1664r734b1779],
12	—	NN	O	—	nn	13	SENT_445	[p27l21t1664r734b1779],
13	phase	NN	O	phase	dobj	10	SENT_445	[p27l21t1664r734b1779],
14	chronic	JJ	O	chronic	amod	16	SENT_445	[p27l781t1664r1161b1755],
15	myeloid	JJ	O	myeloid	amod	16	SENT_445	[p27l1205t1664r1599b1779],
16	leukemia	NN	O	leukemia	dep	13	SENT_445	[p27l1644t1664r2133b1755],
17	.	.	O	.	_	0	SENT_445	[p27l1644t1664r2133b1755],

1	N	NN	O	n	nn	3	SENT_446	[p27l17t1821r102b1904],
2	Engl	NNP	O	Engl	nn	3	SENT_446	[p27l140t1813r437b1930],
3	]	NNP	O	]	nsubj	4	SENT_446	[p27l140t1813r437b1930],
4	Med	VBD	O	med	_	0	SENT_446	[p27l472t1813r688b1904],
5	2003	CD	DATE	2003	dobj	4	SENT_446	[p27l728t1819r1712b1922],
6	;	:	O	;	_	0	SENT_446	[p27l728t1819r1712b1922],
7	348:994	CD	NUMBER	348:994	number	8	SENT_446	[p27l728t1819r1712b1922],
8	—	CD	NUMBER	—	dep	5	SENT_446	[p27l728t1819r1712b1922],
9	1004	CD	DATE	1004	dep	8	SENT_446	[p27l728t1819r1712b1922],
10	.	.	O	.	_	0	SENT_446	[p27l728t1819r1712b1922],

1	26	CD	NUMBER	26	_	0	SENT_447	[p27l17t1972r154b2053],
2	.	.	O	.	_	0	SENT_447	[p27l17t1972r154b2053],

1	Druker	NNP	PERSON	Druker	nn	2	SENT_448	[p27l215t1962r569b2053],
2	BJ	NNP	O	BJ	_	0	SENT_448	[p27l597t1970r720b2071],
3	,	,	O	,	_	0	SENT_448	[p27l597t1970r720b2071],
4	Guilhot	NNP	O	Guilhot	nn	5	SENT_448	[p27l761t1962r1147b2053],
5	F	NN	O	f	appos	2	SENT_448	[p27l1173t1970r1250b2073],
6	,	,	O	,	_	0	SENT_448	[p27l1173t1970r1250b2073],
7	O’Brien	NNP	O	O’Brien	nn	8	SENT_448	[p27l1292t1964r1664b2053],
8	SG	NNP	O	SG	appos	2	SENT_448	[p27l1701t1970r1864b2071],
9	,	,	O	,	_	0	SENT_448	[p27l1701t1970r1864b2071],
10	et	FW	O	et	nn	11	SENT_448	[p27l1905t1982r1995b2052],
11	al.	FW	O	al.	appos	2	SENT_448	[p27l2022t1962r2133b2053],
12	.	.	O	.	_	0	SENT_448	[p27l2022t1962r2133b2053],

1	FiVe	CD	NUMBER	five	number	2	SENT_449	[p27l17t2113r464b2226],
2	—	CD	NUMBER	—	num	3	SENT_449	[p27l17t2113r464b2226],
3	year	NN	NUMBER	year	nsubj	4	SENT_449	[p27l17t2113r464b2226],
4	follow	VBP	O	follow	_	0	SENT_449	[p27l522t2111r1003b2226],
5	—	CD	NUMBER	—	npadvmod	6	SENT_449	[p27l522t2111r1003b2226],
6	up	IN	O	up	advmod	4	SENT_449	[p27l522t2111r1003b2226],
7	of	IN	O	of	_	0	SENT_449	[p27l1066t2111r1181b2202],
8	patients	NNS	O	patient	prep_of	4	SENT_449	[p27l1219t2113r1622b2226],
9	receiving	VBG	O	receive	partmod	8	SENT_449	[p27l1686t2113r2145b2228],
10	imatinib	NN	O	imatinib	dobj	9	SENT_449	[p27l19t2260r460b2351],
11	for	IN	O	for	_	0	SENT_449	[p27l522t2260r668b2351],
12	chronic	JJ	O	chronic	amod	14	SENT_449	[p27l727t2260r1114b2351],
13	myeloid	JJ	O	myeloid	amod	14	SENT_449	[p27l1173t2260r1575b2375],
14	leukemia	NN	O	leukemia	prep_for	10	SENT_449	[p27l1634t2260r2134b2351],
15	.	.	O	.	_	0	SENT_449	[p27l1634t2260r2134b2351],

1	N	NN	O	n	nn	3	SENT_450	[p27l17t2417r102b2500],
2	Engl	NNP	O	Engl	nn	3	SENT_450	[p27l142t2409r369b2526],
3	J	NNP	O	J	nsubj	4	SENT_450	[p27l397t2417r441b2514],
4	Med	VBD	O	med	_	0	SENT_450	[p27l474t2409r690b2500],
5	2006	CD	DATE	2006	dobj	4	SENT_450	[p27l731t2415r1631b2518],
6	;	:	O	;	_	0	SENT_450	[p27l731t2415r1631b2518],
7	355:2408	CD	NUMBER	355:2408	number	8	SENT_450	[p27l731t2415r1631b2518],
8	—	CD	NUMBER	—	dep	5	SENT_450	[p27l731t2415r1631b2518],
9	17	CD	NUMBER	17	dep	8	SENT_450	[p27l731t2415r1631b2518],
10	.	.	O	.	_	0	SENT_450	[p27l731t2415r1631b2518],

1	27	CD	NUMBER	27	_	0	SENT_451	[p27l17t2570r146b2649],
2	.	.	O	.	_	0	SENT_451	[p27l17t2570r146b2649],

1	Hirota	NNP	ORGANIZATION	Hirota	nn	2	SENT_452	[p27l217t2560r546b2649],
2	S	NNP	ORGANIZATION	S	_	0	SENT_452	[p27l581t2566r660b2667],
3	,	,	O	,	_	0	SENT_452	[p27l581t2566r660b2667],
4	Isozaki	NNP	PERSON	Isozaki	nn	5	SENT_452	[p27l700t2558r1068b2649],
5	K	NNP	PERSON	K	appos	2	SENT_452	[p27l1100t2566r1201b2667],
6	,	,	O	,	_	0	SENT_452	[p27l1100t2566r1201b2667],
7	Moriyama	NNP	PERSON	Moriyama	nn	8	SENT_452	[p27l1237t2560r1749b2673],
8	Y	NN	PERSON	y	appos	2	SENT_452	[p27l1777t2566r1862b2667],
9	,	,	O	,	_	0	SENT_452	[p27l1777t2566r1862b2667],
10	et	FW	O	et	nn	11	SENT_452	[p27l1903t2578r1993b2648],
11	al.	FW	O	al.	appos	2	SENT_452	[p27l2020t2558r2135b2649],
12	.	.	O	.	_	0	SENT_452	[p27l2020t2558r2135b2649],

1	Gain	NN	O	gain	nn	2	SENT_453	[p27l19t2706r896b2797],
2	—	NN	O	—	_	0	SENT_453	[p27l19t2706r896b2797],
3	of	IN	O	of	_	0	SENT_453	[p27l19t2706r896b2797],
4	—	CD	NUMBER	—	num	6	SENT_453	[p27l19t2706r896b2797],
5	function	NN	O	function	nn	6	SENT_453	[p27l19t2706r896b2797],
6	mutations	NNS	O	mutation	prep_of	2	SENT_453	[p27l971t2708r1492b2797],
7	of	IN	O	of	_	0	SENT_453	[p27l1571t2706r1688b2797],
8	c	NN	O	c	nn	10	SENT_453	[p27l1743t2706r1973b2797],
9	—	CD	NUMBER	—	num	10	SENT_453	[p27l1743t2706r1973b2797],
10	kit	NN	O	kit	prep_of	2	SENT_453	[p27l1743t2706r1973b2797],
11	in	IN	O	in	_	0	SENT_453	[p27l2042t2708r2141b2795],
12	human	JJ	O	human	amod	15	SENT_453	[p27l19t2855r377b2946],
13	gastrointestinal	JJ	O	gastrointestinal	amod	15	SENT_453	[p27l434t2855r1239b2972],
14	stromal	JJ	O	stromal	amod	15	SENT_453	[p27l1298t2855r1686b2946],
15	tumors	NNS	O	tumor	prep_in	2	SENT_453	[p27l1743t2875r2133b2946],
16	.	.	O	.	_	0	SENT_453	[p27l1743t2875r2133b2946],

1	Science	NN	O	science	_	0	SENT_454	[p27l21t3006r389b3095],
2	1998	CD	DATE	1998	num	1	SENT_454	[p27l433t3012r1284b3113],
3	;	:	O	;	_	0	SENT_454	[p27l433t3012r1284b3113],
4	279:577	CD	NUMBER	279:577	number	5	SENT_454	[p27l433t3012r1284b3113],
5	—	CD	NUMBER	—	dep	1	SENT_454	[p27l433t3012r1284b3113],
6	80	CD	NUMBER	80	dep	5	SENT_454	[p27l433t3012r1284b3113],
7	.	.	O	.	_	0	SENT_454	[p27l433t3012r1284b3113],

1	28	CD	NUMBER	28	_	0	SENT_455	[p27l17t3163r158b3244],
2	.	.	O	.	_	0	SENT_455	[p27l17t3163r158b3244],

1	Demetri	NNP	PERSON	Demetri	nn	2	SENT_456	[p27l215t3155r629b3243],
2	GD	NN	O	gd	_	0	SENT_456	[p27l686t3161r874b3264],
3	,	,	O	,	_	0	SENT_456	[p27l686t3161r874b3264],
4	Von	NNP	PERSON	Von	nn	6	SENT_456	[p27l933t3183r1112b3244],
5	Mehren	NNP	PERSON	Mehren	nn	6	SENT_456	[p27l1165t3153r1553b3244],
6	M	NN	O	m	appos	2	SENT_456	[p27l1608t3161r1733b3262],
7	,	,	O	,	_	0	SENT_456	[p27l1608t3161r1733b3262],
8	Blanke	NNP	PERSON	Blanke	nn	9	SENT_456	[p27l1796t3153r2141b3244],
9	CD	NNP	O	CD	appos	2	SENT_456	[p27l19t3308r195b3411],
10	,	,	O	,	_	0	SENT_456	[p27l19t3308r195b3411],
11	et	FW	O	et	nn	12	SENT_456	[p27l250t3322r340b3393],
12	al.	FW	O	al.	appos	2	SENT_456	[p27l379t3302r494b3393],
13	.	.	O	.	_	0	SENT_456	[p27l379t3302r494b3393],

1	Efficacy	NN	O	efficacy	_	0	SENT_457	[p27l545t3302r955b3417],
2	and	CC	O	and	_	0	SENT_457	[p27l995t3302r1179b3393],
3	safety	NN	O	safety	conj_and	1	SENT_457	[p27l1226t3302r1524b3417],
4	of	IN	O	of	_	0	SENT_457	[p27l1565t3302r1682b3393],
5	imatinib	NN	O	imatinib	nn	6	SENT_457	[p27l1707t3302r2139b3393],
6	mesylate	NN	O	mesylate	prep_of	1	SENT_457	[p27l19t3451r449b3566],
7	in	IN	O	in	_	0	SENT_457	[p27l478t3453r575b3540],
8	advanced	JJ	O	advanced	amod	11	SENT_457	[p27l605t3451r1061b3542],
9	gastrointestinal	JJ	O	gastrointestinal	amod	11	SENT_457	[p27l1092t3451r1878b3568],
10	stromal	JJ	O	stromal	amod	11	SENT_457	[p27l1909t3471r2139b3542, p27l19t3600r209b3690],
11	tumors	NNS	O	tumor	prep_in	1	SENT_457	[p27l257t3620r647b3691],
12	.	.	O	.	_	0	SENT_457	[p27l257t3620r647b3691],

1	N	NN	O	n	nn	3	SENT_458	[p27l700t3608r785b3691],
2	Engl	NNP	O	Engl	nn	3	SENT_458	[p27l830t3600r1058b3717],
3	J	NNP	O	J	nsubj	4	SENT_458	[p27l1094t3608r1137b3705],
4	Med	VBD	O	med	_	0	SENT_458	[p27l1179t3600r1397b3691],
5	2002	CD	DATE	2002	dobj	4	SENT_458	[p27l1444t3606r2139b3709, p28l196t254r499b291],
6	;	:	O	;	_	0	SENT_458	[p27l1444t3606r2139b3709, p28l196t254r499b291],
7	347:472	CD	NUMBER	347:472	num	8	SENT_458	[p27l1444t3606r2139b3709, p28l196t254r499b291],
8	GENOMIC	NN	O	genomic	dep	5	SENT_458	[p27l1444t3606r2139b3709, p28l196t254r499b291],

1	MEDICINE	NNP	O	MEDICINE	_	0	SENT_459	[p28l526t255r855b291],

1	29	CD	NUMBER	29	_	0	SENT_460	[p28l8t441r75b480],
2	.	.	O	.	_	0	SENT_460	[p28l8t441r75b480],

1	DeMatteo	NNP	PERSON	DeMatteo	nn	2	SENT_461	[p28l104t440r344b480],
2	RP	NNP	O	RP	_	0	SENT_461	[p28l365t440r442b490],
3	,	,	O	,	_	0	SENT_461	[p28l365t440r442b490],
4	Lewis	NNP	PERSON	Lewis	nn	5	SENT_461	[p28l465t437r606b481],
5	ll	NN	O	ll	appos	2	SENT_461	[p28l623t440r675b490],
6	,	,	O	,	_	0	SENT_461	[p28l623t440r675b490],
7	Leung	NNP	PERSON	Leung	nn	8	SENT_461	[p28l698t440r852b493],
8	D	NNP	O	D	appos	5	SENT_461	[p28l871t440r921b490],
9	,	,	O	,	_	0	SENT_461	[p28l871t440r921b490],
10	Mudan	NNP	O	Mudan	nn	11	SENT_461	[p28l944t440r1041b481, p28l9t508r100b552],
11	SS	NNP	O	SS	appos	5	SENT_461	[p28l126t511r194b562],
12	,	,	O	,	_	0	SENT_461	[p28l126t511r194b562],
13	WoodruffJM	NNP	O	WoodruffJM	appos	5	SENT_461	[p28l221t508r564b562],
14	,	,	O	,	_	0	SENT_461	[p28l221t508r564b562],
15	Brennan	NNP	PERSON	Brennan	nn	16	SENT_461	[p28l592t512r801b552],
16	MF	NN	O	mf	appos	5	SENT_461	[p28l824t512r914b552],
17	.	.	O	.	_	0	SENT_461	[p28l824t512r914b552],

1	Two	CD	NUMBER	two	number	2	SENT_462	[p28l940t511r1041b553],
2	hundred	CD	NUMBER	hundred	num	5	SENT_462	[p28l9t578r216b623],
3	gastrointestinal	JJ	O	gastrointestinal	amod	5	SENT_462	[p28l233t578r624b635],
4	stromal	JJ	O	stromal	amod	5	SENT_462	[p28l643t578r832b622],
5	tumors	NNS	O	tumor	_	0	SENT_462	[p28l849t587r1039b623],
6	:	:	O	:	_	0	SENT_462	[p28l849t587r1039b623],
7	recurrence	NN	O	recurrence	nn	8	SENT_462	[p28l9t664r270b695],
8	patterns	NNS	O	pattern	dep	5	SENT_462	[p28l300t659r503b706],
9	and	CC	O	and	_	0	SENT_462	[p28l535t650r625b694],
10	prognostic	JJ	O	prognostic	amod	11	SENT_462	[p28l655t651r921b707],
11	factors	NNS	O	factor	conj_and	8	SENT_462	[p28l952t650r1041b694, p28l9t730r102b765],
12	for	IN	O	for	_	0	SENT_462	[p28l121t721r191b765],
13	survival	NN	O	survival	prep_for	11	SENT_462	[p28l208t721r411b766],
14	.	.	O	.	_	0	SENT_462	[p28l208t721r411b766],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_463	[p28l430t725r533b765],
2	Surg	NNP	PERSON	Surg	_	0	SENT_463	[p28l552t724r664b778],
3	2000	CD	DATE	2000	num	2	SENT_463	[p28l680t724r1038b774],
4	;	:	O	;	_	0	SENT_463	[p28l680t724r1038b774],
5	231:51	CD	NUMBER	231:51	number	6	SENT_463	[p28l680t724r1038b774],
6	—	CD	NUMBER	—	dep	2	SENT_463	[p28l680t724r1038b774],
7	8	CD	NUMBER	8	dep	6	SENT_463	[p28l680t724r1038b774],
8	.	.	O	.	_	0	SENT_463	[p28l680t724r1038b774],

1	30	CD	NUMBER	30	_	0	SENT_464	[p28l9t797r75b836],
2	.	.	O	.	_	0	SENT_464	[p28l9t797r75b836],

1	Samuels	NNP	PERSON	Samuels	nn	2	SENT_465	[p28l107t792r308b837],
2	Y	NN	PERSON	y	_	0	SENT_465	[p28l330t796r371b846],
3	,	,	O	,	_	0	SENT_465	[p28l330t796r371b846],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_465	[p28l395t796r538b849],
5	Z	NNP	PERSON	Z	appos	2	SENT_465	[p28l558t796r602b845],
6	,	,	O	,	_	0	SENT_465	[p28l558t796r602b845],
7	Bardelli	NNP	PERSON	Bardelli	nn	8	SENT_465	[p28l628t792r821b836],
8	A	NNP	O	A	appos	2	SENT_465	[p28l842t796r891b845],
9	,	,	O	,	_	0	SENT_465	[p28l842t796r891b845],
10	et	FW	O	et	nn	11	SENT_465	[p28l918t801r962b836],
11	al.	FW	O	al.	appos	2	SENT_465	[p28l982t792r1038b836],
12	.	.	O	.	_	0	SENT_465	[p28l982t792r1038b836],

1	High	JJ	O	high	amod	2	SENT_466	[p28l9t863r127b920],
2	frequency	NN	O	frequency	_	0	SENT_466	[p28l144t863r376b919],
3	of	IN	O	of	_	0	SENT_466	[p28l390t863r445b907],
4	mutations	NNS	O	mutation	prep_of	2	SENT_466	[p28l451t864r690b908],
5	of	IN	O	of	_	0	SENT_466	[p28l707t863r763b907],
6	the	DT	O	the	det	8	SENT_466	[p28l769t863r842b907],
7	PIK3CA	NN	O	pik3ca	nn	8	SENT_466	[p28l858t866r1043b908],
8	gene	NN	O	gene	prep_of	4	SENT_466	[p28l9t948r124b991],
9	in	IN	O	in	_	0	SENT_466	[p28l157t935r205b978],
10	human	JJ	O	human	amod	11	SENT_466	[p28l239t934r414b979],
11	cancers	NNS	O	cancer	prep_in	2	SENT_466	[p28l448t948r650b978],
12	.	.	O	.	_	0	SENT_466	[p28l448t948r650b978],

1	Science	NNP	O	Science	_	0	SENT_467	[p28l688t935r870b978],
2	2004	CD	DATE	2004	num	1	SENT_467	[p28l904t937r1039b987],
3	;	:	O	;	_	0	SENT_467	[p28l904t937r1039b987],
4	304:554	CD	NUMBER	304:554	dep	1	SENT_467	[p28l10t1009r214b1050],
5	.	.	O	.	_	0	SENT_467	[p28l10t1009r214b1050],

1	31	CD	NUMBER	31	_	0	SENT_468	[p28l9t1081r74b1120],
2	.	.	O	.	_	0	SENT_468	[p28l9t1081r74b1120],

1	Stephens	NNP	PERSON	Stephens	nn	2	SENT_469	[p28l107t1076r325b1132],
2	P	NN	O	p	_	0	SENT_469	[p28l343t1080r381b1130],
3	,	,	O	,	_	0	SENT_469	[p28l343t1080r381b1130],
4	Hunter	NNP	PERSON	Hunter	nn	5	SENT_469	[p28l402t1080r575b1121],
5	C	NNP	O	C	appos	2	SENT_469	[p28l591t1079r639b1130],
6	,	,	O	,	_	0	SENT_469	[p28l591t1079r639b1130],
7	Bignell	NNP	PERSON	Bignell	nn	8	SENT_469	[p28l659t1076r832b1133],
8	G	NNP	O	G	appos	2	SENT_469	[p28l850t1079r902b1130],
9	,	,	O	,	_	0	SENT_469	[p28l850t1079r902b1130],
10	et	FW	O	et	nn	11	SENT_469	[p28l924t1085r968b1120],
11	al.	FW	O	al.	appos	2	SENT_469	[p28l982t1076r1038b1120],
12	.	.	O	.	_	0	SENT_469	[p28l982t1076r1038b1120],

1	Lung	NN	O	lung	nn	2	SENT_470	[p28l8t1151r133b1204],
2	cancer	NN	O	cancer	_	0	SENT_470	[p28l171t1161r344b1191],
3	:	:	O	:	_	0	SENT_470	[p28l171t1161r344b1191],
4	intragenic	JJ	O	intragenic	amod	7	SENT_470	[p28l385t1148r636b1204],
5	ERBB2	NN	O	erbb2	nn	7	SENT_470	[p28l674t1150r842b1194],
6	kinase	NN	O	kinase	nn	7	SENT_470	[p28l882t1147r1041b1192],
7	mutations	NNS	O	mutation	dep	2	SENT_470	[p28l9t1220r257b1263],
8	in	IN	O	in	_	0	SENT_470	[p28l285t1220r332b1262],
9	tumours	NNS	O	tumour	prep_in	7	SENT_470	[p28l359t1228r581b1263],
10	.	.	O	.	_	0	SENT_470	[p28l359t1228r581b1263],

1	Nature	NNP	O	Nature	_	0	SENT_471	[p28l610t1223r777b1263],
2	2004	CD	DATE	2004	num	1	SENT_471	[p28l804t1222r1039b1272],
3	;	:	O	;	_	0	SENT_471	[p28l804t1222r1039b1272],
4	431	CD	NUMBER	431	num	6	SENT_471	[p28l804t1222r1039b1272],
5	:	:	O	:	_	0	SENT_471	[p28l804t1222r1039b1272],
6	525-6	CD	NUMBER	525-6	dep	1	SENT_471	[p28l10t1292r160b1333],
7	.	.	O	.	_	0	SENT_471	[p28l10t1292r160b1333],

1	32	CD	NUMBER	32	_	0	SENT_472	[p28l9t1366r76b1405],
2	.	.	O	.	_	0	SENT_472	[p28l9t1366r76b1405],

1	Dutt	NNP	PERSON	Dutt	nn	2	SENT_473	[p28l104t1365r215b1406],
2	A	NNP	O	A	_	0	SENT_473	[p28l234t1365r284b1415],
3	,	,	O	,	_	0	SENT_473	[p28l234t1365r284b1415],
4	Salvesen	NNP	O	Salvesen	nn	5	SENT_473	[p28l311t1361r517b1406],
5	HB	NNP	O	HB	appos	2	SENT_473	[p28l540t1365r630b1414],
6	,	,	O	,	_	0	SENT_473	[p28l540t1365r630b1414],
7	Chen	NNP	O	Chen	nn	8	SENT_473	[p28l656t1361r781b1405],
8	TH	NN	O	th	appos	2	SENT_473	[p28l802t1365r892b1415],
9	,	,	O	,	_	0	SENT_473	[p28l802t1365r892b1415],
10	et	FW	O	et	nn	11	SENT_473	[p28l919t1370r963b1405],
11	al.	FW	O	al.	appos	2	SENT_473	[p28l982t1361r1038b1405],
12	.	.	O	.	_	0	SENT_473	[p28l982t1361r1038b1405],

1	Drug-sensitive	JJ	O	drug-sensitive	amod	3	SENT_474	[p28l8t1433r372b1489],
2	FGFR2	NN	O	fgfr2	nn	3	SENT_474	[p28l402t1435r572b1479],
3	mutations	NNS	O	mutation	_	0	SENT_474	[p28l602t1433r856b1477],
4	in	IN	O	in	_	0	SENT_474	[p28l887t1433r935b1476],
5	endometrial	JJ	O	endometrial	amod	6	SENT_474	[p28l965t1446r1041b1476, p28l9t1503r254b1547],
6	carcinoma	NN	O	carcinoma	prep_in	3	SENT_474	[p28l275t1504r552b1547],
7	.	.	O	.	_	0	SENT_474	[p28l275t1504r552b1547],

1	Proc	NNP	O	Proc	nn	4	SENT_475	[p28l575t1507r685b1547],
2	Natl	NNP	O	Natl	nn	4	SENT_475	[p28l704t1503r810b1547],
3	Acad	NNP	O	Acad	nn	4	SENT_475	[p28l828t1503r951b1547],
4	Sci	NNP	O	Sci	_	0	SENT_475	[p28l973t1504r1042b1547],

1	U	NNP	O	U	nn	3	SENT_476	[p28l9t1579r47b1619],
2	S	NNP	O	S	nn	3	SENT_476	[p28l68t1578r92b1619],
3	A	NNP	O	A	_	0	SENT_476	[p28l112t1579r149b1618],
4	2008	CD	DATE	2008	num	3	SENT_476	[p28l166t1578r574b1628],
5	;	:	O	;	_	0	SENT_476	[p28l166t1578r574b1628],
6	105:8713	CD	NUMBER	105:8713	number	7	SENT_476	[p28l166t1578r574b1628],
7	-7	CD	NUMBER	-7	dep	3	SENT_476	[p28l166t1578r574b1628],
8	.	.	O	.	_	0	SENT_476	[p28l166t1578r574b1628],

1	33	CD	NUMBER	33	_	0	SENT_477	[p28l9t1650r74b1689],
2	.	.	O	.	_	0	SENT_477	[p28l9t1650r74b1689],

1	Levine	NNP	ORGANIZATION	Levine	nn	2	SENT_478	[p28l104t1646r263b1690],
2	RL	NNP	ORGANIZATION	RL	nsubj	7	SENT_478	[p28l282t1649r363b1698],
3	,	,	O	,	_	0	SENT_478	[p28l282t1649r363b1698],
4	Wadleigh	NNP	PERSON	Wadleigh	nn	5	SENT_478	[p28l383t1645r615b1702],
5	M	NNP	O	M	appos	2	SENT_478	[p28l633t1649r694b1699],
6	,	,	O	,	_	0	SENT_478	[p28l633t1649r694b1699],
7	Cools	VBZ	O	cool	_	0	SENT_478	[p28l716t1645r853b1689],
8	J	NN	O	j	dobj	7	SENT_478	[p28l868t1649r900b1699],
9	,	,	O	,	_	0	SENT_478	[p28l868t1649r900b1699],
10	et	FW	O	et	nn	11	SENT_478	[p28l923t1654r966b1689],
11	al.	FW	O	al.	appos	8	SENT_478	[p28l982t1645r1038b1689],
12	.	.	O	.	_	0	SENT_478	[p28l982t1645r1038b1689],

1	Activating	VBG	O	activate	amod	2	SENT_479	[p28l7t1717r260b1773],
2	mutation	NN	O	mutation	_	0	SENT_479	[p28l293t1717r517b1761],
3	in	IN	O	in	_	0	SENT_479	[p28l551t1717r599b1760],
4	the	DT	O	the	det	7	SENT_479	[p28l633t1716r709b1760],
5	tyrosine	NN	O	tyrosine	nn	7	SENT_479	[p28l744t1717r942b1772],
6	kinase	NN	O	kinase	nn	7	SENT_479	[p28l977t1716r1041b1761, p28l9t1801r119b1831],
7	JAK2	NN	O	jak2	prep_in	2	SENT_479	[p28l132t1790r259b1838],
8	in	IN	O	in	_	0	SENT_479	[p28l278t1788r325b1831],
9	polycythemia	NN	O	polycythemia	nn	10	SENT_479	[p28l343t1787r675b1843],
10	Vera	NNP	O	Vera	prep_in	7	SENT_479	[p28l690t1802r803b1840],
11	,	,	O	,	_	0	SENT_479	[p28l690t1802r803b1840],
12	essential	JJ	O	essential	amod	13	SENT_479	[p28l826t1787r1042b1831],
13	thrombocythemia	NN	O	thrombocythemia	conj_and	10	SENT_479	[p28l9t1859r468b1915],
14	,	,	O	,	_	0	SENT_479	[p28l9t1859r468b1915],
15	and	CC	O	and	_	0	SENT_479	[p28l495t1859r585b1903],
16	myeloid	JJ	O	myeloid	amod	17	SENT_479	[p28l610t1859r802b1915],
17	metaplasia	NN	O	metaplasium	prep_in	7	SENT_479	[p28l827t1859r1041b1915, p28l10t1931r75b1974],
18	with	IN	O	with	_	0	SENT_479	[p28l94t1930r205b1975],
19	myelofibrosis	NN	O	myelofibrosis	prep_with	17	SENT_479	[p28l227t1930r575b1986],
20	.	.	O	.	_	0	SENT_479	[p28l227t1930r575b1986],

1	Cancer	NN	O	cancer	nn	2	SENT_480	[p28l600t1933r771b1974],
2	Cell	NN	O	cell	_	0	SENT_480	[p28l792t1930r886b1974],
3	2005	CD	DATE	2005	dep	2	SENT_480	[p28l908t1933r1039b1983],
4	;	:	O	;	_	0	SENT_480	[p28l908t1933r1039b1983],
5	7:387	CD	NUMBER	7:387	num	6	SENT_480	[p28l10t2004r219b2045],
6	-97	CD	NUMBER	-97	dep	2	SENT_480	[p28l10t2004r219b2045],
7	.	.	O	.	_	0	SENT_480	[p28l10t2004r219b2045],

1	34	CD	NUMBER	34	_	0	SENT_481	[p28l9t2076r76b2115],
2	.	.	O	.	_	0	SENT_481	[p28l9t2076r76b2115],

1	Davies	NNP	PERSON	Davies	nn	2	SENT_482	[p28l104t2072r263b2115],
2	H	NNP	PERSON	H	_	0	SENT_482	[p28l295t2075r349b2125],
3	,	,	O	,	_	0	SENT_482	[p28l295t2075r349b2125],
4	Bignell	NNP	PERSON	Bignell	nn	5	SENT_482	[p28l382t2071r555b2128],
5	GR	NN	O	gr	appos	2	SENT_482	[p28l585t2074r675b2124],
6	,	,	O	,	_	0	SENT_482	[p28l585t2074r675b2124],
7	Cox	NN	ORGANIZATION	cox	nn	8	SENT_482	[p28l709t2074r802b2115],
8	C	NN	ORGANIZATION	c	appos	2	SENT_482	[p28l830t2074r878b2125],
9	,	,	O	,	_	0	SENT_482	[p28l830t2074r878b2125],
10	et	FW	O	et	nn	11	SENT_482	[p28l911t2080r955b2115],
11	al.	FW	O	al.	appos	2	SENT_482	[p28l982t2071r1038b2115],
12	.	.	O	.	_	0	SENT_482	[p28l982t2071r1038b2115],

1	Mutations	NNS	O	mutation	_	0	SENT_483	[p28l7t2143r257b2187],
2	of	IN	O	of	_	0	SENT_483	[p28l290t2142r347b2186],
3	the	DT	O	the	det	5	SENT_483	[p28l368t2142r444b2186],
4	BRAF	NN	O	braf	nn	5	SENT_483	[p28l475t2146r613b2189],
5	gene	NN	O	gene	prep_of	1	SENT_483	[p28l645t2156r758b2199],
6	in	IN	O	in	_	0	SENT_483	[p28l790t2143r837b2186],
7	human	JJ	O	human	amod	8	SENT_483	[p28l868t2142r1041b2187],
8	cancer	NN	O	cancer	prep_in	1	SENT_483	[p28l9t2228r181b2258],
9	.	.	O	.	_	0	SENT_483	[p28l9t2228r181b2258],

1	Nature	NNP	O	Nature	_	0	SENT_484	[p28l202t2218r370b2259],
2	2002	CD	DATE	2002	num	1	SENT_484	[p28l389t2217r801b2267],
3	;	:	O	;	_	0	SENT_484	[p28l389t2217r801b2267],
4	417:949	CD	NUMBER	417:949	number	5	SENT_484	[p28l389t2217r801b2267],
5	-54	CD	NUMBER	-54	dep	1	SENT_484	[p28l389t2217r801b2267],
6	.	.	O	.	_	0	SENT_484	[p28l389t2217r801b2267],

1	35	CD	NUMBER	35	_	0	SENT_485	[p28l9t2290r74b2329],
2	.	.	O	.	_	0	SENT_485	[p28l9t2290r74b2329],

1	Flaherty	NNP	ORGANIZATION	Flaherty	nn	2	SENT_486	[p28l104t2285r308b2341],
2	KT	NNP	ORGANIZATION	KT	_	0	SENT_486	[p28l322t2289r403b2339],
3	,	,	O	,	_	0	SENT_486	[p28l322t2289r403b2339],
4	Puzanov	NNP	O	Puzanov	appos	2	SENT_486	[p28l423t2289r632b2330],
5	1	CD	NUMBER	1	num	4	SENT_486	[p28l647t2289r677b2338],
6	,	,	O	,	_	0	SENT_486	[p28l647t2289r677b2338],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_486	[p28l697t2286r801b2330],
8	KB	NN	PERSON	kb	appos	2	SENT_486	[p28l818t2289r904b2339],
9	,	,	O	,	_	0	SENT_486	[p28l818t2289r904b2339],
10	et	FW	O	et	nn	11	SENT_486	[p28l924t2294r968b2329],
11	al.	FW	O	al.	appos	2	SENT_486	[p28l982t2285r1038b2329],
12	.	.	O	.	_	0	SENT_486	[p28l982t2285r1038b2329],

1	Inhibition	NN	O	inhibition	_	0	SENT_487	[p28l8t2356r257b2400],
2	of	IN	O	of	_	0	SENT_487	[p28l281t2356r338b2400],
3	mutated	VBN	O	mutate	dep	6	SENT_487	[p28l351t2356r566b2410],
4	,	,	O	,	_	0	SENT_487	[p28l351t2356r566b2410],
5	activated	VBN	O	activate	amod	6	SENT_487	[p28l592t2356r809b2400],
6	BRAF	NN	O	braf	prep_of	1	SENT_487	[p28l831t2360r970b2403],
7	in	IN	O	in	_	0	SENT_487	[p28l994t2357r1041b2400],
8	metastatic	JJ	O	metastatic	amod	9	SENT_487	[p28l9t2427r265b2470],
9	melanoma	NN	O	melanoma	prep_in	6	SENT_487	[p28l281t2426r554b2470],
10	.	.	O	.	_	0	SENT_487	[p28l281t2426r554b2470],

1	N	NN	O	n	nn	3	SENT_488	[p28l573t2430r616b2471],
2	Engl	NNP	O	Engl	nn	3	SENT_488	[p28l631t2426r741b2483],
3	J	NNP	O	J	nsubj	4	SENT_488	[p28l753t2430r774b2477],
4	Med	VBD	O	med	_	0	SENT_488	[p28l788t2426r893b2470],
5	2010	CD	DATE	2010	dobj	4	SENT_488	[p28l910t2429r1039b2479],
6	;	:	O	;	_	0	SENT_488	[p28l910t2429r1039b2479],
7	363:809	CD	NUMBER	363:809	num	8	SENT_488	[p28l10t2501r288b2542],
8	-19	CD	NUMBER	-19	dep	5	SENT_488	[p28l10t2501r288b2542],
9	.	.	O	.	_	0	SENT_488	[p28l10t2501r288b2542],

1	36	CD	NUMBER	36	_	0	SENT_489	[p28l9t2573r76b2612],
2	.	.	O	.	_	0	SENT_489	[p28l9t2573r76b2612],

1	Barbie	NNP	ORGANIZATION	Barbie	nn	2	SENT_490	[p28l104t2568r261b2612],
2	DA	NNP	ORGANIZATION	DA	_	0	SENT_490	[p28l278t2572r366b2621],
3	,	,	O	,	_	0	SENT_490	[p28l278t2572r366b2621],
4	Tamayo	NNP	PERSON	Tamayo	nn	5	SENT_490	[p28l385t2572r577b2624],
5	P	NN	PERSON	p	appos	2	SENT_490	[p28l595t2572r633b2621],
6	,	,	O	,	_	0	SENT_490	[p28l595t2572r633b2621],
7	Boehm	NNP	PERSON	Boehm	nn	8	SENT_490	[p28l653t2568r827b2612],
8	JS	NNP	O	JS	appos	2	SENT_490	[p28l840t2571r902b2622],
9	,	,	O	,	_	0	SENT_490	[p28l840t2571r902b2622],
10	et	FW	O	et	nn	11	SENT_490	[p28l924t2577r967b2612],
11	al.	FW	O	al.	appos	2	SENT_490	[p28l982t2568r1038b2612],
12	.	.	O	.	_	0	SENT_490	[p28l982t2568r1038b2612],

1	Systematic	JJ	O	systematic	amod	3	SENT_491	[p28l10t2641r272b2696],
2	RNA	NN	O	rna	nn	3	SENT_491	[p28l294t2644r413b2687],
3	interference	NN	O	interference	nsubj	4	SENT_491	[p28l434t2640r730b2684],
4	reveals	VBZ	O	reveal	_	0	SENT_491	[p28l753t2640r921b2685],
5	that	IN	O	that	complm	9	SENT_491	[p28l946t2640r1044b2684],
6	oncogenic	JJ	O	oncogenic	amod	8	SENT_491	[p28l9t2711r261b2767],
7	KRAS-driven	JJ	O	kras-driven	amod	8	SENT_491	[p28l294t2710r613b2757],
8	cancers	NNS	O	cancer	nsubj	9	SENT_491	[p28l648t2724r831b2754],
9	require	VBP	O	require	ccomp	4	SENT_491	[p28l866t2711r1041b2766],
10	TBK1	NN	O	tbk1	dobj	9	SENT_491	[p28l7t2785r156b2827],
11	.	.	O	.	_	0	SENT_491	[p28l7t2785r156b2827],

1	Nature	NNP	O	Nature	_	0	SENT_492	[p28l177t2786r345b2826],
2	2009	CD	DATE	2009	num	1	SENT_492	[p28l365t2785r782b2835],
3	;	:	O	;	_	0	SENT_492	[p28l365t2785r782b2835],
4	462:108	CD	NUMBER	462:108	number	5	SENT_492	[p28l365t2785r782b2835],
5	-12	CD	NUMBER	-12	dep	1	SENT_492	[p28l365t2785r782b2835],
6	.	.	O	.	_	0	SENT_492	[p28l365t2785r782b2835],

1	37	CD	NUMBER	37	_	0	SENT_493	[p28l9t2857r69b2896],
2	.	.	O	.	_	0	SENT_493	[p28l9t2857r69b2896],

1	Scholl	NN	PERSON	scholl	nn	2	SENT_494	[p28l107t2852r255b2896],
2	C	NN	O	c	nsubj	11	SENT_494	[p28l281t2855r329b2906],
3	,	,	O	,	_	0	SENT_494	[p28l281t2855r329b2906],
4	Frohling	VBG	O	frohle	amod	5	SENT_494	[p28l357t2852r571b2909],
5	S	NN	O	s	appos	2	SENT_494	[p28l596t2855r635b2906],
6	,	,	O	,	_	0	SENT_494	[p28l596t2855r635b2906],
7	Dunn	NNP	PERSON	Dunn	dep	11	SENT_494	[p28l663t2856r802b2897],
8	IF	IN	O	if	prep	11	SENT_494	[p28l827t2856r885b2905],
9	,	,	O	,	_	0	SENT_494	[p28l827t2856r885b2905],
10	et	FW	O	et	nn	11	SENT_494	[p28l915t2861r959b2896],
11	al.	FW	O	al.	_	0	SENT_494	[p28l982t2852r1038b2896],
12	.	.	O	.	_	0	SENT_494	[p28l982t2852r1038b2896],

1	Synthetic	JJ	O	synthetic	amod	3	SENT_495	[p28l10t2923r237b2979],
2	lethal	JJ	O	lethal	amod	3	SENT_495	[p28l265t2923r404b2967],
3	interaction	NN	O	interaction	_	0	SENT_495	[p28l432t2924r700b2967],
4	between	IN	O	between	_	0	SENT_495	[p28l729t2923r933b2968],
5	oncogenic	JJ	O	oncogenic	amod	7	SENT_495	[p28l962t2937r1041b2967, p28l9t2995r197b3051],
6	KRAS	NNP	ORGANIZATION	KRAS	nn	7	SENT_495	[p28l237t2997r379b3041],
7	dependency	NN	O	dependency	prep_between	3	SENT_495	[p28l422t2994r713b3050],
8	and	CC	O	and	_	0	SENT_495	[p28l751t2994r841b3038],
9	STK33	NN	O	stk33	nn	10	SENT_495	[p28l883t2997r1040b3039],
10	suppression	NN	O	suppression	prep_between	3	SENT_495	[p28l10t3067r303b3122],
11	in	IN	O	in	_	0	SENT_495	[p28l330t3067r378b3110],
12	human	JJ	O	human	amod	14	SENT_495	[p28l406t3066r578b3111],
13	cancer	NN	O	cancer	nn	14	SENT_495	[p28l607t3080r767b3110],
14	cells	NNS	O	cell	prep_in	3	SENT_495	[p28l794t3066r916b3110],
15	.	.	O	.	_	0	SENT_495	[p28l794t3066r916b3110],

1	Cell	NN	O	cell	_	0	SENT_496	[p28l947t3066r1042b3110],
2	2009	CD	DATE	2009	num	1	SENT_496	[p28l9t3140r420b3190],
3	;	:	O	;	_	0	SENT_496	[p28l9t3140r420b3190],
4	137:821	CD	NUMBER	137:821	number	5	SENT_496	[p28l9t3140r420b3190],
5	-34	CD	NUMBER	-34	dep	1	SENT_496	[p28l9t3140r420b3190],
6	.	.	O	.	_	0	SENT_496	[p28l9t3140r420b3190],

1	38	CD	NUMBER	38	_	0	SENT_497	[p28l9t3213r75b3252],
2	.	.	O	.	_	0	SENT_497	[p28l9t3213r75b3252],

1	Hudson	NNP	LOCATION	Hudson	nn	3	SENT_498	[p28l105t3208r294b3252],
2	T	NN	O	t	nn	3	SENT_498	[p28l308t3211r371b3261],
3	]	NN	O	]	_	0	SENT_498	[p28l308t3211r371b3261],
4	,	,	O	,	_	0	SENT_498	[p28l308t3211r371b3261],
5	Anderson	NNP	PERSON	Anderson	nn	6	SENT_498	[p28l388t3208r623b3252],
6	W	NNP	PERSON	W	appos	3	SENT_498	[p28l637t3212r697b3262],
7	,	,	O	,	_	0	SENT_498	[p28l637t3212r697b3262],
8	Artez	NNP	O	Artez	nn	9	SENT_498	[p28l714t3212r845b3252],
9	A	NNP	O	A	appos	3	SENT_498	[p28l859t3212r908b3261],
10	,	,	O	,	_	0	SENT_498	[p28l859t3212r908b3261],
11	et	FW	O	et	nn	12	SENT_498	[p28l928t3217r971b3252],
12	al.	FW	O	al.	appos	3	SENT_498	[p28l984t3208r1038b3252],
13	.	.	O	.	_	0	SENT_498	[p28l984t3208r1038b3252],

1	International	NNP	O	International	nn	2	SENT_499	[p28l8t3278r334b3322],
2	network	NN	O	network	_	0	SENT_499	[p28l360t3278r565b3323],
3	of	IN	O	of	_	0	SENT_499	[p28l589t3278r646b3322],
4	cancer	NN	O	cancer	nn	6	SENT_499	[p28l663t3292r823b3322],
5	genome	NN	O	genome	nn	6	SENT_499	[p28l848t3292r1041b3335],
6	projects	NNS	O	project	prep_of	2	SENT_499	[p28l8t3351r216b3406],
7	.	.	O	.	_	0	SENT_499	[p28l8t3351r216b3406],

1	Nature	NNP	O	Nature	_	0	SENT_500	[p28l237t3354r405b3395],
2	2010	CD	DATE	2010	num	1	SENT_500	[p28l425t3353r814b3403],
3	;	:	O	;	_	0	SENT_500	[p28l425t3353r814b3403],
4	464:993	CD	NUMBER	464:993	number	5	SENT_500	[p28l425t3353r814b3403],
5	-8	CD	NUMBER	-8	dep	1	SENT_500	[p28l425t3353r814b3403],
6	.	.	O	.	_	0	SENT_500	[p28l425t3353r814b3403],

1	39	CD	NUMBER	39	_	0	SENT_501	[p28l9t3425r74b3464],
2	.	.	O	.	_	0	SENT_501	[p28l9t3425r74b3464],

1	Ding	VBG	PERSON	ding	_	0	SENT_502	[p28l104t3421r226b3477],
2	L	NN	PERSON	l	dobj	1	SENT_502	[p28l247t3424r290b3473],
3	,	,	O	,	_	0	SENT_502	[p28l247t3424r290b3473],
4	Ellis	NNP	PERSON	Ellis	nn	6	SENT_502	[p28l316t3420r422b3464],
5	M	NNP	O	M	nn	6	SENT_502	[p28l446t3424r524b3473],
6	]	NN	O	]	appos	2	SENT_502	[p28l446t3424r524b3473],
7	,	,	O	,	_	0	SENT_502	[p28l446t3424r524b3473],
8	Li	NNP	PERSON	Li	nn	9	SENT_502	[p28l551t3421r596b3464],
9	S	NNP	PERSON	S	appos	2	SENT_502	[p28l621t3423r659b3473],
10	,	,	O	,	_	0	SENT_502	[p28l621t3423r659b3473],
11	et	FW	O	et	nn	12	SENT_502	[p28l688t3429r731b3464],
12	al.	FW	O	al.	appos	2	SENT_502	[p28l752t3420r808b3464],
13	.	.	O	.	_	0	SENT_502	[p28l752t3420r808b3464],

1	Genome	NNP	O	Genome	nn	2	SENT_503	[p28l835t3423r1041b3464],
2	remodelling	NN	O	remodelling	_	0	SENT_503	[p28l9t3491r311b3548],
3	in	IN	O	in	_	0	SENT_503	[p28l332t3492r380b3535],
4	a	DT	O	a	det	8	SENT_503	[p28l403t3506r428b3535],
5	basal-like	JJ	O	basal-like	amod	8	SENT_503	[p28l451t3491r687b3536],
6	breast	NN	O	breast	nn	8	SENT_503	[p28l711t3491r861b3535],
7	cancer	NN	O	cancer	nn	8	SENT_503	[p28l882t3505r1043b3535],
8	metastasis	NN	O	metastasis	prep_in	2	SENT_503	[p28l9t3563r273b3606],
9	and	CC	O	and	_	0	SENT_503	[p28l303t3562r393b3606],
10	xenograft	NN	O	xenograft	prep_in	2	SENT_503	[p28l420t3562r678b3619],
11	.	.	O	.	_	0	SENT_503	[p28l420t3562r678b3619],

1	Nature	NNP	O	Nature	_	0	SENT_504	[p28l709t3566r880b3607],
2	2010	CD	DATE	2010	num	1	SENT_504	[p28l908t3565r1039b3615],
3	;	:	O	;	_	0	SENT_504	[p28l908t3565r1039b3615],
4	4642999-1005	CD	NUMBER	4642999-1005	dep	1	SENT_504	[p28l8t3637r352b3678],
5	.	.	O	.	_	0	SENT_504	[p28l8t3637r352b3678],

1	40	CD	NUMBER	40	_	0	SENT_505	[p28l8t3710r76b3749],
2	.	.	O	.	_	0	SENT_505	[p28l8t3710r76b3749],

1	Shah	NNP	PERSON	Shah	nn	2	SENT_506	[p28l107t3705r226b3749],
2	SP	NN	O	sp	_	0	SENT_506	[p28l254t3708r318b3758],
3	,	,	O	,	_	0	SENT_506	[p28l254t3708r318b3758],
4	Morin	NNP	PERSON	Morin	nn	5	SENT_506	[p28l347t3706r498b3749],
5	RD	NNP	O	RD	appos	2	SENT_506	[p28l524t3709r613b3758],
6	,	,	O	,	_	0	SENT_506	[p28l524t3709r613b3758],
7	Khattra	NNP	PERSON	Khattra	nn	8	SENT_506	[p28l643t3705r832b3750],
8	J	NNP	PERSON	J	appos	2	SENT_506	[p28l852t3709r885b3758],
9	,	,	O	,	_	0	SENT_506	[p28l852t3709r885b3758],
10	et	FW	O	et	nn	11	SENT_506	[p28l915t3714r959b3749],
11	al.	FW	O	al.	appos	2	SENT_506	[p28l982t3705r1038b3749],
12	.	.	O	.	_	0	SENT_506	[p28l982t3705r1038b3749],

1	Mutational	JJ	O	mutational	amod	2	SENT_507	[p28l7t3776r279b3820],
2	evolution	NN	O	evolution	nsubjpass	13	SENT_507	[p28l308t3776r534b3820],
3	in	IN	O	in	_	0	SENT_507	[p28l562t3777r609b3819],
4	a	DT	O	a	det	7	SENT_507	[p28l637t3791r662b3820],
5	lobular	JJ	O	lobular	amod	7	SENT_507	[p28l689t3776r866b3820],
6	breast	NN	O	breast	nn	7	SENT_507	[p28l894t3776r1044b3820],
7	mas	NNS	O	ma	prep_in	2	SENT_507	[p28l1117t450r1215b480],
8	to	TO	O	to	_	0	SENT_507	[p28l1236t445r1283b480],
9	gefitinib	NN	O	gefitinib	prep_to	7	SENT_507	[p28l1303t436r1516b493],
10	or	CC	O	or	_	0	SENT_507	[p28l1537t450r1587b480],
11	erlotinib	NN	O	erlotinib	prep_to	7	SENT_507	[p28l1605t436r1816b480],
12	is	VBZ	O	be	auxpass	13	SENT_507	[p28l1836t437r1874b480],
13	associated	VBN	O	associate	_	0	SENT_507	[p28l1894t436r2149b480],
14	with	IN	O	with	_	0	SENT_507	[p28l1114t508r1225b553],
15	a	DT	DURATION	a	det	17	SENT_507	[p28l1251t523r1276b552],
16	second	JJ	DURATION	second	amod	17	SENT_507	[p28l1301t508r1470b552],
17	mutation	NN	O	mutation	prep_with	13	SENT_507	[p28l1496t509r1721b552],
18	in	IN	O	in	_	0	SENT_507	[p28l1746t509r1793b551],
19	the	DT	O	the	det	22	SENT_507	[p28l1819t508r1895b552],
20	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_507	[p28l1920t511r2065b555],
21	kinase	NN	O	kinase	nn	22	SENT_507	[p28l2085t508r2148b553, p28l1117t592r1226b622],
22	domain	NN	O	domain	prep_in	17	SENT_507	[p28l1246t578r1448b622],
23	.	.	O	.	_	0	SENT_507	[p28l1246t578r1448b622],

1	PLoS	NNP	O	PLoS	nn	2	SENT_508	[p28l1469t581r1587b622],
2	Med	NNP	O	Med	_	0	SENT_508	[p28l1606t578r1712b622],
3	2005	CD	DATE	2005	num	2	SENT_508	[p28l1731t581r2071b631],
4	;	:	O	;	_	0	SENT_508	[p28l1731t581r2071b631],
5	2	CD	NUMBER	2	number	6	SENT_508	[p28l1731t581r2071b631],
6	(	CD	NUMBER	(	dep	2	SENT_508	[p28l1731t581r2071b631],
7	3	CD	NUMBER	3	num	8	SENT_508	[p28l1731t581r2071b631],
8	)	NN	O	)	dep	6	SENT_508	[p28l1731t581r2071b631],
9	:	:	O	:	_	0	SENT_508	[p28l1731t581r2071b631],
10	e73	NN	O	e73	dep	6	SENT_508	[p28l1731t581r2071b631],
11	.	.	O	.	_	0	SENT_508	[p28l1731t581r2071b631],

1	44	CD	NUMBER	44	_	0	SENT_509	[p28l1115t656r1185b694],
2	.	.	O	.	_	0	SENT_509	[p28l1115t656r1185b694],

1	Antonescu	NNP	PERSON	Antonescu	nn	2	SENT_510	[p28l1211t654r1473b695],
2	CR	NN	O	cr	_	0	SENT_510	[p28l1490t653r1575b704],
3	,	,	O	,	_	0	SENT_510	[p28l1490t653r1575b704],
4	Besmer	NN	PERSON	besmer	nn	5	SENT_510	[p28l1595t654r1778b694],
5	P	NN	PERSON	p	appos	2	SENT_510	[p28l1793t654r1830b703],
6	,	,	O	,	_	0	SENT_510	[p28l1793t654r1830b703],
7	Guo	NNP	PERSON	Guo	nn	8	SENT_510	[p28l1851t653r1951b695],
8	T	NN	O	t	appos	2	SENT_510	[p28l1968t653r2011b704],
9	,	,	O	,	_	0	SENT_510	[p28l1968t653r2011b704],
10	et	FW	O	et	nn	11	SENT_510	[p28l2032t659r2076b694],
11	al.	FW	O	al.	appos	2	SENT_510	[p28l2090t650r2146b694],
12	.	.	O	.	_	0	SENT_510	[p28l2090t650r2146b694],

1	Acquired	VBN	O	acquire	csubj	9	SENT_511	[p28l1115t721r1338b777],
2	resistance	NN	O	resistance	dobj	1	SENT_511	[p28l1355t722r1600b765],
3	to	TO	O	to	_	0	SENT_511	[p28l1618t730r1664b765],
4	imatinib	NN	O	imatinib	prep_to	1	SENT_511	[p28l1682t721r1892b765],
5	in	IN	O	in	_	0	SENT_511	[p28l1910t722r1957b765],
6	gastrointestinal	JJ	O	gastrointestinal	amod	8	SENT_511	[p28l1974t730r2148b778, p28l1116t792r1351b836],
7	stromal	JJ	O	stromal	amod	8	SENT_511	[p28l1376t792r1565b836],
8	tumor	NN	O	tumor	prep_in	1	SENT_511	[p28l1589t801r1742b837],
9	occurs	VBZ	O	occur	_	0	SENT_511	[p28l1765t806r1924b837],
10	through	IN	O	through	_	0	SENT_511	[p28l1950t792r2149b849],
11	secondary	JJ	O	secondary	amod	13	SENT_511	[p28l1117t863r1363b919],
12	gene	NN	O	gene	nn	13	SENT_511	[p28l1378t877r1490b920],
13	mutation	NN	O	mutation	prep_through	9	SENT_511	[p28l1508t864r1741b908],
14	.	.	O	.	_	0	SENT_511	[p28l1508t864r1741b908],

1	Clin	NNP	O	Clin	nn	3	SENT_512	[p28l1763t863r1862b907],
2	Cancer	NNP	O	Cancer	nn	3	SENT_512	[p28l1880t866r2047b907],
3	Res	NNP	O	Res	_	0	SENT_512	[p28l2063t867r2148b910],
4	2005	CD	DATE	2005	num	3	SENT_512	[p28l1117t937r1531b987],
5	;	:	O	;	_	0	SENT_512	[p28l1117t937r1531b987],
6	11:4182	CD	NUMBER	11:4182	number	7	SENT_512	[p28l1117t937r1531b987],
7	-90	CD	NUMBER	-90	dep	3	SENT_512	[p28l1117t937r1531b987],
8	.	.	O	.	_	0	SENT_512	[p28l1117t937r1531b987],

1	45	CD	NUMBER	45	_	0	SENT_513	[p28l1115t1012r1182b1050],
2	.	.	O	.	_	0	SENT_513	[p28l1115t1012r1182b1050],

1	Emery	NNP	ORGANIZATION	Emery	nn	2	SENT_514	[p28l1212t1010r1369b1062],
2	CM	NN	ORGANIZATION	cm	_	0	SENT_514	[p28l1405t1009r1501b1060],
3	,	,	O	,	_	0	SENT_514	[p28l1405t1009r1501b1060],
4	Vijayendran	NNP	O	Vijayendran	nn	5	SENT_514	[p28l1540t1006r1831b1062],
5	KG	NNP	O	KG	appos	2	SENT_514	[p28l1869t1009r1957b1059],
6	,	,	O	,	_	0	SENT_514	[p28l1869t1009r1957b1059],
7	Zipser	NNP	PERSON	Zipser	nn	8	SENT_514	[p28l1997t1007r2150b1062],
8	MC	NNP	O	MC	appos	2	SENT_514	[p28l1115t1079r1212b1130],
9	,	,	O	,	_	0	SENT_514	[p28l1115t1079r1212b1130],
10	et	FW	O	et	nn	11	SENT_514	[p28l1241t1085r1285b1120],
11	al.	FW	O	al.	appos	2	SENT_514	[p28l1306t1076r1362b1120],
12	.	.	O	.	_	0	SENT_514	[p28l1306t1076r1362b1120],

1	MEK1	NN	O	mek1	nn	2	SENT_515	[p28l1388t1079r1538b1121],
2	mutations	NNS	O	mutation	nsubj	3	SENT_515	[p28l1563t1077r1811b1121],
3	confer	VBP	O	confer	_	0	SENT_515	[p28l1838t1076r1994b1120],
4	resistance	NN	O	resistance	dobj	3	SENT_515	[p28l2018t1077r2148b1120, p28l1117t1156r1248b1191],
5	to	TO	O	to	_	0	SENT_515	[p28l1268t1156r1314b1191],
6	MEK	NN	O	mek	nn	9	SENT_515	[p28l1333t1151r1454b1192],
7	and	CC	O	and	_	0	SENT_515	[p28l1472t1147r1562b1191],
8	B-RAF	NN	O	b-raf	nn	9	SENT_515	[p28l1581t1151r1739b1194],
9	inhibition	NN	O	inhibition	prep_to	3	SENT_515	[p28l1759t1147r2018b1191],
10	.	.	O	.	_	0	SENT_515	[p28l1759t1147r2018b1191],

1	Proc	NNP	O	Proc	nn	7	SENT_516	[p28l2040t1151r2149b1191],
2	Natl	NNP	O	Natl	nn	7	SENT_516	[p28l1115t1219r1220b1263],
3	Acad	NNP	O	Acad	nn	7	SENT_516	[p28l1237t1219r1357b1263],
4	Sci	NNP	O	Sci	nn	7	SENT_516	[p28l1378t1220r1446b1263],
5	U	NNP	O	U	nn	7	SENT_516	[p28l1464t1223r1503b1263],
6	S	NNP	O	S	nn	7	SENT_516	[p28l1523t1222r1546b1263],
7	A	NNP	O	A	_	0	SENT_516	[p28l1565t1223r1602b1262],
8	2009	CD	DATE	2009	num	7	SENT_516	[p28l1620t1222r2068b1272],
9	;	:	O	;	_	0	SENT_516	[p28l1620t1222r2068b1272],
10	106:20411	CD	NUMBER	106:20411	number	11	SENT_516	[p28l1620t1222r2068b1272],
11	-6	CD	NUMBER	-6	dep	7	SENT_516	[p28l1620t1222r2068b1272],
12	.	.	O	.	_	0	SENT_516	[p28l1620t1222r2068b1272],

1	46	CD	NUMBER	46	_	0	SENT_517	[p28l1115t1294r1185b1333],
2	.	.	O	.	_	0	SENT_517	[p28l1115t1294r1185b1333],

1	Engelman	NNP	PERSON	Engelman	nn	2	SENT_518	[p28l1212t1289r1465b1346],
2	JA	NNP	O	JA	_	0	SENT_518	[p28l1493t1293r1564b1342],
3	,	,	O	,	_	0	SENT_518	[p28l1493t1293r1564b1342],
4	Zejnullahu	NNP	PERSON	Zejnullahu	nn	5	SENT_518	[p28l1600t1289r1869b1345],
5	K	NNP	PERSON	K	appos	2	SENT_518	[p28l1902t1293r1952b1343],
6	,	,	O	,	_	0	SENT_518	[p28l1902t1293r1952b1343],
7	Mitsudomi	NNP	ORGANIZATION	Mitsudomi	nn	8	SENT_518	[p28l1986t1290r2148b1334, p28l1117t1361r1244b1405],
8	T	NN	ORGANIZATION	t	appos	2	SENT_518	[p28l1262t1364r1306b1415],
9	,	,	O	,	_	0	SENT_518	[p28l1262t1364r1306b1415],
10	et	FW	O	et	nn	11	SENT_518	[p28l1329t1370r1373b1405],
11	al.	FW	O	al.	appos	2	SENT_518	[p28l1390t1361r1446b1405],
12	.	.	O	.	_	0	SENT_518	[p28l1390t1361r1446b1405],

1	MET	NN	O	met	nn	2	SENT_519	[p28l1468t1364r1585b1405],
2	amplification	NN	O	amplification	nsubj	3	SENT_519	[p28l1603t1361r1937b1417],
3	leads	VBZ	O	lead	_	0	SENT_519	[p28l1957t1361r2080b1405],
4	to	TO	O	to	_	0	SENT_519	[p28l2102t1370r2148b1405],
5	gefltinib	JJ	O	gefltinib	amod	6	SENT_519	[p28l1116t1432r1330b1489],
6	resistance	NN	O	resistance	prep_to	3	SENT_519	[p28l1347t1433r1593b1476],
7	in	IN	O	in	_	0	SENT_519	[p28l1609t1433r1656b1476],
8	lung	NN	O	lung	nn	9	SENT_519	[p28l1672t1432r1783b1489],
9	cancer	NN	O	cancer	prep_in	6	SENT_519	[p28l1798t1446r1959b1476],
10	by	IN	O	by	_	0	SENT_519	[p28l1974t1432r2029b1488],
11	activating	VBG	O	activate	prepc_by	3	SENT_519	[p28l2043t1433r2148b1476, p28l1114t1504r1265b1560],
12	ERBB3	NN	O	erbb3	nn	13	SENT_519	[p28l1281t1506r1445b1550],
13	signaling	NN	O	signaling	dobj	11	SENT_519	[p28l1467t1503r1703b1560],
14	.	.	O	.	_	0	SENT_519	[p28l1467t1503r1703b1560],

1	Science	NNP	O	Science	_	0	SENT_520	[p28l1727t1504r1903b1547],
2	2007	CD	DATE	2007	num	1	SENT_520	[p28l1922t1506r2146b1556],
3	;	:	O	;	_	0	SENT_520	[p28l1922t1506r2146b1556],
4	316	CD	NUMBER	316	num	6	SENT_520	[p28l1922t1506r2146b1556],
5	:	:	O	:	_	0	SENT_520	[p28l1922t1506r2146b1556],
6	1039-43	CD	NUMBER	1039-43	dep	1	SENT_520	[p28l1118t1578r1322b1619],
7	.	.	O	.	_	0	SENT_520	[p28l1118t1578r1322b1619],

1	47	CD	NUMBER	47	_	0	SENT_521	[p28l1115t1651r1178b1689],
2	.	.	O	.	_	0	SENT_521	[p28l1115t1651r1178b1689],

1	Press	NNP	O	Press	nn	2	SENT_522	[p28l1212t1649r1339b1689],
2	RD	NNP	O	RD	_	0	SENT_522	[p28l1364t1649r1453b1699],
3	,	,	O	,	_	0	SENT_522	[p28l1364t1649r1453b1699],
4	Love	NNP	O	Love	nn	5	SENT_522	[p28l1480t1649r1591b1690],
5	Z	NNP	O	Z	appos	2	SENT_522	[p28l1614t1649r1659b1699],
6	,	,	O	,	_	0	SENT_522	[p28l1614t1649r1659b1699],
7	Tronnes	NNP	ORGANIZATION	Tronnes	nn	8	SENT_522	[p28l1684t1649r1885b1689],
8	AA	NNP	ORGANIZATION	AA	appos	2	SENT_522	[p28l1909t1649r1997b1699],
9	,	,	O	,	_	0	SENT_522	[p28l1909t1649r1997b1699],
10	et	FW	O	et	nn	11	SENT_522	[p28l2025t1654r2069b1689],
11	al.	FW	O	al.	appos	2	SENT_522	[p28l2090t1645r2146b1689],
12	.	.	O	.	_	0	SENT_522	[p28l2090t1645r2146b1689],

1	BCR-ABL	NN	MISC	bcr-abl	nn	3	SENT_523	[p28l1116t1719r1339b1763],
2	mRNA	NN	O	mrna	nn	3	SENT_523	[p28l1370t1720r1538b1763],
3	levels	NNS	O	level	nsubj	17	SENT_523	[p28l1567t1716r1700b1761],
4	at	IN	O	at	_	0	SENT_523	[p28l1733t1725r1777b1760],
5	and	CC	O	and	_	0	SENT_523	[p28l1806t1716r1896b1760],
6	after	IN	O	after	_	0	SENT_523	[p28l1927t1716r2043b1760],
7	the	DT	O	the	det	8	SENT_523	[p28l2073t1716r2149b1760],
8	time	NN	O	time	prep_after	3	SENT_523	[p28l1117t1788r1227b1831],
9	of	IN	O	of	_	0	SENT_523	[p28l1253t1787r1310b1831],
10	a	DT	O	a	det	15	SENT_523	[p28l1325t1802r1351b1831],
11	complete	JJ	O	complete	amod	12	SENT_523	[p28l1376t1787r1598b1843],
12	cytogenetic	JJ	O	cytogenetic	amod	15	SENT_523	[p28l1625t1788r1905b1844],
13	response	NN	O	response	nn	15	SENT_523	[p28l1931t1801r2149b1843],
14	(	CD	NUMBER	(	num	15	SENT_523	[p28l1119t1862r1260b1910],
15	CCR	NN	ORGANIZATION	ccr	prep_of	8	SENT_523	[p28l1119t1862r1260b1910],
16	)	CD	NUMBER	)	prep_at	3	SENT_523	[p28l1119t1862r1260b1910],
17	predict	VBP	O	predict	_	0	SENT_523	[p28l1279t1859r1453b1915],
18	the	DT	O	the	det	19	SENT_523	[p28l1468t1859r1543b1903],
19	duration	NN	O	duration	dobj	17	SENT_523	[p28l1561t1859r1770b1904],
20	of	IN	O	of	_	0	SENT_523	[p28l1788t1859r1844b1903],
21	CCR	NN	ORGANIZATION	ccr	prep_of	19	SENT_523	[p28l1851t1862r1963b1906],
22	in	IN	O	in	_	0	SENT_523	[p28l1974t1860r2021b1903],
23	imatinib	NN	O	imatinib	nn	25	SENT_523	[p28l2038t1860r2148b1903, p28l1117t1930r1232b1974],
24	mesylate-treated	JJ	O	mesylate-treated	amod	25	SENT_523	[p28l1251t1930r1658b1986],
25	patients	NNS	O	patient	prep_in	17	SENT_523	[p28l1675t1931r1871b1986],
26	with	IN	O	with	_	0	SENT_523	[p28l1888t1930r1999b1975],
27	CML	NN	ORGANIZATION	cml	prep_with	25	SENT_523	[p28l2017t1933r2145b1974],
28	.	.	O	.	_	0	SENT_523	[p28l2017t1933r2145b1974],

1	Blood	NN	O	blood	_	0	SENT_524	[p28l1116t2001r1258b2045],
2	2006	CD	DATE	2006	num	1	SENT_524	[p28l1277t2004r1695b2054],
3	;	:	O	;	_	0	SENT_524	[p28l1277t2004r1695b2054],
4	107:4250	CD	NUMBER	107:4250	number	5	SENT_524	[p28l1277t2004r1695b2054],
5	-6	CD	NUMBER	-6	dep	1	SENT_524	[p28l1277t2004r1695b2054],
6	.	.	O	.	_	0	SENT_524	[p28l1277t2004r1695b2054],

1	48	CD	NUMBER	48	_	0	SENT_525	[p28l1115t2075r1185b2116],
2	.	.	O	.	_	0	SENT_525	[p28l1115t2075r1185b2116],

1	Fleischhacker	NNP	PERSON	Fleischhacker	nn	2	SENT_526	[p28l1212t2071r1550b2116],
2	M	NNP	O	M	_	0	SENT_526	[p28l1565t2075r1627b2124],
3	,	,	O	,	_	0	SENT_526	[p28l1565t2075r1627b2124],
4	Schmidt	NNP	PERSON	Schmidt	nn	5	SENT_526	[p28l1650t2071r1854b2115],
5	B.	NNP	O	B.	appos	2	SENT_526	[p28l1870t2075r1915b2115],
6	Circulating	VBG	O	circulate	partmod	5	SENT_526	[p28l1937t2071r2148b2116, p28l1116t2143r1197b2199],
7	nucleic	JJ	O	nucleic	amod	8	SENT_526	[p28l1223t2142r1398b2187],
8	acids	NNS	O	acid	dobj	6	SENT_526	[p28l1426t2142r1550b2186],
9	(	CD	NUMBER	(	num	10	SENT_526	[p28l1582t2145r1752b2193],
10	CNAs	NNS	MISC	cna	tmod	6	SENT_526	[p28l1582t2145r1752b2193],
11	)	CD	NUMBER	)	nsubj	14	SENT_526	[p28l1582t2145r1752b2193],
12	and	CC	O	and	_	0	SENT_526	[p28l1783t2142r1874b2186],
13	cancer	NN	O	cancer	conj_and	11	SENT_526	[p28l1903t2156r2066b2186],
14	—	VBP	O	—	rcmod	10	SENT_526	[p28l2091t2167r2151b2172],
15	a	DT	O	a	det	16	SENT_526	[p28l1116t2229r1141b2258],
16	survey	NN	O	survey	dobj	14	SENT_526	[p28l1160t2229r1321b2270],
17	.	.	O	.	_	0	SENT_526	[p28l1160t2229r1321b2270],

1	Biochim	NNP	PERSON	Biochim	nn	3	SENT_527	[p28l1341t2214r1544b2258],
2	Biophys	NNP	PERSON	Biophys	nn	3	SENT_527	[p28l1561t2214r1749b2270],
3	Acta	NNP	PERSON	Acta	_	0	SENT_527	[p28l1767t2218r1875b2258],
4	2007	CD	DATE	2007	num	3	SENT_527	[p28l1893t2217r2146b2267],
5	;	:	DATE	;	_	0	SENT_527	[p28l1893t2217r2146b2267],
6	1775	CD	DATE	1775	num	8	SENT_527	[p28l1893t2217r2146b2267],
7	:	:	O	:	_	0	SENT_527	[p28l1893t2217r2146b2267],
8	181-232	CD	NUMBER	181-232	dep	3	SENT_527	[p28l1118t2288r1317b2329],
9	.	.	O	.	_	0	SENT_527	[p28l1118t2288r1317b2329],

1	49	CD	NUMBER	49	_	0	SENT_528	[p28l1115t2361r1182b2400],
2	.	.	O	.	_	0	SENT_528	[p28l1115t2361r1182b2400],

1	Diehl	NNP	PERSON	Diehl	nn	2	SENT_529	[p28l1212t2356r1344b2400],
2	F	NN	O	f	_	0	SENT_529	[p28l1368t2360r1406b2409],
3	,	,	O	,	_	0	SENT_529	[p28l1368t2360r1406b2409],
4	Schmidt	NNP	PERSON	Schmidt	nn	5	SENT_529	[p28l1436t2356r1639b2400],
5	K	NNP	PERSON	K	appos	2	SENT_529	[p28l1662t2360r1710b2409],
6	,	,	O	,	_	0	SENT_529	[p28l1662t2360r1710b2409],
7	Choti	NNP	PERSON	Choti	nn	8	SENT_529	[p28l1739t2356r1873b2400],
8	MA	NNP	O	MA	appos	2	SENT_529	[p28l1895t2360r1995b2409],
9	,	,	O	,	_	0	SENT_529	[p28l1895t2360r1995b2409],
10	et	FW	O	et	nn	11	SENT_529	[p28l2024t2365r2068b2400],
11	al.	FW	O	al.	appos	2	SENT_529	[p28l2090t2356r2145b2400],
12	.	.	O	.	_	0	SENT_529	[p28l2090t2356r2145b2400],

1	Circulating	VBG	O	circulate	_	0	SENT_530	[p28l1117t2426r1395b2483],
2	mutant	JJ	O	mutant	amod	3	SENT_530	[p28l1416t2435r1595b2471],
3	DNA	NN	MISC	dna	dobj	1	SENT_530	[p28l1614t2430r1732b2470],
4	to	TO	O	to	aux	5	SENT_530	[p28l1753t2435r1800b2470],
5	assess	VB	O	assess	xcomp	1	SENT_530	[p28l1823t2441r1974b2470],
6	tumor	NN	O	tumor	nn	7	SENT_530	[p28l1998t2435r2150b2471],
7	dynamics	NNS	O	dynamics	dobj	5	SENT_530	[p28l1117t2498r1365b2554],
8	.	.	O	.	_	0	SENT_530	[p28l1117t2498r1365b2554],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_531	[p28l1387t2502r1475b2543],
2	Med	NNP	O	Med	_	0	SENT_531	[p28l1489t2498r1595b2542],
3	2008	CD	DATE	2008	num	2	SENT_531	[p28l1615t2501r2002b2551],
4	;	:	O	;	_	0	SENT_531	[p28l1615t2501r2002b2551],
5	14:985	CD	NUMBER	14:985	number	6	SENT_531	[p28l1615t2501r2002b2551],
6	-90	CD	NUMBER	-90	dep	2	SENT_531	[p28l1615t2501r2002b2551],
7	.	.	O	.	_	0	SENT_531	[p28l1615t2501r2002b2551],

1	50	CD	NUMBER	50	_	0	SENT_532	[p28l1117t2573r1183b2612],
2	.	.	O	.	_	0	SENT_532	[p28l1117t2573r1183b2612],

1	Maheswaran	NNP	MISC	Maheswaran	nn	2	SENT_533	[p28l1211t2568r1527b2613],
2	S	NNP	O	S	_	0	SENT_533	[p28l1546t2571r1585b2622],
3	,	,	O	,	_	0	SENT_533	[p28l1546t2571r1585b2622],
4	Sequist	NNP	O	Sequist	nn	5	SENT_533	[p28l1607t2569r1785b2624],
5	LV	NNP	O	LV	appos	2	SENT_533	[p28l1799t2572r1866b2622],
6	,	,	O	,	_	0	SENT_533	[p28l1799t2572r1866b2622],
7	Nagrath	NNP	PERSON	Nagrath	nn	8	SENT_533	[p28l1886t2568r2088b2625],
8	S	NNP	O	S	appos	2	SENT_533	[p28l2107t2571r2145b2621],
9	,	,	O	,	_	0	SENT_533	[p28l2107t2571r2145b2621],
10	et	FW	O	et	nn	11	SENT_533	[p28l1117t2649r1161b2684],
11	al.	FW	O	al.	appos	2	SENT_533	[p28l1185t2640r1240b2684],
12	.	.	O	.	_	0	SENT_533	[p28l1185t2640r1240b2684],

1	Detection	NN	O	detection	_	0	SENT_534	[p28l1270t2641r1508b2684],
2	of	IN	O	of	_	0	SENT_534	[p28l1535t2640r1592b2684],
3	mutations	NNS	O	mutation	prep_of	1	SENT_534	[p28l1609t2641r1857b2685],
4	in	IN	O	in	_	0	SENT_534	[p28l1885t2641r1932b2684],
5	EGFR	NN	ORGANIZATION	egfr	prep_in	3	SENT_534	[p28l1958t2644r2079b2685],
6	in	IN	O	in	_	0	SENT_534	[p28l2101t2641r2149b2684],
7	circulating	VBG	O	circulate	prepc_in	5	SENT_534	[p28l1117t2710r1385b2767],
8	lung-cancer	JJ	O	lung-cancer	amod	9	SENT_534	[p28l1420t2710r1712b2767],
9	cells	NNS	O	cell	dobj	7	SENT_534	[p28l1748t2710r1870b2754],
10	.	.	O	.	_	0	SENT_534	[p28l1748t2710r1870b2754],

1	N	NN	O	n	nn	3	SENT_535	[p28l1909t2714r1951b2754],
2	Engl	NNP	O	Engl	nn	3	SENT_535	[p28l1987t2710r2098b2767],
3	J	NNP	O	J	nsubj	4	SENT_535	[p28l2129t2714r2150b2761],
4	Med	VBD	O	med	_	0	SENT_535	[p28l1115t2782r1221b2826],
5	2008	CD	DATE	2008	dobj	4	SENT_535	[p28l1240t2785r1651b2835],
6	;	:	O	;	_	0	SENT_535	[p28l1240t2785r1651b2835],
7	359:366	CD	NUMBER	359:366	num	8	SENT_535	[p28l1240t2785r1651b2835],
8	-77	CD	NUMBER	-77	dep	5	SENT_535	[p28l1240t2785r1651b2835],
9	.	.	O	.	_	0	SENT_535	[p28l1240t2785r1651b2835],

1	51	CD	NUMBER	51	_	0	SENT_536	[p28l1117t2858r1181b2896],
2	.	.	O	.	_	0	SENT_536	[p28l1117t2858r1181b2896],

1	McBride	NNP	ORGANIZATION	McBride	nn	2	SENT_537	[p28l1211t2852r1415b2896],
2	DJ	NNP	ORGANIZATION	DJ	_	0	SENT_537	[p28l1431t2856r1499b2906],
3	,	,	O	,	_	0	SENT_537	[p28l1431t2856r1499b2906],
4	Orpana	NNP	ORGANIZATION	Orpana	nn	5	SENT_537	[p28l1519t2855r1703b2908],
5	AK	NNP	ORGANIZATION	AK	appos	2	SENT_537	[p28l1717t2856r1806b2905],
6	,	,	O	,	_	0	SENT_537	[p28l1717t2856r1806b2905],
7	Sotiriou	NNP	PERSON	Sotiriou	nn	8	SENT_537	[p28l1828t2853r2023b2897],
8	C	NNP	O	C	appos	2	SENT_537	[p28l2040t2855r2087b2906],
9	,	,	O	,	_	0	SENT_537	[p28l2040t2855r2087b2906],
10	et	FW	O	et	nn	11	SENT_537	[p28l2108t2861r2151b2896],
11	al.	FW	O	al.	appos	2	SENT_537	[p28l1116t2923r1172b2967],
12	.	.	O	.	_	0	SENT_537	[p28l1116t2923r1172b2967],

1	Use	NN	O	use	_	0	SENT_538	[p28l1203t2927r1292b2967],
2	of	IN	O	of	_	0	SENT_538	[p28l1321t2923r1378b2967],
3	cancer-specific	JJ	O	cancer-specific	amod	5	SENT_538	[p28l1396t2923r1767b2979],
4	genomic	JJ	O	genomic	amod	5	SENT_538	[p28l1795t2924r2006b2980],
5	rearrangements	NNS	O	rearrangement	prep_of	1	SENT_538	[p28l2034t2938r2148b2967, p28l1117t3003r1411b3051],
6	to	TO	O	to	aux	7	SENT_538	[p28l1443t3003r1490b3038],
7	quantify	VB	O	quantify	infmod	1	SENT_538	[p28l1521t2994r1733b3050],
8	disease	NN	O	disease	nn	9	SENT_538	[p28l1761t2994r1942b3038],
9	burden	NN	O	burden	dobj	7	SENT_538	[p28l1973t2994r2149b3039],
10	in	IN	O	in	_	0	SENT_538	[p28l1116t3067r1164b3109],
11	plasma	NN	O	plasma	prep_in	9	SENT_538	[p28l1197t3066r1375b3122],
12	from	IN	O	from	_	0	SENT_538	[p28l1407t3066r1527b3110],
13	patients	NNS	O	patient	prep_from	7	SENT_538	[p28l1559t3067r1754b3122],
14	with	IN	O	with	_	0	SENT_538	[p28l1787t3066r1898b3111],
15	solid	JJ	O	solid	amod	16	SENT_538	[p28l1931t3066r2048b3110],
16	tumors	NNS	O	tumor	prep_with	13	SENT_538	[p28l2082t3075r2148b3111, p28l1117t3151r1254b3181],
17	.	.	O	.	_	0	SENT_538	[p28l2082t3075r2148b3111, p28l1117t3151r1254b3181],

1	Genes	NNS	O	gene	nn	2	SENT_539	[p28l1278t3140r1428b3181],
2	Chromosomes	NNS	O	chromosome	_	0	SENT_539	[p28l1450t3137r1806b3181],
3	Cancer	NN	O	cancer	dep	2	SENT_539	[p28l1828t3140r1999b3181],
4	2010	CD	DATE	2010	num	3	SENT_539	[p28l2018t3140r2147b3190],
5	;	:	O	;	_	0	SENT_539	[p28l2018t3140r2147b3190],
6	49:1062	CD	NUMBER	49:1062	num	7	SENT_539	[p28l1116t3211r1364b3252],
7	-9	CD	NUMBER	-9	dep	2	SENT_539	[p28l1116t3211r1364b3252],
8	.	.	O	.	_	0	SENT_539	[p28l1116t3211r1364b3252],

1	52	CD	NUMBER	52	_	0	SENT_540	[p28l1117t3284r1184b3322],
2	.	.	O	.	_	0	SENT_540	[p28l1117t3284r1184b3322],

1	Leary	NNP	PERSON	Leary	nn	2	SENT_541	[p28l1212t3282r1349b3334],
2	RI	NN	PERSON	rus	_	0	SENT_541	[p28l1362t3282r1430b3331],
3	,	,	O	,	_	0	SENT_541	[p28l1362t3282r1430b3331],
4	Kinde	NN	O	kinde	appos	2	SENT_541	[p28l1449t3278r1594b3323],
5	I	PRP	O	I	dep	4	SENT_541	[p28l1610t3282r1640b3331],
6	,	,	O	,	_	0	SENT_541	[p28l1610t3282r1640b3331],
7	Diehl	NNP	PERSON	Diehl	nn	8	SENT_541	[p28l1659t3278r1791b3322],
8	F	NN	O	f	appos	2	SENT_541	[p28l1806t3282r1844b3332],
9	,	,	O	,	_	0	SENT_541	[p28l1806t3282r1844b3332],
10	et	FW	O	et	nn	11	SENT_541	[p28l1864t3287r1908b3322],
11	al.	FW	O	al.	appos	2	SENT_541	[p28l1921t3278r1977b3322],
12	.	.	O	.	_	0	SENT_541	[p28l1921t3278r1977b3322],

1	Development	NN	O	development	_	0	SENT_542	[p28l1996t3278r2148b3323, p28l1117t3359r1305b3406],
2	of	IN	O	of	_	0	SENT_542	[p28l1329t3350r1386b3394],
3	personalized	JJ	O	personalized	amod	5	SENT_542	[p28l1402t3350r1722b3406],
4	tumor	NN	O	tumor	nn	5	SENT_542	[p28l1749t3359r1901b3395],
5	biomarkers	NNS	O	biomarker	prep_of	1	SENT_542	[p28l1927t3350r2148b3395, p28l1117t3434r1186b3464],
6	using	VBG	O	use	partmod	1	SENT_542	[p28l1216t3421r1352b3477],
7	massively	RB	O	massively	advmod	6	SENT_542	[p28l1379t3420r1615b3476],
8	parallel	JJ	O	parallel	amod	9	SENT_542	[p28l1641t3420r1827b3476],
9	sequencing	NN	O	sequencing	dobj	6	SENT_542	[p28l1857t3421r2146b3477],
10	.	.	O	.	_	0	SENT_542	[p28l1857t3421r2146b3477],

1	Sci	NNP	O	Sci	nn	3	SENT_543	[p28l1118t3492r1186b3535],
2	Transl	NNP	O	Transl	nn	3	SENT_543	[p28l1203t3491r1359b3535],
3	Med	NNP	O	Med	_	0	SENT_543	[p28l1376t3491r1482b3535],
4	2010	CD	DATE	2010	num	3	SENT_543	[p28l1502t3494r1857b3544],
5	;	:	O	;	_	0	SENT_543	[p28l1502t3494r1857b3544],
6	2:20	CD	NUMBER	2:20	num	7	SENT_543	[p28l1502t3494r1857b3544],
7	ra14	NN	O	ra14	dep	3	SENT_543	[p28l1502t3494r1857b3544],
8	.	.	O	.	_	0	SENT_543	[p28l1502t3494r1857b3544],

1	53	CD	NUMBER	53	_	0	SENT_544	[p28l1117t3567r1181b3606],
2	.	.	O	.	_	0	SENT_544	[p28l1117t3567r1181b3606],

1	Kwak	NNP	PERSON	Kwak	nn	2	SENT_545	[p28l1213t3562r1350b3607],
2	EL	NNP	O	EL	_	0	SENT_545	[p28l1368t3566r1443b3616],
3	,	,	O	,	_	0	SENT_545	[p28l1368t3566r1443b3616],
4	Camidge	NNP	O	Camidge	nn	5	SENT_545	[p28l1468t3562r1686b3619],
5	DR	NN	O	dr	appos	2	SENT_545	[p28l1707t3566r1797b3616],
6	,	,	O	,	_	0	SENT_545	[p28l1707t3566r1797b3616],
7	Clark	NNP	PERSON	Clark	nn	8	SENT_545	[p28l1822t3562r1955b3607],
8	J	NNP	PERSON	J	appos	2	SENT_545	[p28l1969t3566r2002b3616],
9	,	,	O	,	_	0	SENT_545	[p28l1969t3566r2002b3616],
10	et	FW	O	et	nn	11	SENT_545	[p28l2027t3571r2071b3606],
11	al.	FW	O	al.	appos	2	SENT_545	[p28l2090t3562r2145b3606],
12	.	.	O	.	_	0	SENT_545	[p28l2090t3562r2145b3606],

1	Clinical	JJ	O	clinical	amod	2	SENT_546	[p28l1117t3634r1307b3678],
2	activity	NN	O	activity	nsubj	3	SENT_546	[p28l1322t3635r1500b3690],
3	observed	VBN	O	observe	_	0	SENT_546	[p28l1514t3634r1731b3678],
4	in	IN	O	in	_	0	SENT_546	[p28l1746t3635r1794b3678],
5	a	DT	O	a	det	6	SENT_546	[p28l1809t3649r1834b3678],
6	phase	NN	O	phase	prep_in	3	SENT_546	[p28l1848t3634r1990b3690],
7	I	PRP	O	I	dep	6	SENT_546	[p28l2005t3638r2022b3678],
8	dose	NN	O	dose	nn	10	SENT_546	[p28l2038t3634r2149b3678],
9	escalation	NN	O	escalation	nn	10	SENT_546	[p28l1117t3705r1366b3749],
10	trial	NN	O	trial	dobj	3	SENT_546	[p28l1388t3705r1490b3749],
11	of	IN	O	of	_	0	SENT_546	[p28l1512t3705r1568b3749],
12	an	DT	O	a	det	14	SENT_546	[p28l1580t3719r1638b3749],
13	oral	JJ	O	oral	amod	14	SENT_546	[p28l1660t3705r1755b3749],
14	c-met	NN	O	c-met	prep_of	10	SENT_546	[p28l1777t3714r1914b3749],
15	and	CC	O	and	_	0	SENT_546	[p28l1933t3705r2023b3749],
16	ALK	NN	O	alk	nn	17	SENT_546	[p28l2042t3709r2150b3750],
17	inhibitor	NN	O	inhibitor	prep_of	10	SENT_546	[p28l1116t3776r1340b3829],
18	,	,	O	,	_	0	SENT_546	[p28l1116t3776r1340b3829],
19	PF-02341066	NN	O	pf-02341066	appos	14	SENT_546	[p28l1361t3779r1683b3820],
20	.	.	O	.	_	0	SENT_546	[p28l1361t3779r1683b3820],

1	J	NNP	O	J	nn	3	SENT_547	[p28l1700t3780r1721b3827],
2	Clin	NNP	O	Clin	nn	3	SENT_547	[p28l1738t3776r1837b3820],
3	Oncol	NNP	O	Oncol	_	0	SENT_547	[p28l1856t3776r1998b3820],
4	2009	CD	DATE	2009	num	3	SENT_547	[p28l2017t3779r2146b3829],
5	;	:	O	;	_	0	SENT_547	[p28l2017t3779r2146b3829],

1	tumour	NN	O	tumour	nsubj	2	SENT_548	[p29l9t30r194b66],
2	profiled	VBD	O	profile	_	0	SENT_548	[p29l209t21r407b77],
3	at	IN	O	at	_	0	SENT_548	[p29l424t30r469b65],
4	single	JJ	O	single	amod	6	SENT_548	[p29l485t21r629b78],
5	nucleotide	NN	O	nucleotide	nn	6	SENT_548	[p29l647t21r901b66],
6	resolution	NN	O	resolution	prep_at	2	SENT_548	[p29l919t35r1041b65, p29l8t93r166b137],
7	.	.	O	.	_	0	SENT_548	[p29l919t35r1041b65, p29l8t93r166b137],

1	Nature	NNP	O	Nature	_	0	SENT_549	[p29l187t97r355b137],
2	2009	CD	DATE	2009	num	1	SENT_549	[p29l375t96r794b146],
3	;	:	O	;	_	0	SENT_549	[p29l375t96r794b146],
4	461:809	CD	NUMBER	461:809	number	5	SENT_549	[p29l375t96r794b146],
5	-13	CD	NUMBER	-13	dep	1	SENT_549	[p29l375t96r794b146],
6	.	.	O	.	_	0	SENT_549	[p29l375t96r794b146],

1	41	CD	NUMBER	41	_	0	SENT_550	[p29l8t169r74b207],
2	.	.	O	.	_	0	SENT_550	[p29l8t169r74b207],

1	Engelman	NNP	PERSON	Engelman	nn	2	SENT_551	[p29l104t163r354b220],
2	JA	NNP	O	JA	nsubj	6	SENT_551	[p29l378t167r448b217],
3	,	,	O	,	_	0	SENT_551	[p29l378t167r448b217],
4	Settleman	NNP	O	Settleman	nn	5	SENT_551	[p29l483t163r730b207],
5	J.	NNP	O	J.	nsubj	6	SENT_551	[p29l754t167r787b214],
6	Acquired	VBD	O	acquire	_	0	SENT_551	[p29l818t163r1041b219],
7	resistance	NN	O	resistance	dobj	6	SENT_551	[p29l9t236r255b279],
8	to	TO	O	to	_	0	SENT_551	[p29l289t244r336b279],
9	tyrosine	NN	O	tyrosine	nn	11	SENT_551	[p29l372t236r570b291],
10	kinase	NN	O	kinase	nn	11	SENT_551	[p29l604t235r764b280],
11	inhibitors	NNS	O	inhibitor	prep_to	6	SENT_551	[p29l798t235r1040b279],
12	during	IN	O	during	_	0	SENT_551	[p29l9t306r175b363],
13	cancer	NN	O	cancer	nn	14	SENT_551	[p29l201t320r361b350],
14	therapy	NN	O	therapy	prep_during	6	SENT_551	[p29l387t306r579b362],
15	.	.	O	.	_	0	SENT_551	[p29l387t306r579b362],

1	Curr	NNP	PERSON	Curr	nn	4	SENT_552	[p29l611t309r722b351],
2	Opin	NNP	PERSON	Opin	nn	4	SENT_552	[p29l748t307r869b362],
3	Genet	NNP	PERSON	Genet	nn	4	SENT_552	[p29l897t309r1044b350],
4	Dev	NNP	O	Dev	_	0	SENT_552	[p29l8t382r102b423],
5	2008	CD	DATE	2008	num	4	SENT_552	[p29l119t381r445b431],
6	;	:	O	;	_	0	SENT_552	[p29l119t381r445b431],
7	18:73	CD	NUMBER	18:73	number	8	SENT_552	[p29l119t381r445b431],
8	—	CD	NUMBER	—	dep	4	SENT_552	[p29l119t381r445b431],
9	9	CD	NUMBER	9	dep	8	SENT_552	[p29l119t381r445b431],
10	.	.	O	.	_	0	SENT_552	[p29l119t381r445b431],

1	42	CD	NUMBER	42	_	0	SENT_553	[p29l8t454r76b492],
2	.	.	O	.	_	0	SENT_553	[p29l8t454r76b492],

1	O’Hare	JJ	O	o’hare	amod	2	SENT_554	[p29l105t451r279b492],
2	T	NN	O	t	_	0	SENT_554	[p29l311t452r355b502],
3	,	,	O	,	_	0	SENT_554	[p29l311t452r355b502],
4	Eide	NNP	PERSON	Eide	nn	5	SENT_554	[p29l391t448r495b492],
5	CA	NNP	O	CA	appos	2	SENT_554	[p29l529t451r613b502],
6	,	,	O	,	_	0	SENT_554	[p29l529t451r613b502],
7	Deininger	NNP	PERSON	Deininger	nn	8	SENT_554	[p29l649t449r897b505],
8	MW	NNP	O	MW	appos	5	SENT_554	[p29l928t452r1038b492],
9	.	.	O	.	_	0	SENT_554	[p29l928t452r1038b492],

1	Bcr	NNP	O	Bcr	_	0	SENT_555	[p29l8t519r190b563],
2	.	.	O	.	_	0	SENT_555	[p29l8t519r190b563],

1	—	NN	O	—	_	0	SENT_556	[p29l8t519r190b563],
2	.	.	O	.	_	0	SENT_556	[p29l8t519r190b563],

1	Abl	NN	O	abl	nn	4	SENT_557	[p29l8t519r190b563],
2	kinase	NN	O	kinase	nn	4	SENT_557	[p29l221t519r380b564],
3	domain	NN	O	domain	nn	4	SENT_557	[p29l411t519r599b563],
4	mutations	NNS	O	mutation	_	0	SENT_557	[p29l630t520r893b572],
5	,	,	O	,	_	0	SENT_557	[p29l630t520r893b572],
6	drug	NN	O	drug	nn	7	SENT_557	[p29l927t519r1043b576],
7	resistance	NN	O	resistance	conj_and	4	SENT_557	[p29l9t592r268b645],
8	,	,	O	,	_	0	SENT_557	[p29l9t592r268b645],
9	and	CC	O	and	_	0	SENT_557	[p29l307t591r397b635],
10	the	DT	O	the	det	11	SENT_557	[p29l433t591r509b635],
11	road	NN	O	road	conj_and	4	SENT_557	[p29l545t591r653b635],
12	to	TO	O	to	_	0	SENT_557	[p29l690t600r736b635],
13	a	DT	O	a	det	14	SENT_557	[p29l772t606r797b635],
14	cure	NN	O	cure	prep_to	11	SENT_557	[p29l833t605r936b635],
15	for	IN	O	for	_	0	SENT_557	[p29l973t591r1043b635],
16	chronic	JJ	O	chronic	amod	18	SENT_557	[p29l9t661r198b705],
17	myeloid	JJ	O	myeloid	amod	18	SENT_557	[p29l229t661r425b717],
18	leukemia	NN	O	leukemia	prep_for	14	SENT_557	[p29l456t661r699b706],
19	.	.	O	.	_	0	SENT_557	[p29l456t661r699b706],

1	Blood	NN	O	blood	_	0	SENT_558	[p29l733t661r878b705],
2	2007	CD	DATE	2007	num	1	SENT_558	[p29l909t664r1039b714],
3	;	:	O	;	_	0	SENT_558	[p29l909t664r1039b714],
4	110:2242	CD	NUMBER	110:2242	number	5	SENT_558	[p29l11t735r287b776],
5	—	CD	NUMBER	—	dep	1	SENT_558	[p29l11t735r287b776],
6	9	CD	NUMBER	9	dep	5	SENT_558	[p29l11t735r287b776],
7	.	.	O	.	_	0	SENT_558	[p29l11t735r287b776],

1	43	CD	NUMBER	43	_	0	SENT_559	[p29l8t809r74b848],
2	.	.	O	.	_	0	SENT_559	[p29l8t809r74b848],

1	Pao	NNP	O	Pao	nn	2	SENT_560	[p29l104t808r190b848],
2	W	NNP	O	W	_	0	SENT_560	[p29l210t808r270b858],
3	,	,	O	,	_	0	SENT_560	[p29l210t808r270b858],
4	Miller	NNP	ORGANIZATION	Miller	nn	5	SENT_560	[p29l293t804r442b848],
5	VA	NNP	ORGANIZATION	VA	appos	2	SENT_560	[p29l458t808r538b858],
6	,	,	O	,	_	0	SENT_560	[p29l458t808r538b858],
7	Politi	NNP	PERSON	Politi	nn	8	SENT_560	[p29l561t804r690b848],
8	KA	NN	O	ka	appos	2	SENT_560	[p29l710t808r799b858],
9	,	,	O	,	_	0	SENT_560	[p29l710t808r799b858],
10	et	FW	O	et	nn	11	SENT_560	[p29l823t813r866b848],
11	al.	FW	O	al.	appos	2	SENT_560	[p29l884t804r940b848],
12	.	.	O	.	_	0	SENT_560	[p29l884t804r940b848],

1	Acquired	VBN	O	acquire	_	0	SENT_561	[p29l961t808r1041b848, p29l9t874r167b930],
2	resistance	NN	O	resistance	tmod	1	SENT_561	[p29l198t875r443b918],
3	of	IN	O	of	_	0	SENT_561	[p29l475t874r531b918],
4	lung	NN	O	lung	nn	5	SENT_561	[p29l551t874r662b931],
5	adenocarcino27	NN	O	adenocarcino27	prep_of	2	SENT_561	[p29l690t874r1041b918, p29l1117t21r1465b77],
6	:	:	O	:	_	0	SENT_561	[p29l690t874r1041b918, p29l1117t21r1465b77],
7	Suppl	NNP	O	Suppl	nn	9	SENT_561	[p29l690t874r1041b918, p29l1117t21r1465b77],
8	:148	CD	NUMBER	:148	num	9	SENT_561	[p29l690t874r1041b918, p29l1117t21r1465b77],
9	s.	NN	O	s.	dep	2	SENT_561	[p29l690t874r1041b918, p29l1117t21r1465b77],

1	abstract	JJ	O	abstract	_	0	SENT_562	[p29l1487t21r1697b65],
2	.	.	O	.	_	0	SENT_562	[p29l1487t21r1697b65],

1	54	CD	NUMBER	54	_	0	SENT_563	[p29l1117t99r1183b137],
2	.	.	O	.	_	0	SENT_563	[p29l1117t99r1183b137],

1	Durbin	NNP	PERSON	Durbin	nn	2	SENT_564	[p29l1212t93r1387b137],
2	RM	NN	O	rm	_	0	SENT_564	[p29l1418t97r1519b146],
3	,	,	O	,	_	0	SENT_564	[p29l1418t97r1519b146],
4	Abecasis	NNP	PERSON	Abecasis	nn	5	SENT_564	[p29l1552t93r1766b137],
5	GR	NN	O	gr	appos	2	SENT_564	[p29l1799t96r1890b146],
6	,	,	O	,	_	0	SENT_564	[p29l1799t96r1890b146],
7	Altshuler	NNP	PERSON	Altshuler	nn	8	SENT_564	[p29l1923t93r2150b137],
8	DL	NNP	O	DL	appos	2	SENT_564	[p29l1116t167r1199b217],
9	,	,	O	,	_	0	SENT_564	[p29l1116t167r1199b217],
10	et	FW	O	et	nn	11	SENT_564	[p29l1222t172r1266b207],
11	al.	FW	O	al.	appos	2	SENT_564	[p29l1283t163r1338b207],
12	.	.	O	.	_	0	SENT_564	[p29l1283t163r1338b207],

1	A	DT	O	a	det	2	SENT_565	[p29l1359t167r1396b207],
2	map	NN	O	map	_	0	SENT_565	[p29l1415t177r1520b219],
3	of	IN	O	of	_	0	SENT_565	[p29l1541t163r1597b207],
4	human	JJ	O	human	amod	6	SENT_565	[p29l1607t163r1780b208],
5	genome	NN	O	genome	nn	6	SENT_565	[p29l1799t177r1993b220],
6	variation	NN	O	variation	prep_of	2	SENT_565	[p29l2011t164r2148b208, p29l1117t236r1214b279],
7	from	IN	O	from	_	0	SENT_565	[p29l1251t235r1371b279],
8	population-scale	JJ	O	population-scale	amod	9	SENT_565	[p29l1407t235r1819b291],
9	sequencing	NN	O	sequencing	prep_from	2	SENT_565	[p29l1857t236r2146b292],
10	.	.	O	.	_	0	SENT_565	[p29l1857t236r2146b292],

1	Nature	NNP	O	Nature	_	0	SENT_566	[p29l1115t310r1283b351],
2	2010	CD	DATE	2010	num	1	SENT_566	[p29l1303t309r1736b359],
3	;	:	O	;	_	0	SENT_566	[p29l1303t309r1736b359],
4	467:1061	CD	NUMBER	467:1061	number	5	SENT_566	[p29l1303t309r1736b359],
5	-73	CD	NUMBER	-73	dep	1	SENT_566	[p29l1303t309r1736b359],
6	.	.	O	.	_	0	SENT_566	[p29l1303t309r1736b359],

1	55	CD	NUMBER	55	_	0	SENT_567	[p29l1117t384r1182b422],
2	.	.	O	.	_	0	SENT_567	[p29l1117t384r1182b422],

1	Hindorff	JJ	ORGANIZATION	hindorff	amod	2	SENT_568	[p29l1213t378r1445b422],
2	LA	NNP	ORGANIZATION	LA	_	0	SENT_568	[p29l1460t382r1541b431],
3	,	,	O	,	_	0	SENT_568	[p29l1460t382r1541b431],
4	Junkins	NNP	ORGANIZATION	Junkins	nn	5	SENT_568	[p29l1564t378r1759b429],
5	HA	NNP	ORGANIZATION	HA	appos	2	SENT_568	[p29l1786t382r1881b431],
6	,	,	O	,	_	0	SENT_568	[p29l1786t382r1881b431],
7	Mehta	NNP	ORGANIZATION	Mehta	nn	8	SENT_568	[p29l1908t378r2065b422],
8	JP	NNP	ORGANIZATION	JP	appos	2	SENT_568	[p29l2084t382r2146b431],
9	,	,	O	,	_	0	SENT_568	[p29l2084t382r2146b431],
10	and	CC	O	and	_	0	SENT_568	[p29l1116t448r1207b492],
11	Manolio	NNP	O	Manolio	nn	12	SENT_568	[p29l1229t448r1437b492],
12	TA	NNP	O	TA	appos	2	SENT_568	[p29l1459t451r1543b492],
13	.	.	O	.	_	0	SENT_568	[p29l1459t451r1543b492],

1	A	DT	O	a	det	2	SENT_569	[p29l1568t452r1605b492],
2	catalog	NN	O	catalog	_	0	SENT_569	[p29l1628t448r1811b505],
3	of	IN	O	of	_	0	SENT_569	[p29l1833t448r1890b492],
4	published	VBN	O	publish	amod	7	SENT_569	[p29l1902t448r2149b504],
5	genome-wide	JJ	O	genome-wide	amod	7	SENT_569	[p29l1116t519r1453b576],
6	association	NN	O	association	nn	7	SENT_569	[p29l1497t520r1780b563],
7	studies	NNS	O	study	prep_of	2	SENT_569	[p29l1825t519r2015b564],
8	.	.	O	.	_	0	SENT_569	[p29l1825t519r2015b564],

1	National	NNP	ORGANIZATION	National	nn	7	SENT_570	[p29l2061t523r2148b563, p29l1117t591r1263b635],
2	Human	NNP	ORGANIZATION	Human	nn	7	SENT_570	[p29l1295t595r1482b635],
3	Genome	NNP	ORGANIZATION	Genome	nn	7	SENT_570	[p29l1514t594r1723b635],
4	Research	NNP	ORGANIZATION	Research	nn	7	SENT_570	[p29l1755t591r1983b638],
5	Institute	NNP	ORGANIZATION	Institute	nn	7	SENT_570	[p29l2015t592r2148b635, p29l1117t670r1212b706],
6	(	NNP	O	(	nn	7	SENT_570	[p29l1265t661r1508b712],
7	Available	NNP	O	Available	_	0	SENT_570	[p29l1265t661r1508b712],
8	at	IN	O	at	_	0	SENT_570	[p29l1558t670r1603b705],
9	http	NN	O	http	prep_at	7	SENT_570	[p29l1650t661r2149b718],
10	:	:	O	:	_	0	SENT_570	[p29l1650t661r2149b718],
11	l/wwW	NN	O	l/www	dep	7	SENT_570	[p29l1650t661r2149b718],
12	.	.	O	.	_	0	SENT_570	[p29l1650t661r2149b718],

1	genome	NN	O	genome	_	0	SENT_571	[p29l1650t661r2149b718],
2	.	.	O	.	_	0	SENT_571	[p29l1119t732r1551b789],

1	govlgwastudies	NNS	O	govlgwastudy	_	0	SENT_572	[p29l1119t732r1551b789],
2	.	.	O	.	_	0	SENT_572	[p29l1119t732r1551b789],
3	)	SYM	O	)	dep	1	SENT_572	[p29l1119t732r1551b789],

1	Copyright	NN	O	copyright	_	0	SENT_573	[p29l1118t811r1298b860],
2	©	CD	NUMBER	©	num	6	SENT_573	[p29l1316t815r1356b855],
3	2011	CD	DATE	2011	num	6	SENT_573	[p29l1375t814r1465b848],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_573	[p29l1487t811r1756b848],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_573	[p29l1774t811r1922b848],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_573	[p29l1937t813r2076b859],
7	.	.	O	.	_	0	SENT_573	[p29l1937t813r2076b859],

1	350	CD	NUMBER	350	num	2	SENT_574	[p29l149t1006r206b1029],
2	NENGLJMED364	NN	O	nengljmed364	_	0	SENT_574	[p29l948t1010r1200b1038],
3	;	:	O	;	_	0	SENT_574	[p29l948t1010r1200b1038],
4	4	CD	NUMBER	4	num	6	SENT_574	[p29l948t1010r1200b1038],
5	NEJM.ORG	NN	O	nejm.org	nn	6	SENT_574	[p29l1235t1016r1359b1038],
6	JANUARY27	NN	O	january27	dep	2	SENT_574	[p29l1390t1016r1546b1038],
7	,	,	O	,	_	0	SENT_574	[p29l1390t1016r1546b1038],
8	2011	CD	DATE	2011	appos	6	SENT_574	[p29l1557t1016r1609b1032],

1	The	DT	O	the	det	4	SENT_575	[p29l936t1049r987b1073],
2	New	NNP	O	New	nn	4	SENT_575	[p29l996t1050r1058b1073],
3	England	NNP	O	England	nn	4	SENT_575	[p29l1067t1049r1178b1080],
4	Journal	NNP	O	Journal	_	0	SENT_575	[p29l1187t1049r1284b1073],
5	of	IN	O	of	_	0	SENT_575	[p29l1294t1049r1323b1073],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_575	[p29l1330t1049r1455b1073],

1	Downloaded	VBN	O	download	_	0	SENT_576	[p29l378t1090r548b1113],
2	from	IN	O	from	_	0	SENT_576	[p29l557t1090r622b1113],
3	nejmorg	NN	O	nejmorg	prep_from	1	SENT_576	[p29l630t1090r749b1120],
4	at	IN	O	at	_	0	SENT_576	[p29l759t1094r782b1113],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_576	[p29l790t1090r973b1113],
6	on	IN	O	on	_	0	SENT_576	[p29l982t1097r1015b1113],
7	January	NNP	DATE	January	prep_on	1	SENT_576	[p29l1023t1090r1126b1120],
8	5	CD	DATE	5	num	7	SENT_576	[p29l1136t1090r1159b1117],
9	,	,	DATE	,	_	0	SENT_576	[p29l1136t1090r1159b1117],
10	2014	CD	DATE	2014	num	7	SENT_576	[p29l1169t1090r1242b1113],
11	.	.	O	.	_	0	SENT_576	[p29l1169t1090r1242b1113],

1	For	IN	O	for	_	0	SENT_577	[p29l1252t1090r1299b1113],
2	personal	JJ	O	personal	amod	3	SENT_577	[p29l1307t1090r1419b1120],
3	use	NN	O	use	pobj	1	SENT_577	[p29l1428t1097r1472b1113],
4	only	RB	O	only	advmod	3	SENT_577	[p29l1481t1090r1546b1120],
5	.	.	O	.	_	0	SENT_577	[p29l1481t1090r1546b1120],

1	No	DT	O	no	det	3	SENT_578	[p29l1557t1090r1596b1113],
2	other	JJ	O	other	amod	3	SENT_578	[p29l1606t1090r1674b1113],
3	uses	NNS	O	use	_	0	SENT_578	[p29l1683t1097r1739b1113],
4	without	IN	O	without	_	0	SENT_578	[p29l1749t1090r1850b1113],
5	permission	NN	O	permission	prep_without	3	SENT_578	[p29l1858t1090r2011b1120],
6	.	.	O	.	_	0	SENT_578	[p29l1858t1090r2011b1120],

